!"#"
$"
%&'()'* +,
-
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`abacdefghfihjklgdedldefghmacngeokahpqrslgect_- . /./X/.1-u;:-;:[6348-6367G?4?Z-6-@=84?4;3-FH?5-9=-F6@=-@H:43[-5I=-<674@654;3-K:;8=??-A63@-@=5647=@-43-5I=-vwx1-6?-5;-WI=5I=: 63-435=:367-;:-=y5=:367-zH63545654;3-5=8I34zH=-W477-9=-:;H543=7G-=FK7;G=@/ - .././X/01-JI=-435=:367-?563@6:@-F=5I;@-;>-zH63545654;3-8633;5-9=-=FK7;G=@-H37=??-677-;>-5I=->;77;W43[-8;3@454;3?-6:=-F=5{ .././X/01-./-JI=-435=:367-?563@6:@-FH?5-9=-6@@=@-K;?5N=y5:6854;3/-u;:-Q=5I;@-|0|/0Z-45-4?-6@@=@-K:=N=y5:6854;3/ .././X/01-0/-JI=-435=:367-?563@6:@-FH?5-9=-6@@=@-zH63545654<=7G/ .././X/01-X/-23G-6367G5=-5I65-4?-6-56:[=5-6367G5=-H?43[-5I=-F=5I;@-;>-435=:=?5-F6G-3;5-9=-?=7=85=@->;:-H?=-6?-5I=-435=:367 ?563@6:@/ - .././X/01-R/-JI=-8;38=35:654;3-;>-5I=-435=:367-?563@6:@A?1-FH?5-3;5-=y8==@-5I=-86749:654;3-:63[=-;>-5I=-F=5I;@-56:[=5-6367G5=?/ B3-86?=?-WI=:=-5I=-56:[=5-6367G5=?-6:=-6??;8465=@-W45I-F;:=-5I63-;3=-86749:654;3-:63[=-A4/=/-6367G5=?-}.NR}-6:=-86749:65=@->:;F .-5;-.S-~[PZ-WI47=-6367G5=-}|}-4?-86749:65=@->:;F-.S-5;-.SS-~[PZ-63@-6367G5=?-}N.S}-6:=-86749:65=@->:;F-0/|-5;-0|-~[P1Z-5I= 8;38=35:654;3-;>-5I=-435=:367-?563@6:@-FH?5-9=-K:=K6:=@-65-6-7=<=7-9=5W==3-5I=-I4[I=?5-86749:654;3-?563@6:@-;>-5I=-I4[I=?5-63@ 7;W=?5-69?;7H5=-86749:654;3-:63[=/-A=/[/-6KK:;y4F65=7G-|S-~[P-43-5I=-=y6FK7=-[4<=31/ - .././X/X1-JI=-H?=-;>-435=:367-?563@6:@-zH63545654;3-4?-;>-[:=65=?5-9=3=>45-43-5I;?=-F=5I;@?-?H9=85-5;-6-[:=65-@=67-;>-43=854;3 <6:4694745GZ-63@-5IH?-6-[:=65-@=67-;>-<6:4694745G-43-5I=-69?;7H5=-F6??-43=85=@-;35;-5I=-8;7HF3A?1-=FK7;G=@/-JI=-@:6W968Y-5; 5I4?-5=8I34zH=->;:-C-F=5I;@?-4?-5I65-63G-8;FK;H3@-5I65-=yI4945?-6-?4F476:-:=5=354;3-54F=-6?-5I=-8;FK;H3@-H?=@->;:-5I= 435=:367-?563@6:@-W477-9=-4@=354>4=@-6?-5I=-435=:367-?563@6:@Z-7=6@43[-5;-=::;3=;H?-zH63545654;3/-u;:-5I4?-:=6?;3Z-5I=-435=:367 ?563@6:@-5=8I34zH=-4?-F;?5-H?=>H7->;:-CQv-WI=:=-@=H5=:65=@-6367G5=?-3;5-365H:677G-;88H::43[-863-9=-@=5=85=@-63@ zH6354>4=@/ - \\]\]_-`abacdefghfihlbe
rldefghadnf-
. /./R/.1-H:43[-5I=-F=5I;@-<674@654;3-K:;8=??Z-6-7=6?5-?zH6:=-:=[:=??4;3-4?-43454677G-5:4=@-6?-6-86749:654;3-F=5I;@/-JI= :=?K;3?=?->:;F-=68I-;>-5I=-86749:654;3-?563@6:@?-FH?5-5I=3-9=-43KH5-435;-5I=-743=6:-:=[:=??4;3-=zH654;3-5;-@=5=:F43=-WI=5I=: ;:-3;5-5I=-8;::=?K;3@43[-8;38=35:654;3?-F==5-5I=-688=K5638=-8:45=:46-43-5I=-F=5I;@/-C6749:654;3-F=5I;@-63@-688=K5638= 8:45=:46-6:=->;77;W=@-6?-677;W=@-9G-F=5I;@-63@-F=5I;@-?K=84>48654;3?/-B>-5I=-688=K5638=-8:45=:46-8633;5-9=-F=5-H?43[-6-743=6: :=[:=??4;3Z-5I=3-6-?=8;3@-;:@=:-K;7G3;F467->45-863-9=-H?=@-5;->45-5I=-@656Z-W45I-:0--S/-6?-5I=-688=K5638=-8:45=:46/-B3-5I= =<=35-5I65-3=45I=:-6-?4FK7=-743=6:-:=[:=??4;3-3;:-6-?=8;3@-;:@=:-K;7G3;F467->45-:=?H75-43-63-=zH654;3-WI48I-F==5?-5I=-86749:654;3 688=K5638=-8:45=:46Z-5I=3-5I=-86749:654;3-:63[=-FH?5-9=-9:;Y=3-@;W3-435;-5W;-;:-F;:=-?F677=:-:63[=?/-O68I-;>-5I=-?H9?=zH=35 :63[=?-FH?5-43@4<4@H677G-F==5-677-;>-5I=-:=zH4:=F=35?->;:-6-?43[7=-86749:654;3-:63[=/-B>-6-743=6:-:=[:=??4;3-W;:Y?Z-6-?43[7= 6<=:6[=-:=?K;3?=->685;:-F6G-9=-H?=@-4>-5I=-86749:654;3-4?-743=6:-5I:;H[I-5I=-;:4[43-63@-45-4?-8;3?4?5=35-W45I-5I=-:=>=:=38=@ F=5I;@/ - .././R/01-2?-K6:5-;>-5I=-<674@654;3-K:;8=??Z-5I=-?K=84>48-86749:654;3-:63[=-63@-86749:654;3-67[;:45IF-FH?5-9=-@=5=:F43=@-63@ @;8HF=35=@-43-5I=-vwx/-w38=-@=5=:F43=@-43-5I4?-F633=:Z-5I=-?6F=-K:;5;8;7?-FH?5-9=->;77;W=@-=68I-54F=-5I=-F=5I;@-4? =FK7;G=@/-JI4?-W477-=3?H:=-5I65-@656-:=@H854;3-4?-3;5-K=:>;:F=@-@4>>=:=357G-;3-?=K6:65=-@656-?=5?-;:-9G-@4>>=:=35-6367G?5?/ - \\]\]_-egekhk
arhfihlbe
rldefghaabt C6749:654;3-:=zH4:=F=35?-63@-K:;8=@H:=?-6:=-43-vwx0|.T/ -
\\]\]_-`abacdefghfihlbe
rldefghaabt-
. /.//.1-JI=-7;W=?5-86749:654;3-?563@6:@-?I677-9=-5I=-7;W=?5-8;38=35:654;3->;:-WI48I-zH63545654<=-@656-6:=-5;-9= :=K;:5=@-W45I;H5-zH674>48654;3/-LJMBNOPND.QRN0S.TNU=<0/0N./T/././[V/ - .././/01-JI=-I4[I=?5-86749:654;3-?563@6:@-?I677-9=-5I=-I4[I=?5-8;38=35:654;3->;:-WI48I-zH63545654<=-@656-6:=-5; 9=-:=K;:5=@-W45I;H5-zH674>48654;3-LJMBNOPND.QRN0S.TNU=<0/0N./T/././IV/ - \\]\]_-lbe
rldefghglbdeclbh`aokagca-
.././T/.1-JI=-86749:654;3-FH?5-K:;[:=??->:;F-5I=-6367G?4?-;>-5I=-7;W=?5-5;-I4[I=?5-?563@6:@-H37=??-5I=-43?5:HF=35654;3-@;=? 3;5-K=:F45-45-;:-5I=-F=5I;@-:=zH4:=?-86749:654;3->:;F-I4[I-5;-7;W/-2-9763Y-FH?5-9=-6367G=@-6>5=:-5I=-I4[I=?5-86749:654;3 ?563@6:@-4>-86::G-;<=:-4?-?H?K=85=@/-UH3343[-5I=-9763Y-6>5=:-5I=-I4[I=?5-867-?5@-4?-3;5-67W6G?->;77;W=@-43-677-F=5I;@?-H37=??-45 I6?-9==3-K:=<4;H?7G-@=5=:F43=@-5I65-5I=:=-4?-K;5=35467-86::G-;<=:/- - .././T/01-B>-5I=-6367G?4?-:=zH4:=?-63-4345467-I4[I-?563@6:@-5;-?=5-5I=-[643-6-9763Y-FH?5-9=-:H3-9=>;:=-?56:543[-W45I-5I=-7;W 86749:654;3-?563@6:@-H37=??-5I=-43?5:HF=35654;3-@;=?-3;5-K=:F45-45/ - \\]\]_-lbe
rldefghccadlgcahredarel UNCONTROLLED 94 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +,
-./012345/0627890230:434/51907;40<51<=1574>0?51=406./08753>5/>80@=823:07;40<512A/572.30<=/?40./0/48B.384065<7./C0D=870A40E27;23 FGH0.607;403.D23510?51=406./0D2>I14?4108753>5/>8J0K.E4?4/907;40?51=40>474/D234>0AL07;40<512A/572.30<=/?406./07;401.E487 8753>5/>0@<.3<J02805707;40MNOC0D=870A40E27;230P0QGH0.607;407/=40?51=40./0P0RQH0.607;407/=40?51=402607;401.E48708753>5/>028 SQT0U0VFGT0MNOJ0W<<=/5740X=53727572.305707;40MNO014?410D5L0/4X=2/40=840.605084<.3>0./>4/06270./084B5/572.30.607;40<=/?40237. D=172B14012345/084:D4378J0M2>014?4108753>5/>80@<.3<J0S0FGT0MNOC0D=870A40E27;230P0FGH0.607;407/=40?51=4J0N414?5370YZ[80D=87 A40/4?24E4>06./07;40D47;.>053>015A./57./L0<512A/572.30?4/262<572.308B4<262<0</274/2590E;2<;0D5L0A40>2664/43706/.D07;.84087574> ;4/4J 0 \\]^_0`abcdbedbfgdbhciejkbcg`lmdnilcdab0 FFJRJFC0o.3723=23:0<512A/572.30@ooC0280/=30580/4X=2/4>0AL07;40D47;.>J0N464/07.08B4<262<0YZ[807.0>474/D23407;406/4X=43<L053> 5<<4B753<40</274/250.60<.3723=23:0<512A/572.30?4/262<572.38J 0 FFJRJRC0p;40<.3723=23:0<512A/572.308753>5/>0D=870A40345/07;40D2>IB.2370.607;40<512A/572.30<=/?40=3148807;40D47;.>0/4X=2/48 /.7572.30.60<.3<437/572.3014?418J 0 FFJRJqC0p;40<51<=1574>0?51=406./07;40<.3723=23:0<512A/572.308753>5/>0D=870A40E27;230<.37/.1012D278087574>02307;408B4<262<0YZ[J FFJRJrC0o512A/572.308;5110A40?4/2624>06./045<;0A57<;06./045<;0<.DB.=3>90414D43790./0.7;4/0>28</4740<;4D2<5108B4<248904s<4B706./ D=172I<.DB.343705351L74808=<;0580W/.<1./890o;1./>53490./0p.s5B;4340E;4/4050/4B/48437572?40<;4D2<510/41574>08=A8753<40./ D2s7=/40<530A40=84>J0 0 FFJRJQC0t387/=D4370<512A/572.30?4/262<572.30D=870A40B4/6./D4>u FFJRJQJFC0W707;40A4:23323:053>043>0.6045<;05351L72<510A57<;0@4s<4B7902605302374/35108753>5/>0280=84>v0.31L0.340?4/262<572.30344>8 7.0A40B4/6./D4>05707;40A4:23323:0.607;405351L72<510A57<;CJ0W80B4/0Y753>5/>0M47;.>8084<72.380FGRG053>0qGRG90/=30oow804?4/L FG085DB148J 0 FFJRJQJRC0x;434?4/02702804sB4<74>07;5707;405351L72<5108L874D0D5L0A40.=70.60<512A/572.30./0D2:;703.70D44707;40?4/262<572.3 5<<4B753<40</274/25J 0 FFJRJQJqC0t607;4072D40B4/2.>06./0<512A/572.30.607;40D.870B/4?2.=80<512A/572.30;5804sB2/4>90./ FFJRJQJrC0-./05351L72<5108L874D807;570<.37523050<512A/572.30?4/262<572.30/4X=2/4D437J FFJRJyC0t607;40D47;.>0>.4803.708B4<26L0</274/2506./07;405<<4B753<40.6050<.3723=23:02387/=D4370<512A/572.390?4/262<572.30D=870A4 4875A128;4>904J:J90/41572?40B4/<4370>2664/43<4J 0 FFJRJzC0t607;40<.3723=23:02387/=D4370<512A/572.30?4/262<572.30/48=1780.A75234>05/40.=782>404875A128;4>05<<4B753<40</274/259 <.//4<72?405<72.380D=870A40B4/6./D4>J 0 \\]{_0ebl``k|clnmkg`abcdbedbfgdbhciejkbcg`lmdnilcdabg}kid~d`lcdabh0 FFJqJFC0t60/.=72340<.//4<72?405<72.30B/.<4>=/480652107.0B/.>=<405084<.3>0<.384<=72?40@2DD4>2574C0<512A/572.30?4/262<572.30E27;23 5<<4B753<40</274/25907;430427;4/07;4015A./57./L0;5807.0>4D.387/57405<<4B75A140B4/6./D53<405674/0<.//4<72?405<72.30E27;07E. <.384<=72?40<512A/572.30?4/262<572.3890./05034E0232725102387/=D4370<512A/572.30D=870A40B4/6./D4>J 0 FFJqJRC0t607;4015A./57./L0;5803.70?4/2624>0<512A/572.39085DB1405351L8480D5L03.70.<<=/0=372107;405351L72<5108L874D0280<512A/574>0./ <512A/572.30?4/2624>J0t6085DB14805/405351L4>0=823:0508L874D0.30E;2<;07;40<512A/572.30;5803.70L470A4430?4/2624>07;40/48=17808;511 A40615::4>J 0 FFJqJqC00t607;4840</274/2505/403.70D47905084<.3>0<.3723=23:0<512A/572.308753>5/>0D=870A40/=30@427;4/06/48;1L0B/4B5/4>0./05 84<.3>0234<72.3905805BB/.B/2574CJ0.023>2?2>=5105351L740<530652107;40oo0</274/2507E.0<.384<=72?4072D48J0t607;40</274/2505/408721103.7 D47905034E023272510<512A/572.30D=870A40/=3053>07;4034E0<512A/572.30<=/?40?4/2624>J0p;4015A./57./L0X=512624807;40>5750E27;0w0615: 2607;4085DB140>5750280588.<2574>0E27;065214>0<512A/572.30?4/262<572.3J0 0 FFJqJrC0W80B4/0ptIOIwFMrIRGFzIN4?RJRIFJzJqJRJ590>5750588.<2574>0E27;0530=35<<4B75A140<512A/572.30?4/262<572.30D5L0A406=11L =845A140=3>4/07;406.11.E23:08B4<2510<.3>272.38u 0 FFJqJrJFC0x;4307;405<<4B753<40</274/2506./07;40B.8272?40<.37/.105/404s<44>4>0;2:;0@2J4J90;2:;0A258C053>07;4/405/40588.<2574> 85DB14807;5705/403.3I>474<78907;4307;.8403.3I>474<780D5L0A40/4B./74>0E27;0>5750X=5126L23:0<.>48904s<4B70E;4303.70511.E4>0AL D47;.>0./0/4:=1572.380./08B4<2510B/.4<78J 0 FFJqJrJRC0 x;4307;405<<4B753<40</274/2506./07;40B.8272?40<.37/.105/404s<44>4>[email protected];.84085DB140/48=1780D5L0A40/4B./74>026 7;4L04s<44>050D5s2D=D0/4:=157./L012D27 >4<282.3014?410E27;0>5750X=5126L23:0<.>48J 0
UNCONTROLLED 95 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +
,-./012345067/
,-8,./969:;73<9:=012345067/ >?@>@>A/BCC/DEFGHIDJK/GL/HMNHDMCO/IPGJKPGJDQR/GJLHDSKDQR/PJQ/SCDPJDQ@/ / >?@>@?A/TB/UV/WWX>@?/SNJKPGJL/P/CGLK/NY/KZD/IP[NM/PJPCOKGSPC/DEFGHIDJK/FLDQ/QFMGJ\/LPIHCD/HMDHPMPKGNJ/PJQ/PJPCOLGL@/UNM ]GSMN^GNCN\OR/HMDLLFMD/SNN_DML/PMD/JNK/FLDQ/YNM/LKDMGCG`PKGNJ/NY/\MNaKZ/IDQGP/bcdefghfi>]jf?W>kflDm?@Wf>@n@X@n@^@GG@P@>o@ / ,-8-./p244qr7=012345067/ ,-8-8,./stutvwxy zDD/dNJ]DKZNQfzV{?j>W/|PCPJSD/]PGJKDJPJSD@ / ,-8-8-./7x}~xtx=5vv zDD/dNJ]DKZNQfzV{?j>j/cDIHDMPKFMD/]NJGKNMGJ\/PJQ/cZDMINIDKDM/ PCG^MPKGNJ@/ /
,-8-8./4~xy zDD/
#
"
$""""
# !
%
$% /
,-8-8./5wu=u}xw=0~}xv=7630:,5-,rx-8,88888 iNCFIDKMGS/gEFGHIDJK/LZPCC/^D/SPCG^MPKDQ/PL/YNCCNaL / >?@?@@>A/gEFGHIDJK/aGKZ/INmP^CD/HPMKL/LFSZ/PL/PFKNIPKGS/QGLHDJLDMLR/QGLHDJLDMLQGCFKDMLR/PJQ/IDSZPJGSPC/ZPJQ/HGHDKKDL/LZPCC ^D/mDMGYGDQ/YNM/PSSFMPSO/EFPMKDMCO@ / >?@?@@?A/gEFGHIDJK/LFSZ/PL/YGCKDM/YFJJDCLR/^NKKCDLR/JNJfSCPLL/B/\CPLLaPMD/PJQ/NKZDM/IPM_DQ/SNJKPGJDML/LZPCC/^D/mDMGYGDQ/NJSD HDM/CNK/HMGNM/KN/YGMLK/FLD@ / >?@?@@XA/cZD/mNCFID/NY/KZD/QGLHNLP^CD/mNCFIDKMGS/DEFGHIDJK/LFSZ/PL/LPIHCD/^NKKCDLR/QGLHNLP^CD/HGHDKKDLR/PJQ/IGSMNHGHDKKD KGHL/LZPCC/^D/SZDS_DQ/NJSD/HDM/CNK@ / >?@?@@A/iDMGYGSPKGNJ/NY/mNCFID/LZPCC/^D/SNJLGQDMDQ/PSSDHKP^CD/GY/KZD/PSSFMPSO/GL/aGKZGJ/?@j/NY/D HDSKDQ/mNCFID@/cZGL mDMGYGSPKGNJ/SPJ/^D/mNCFIDKMGS/PL/SNIHPMDQ/KN/ CPLL/B/NM/\MPmGIDKMGS@/¡CPLL/IGSMNCGKDM/LOMGJ\DL/PJQ/
CPLL/B/\CPLLaPMD/PMD D DIHK/YMNI/PJO/mDMGYGSPKGNJ/MDEFGMDIDJKL/^DONJQ/GJLHDSKGNJ/PJQ/mDMGYGDQ/PL/SNIHCOGJ\/aGKZ/LHDSGYGSPKGNJL/NM/MDEFGMDIDJKL QDYGJDQ/GJ/KZD/IDKZNQL/YNM/KZD/KDLKL@/lDSNMQL/NY/PSKGNJL/KP_DJ/KN/SZDS_/SNIHCGPJSD/GL/IPGJKPGJDQ/bcdefghfi>]?f?W>kflDm?@>f j@j@>X@>@D@G/¢/@k@?o@ / >?@?@@jA/]DSZPJGSPC/QDmGSDL/LZPCC/^D/mDMGYGDQ/HMGNM/KN/YGMLK/FLD/PJQ/NJ/P/EFPMKDMCO/^PLGL@/]DSZPJGSPC/QDmGSDL/FLDQ/PK/INMD/KZPJ NJD/mNCFID/LZPCC/^D/mDMGYGDQ/PK/mNCFIDL/^MPS_DKGJ\/KZD/MPJ\D/NY/FLD/£ZG\ZDLK/PJQ/CNaDLK/mNCFID/FLDQAR/PJQ/PK/KZD/IGQfHNGJK/NY KZD/mNCFIDL/FLDQ/^O/KZD/QDmGSD/bcdefghfi>]?f?W>kflDm?@>fj@j@>X@>@D@GGGo@ / ,-8-8./¤utyy¥tx lDYDM/SFMMDJK/dNJ]DKZNQfzV{?j>/YNM/\CPLLaPMD/SCDPJGJ\@/BCC/SCPLL/mNCFIDKMGS/\CPLLaPMD/GL/QMGDQ/PK/MNNI/KDIHDMPKFMD/MPKZDM KZPJ/NmDJ/^P_DQ@ / cZD/aPLZGJ\/PJQ/LKDMGCG`PKGNJ/HMNSDQFMDL/YNM/CP^NMPKNMO/\CPLLaPMD/PMD/KDLKDQ/PJJFPCCO/^O/KDLKGJ\/\CPLLaPMD/YNM/GJZG^GKNMO MDLGQFDL/PL/LZNaJ/GJ/zKPJQPMQ/]DKZNQL@/ / ,-8-8./¦tx=1tu=§ux cZD/HFMD/aPKDM/LOLKDI/YNM/ggBf]/aPL/PLLDI^CDQ/^O/¨z/UGCKDM/GJ/©PJFPMO/?WWX@/eK/SNJLGLKL/NY/IG DQ/^DQ/QDGNJG`DMLR/FCKMPmGNCDK QGLGJYDSKGNJR/YGCKMPKGNJR/PJQ/PJ/NM\PJGS/LSPmDJ\DM/LGQD/LKMDPI/MDKFMJ/CNNH@/cZD/LOLKDI/GL/SNJJDSKDQ/KN/P/SNJQFSKGmGKO/IDKDM aZGSZ/LG\JPCL/aZDJ/KZD/IG DQ/^DQ/MDLGJ/QDIGJDMPCG`DML/JDDQ/KN/^D/SZPJ\DQ@ / cZD/EFPCGKO/NY/CP^NMPKNMO/HFMD/aPKDM/GL/PJPCO`DQ/INJKZCO/YNM/SNJQFSKGmGKOR/HªR/SZCNMGJD/MDLGQFPCR/cV R/PJQ/LKPJQPMQ/HCPKD/SNFJK PJQ/PJJFPCCO/YNM/aPKDM/LFGKP^GCGKO/MPKGNR/GJZG^GKNMO/MDLGQFD/£PJJFPCCOR/DPSZ/KGID/JDa/CNK/NY/QDKDM\DJK/PJQ/YNM/JDa/aPLZGJ\ HMNSDQFMDLAR/PJQ/KMPSD/IDKPCL/£{^R/ QR/
MR/
FR/dGR/PJQ/«JA@/cP^CD/>?fX/CGLKL/KZD/PSSDHKPJSD/SMGKDMGP/YNM/KZDLD/PJPCOKDL@/cZGL/QPKP GL/MDSNMQDQ/PJQ/LF^IGKKDQ/KN/KZD/TB/QDHPMKIDJK@/cZDLD/MDHNMKL/PMD/aGKZ/KZD/TB/¬DHPMKIDJK/YNM/MDmGDa/PJQ/IPGJKPGJDQ/YNM/KDJ ODPML@/ / ,-8-8./q==pxwx BCC/IP[NM/GJLKMFIDJKL/GY/NYY/CGJD/aGCC/^D/CP^DCDQ/®NFK/NY/LDMmGSD¯/FJKGC/MDHPGM@ / ,-8./4r006730=593670696<0/ ,-88,./rvx=5tvxvtvwx=9wxy ggBf]/SPMMGDL/IPGJKDJPJSD/SNJKMPSKL/NJ/PCC/IP[NM/CP^NMPKNMO/DEFGHIDJKR/FJQDM/aZGSZ/IFSZ/NY/KZD/HMDmDJKPKGmD/IPGJKDJPJSD/GL HDMYNMIDQ@/lNFKGJD/LDMmGSGJ\R/LFSZ/PL/SCDPJGJ\/NY/MNQLR/LNFMSDR/NM/QDKDSKNMLR/GL/HDMYNMIDQ/NJ/P/MD\FCPM/^PLGL/^O/KZD/PJPCOLK@ cZGL/KOHD/NY/LDMmGSD/GL/HDMYNMIDQ/PSSNMQGJ\/KN/KZD/HMNSDQFMDL/PJQ/PK/KZD/YMDEFDJSO/LHDSGYGDQ/^O/KZD/IPJFYPSKFMDM@/lNFKGJD IPGJKDJPJSD/GL/QNJD/aZDJ/GJLKMFIDJK/HDMYNMIPJSD/LKPMKL/KN/QD\MPQD/PL/QDINJLKMPKDQ/^O/P/YPGCFMD/KN/IDDK/NJD/NM/INMD/T SMGKDMGPR/QDSMDPLDQ/GNJ/LDJLGKGmGKOR/QD\MPQGJ\/HDP_/MDLNCFKGNJR/CNaDMDQ/MDLHNJLD/YPSKNMLR/NM/LZGYKL/GJ/SPCG^MPKGNJ/SFMmDL@/BSKGmGKGDL KZPK/PMD/HDMYNMIDQ/NJ/P/MNFKGJD/^PLGL/SPJ/^D/YNFJQ/GJ/KZD/eJLKMFIDJK/]PGJKDJPJSD/zV{@ UNCONTROLLED 96 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +
,
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`O,aD=AMDF?A@C@b>,=DBCW,?RQC,ELC=?EMEFD?EH=,D=L,>C@EDG,=ABJC@,H@,H?UC@,A=E_AC,ELC=?EMEFD?EH= cO,dD?C,@CFCETCL,D=L,LD?C,QGDFCL,E=,>C@TEFC eO,fA@@C=?,GHFD?EH=W,[UC@C,DQQ@HQ@ED?C gO,fH=LE?EH=,[UC=,@CFCETCL,hCOIO,=C[W,A>CLW,@CFH=LE?EH=CLi jO,fHQR,HM,BD=AMDF?A@C@b>,E=>?@AF?EH=>,[UC@C,DTDEGDJGC kO,dD?C>,D=L,@C>AG?>,HM,FDGEJ@D?EH=>,D=LlH@,TC@EMEFD?EH=>,D=L,LD?C,HM,?UC,=CY?,FDGEJ@D?EH=,D=LlH@,TC@EMEFD?EH= mO,dC?DEG>,HM,BDE=?C=D=FC,QGD=,FD@@ECL,HA?,?H,LD?C,D=L,QGD==CL,MH@,?UC,MA?A@C nO,oE>?H@R,HM,D=R,LDBDICW,BDGMA=F?EH=W,BHLEMEFD?EH=,H@,@CQDE@ ]pO,qCFH@L>,HM,>C@TEFC,FDGG> ]]O,fDGEJ@D?EH=,>?D?A>,MH@,E=>?@ABC=?,?UD?,D@C,FDGEJ@D?CL,HA?>ELC,?UC,LE@CF?,FH=?@HG,HM,?UC,GDJH@D?H@R,D@C,FUCFKCL,JCMH@C,A>C hDM?C@,D=,E=>?@ABC=?,E>,@C?A@=CL,M@HB,HA?>ELC,@CQDE@i,rV^<SXsSt]a`S`p]jSqCT`O]SgOgOnur<vwl<Xf,]kp`g\`p]khXiSjOeO`uO , -./0/01,x389;8y784z{|}:8~,
]`OcOcO]i,P=,CMMH@?,E>,BDLC,?H,UDTC,D,MA=F?EH=DGGR,C_AETDGC=?,JDFKAQ,E=>?@ABC=?,DTDEGDJGC,E=,FD>C,HM,D,FD?D>?@HQUEF,E=>?@ABC=? MDEGA@CO,aDE=?C=D=FC,FH=?@DF?>,D@C,FD@@ECL,H=,?UC,BDNH@,E=>?@ABC=?>,D=L,IC=C@DGGR,Q@HTELC,MH@,`eSem,UHA@,@C>QH=>C,MH@,@CQDE@>O <M,=CFC>>D@RW,XXPSa,UD>,D,GE>?,HM,_ADGEMECL,GDJH@D?H@EC>,?H,>AJFH=?@DF?,[H@K,?HW,AQH=,FGEC=?,DQQ@HTDGO , ]`OcOcO`i,<=,?UC,CTC=?,D,UHGLE=I,?EBC,CYQE@C>,[UEGC,?UC,>DBQGC,E>,E=,?UC,FA>?HLR,HM,XXPSaW,D=,@HNCF?,aD=DIC@,[EGG,FDGG,?UC FGEC=?,?H,E=MH@B,?UCB,HM,?UE>,>E?AD?EH=O,D>CL,H=,>AJ>C_AC=?,D@@D=ICBC=?>,BDLC,JC?[CC=,?UC,GDJ,D=L,?UC,FGEC=?W,MCC>,MH@,@CS >DBQGE=I,D=L,>AJ>C_AC=?,D=DGR>E>,BDR,JC,E=FA@@CL,JR,?UC,GDJO , ]`OcOcO`i,vCC,qSovSvw`gepp,MH@,?UC,A>E=C>>,fH=?E=AE?R,GD=O , -01,2x
{
x
{{x2,
-0/-1,
x{2x
P,F@E?EFDG,LEBC=>EH=,HM,D=R,_ADGE?R,D>>A@D=FC,Q@HI@DB,E>,?UC,DJEGE?R,?H,LHFABC=?,[UD?,E>,HFFA@@E=I,E=,?UC,GDJH@D?H@RO PFFH@LE=IGRW,XXPSa,A>C>,D,=ABJC@,HM,MH@B>,?H,LHFABC=?,TD@EHA>,D>QCF?>,HM,GDJH@D?H@R,Q@HFCLA@C>O,P,LE>FA>>EH=,HM,?UC>C,MH@B> MHGGH[>O , -0/-/-1,8:}z9;4:}{2:9:{:8{5:};9z{x3893}{36~ @E=?CL,MH@B>,D@C,A>CL,JR,D=DGR>?>,?H,>?D=LD@LEZC,?UC,MH@BD?,HM,@HA?E=C,D=DGR>C>O,H@,D=DGR>C>,[UC@C,MH@B>,D@C,=H?,DTDEGDJGCW ?UC,D=DGR>?,@CFH@L>,DGG,@C_AE@CL,E=MH@BD?EH=,E=,D,=H?CJHHKO,VUC,MH@B>,D@C,LC>EI=CL,?H,BE=EBEZC,FDGFAGD?EH=,C@@H@>,D=L,Q@HTELC,D >ABBD@R,HM,DGG,_ADGE?R,FH=?@HG,LD?D,IC=C@D?CL,MH@,?UC,@A=O,PGG,=C[,[H@K>UCC?,FDGFAGD?EH=>,D@C,BD=ADGGR,TDGELD?CLW,D=L,?UC TDGELD?EH=>,D@C,LHFABC=?CLO,PM?C@,FHBQGC?EH=,HM,?UC,TDGELD?EH=>W,DGG,[H@K,>UCC?>,D@C,GHFKCL,?H,Q@CTC=?,D=R,FUD=IC,E= FDGFAGD?EH=>O , P=DGR>?>,D@C,@C>QH=>EJGC,MH@,BDE=?DE=E=I,?UC>C,MH@B>O,VUC,P,I@HAQ,>QH?,FUCFK>,?UC>C,MH@B>,QC@EHLEFDGGRO,VUC>C,MH@B>,D@C DF?ETCGR,BDE=?DE=CL,E=,UD@LFHQR,A=?EG,>FD==CLW,?UC=,>?H@CL,CGCF?@H=EFDGGRO , -0/-/.1,x36:93y:6~{:8{2:9:{|347~~;8y fU@HBD?HI@DB>,D=L,>?@EQ,FUD@?,@CFH@LE=I>,D@C,D>>EI=CL,A=E_AC,DGQUDS=ABC@EF,FHLC>,D=L,JDFKCLSAQ,H=,?UC,>C@TC@,H@,D= CY?C@=DG,UD@L,L@ETCO,<=MH@BD?EH=,FH=?DE=CL,[E?UE=,?UC,FHLC,E=FGALC>,?C>?W,LD?C,D=L,=ABC@EFDG,>C_AC=FCO , fHBQA?C@,@CFH@L>,D@C,>?H@CL,JR,E=?C@=DG,>DBQGC,<d,D=L,?C>?,D=L,?UC@CMH@C,FD=,JC,_AC@ECL,H=,?UE>,E=MH@BD?EH=O vFD==CL,UD@LFHQR,HA?QA?>,HM,FU@HBD?HI@DB>,D=L,LD?D,Q@HFC>>E=I,D@C,MEGCL,[E?U,?UC,D=DGR?EFDG,LD?D,MH@B>O,fU@HBD?HI@DB>,D=L GEJ@D@R,>CD@FUC>,D@C,>?H@CL,H=,HQ?EFDG,L@ETC>,hfdldtdi,D=LlH@,>HGEL,>?D?C,od>W,D=L,?UC,E=MH@BD?EH=,E>,@C?@ECTDJGC,AQH=,FGEC=? @C_AC>?O, , -0/-/01,{87893z{x3893}{3y~ qCFH@L>,D@C,BDE=?DE=CL,H=,?UC,QA@FUD>C,HM,GDJH@D?H@R,>AQQGEC>,LC?DEGE=I,?UC,TC=LH@W,QA@FUD>C,H@LC@,=ABJC@W,LD?C,HM,H@LC@W,D=L LD?C,HM,@CFCEQ?O,H??GC>,HM,@CDIC=?>,D@C,LD?CL,AQH=,@CFCETCL,>H,?UD?,?UC,>UCGM,GEMC,FD=,JC,BH=E?H@CLO , -0/-/1,934{9:8:{3y~ P,GHIJHHK,E>,BDE=?DE=CL,MH@,Q@CQD@D?EH=,HM,D=DGR?EFDG,>?HFK,>?D=LD@L>,MH@,CDFU,I@HAQO,XDFU,GHI,FH=?DE=>,?UC,LD?C,HM,M@C>U,>?HFK Q@CQD@D?EH=W,?UC,GH?,=ABJC@,D=L,>AQQGEC@W,?UC,Q@CQD@C@>,E=E?EDG>W,D=L,?UC,[CEIU?>,A>CL,?H,Q@CQD@C,?UC,>?HFKO , -0/-/1,:497;3}3y;4:}{39{7;:{3y UNCONTROLLED 97 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +
,-./012324-50.60/2708431.94.:.;43<:082=4<>05?20=<52012324@2=04A0/.52=0B-./05?203./5<4/21C0D2=4<0AB--:42A0<120=<52=0/.50./:E B-./012324-509B50<:A.07?2/04/454<::E0.-2/2=C0F0714552/0123.1=0.60GB<:45E03./51.:0./082=4<>08<5214<:A>0</=02GB4-82/504A0:.;;2= 4/5.05?20D431.0HI09..JC0K?20123.1=04/3:B=2A05?2012AB:5A0.605?203?23J>05?204/454<:A0.605?204/=4@4=B<:0-216.184/;05?203?23J>0</=05?2 =<52C0D2=4<0-12-<12=04/05?20:<904A0:.;;2=04/5.05?20L12-<12=0D2=4<0M.;09E05?20</<:EA5C0K?2A20123.1=A04/3:B=2082=4<0:.50/B8921> =<520.60-12-<1<54./>08</B6<35B1210</=0:.50/B8921>05E-20</=0<8.B/50.6082=4<0-12-<12=>0A5214:4N<54./054820</=0528-21<5B12> 64/<:0-O>05?20</<:EA5PA04/454<:A>0</=02Q-41<54./0=<52C 0 RSTRTUV0WXYZ[\]^XZ_`aXbZa[bXc_dXe_`dbXZ^XdXf^_gacY0
hiChCjChk0l?2/04/0BA2>05?20.-21<54/;0528-21<5B12A0.604/3B9<5.1A>07<52109<5?A>0?.50<410.@2/A>0</=012614;21<5.1A0<1203?23J2= =<4:E0</=0123.1=2=C0F=mBA582/5A0.10A21@43203<::A0<1208<=207?2/012GB412=C0FB5.3:<@20A5214:45E03?23JA>0BA4/;0<8-B:2A0.609<35214<: A-.12A>0<1208<=20<50:2<A508./5?:E>0.107?2/2@210<0-1.9:2804A0ABA-2352=09B50<::04528A0<120<B5.3:<@2=0745?0A5214:45E04/=43<5.1 5<-2C0n23.1=A0.605?208<4/52/</320<1208<4/5<4/2=04/02GB4-82/50:.;AC 0 hiChCjCok0F0A2-<1<5208<4/52/</320:.;9..J04A08<4/5<4/2=06.102<3?0</<:E543<:04/A51B82/5C0K?2A20:.;A03./5<4/0<0123.1=0.601.B54/2 8<4/52/</320<A072::0<A0</E012-<4107.1J012GB412=0=B14/;04/A51B82/50A25pB-C 0 RSTRTqV0ra[[^fZbs^_tfZbaX K?202uvnF06.18012GB412A0=.3B82/5<54./0./05?20=252184/<54./0.605?20.B5p.6p3./51.:02@2/50.10@<14</32>05?20=4<;/.A543A -216.182=05.0914/;05?202@2/509<3J0B/=2103./51.:>0</=05?208<//2104/07?43?012p2A5<9:4A?82/50.603./51.:07<A0=28./A51<52=C0K?2 </<:EA50</[email protected]:252A05?20IFn0./02uvnF0</=0AB9845A04505.05?20HF0=2-<1582/506.1012@427C0K?2/0HF0=4A5149B52A05?2 3.112354@20<354./05.05?20<--1.-14<520L1.m2350D</<;210A.05?<505?203:42/508<E09203./5<352=0460/232AA<1EC000 0 RSTwV0rxyz{xg_x|_{}rx{~ 4;B12A0hiph0</=0hipo0<1202Q<8-:2A0.607.1JA?225A0</=0/.529..JA0BA2=04/0=<5<012=B354./C 0 RSTwTRV0^X^[d_{^fa[eY_0
hiCoChChk0K?20:<9.1<5.1EA0=.3B82/503./51.:0-1.32=B1204/3:B=2A04=2/54643<54./>03.::2354./>04/=2Q4/;>0<332AA>064:4/;>0A5.1<;2> 8<4/52/</320</=0=4A-.A<:0.60GB<:45E0</=0523?/43<:0123.1=AC0HB<:45E0123.1=A04/3:B=2012-.15A061.804/521/<:0<B=45A0</= 8</<;282/5012@427A0<A072::0<A0123.1=A0.603.112354@20</=0-12@2/54@20<354./AC0n23.1=A0<1204/05?206.180.60?<1=03.-E0.102:2351./43 82=4<C 0 hiCoChCok0F::0123.1=A0<12012GB412=05.0920:2;49:20</=0<120A5.12=0</=0125<4/2=04/0AB3?0<07<E05?<505?2E0<12012<=4:E0125142@<9:204/ 6<34:4542A05?<50-1.@4=20<0AB45<9:202/@41./82/505.0-12@2/50=<8<;20.10=25214.1<54./0</=05.0-12@2/50:.AAC0n23.1=A0<120125<4/2= 6.10h0E2<1A0?2:=0A23B120</=04/03./64=2/320<A0-210K vpMphDopohjpn2@oChpChiChCi0</=0ChiCiC90vvI hoohkpCCoC0h0E2<1A0<12012GB412=06.10D<AA<3?BA255A>0O<7<44>0</=0 270.1J0A<8-:2AC0:2351./430123.1=A0<12 125<4/2=06.100h0E2<1A>0.14;4/<:0?<1=3.-42A0125<4/2=06.100E2<1A>0</=0.14;4/<:0?<1=3.-42A0.60IIA0125<4/2=06.10h0E2<1AC00n23.1= 1252/54./04A0:./;210<A012GB412=09E0:<702C;C0M2<=0</=0I.--210nB:20=<5<0ho0E2<1A>0FA92A5.A0i0E2<1AkC 0 hiCoChCik0FpD02/AB12A05?<50<82/=82/5A05.0523?/43<:0123.1=A03</092051<[email protected]@21A4./A0.105.0.14;4/<:0.9A21@<54./AC .5?05?20.14;4/<:0</=0<82/=2=0=<5<0</=064:2A0A?<::0920125<4/2=>04/3:B=4/;05?20=<520.60<:521<54./>0</04/=43<54./0.605?20<:5212= <A-235A0</=05?20-21A.//2:012A-./A49:206.105?20<:521<54./A0vvI0hoohkpCCoC 0 K?20:<9.1<5.1E0?<A048-:282/52=0-1.32=B12A05.0-1.52350</=09<3JpB-0123.1=A0A5.12=02:2351./43<::E0</=05.0-12@2/50B/<B5?.14N2= <332AA05.0.10<82/=82/50.605?2A20123.1=A09E0A2554/;0B-0:2@2:0.60A23B145E0</=.10=2A4;/<54/;0<--1.-14<520-21A.//2:012A-./A49:2 6.105?20A23B145E0.605?20123.1=AC 0 hiCoChCk0K?206.::.74/;04/6.18<54./04A0=.3B82/52=0<A0-210K vpMphDopohjpn2@oChpChiCiC hC0K?20123.1=A04/3:B=205?204=2/545E0.60-21A.//2:04/@.:@2=04/0A<8-:4/;>0A<8-:2012324-5>0-12-<1<54./>03<:491<54./>0.1052A54/;C oC0F::04/6.18<54./0/232AA<1E06.105?20?4A5.143<:0123./A51B354./0.60=<5<012:<54/;05.05?20:<9.1<5.1E06<34:4542A02GB4-82/5>0</<:E543<: 52A50825?.=A>0</=012:<52=0:<9.1<5.1E0<354@4542A>0AB3?0<A0A<8-:2012324-5>0A<8-:20-12-<1<54./>0.10=<5<0@214643<54./0<12 =.3B82/52=C iC0K?20123.1=0J22-4/;0AEA52806<34:45<52A05?20125142@<:0.60<::07.1J4/;064:2A0</=0<13?4@2=0123.1=A06.104/A-2354./0</=0@214643<54./ -B1-.A2A09E0A2554/;06.18<506.10/<84/;02:2351./43064:2AC C0F::03?</;2A05.0123.1=A0<120A4;/2=0.104/454<:2=09E012A-./A49:20A5<66C0K?2012<A./06.105?20A4;/<5B120.104/454<:A04A03:2<1:E 4/=43<52=04/05?20123.1=A0AB3?0<A0A<8-:2=09E>0-12-<12=09E>0.1012@4272=09EC C0F::0;2/21<52=0=<5<02Q32-505?.A205?<50<120;2/21<52=09E0<B5.8<52=0=<5<03.::2354./0AEA528A>0<120123.1=2=0=41235:E>0-1.8-5:E </=0:2;49:E04/0-218</2/504/J0K vpMphDopohjpn2@oChpChiCiC;C jC0/5142A04/0123.1=A0<120/.50.9:4521<52=09E0825?.=A0AB3?0<A021<AB12A>0.@21714552/064:2A0.108<1J4/;AC0F::03.112354./A05.0123.1= J22-4/;0211.1A0<1208<=209E0./20:4/208<1J2=05?1.B;?05?20211.1C0K?204/=4@4=B<:08<J4/;05?203.112354./0A4;/A0.104/454<:Ak0</= =<5205?203.112354./C0l?2/03.112354./A0<120=B205.012<A./A0.5?2105?</051</A314-54./0211.1A>05?2012<A./06.105?203.112354./ A?<::0920=.3B82/52=0K vpMphDopohjpn2@oChpChiCiC;C44C0K?2A203145214<0<:A.0<--:E05.02:2351./43<::E08<4/5<4/2= 123.1=A0K vpMphDopohjpn2@oChpChiCoCi>0ChiCiC;C40vvI0hoohkpCCoC0K?20:<9.1<5.1E0J22-A 3.112A-./=2/32012:<54/;05.0:<90<[email protected].3B82/5<54./04/3:B=2A028<4:03.112A-./=2/320925722/05?2 L1.m2350D</<;210</=03:42/5C 0 RSTwTwV0z^fXbfd_{^fa[eY0
hiCoCoChk0K?20:<9.1<5.1E0125<4/A0523?/43<:0123.1=A0.60.14;4/<:0.9A21@<54./A>0=214@2=0=<5<0</=0AB664342/504/6.18<54./05.02A5<9:4A? </0<B=45051<4:>03<:491<54./0123.1=A>0A5<660123.1=A0</=0<03.-E0.602<3?052A5012-.1504AAB2=>06.10<0=264/2=0-214.=C0K?20123.1=06.102<3? 2/@41./82/5<:052A50.103<:491<54./03./5<4/A0AB664342/504/6.18<54./05.06<34:45<520</=05.02/<9:205?202/@41./82/5<:052A505.092 UNCONTROLLED 98 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +,
-./.01.23452.-3675281875930936:79.3093/7998;:.31731<.37-8=850:>3?<.31.6<5860:3-.67-293856:42.31<.3201.305231<.382.5181@37A /.-9755.:3-.9/7598;:.3A7-31<.3/.-A7-B056.37A3.06<3.5C8-75B.510:31.91D36<.6E85=37A3-.94:19D390B/:85=3F8A390B/:85=36752461.23;@ GGHIJK32764B.51.237531<.3LML3NOPMQOGL3RSTUVWUTRSFGKIS>V>RX>3Y.67-2937A3.Z48/B.513-.A.-.56.3B01.-80:9D3-.94:19D 066./1056.36-81.-80D3-.:.C0513201.9305231<.3/.-87237A3C0:[email protected]:973B0851085.23NOPMQOGL3RSTUVWUTRSFGKI[>\>R]>AX> 3 R]>U>U>UK3M;9.-C018759D320103052360:64:01875930-.3-.67-2.230131<.318B.31<[email protected];:.31731<.39/.68A863109E> R]>U>U>]K3^<.53B8910E.937664-3853-.67-29D3.06<3B8910E.38936-799.23741D35713.-09.2D3B02.38::.=8;:.37-32.:.1.2D305231<.367--.61 C0:4.3.51.-.230:75=982.>3H::3946<30:1.-0187593173-.67-2930-.3858180:.230523201.23;@31<.3/.-9753B0E85=31<.367--.61875>3O531<.3609. 7A3-.67-293917-.23.:.61-75860::@D3.Z48C0:.513B.094-.930-.310E.531730C7823:79937-36<05=.37A37-8=850:32010>3^<.5367--.61875930-. 24.3173-.09759371<.-31<0531-0596-8/18753.--7-9D31<.3-.09753A7-31<.367--.6187539<0::3;.32764B.51.23N?_OIG`IaRJUIUTR[IY.CU>RI \>R]>]>=>88X>3 3 R]>U>U>\K3G06<3-./7-137-32764B.51938994.239<0::3856:42.31<.350B.F9KD3A4561875F9K3052398=5014-.F9K37-3.Z48C0:.513.:.61-7586 82.518A860187537A3/.-975F9K3041<7-8b85=31<.3-./7-137-32764B.519D30523201.37A38994.>3c9.37A367B/41.-3/099d7-23458Z4.3173.06< 050:@9130523:.C.:37A39.64-81@3/-.C.5193:79937A37-8=850:32010305236<05=.37A32010> 3 efgfh3ijkjlmknojpq3 R]>]>RK3GGHIJ3B085108593.:.61-75863-./7-13A8:.93A7-3013:[email protected]>3?<.3-./7-13A8:.930-.37-=058b.230:/<0;.1860::@3;@36:8.513052 675108530367/@37A31<.3-./7-139.5131731<.36:8.51D3649172@385A7-B018753052396<.24:85=385A7-B01875>3Y./7-13A8:.930:973856:42. 94;6751-0617-3-./7-19>3?<.3960550;:.394//7-185=3-0d32010389396055.23d81<85398r3B751<930523917-.23.:.61-75860::@38531<.3GGHI J39.64-.239.-C.->3?<.3575I960550;:.320103F8>.>3<0-2;74523:7=;77E9K30-.3917-.23853039.64-.237AA981.3917-0=.3A7-3031710:37A3RT @[email protected]<49.119D30523_.d3t7-E>3?<.9.3A8:.930-.36.51-0::@3:7601.23052303649172805389 0998=5.23173B0851085D3-.1-8.C.D3052367/@3A8:.930935..2.2> 3 R]>]>UK3O591-4B.513-0d320103893917-.23753.06<38591-4B.51u9367B/41.->3v0103893;06E.2I4/3173035.1d7-E39.-C.-37-3053.r1.-50: <0-232-8C.3FL<-7B.:.753893;06E.234/31731<.35.1d7-E39.-C.-30523wLJPQ`LJP3893;06E.234/3173053.r1.-50:3<0-232-8C.>3OA 8591-4B.51930-.328-.613-.02305231-0596-8;.2385173571.;77E9D31<.531<.3571.;77E930-.3917-.238531<.3:0;34518:31<[email protected] 0523A8:.2>3 3 R]>]>]K3H::3-0d3201038937-=058b.23;@38591-4B.5137-31.91D31<.536<-757:7=860::@>3`7=;77E93946<309390B/:.3649172@37-3;0:056. 60:8;-0187530-.37-=058b.236<-757:7=860::@> 3 R]>]>\K33G:.61-7586320103A-7B3?H`P3893917-.23753039.64-.239.-C.-385303201036.51.-3853L7:7-027> efgxh3inyz{q|klyn|kon}3 R]>\>RK3v764B.513L751-7:3/-76.24-.930-.38B/:.B.51.231<0130::7d3A7-302.Z401.32764B.5101875305236751-7:37A39/.68A86 2764B.519>3?<.9.3/[email protected]<0130::7d93A7-31-06E85=D31-08585=32764B.5101875D31-06.0;8:81@ 7A37AA8680:367/8.9305231<.318B.3/.-87231<.3/-76.24-.37-32764B.513d093853A7-6.>3v764B.51938994.231730::3/.-9755.:38531<. :0;7-017-@3093/0-137A31<.3~40:81@[email protected]~PK39<0::3;.3-.C8.d.2305230//-7C.23A7-349.3173041<7-8b.23/.-9755.:3/-87-317349.>3?<. :8913d8::382.518A@31<.364--.513-.C8987539101493173.594-.31<01385C0:8237-37;97:.1.32764B.51930-.3571349.2>3?<.32764B.5136751-7: /-76.24-.93856:42.931<0131<.3041<7-8b.23.281875937A32764B.51930-.3066.998;:.3;@31<.3050:@9193052385C0:8237-37;97:.1. 2764B.51930-.3/-7B/1:@3-.B7C.23A-7B349.>3~P32764B.5193946<3093PM930523~J30-.3458Z4.:@382.518A8.23856:4285=31<. A7::7d85=W 3v01.37A38994.3052Q7-3-.C898753Ov3 30=.354B;.-85=3 3?710:354B;.-37A3/[email protected]>3 3 3O99485=3041<7-818.93N?_OIG`IaRJUIUTR[IY.CU>RI\>]>]>RXNOPMQOGL3RSTUVWUTRSFGKI>]>UX 3 3 R]>\>UK3 ?73.594-.31<0131<.3~J30523PM93-.B085.236751-7::.232764B.519D31<.3B091.-3PM930523~J3F7-8=850:37AA8680:3C.-987537A31<.3PM 0523~JK3052367/8.937A31<.3PM30523~40:81@3J0540:3d8::3;.382.518A8.231<-74=<31<.3v\[email protected]>3?<.3~H32./0-1B.513E../9375. <0-2367/@37A31<.30//-7C.23.:.61-75863v\3PM9D3/-851.23753;:4.39.64-81@3/0/.-D309303;06E4/3853609.31<.39.-C.-36-09<.937-371<.- 45A7-.9..5368-64B91056.9> 3 O531<.3.C.5137A303675A:86137-32896-./056@3;.1d..53/7:868.9D31<.37-2.-37A3/-.6.2.56.38531<.3v\[email protected]::7d9 45:.99371<.-d89.3571.2W 3 3 R>3~40:81@3J0540:30523~40:81@37:868.9 U>3PM9 ]>3^7-E3O591-4618759 \>3M1<.-3FA7-B9D3A:7d36<0-19D3:8919D3.16>K UNCONTROLLED 99 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +
,
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`ab,cdefghijkelminhokjdkedijpdqqhckcdefghijo, -./S/-1,YJJ,>CKBG4H@8,<H>9C=,K3<HD48,?88B4>,@C,L4=8CHH4J,?H,@34,J<AC=<@C=F,<=4,=4P?4R4>,<H>,<LL=CP4>,L=?C=,@C,B84/,5678,<=4 <LL=CP4>,AF,<@,J4<8@,@RC,CI,@34,ICJJCR?HD,L4=8CHH4J,>4L4H>?HD,CH,@34,@FL4,CI,567r,:B<J?@F,;<H<D4=X,54K@?CH,;<H<D4=X,Q<A E?=4K@C=X,6L4=<@?CH8,;<H<D4=/,Y,G<8@4=,J?8@,C=,<H,4UB?P<J4H@,>CKBG4H@,KCH@=CJ,L=CK4>B=4,?>4H@?IF?HD,@34,KB==4H@,=4P?8?CH,8@<@B8 <H>,>?8@=?AB@?CH,CI,>CKBG4H@8,?H,@34,J<AC=<@C=F,<=4,48@<AJ?834>,<H>,<=4,=4<>?JF,<P<?J<AJ4,@C,L=4KJB>4,@34,B84,CI,?HP<J?>,<H>9C= CA8CJ4@4,>CKBG4H@8/, , -./S/]1,YHF,K3<HD489<J@4=<@?CH8,@C,J<AC=<@C=F,>CKBG4H@8,<=4,@=<KN4>,<H>,L=CL4=JF,?>4H@?I?4>/,YG4H>G4H@8,<=4,KJ4<=JF,G<=N4>X ><@4>,<H>,?H?@?<J4>,<H>,=4P?84>,>CKBG4H@8,<=4,IC=G<JJF,=4s?88B4>,?GG4>?<@4JF/,YHF,CA8CJ4@4,>CKBG4H@8,<=4,=4GCP4>,I=CG KC==48LCH>?HD,A?H>4=8,<=4,<=K3?P4>,<H>,8@C=4>,?H,<,84KB=4>,LJ<K4/ , ^_`tb,mpeluvmqkowojhg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`xb,ojmicmpckdyhpmjuinkypdehcfphokzodyb, -./{/-1,Q<AC=<@C=?48,83<JJ,G<?H@<?H,5678,@3<@,<KKB=<@4JF,=4IJ4K@,<JJ,L3<848,CI,KB==4H@,J<AC=<@C=F,<K@?P?@?48,8BK3,<8,<88488?HD ><@<,?H@4D=?@FX,KC==4K@?P4,<K@?CH8X,<H>,<JJ,@48@,G4@3C>8/ , -./{/]1,|34H,<H,<G4H>G4H@,@C,@34,567,?8,H44>4>X,8BK3,<8,<,G?HC=,BL><@4,@C,@34,4H@?=4,L=CK4>B=4X,@34,J<AC=<@C=F,R?JJ,HC@4 @34,BL><@48,?H,I44>A<KN,8@<@B8,<H>,@34F,R?JJ,A4,?HKJB>4>,?H,@34,H4}@,BL><@4,CI,@34,567/ , -./{/.1, 234,ICJJCR?HD,IC=G<@,GB8@,A4,B84>,IC=,<JJ,I?H<J,@4K3H?K<J,5678/ -/,l~~k Y,34<>4=,GB8@,A4,?HKJB>4>,?H,4<K3,L<D4,CI,@34,<@@<K3G4H@8,CI,567/,234,34<>4=,GB8@,?HKJB>4,@34,567,=4I4=4HK4,H<G4,C= HBGA4=X,@34,=4P?8?CH,HBGA4=X,@34,><@4,@34,=4P?8?CH,A4D<HX,L<D4,HBGA4=,<H>,@C@<J,HBGA4=,CI,L<D48/ ]/,e~ky ~k 234,567,KCP4=,L<D4,KCH8?8@8,CI,<,8BGG<=F,CI,@34,GC8@,=4K4H@,=4P?8?CH,?HIC=G<@?CH,<H>,@34,4J4K@=CH?K,8?DH<@B=489?H?@?<J8,CI @34,<LL=CP?HD,L4=8CHH4J,844,84K@?CH,-./S/-1,8@<@?HD,@3<@,@34F,<LL=CP4>,@34,567/,234,<LL=CP<J94II4K@?P4,><@4,<I@4=,<JJ <LL=CP4=8,3<P4,8?DH4>,?8,?HKJB>4>,CH,@34,KCP4=,L<D4/,234,4II4K@?P4,><@4,?8,@34,8<G4,><@4,<8,@34,<LL=CP<J,><@4/,567 @=<?H?HD,=4KC=>8,<=4,>B4,R?@3?H,],R44N8,CI,@34,<LL=CP<J94II4K@?P4,><@4/ ./,, -/,j~ ]/,o~kkm Y,A=?4I,>48K=?L@?CH,CI,@34,@FL48,CI,G<@=?K48,@34,G4@3C>,?8,<LLJ?K<AJ4,@C,<8,R4JJ,<8,@34,=4DBJ<@C=F,L=CD=<G8,@3<@,G<F,A4 8BLLC=@4>,AF,@34,B84,CI,@34,G4@3C>/,23?8,84K@?CH,?8,<J8C,B84>,@C,?H>?K<@4,<HF,8L4K?<J,@=<?H?HD,C=,J4P4J,CI,<A?J?@F,=4UB?=4> @C,L4=IC=G,@34,G4@3C>/ ./,g~ko Y,A=?4I,>48K=?L@?CH,CI,@34,G4@3C>X,8?GLJ4,8@<@4G4H@,CI,<H<JF@?K<J,@4K3H?UB4,<H>,<HF,L=4s@=4<@G4H@,8@4L8/ 0/,u~~~~ 23?8,84K@?CH,GB8@,?HKJB>4,<HF,NHCRH,?H@4=I4=4HK48X,<8,R4JJ,<8,LC@4H@?<J,?H@4=I4=4HK48X,L<=@?KBJ<=JF,IC=,[9KCHP4H@?CH<J >4@4K@C=,G4@3C>8/,V@,GB8@,<J8C,?HKJB>4,<HF,?H@4=I4=4HK48,@3<@,G<F,A4,L=484H@,<8,<,=48BJ@,CI,?GL=CL4=,8<GLJ?HD L=CK4>B=48X,4UB?LG4H@,KJ4<H?HD,C=,<H<JF@?K<J,@4K3H?UB4,GB8@,A4,J?8@4>,34=4/ S/,o~ke~kk 5L4K?IF,<HF,NHCRH,C=,8B8L4K@4>,K<=K?HCD4H8X,GB@<D4H8X,C=,@4=<@CD4H8,<GCHD,@34,8@<H><=>8,C=,=4<D4H@8,B84>/ VH>?K<@4,@3<@,@34,5E5,5<I4@F,E<@<,5344@81,<=4,<P<?J<AJ4,<H>,R34=4,@34F,<=4,JCK<@4>/,<K3,<H<JF8@,?8,=4UB?=4>,@C I<G?J?<=?4,3?G934=84JI,R?@3,@34,KCH@4H@8,CI,@34,5E5,A4IC=4,L4=IC=G?HD,@34,<H<JF8?8/, , <K3,567,?HKJB>48,=4I4=4HK4,@C,@34,Q<AC=<@C=F,[34G?K<J,FD?4H4,7J<H,<8,L4=,65Y,5@<H><=>,],[M,--\/-0S\X 6KKBL<@?CH<J,}LC8B=4,@C,<<=>CB8,[34G?K<J8,?H,Q<AC=<@C=?48s?H<J,MBJ4/, Z/,u~mk 234,?H8@=BG4H@<@?CH,B84>X,?HKJB>?HD,8L4K?I?K,KCJBGH8,4GLJCF4>,IC=,[X,Q[X,C=,[9;5,<H>,R34@34=,C=,HC@,@34=4,?8,< UNCONTROLLED 100 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +
,-./0-1203425637.-/086-12569:/3; <;2=>?@>ABCD?AEDFB?AE?GEC HIJ2K6:-5JK26720992K80340-4K20342-J0LJ38K20-J29.K8J4;2 M;2F?NOP>DQRPP>SBTRAUDVG>C>GW?BTRAD?AEDX?AEPTA@DY Z34.508J2[6889J281,J\2,-JKJ-]08.]J20342]69:/J23J5JKK0-1276-203091K.K;2Z359:4J2I694.3L28./JK276-2K80340-4K; ^;2Q?PT_G?BTRADVGRS>E`G>DYD aJ80.9J42,-J,0-08.632.3K8-:58.63K276-2J05I2509.[-08.63\2bcd26-2edfeda2K80340-42/:K82[J2.359:4J4;2g280[9J2/:K82[J ,-JKJ382862KI6h2I6h240.912509.[-08.63203425638-692K80340-42K69:8.63K20-J2,-J,0-J427-6/2h6-i.3L2K865i2K80340-4K; c09.[-08.6327-Jj:J3512/:K82[J2K,J5.7.J4;2kl,.-08.632.376-/08.632/:K82[J2.359:4J4276-2J05I281,J2672K80340-42,-J,0-J4; mn;2oA?PpBTS?PDVGRS>E`G>DYD d.35J28IJ2,:-,6KJ267202dqr2.K2862,-6].4J259J0-2.3K8-:58.6328620]6.4296KK2672iJ12.376-/08.6327-6/263J203091K828620368IJ-\ .82.K25-.8.50928I0828I.K2KJ58.632[J24J80.9J42J36:LI28I082031203091K825032038.5.,08J2034280iJ20,,-6,-.08J256--J58.]J2058.63 .328IJ2J]J3828I08202,-6[9J/2KI6:9420-.KJ; mm;2s`?PTBpDQRABGRPD=>t`TG>N>ABCDYD HI.K2KJ58.632/:K824JK5-.[J28IJ256/,63J38K\25635J38-08.63K\27-Jj:J351\20342055J,8035J25-.8J-.0276-28IJ2bcd26-2edfeda K0/,9JK\20K2hJ9920K2031268IJ-2/J8I642K,J5.7.52uc2-Jj:.-J/J38K\2K:5I20K28:3.3L\2[903iK\26-2509.[-08.632-Jj:.-J/J38K; mv;2Q?PS`P?BTRACDYD g992-J9J]03825095:908.63K2/:K82[J2.359:4J4\2K:5I20K2I6h2.3K8-:/J382-JK,63KJ2-J908JK28625635J38-08.63\28IJ25095:908.63267 -JK,63KJ270586-K\2J85; mw;2x>ByREDV>GzRGN?AS>DYD HIJ2-JK:98K26728IJ2.3.8.092/J8I642]09.408.632,-65JKK2/:K82[J2.359:4J4;2Zac\25638.3:.3L24J/63K8-08.63267250,0[.9.81\ eab\20342[903iK2-JK:98K20-J2.359:4J420K2-Jj:.-J42[128IJ2/J8I64;2HIJ276996h.3L2.376-/08.632/:K82[J2,-JKJ38{ d808.K8.5099125095:908J42eabK2|}n2c~2r0-82mw2g,,J34.l2\ eab2K,.iJ29J]J9K\2kkgeK2ebK\2g55:-051276-2J05I256/,6:34; Zacf5638.3:.3L24J/63K8-08.63267250,0[.9.812 m};2=>z>G>AS>C g29.K82672/J8I642-J7J-J35JK\2K:5I20K28IJ2-J9J]0382 nn2KJ-.JK2/J8I64K2|.359:4.3L2-J].K.6323:/[J-20342408J\26- d80340-42eJ8I64K2/:K82[J2,-6].4J4; m ;2>WT?BTRACDzGRND=>z>G>AS>EDx>ByRERPR@pDYD g2-J].Jh26728IJ2-J7J-J35J42/J8I642.K250-J7:9912/04J20342kkge2h.992K,J5.71203120-J0K2.32hI.5I26:-2/J8I64246JK2368 56376-/2862-J7J-J35J42/J8I642-Jj:.-J/J38K;2Z720312K:5I24J].08.63K20-J2368J4\2032Jl,90308.6320K2862hI082098J-308.]J h0K2:KJ420342hI12.K24JK5-.[J4;2HIJ-J20-J28h62[0K.5281,JK2672/J8I642/64.7.508.63K{2|m28I6KJ28I0820-J2I0-4h0-J -J908J420342|v28I6KJ28I0820-J2,69.5126-2,-65J4:-092/64.7.508.63K; m;2x>ByRED>B>SBTRADTNTB b0[6-086-12,-65J4:-JK26725634:58.3L2eab2K8:4.JK203420256,126728IJ2.3.8.092eab2K8:412h.992[J2.359:4J4; m<;2>NRACBG?BTRADRzDQ?O?_TPTBpDY b0[6-086-12,-65J4:-JK26725634:58.3L2Zacfaqc2K8:4.JK203420256,126728IJ2.3.8.092aqc2K8:412h.992[J2.359:4J4; mM;2>zTATBTRACDY aJ7.3.8.63K2h.992[J2-J7J--J428628IJ2u:09.812e03:092K.35J28IJ2u:09.812e03:092.359:4JK202L96KK0-12KJ58.6328I0824J7.3JK2099 8IJ28J-/K2:KJ42[128IJ290[6-086-1; m^;2VRPP`BTRADVG>W>ABTRADY r68J38.0928I-J0826728IJ2K80340-4K20342-J0LJ38K28628IJ2J3].-63/J382.K2044-JKKJ42.328IJ2dqr; vn;2?CB>Dx?A?@>N>AB Z32044.8.6328628IJ2I00-46:K2h0K8J2,-68656924.K5:KKJ42.328IJ2dqr\28IJ276996h.3L2-J7J-J35JK2hIJ-J28IJ2.376-/08.632503 [J27.3420-J209K62.359:4J4{ 2HIJ2b0[20h0K8J2e030LJ/J382r9032 2HIJ27J4J-092I00-46:K2h0K8J2/030LJ/J382-JL:908.63K2JK6:-5JK2c63KJ-]08.6320342J56]J-12g582|cgH.89J2}n267 8IJ2c64J2672~J4J-092JL:908.63K\2r0-8K2vn28I-6:LI2v<n2|}n2c~2vnv<n2 2cg200-46:K20K8J2c638-692b0h2|cbcc2H.89J2vv2hIJ-J2}n2c~2h0K24:,9.508J42.3862cc2H.89J2vv2 vm;2=>WTCTRAC J].K.63K20-J24.K5:KKJ42.359:4.3L28IJ2408JK2hIJ32-J].K.63K20-J2/04J203428IJ20,,-6,-.08J2KJ58.6323:/[J-K2hIJ-J28IJ -J].K.63K256:942[J276:34; vv;2oBB?SyN>ABC g256,126728IJ2[J35I2KIJJ82:KJ4276-28IJ203091K.K20342hIJ-J20,,9.50[9J\2032Jl0/,9J25I-6/086L-0/26728IJ2K80340-4K\ 5095:908.63K20342031268IJ-2-J9J]038208805I/J38K; 2 2 2ooD=QUDooUDoD=V= HIJ2,-65JKK26728-03K76-/.3L2-0h2030918.509240802.3862027.3.KIJ42-J,6-82.3]69]JK2K8J,K2hI.5I20-J2LJ3J-09912L-6:,J42.38628IJ 508JL6-.JK267240802-J4:58.63\240802]09.408.63\20342-J,6-8.3L;2Z82.3]69]JK2/08IJ/08.5092/64J9.3L26728IJ2K80340-42509.[-08.63 5:-]JK\2K808.K8.509203091K.K26728IJ205j:.-J424080\25095:908.63K28620556:38276-2,-J,0-08.632K8J,K203424.9:8.63\2]J-.7.508.63267 04IJ-J35J2862j:09.8120KK:-035J2,-65J4:-JK\203428IJ2LJ3J-08.632672I0-456,126:8,:8; 2 2ooD=Q g82kkge28IJ203091K82,J-76-/.3L203203091K.K2I0K28IJ2,-./0-12-JK,63K.[.9.81276-2-J4:5.3L2-0h24080;2HI.K2,-65JKK2563K.K8K267 563]J-8.3L2-0h240802]09:JK2.38627.309\2-J,6-80[9J2]09:JK2[1256/,0-.3L2.34.].4:092K0/,9J2-JK:98K28628I6KJ26[80.3J4276-2509.[-08.63 ,:-,6KJK203428IJ320556:38.3L276-203124.9:8.6326-25635J38-08.632,-65J4:-JK; 2 UNCONTROLLED 101 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
!"#"
$"
%&'()'* ++
,-./012324567/5.82.92:2950642;:<=602>.7642?.78/2:;2.802950642;:<[email protected]:8:6EF02.802950642;:<=602:842/>. 45990C08/24567/5.8;2.92/B02950642;:<=60D2/B0;02>.7642?.78/2:;2/BC002950642;:<=60;2582:82:8:6E;5;2G:/?BH@ I JKLILMNLONINPIQKRSKITUQIVUNUIWTPXINKLIROYNTZXLONIOLLVYINPI[LIXUNKLXUNRSU\\]I^TPSLYYLVI_UTRLYIVL^LOVRO`IPOINKLIUOU\]YRYaIbPT NKLIWP\\PQRO`IXLNKPVYIWRORYKLVIVUNUIRYIVRTLSN\]ITLUVIWTPXINKLIROYNTZXLONcI^deISPOVZSNR_RN]eIY^LSNTP^KPNPXLNTRSfSP\PTRXLNTRS XLUYZTLXLONYIgRaLahIiKLXRSU\IjM]`LOIkLXUOVIgijkleIiKTPXRZXImneI^KLOP\YeI^KPY^KPTZYeIoLNK]\LOLIp\ZLIqSNR_UNLV rZ[YNUOSLYIgopqreIPTISPXXPO\]IsOPQOIUYIYZTWUSNUONYleIPVPTIUOVI^TLYLOSLfU[YLOSLI[USNLTRP\P`RSU\INLYNYaIjNKLTIXLNKPVY TLtZRTLIXUNKLXUNRSU\ISU\SZ\UNRPOYIUOVIROIYPXLISUYLYeIYZSKIUYIWPTI^LYNRSRVLYI[]IuieItZU\RNUNR_LIUYYLYYXLONIPWIUSNZU\I^TLYLOSLa I pL\PQIRYIUOIPZN\ROLIPWINKLIVUNUITLVZSNRPOINLSKORtZLYIZYLVI[]INLSKOP\P`]aI vwxvxvyIz{|}~|z{ qIVUNUITLVZSNRPOIYPWNQUTLIY]YNLXIRYIZYLVINPISU\SZ\UNLINUT`LNISPX^PZOVISPOSLONTUNRPOYaIJKLYLISPOSLONTUNRPOYIUTLISU\SZ\UNLVI[] XZ\NR^\]RO`INKLIU_LTU`LITLY^POYLIWUSNPTIWPTINKLISPX^PZOVI[]INKLIUTLUISPZONIUYIVLNLTXROLVI[]INKLIROYNTZXLONaIq_LTU`L TLY^POYLIWUSNPTYIUTLIVLNLTXROLVINKTPZ`KI\ROLUTITL`TLYYRPOIVZTRO`IRORNRU\ISU\R[TUNRPOeIUOVIXU]IPO\]I[LIZYLVIRWINKLISPTTL\UNRPO STRNLTRUIKU_LI[LLOIXLNaIJKRYIUYYZXLYI\ROLUTRN]IPWINKLISU\R[TUNRPOISZT_LINKTPZ`KINKLIPTR`ROaInWI\ROLUTRN]IRYIOPNILYNU[\RYKLVINKLOIU YLSPOVIPTVLTIWRNIg\P`UTRNKXRSITL`TLYYRPOlIXU]I[LIZYLVINPIVLNLTXROLITLY^POYLIWUSNPTYaIqOPNKLTIU\NLTOUNR_LIRYINPIZYLIYRO`\LI^PRON SU\R[TUNRPOeIQKRSKIXUNSKLYINKLIUTLUISPZONYIWTPXIUIYRO`\LISU\R[TUNRPOI^PRONINPINKLIUTLUISPZONYIPWINKLIYUX^\LeIZ^POIQKRSKIU YUX^\LISPOSLONTUNRPOIRYIVLNLTXROLVaIrRO`\LI^PRONISU\R[TUNRPOIRYITUTL\]IZYLVa I nOIU\\ISUYLYIVUNUIRYITLVZSLVI[]INKLIVUNUITLVZSNRPOIYPWNQUTLaITP`TUXYIWPTI\ROLUTeI\P`UTRNKXRSIUOVIYRO`\LI^PRONISU\R[TUNRPOYIUTL U_UR\U[\LIPOISPXXUOVIQKLOIU\\PQLVI[]IXLNKPVITLWLTLOSLaIrUX^\LIVR\ZNRPOIWUSNPTYIUTLILONLTLVIRONPINKLIVUNUITLVZSNRPOIYPWNQUTL ^TRPTINPIUOU\]YRYIUOVISU\SZ\UNLVIRONPINKLIWROU\ITLYZ\NaI I vwxvxyIz{
L^PTNU[\LITLYZ\NYIUTLI^TP_RVLVI[]INKLIVUNUITLVZSNRPOIYPWNQUTLIWPTIuiforIUOU\]YLYIZYRO`I\ROLUTIU_LTU`LITLY^POYLIWUSNPTYeIPT OVIPTVLTIWRNYeIUYIVLYSTR[LVeILMSL^NIWPTIVR\ZNLVIYUX^\LYaIbPTIVR\ZNLVIYUX^\LYINKLITLYZ\NIWTPXINKLIY]YNLXIRYIXZ\NR^\RLVI[]INKL VR\ZNRPOIWUSNPTaI L^PTNRO`I\RXRNYIUTLIUVZYNLVIXUOZU\\]IUYIQL\\a I
q\\ITL`TLYYRPOYIUOVISU\R[TUNRPOISU\SZ\UNRPOYIUTLI^LTWPTXLVI[]INKLIY]YNLXIYPWNQUTLaI vwxvxyI} niIIniorITLYZ\NYIUTLI^TPSLYYLVIUOVINTUOYWLTTLVIVRTLSN\]IRONPIJqraIkR\ZNRPOIUOVISU\R[TUNRPOIROWPTXUNRPOIRYILONLTLVIUOV ^TPSLYYLVI[]INKLIniIYPWNQUTLI^TRPTINPIVUNUINTUOYWLTa I q\\IPNKLTITLYZ\NYIUTLITL^PTNU[\LIVRTLSN\]IPWWINKLIY]YNLXaI vwxvxwyI|{||{||{{||~{ q\\ITLYZ\NYIUTLITL^PTNU[\LIVRTLSN\]IPWWINKLIY]YNLXIYPWNQUTLIPTIVRTLSN\]ITLUVIPWWIROYNTZXLONaIJKLISL\\ISPOYNUONIWPTINKLISPOVZSNR_RN] XLNLTIRYIaIq\\IYUX^\LYIUOVIYNUOVUTVYIUTLIU\\PQLVINPISPXLINPITPPXINLX^LTUNZTLI^TRPTINPIUOU\]YRYaIJLX^LTUNZTLISPTTLSNRPOIRY OPNIOLLVLVa I vwxvxyI{z JKLIU[R\RN]IPWIUOIROVR_RVZU\IUOU\]YNINPISPZONISP\PORLYIUSSZTUNL\]IYKU\\I[LI_LTRWRLVIUNI\LUYNIPOSLI^LTIXPONKeI[]IKU_RO`INQPIPT XPTLIUOU\]YNYISPZONISP\PORLYIWTPXINKLIYUXLI^\UNLIPOIPOLI^PYRNR_LIYUX^\LaIiPZONYIXZYNI[LIQRNKROIIVRWWLTLOSLINPI[L USSL^NU[\LIJnmo L_aaa a ¡a I
vwxyI}}|¢}}~ iU\SZ\UNRPOYIUOVIVUNUINTUOYWLTYIUTLIYZ[LSNINPIU^^TP^TRUNLISKLSsYIROIUIY]YNLXUNRSIXUOOLTIJnmo L_aa£aa¡ nrjfniIhglaa¡a ¤^POISPX^\LNRPOIPWILUSKIUOU\]NRSU\ITZOeINKLIUOU\]YNISKLSsYINKLITUQIVUNUIUOVI¥iINPIVLNLTXROLIRWINKLITZOIRYIUSSL^NU[\LIWPT YZ[XRYYRPOaIkUNUIUTLILONLTLVIRONPINKLInorILRNKLTIXUOZU\\]IPTI[]IL\LSNTPORSIVUNUIZ^\PUVIZYRO`IWR\LYI`LOLTUNLVI[]IVUNU UStZRYRNRPOI^TP`TUXYIUNNUSKLVINPIROYNTZXLONYeIQKRSKIUTLINKLOIRX^PTNLVIRONPIJqraIJKLIVUNUI^USsU`LIRYIYZ[XRNNLV L\LSNTPORSU\\]INPINKLIrZ^LT_RYPTIPTILLTIqOU\]YNIWPTITL_RLQaIJKLIYZ[XRNNLVI^USsU`LISPONUROYIU\\ITL\L_UONIVPSZXLONUNRPOIYZSKIUY SKTPXUNP`TUXYeIROYNTZXLONITZOI\P`YeIVR`LYNRPOI\P`YeIROWPTXUNRPOIU[PZNISU\R[TUNRPOIPTIYLSPOVIYPZTSLIYNUOVUTVYIUOVITLU`LONYe PNKLTI^TRONLVI^U`LYIWTPXINKLIROYNTZXLONYeITLYZ\NIYZXXUT]IYKLLNYeIUOVfPTIUISKLSs\RYNaIJKLI L_RLQLTIRYITLY^POYR[\LIWPTI_LTRW]RO` NKLI_U\RVRN]IPWINKLIVUNUI[]IVLNLTXRORO`IRWIU\\ItZU\RN]ISPONTP\I^UTUXLNLTYIKU_LI[LLOIUOU\]¦LVIUOVIUTLIQRNKROIXLNKPVIUSSL^NUOSL \RXRNYeISKLSsRO`ISU\SZ\UNRPOYeIUYYLYYRO`INKLIUSSL^NU[R\RN]IPWISKTPXUNP`TU^K]eIUOVIUVVTLYYRO`IUO]IROSPOYRYNLOSRLYIROINKLIVUNU QRNKINKLIUOU\]YNaIkL_RUNRPOYIWTPXINKLIXLNKPVIXZYNI[LIVPSZXLONLVI[]INKLIUOU\]YNIUOVfPTITL_RLQLTaIJKLIVPSZXLONUNRPOIXZYN LM^\UROINKLIVL_RUNRPOeIUO]IW\U`YIUYYPSRUNLVIQRNKINKLIVL_RUNRPOIUOVINKLIUSSL^NU[R\RN]IPWINKLIVUNUaIJKLITL_RLQIROS\ZVLYIUI^LTZYU\IPW NKLIYZ^^PTNRO`IVPSZXLONUNRPOINPILOYZTLINKUNINKLIVPSZXLONUNRPOIRYI^TLYLONIUOVIRYISPX^\LNLaIpLWPTLINKLI L_RLQLTIPTImU\RVUNPT U^^TP_LYINKLIVUNUIROIJqreIVUNUIROINKLI^USsU`LIRYISKLSsLVIU`UROYNIJqrINPILOYZTLINKUNINKLTLIUTLIOPINTUOYSTR^NRPOILTTPTYe TLNLYNYIKU_LI[LLOI^TP^LT\]IRORNRUNLVeINKLIU^^TP^TRUNLIW\U`YIKU_LI[LLOIUVVLVeIUOVIUO]ISPXXLONYITL`UTVRO`IVUNUfYUX^\L RONL`TRN]IKU_LI[LLOIUVVLVIUNINKLITZOfYUX^\LI\L_L\a I §KLOIU\\ITLYZ\NYIUOVISU\SZ\UNRPOYIWPTIUIWP\VLTIKU_LI[LLOIU^^TP_LVeIUOILXUR\IRYIYLONINPINKLITPLSNIoUOU`LTIYNUNRO`INKUNINKL TL^PTNIKUYI[LLOITL\LUYLVaIJKLITL^PTNISPX^POLONYIUTLIXLT`LVIUOVINKLILONRTLI^USsU`LIRYITL_RLQLVI[]INKLITPLSNIoUOU`LTIPO \ROLaIJKLIL\LSNTPORSIYR`OUNZTLIPWINKLITPLSNIoUOU`LTIRYIUVVLVINPINKLISP_LTI^U`LI[LWPTLINKLITL^PTNIRYITL\LUYLVINPINKLIS\RLONa I qO]I\P`[PPsYIYZSKIUYIYUX^\LI^TL^UTUNRPOeIROYNTZXLONIXURONLOUOSLeISU\R[TUNRPOeIRONLTOU\ISZYNPV]eIUOVIVRY^PYU\IUTLITL_RLQLVI[] NKLIYZ^LT_RYPTfXUOU`LTIPWINKUNI`TPZ^aInORNRU\YIUOVIVUNLIPWITL_RLQIUTLIQTRNNLOIPOINKLIWROU\I^U`LITL_RLQLVaIJKLITL_RLQIQR\\IWPSZY UNCONTROLLED 102 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +
,-./,012343-3556.7//897/:6.493-;56.,11,948-<4<35.=,9.<019,>303-46.7-;./,012<7-/3?. . @ABCD.EFGFHIJKLJMHNOPLQRSQOIIJPFGLOTHOUHIJVWPGV X22.7-72:4</72.;747.0854.Y3.93><3Z3;.Y:.7.1339.7-72:54.[872<=<3;.<-.4\74.7-72:5<5.,9.4\3.]9,81.58139><5,9?.^8139><5,95.793 824<07432:.9351,-5<Y23.=,9.4\3.[872<4:.,=.931,943;.9358245?._747.93><3Z.<-/28;35.4\3.=,22,Z<-]` . ab?c?ad.e\3/f<-].722.ge.;747.7]7<-54.4\3.ge./9<439<7? ab?c?hd.X22.4\3.570123./72/8274<,-5.0854.Y3./\3/f3;?.^701235.Z\</\.793.51,4./\3/f3;.0854.Y3.079f3;.Y:.4\3.93><3Z<-] 7-72:54? . ab?c?cd.i\3.7-72:4</72.98-.5\334.0854.Y3.5<]-3;.Y:.4\3.19<079:.7-72:54.7-;.4\3.93><3Z<-].1339.7-72:54?.e\7-]35.4,.93/,9;5 0854.Y3.5<]-3;.7-;.<-<4<723;.Y:.9351,-5<Y23.547==.jiklmnompaqhmhrasmt3>h?amb?ac?h?cujl^vwlne.axrhy`hraxzndmx?y?hu?. . ab?c?bd.X22.53/,-;79:.93><3Z395.,9.^8139><5,95.0854./\3/f.722.;747.5\3345?.{,9.<-,9]7-</5.7-;.034725.4\3:.0854.>39<=:.;747 3-49:.=,9.4\,53.5701235.Y:./\3/f<-].4\3.;747Y753?.i\3.53/,-;79:.93><3Z39.,9.^8139><5,9.93><3Z5.7-;.5<]-5.4\3.;747.93><3Z /\3/f2<54?.{,9.,9]7-</56.4\3.53/,-;79:.93><3Z39.,9.^8139><5,9.0854./9,55./\3/f.722.931,945.=,9.497-5/9<14<,-.399,9.=9,0.Y3-/\ 5\3345?.X22.2,]Y,,f5.0854.<-/28;3.53/,-;79:.93><3Z5.74.23754.0,-4\2:.,9.Z\3-.4\3.17]3.<5./,012343;6.Z\</\3>39.,//895.=<954? . ab?c?yd..X22.^8139><5,95.,9.;35<]-33.0854.>72<;743.4\3.;747.931,943;.<-4,.4\3./,018439.5:5430?.i\3.931,945.793.4\3-.19<-43; 7-;.93><3Z3;6.5<]-3;.7-;.784\,9<|3;.Y:.4\3.}9,~3/4.q7-7]39.19<,9.4,.9323753? . ab?c?sd.X5.1794.,=.4\3.7--872.<-439-72.78;<456.4\3.g872<4:.q7-7]39.,9.gX.547==.0854.51,4./\3/f.;747.5\3345.4,.<-5893.4\74.4\3 1339.93><3Z5.793.Y3<-].139=,903;.7-;.4\74.93><3Z.19,/355.<5.497/37Y23.4,.4\3.1339.93><3Z? . ab?c?xd.e,993274<,-.,=.9358245.=,9.;<==393-4./\797/439<54</5.,=.7.570123.z370123.i,472.}\,51\743..v94\,1\,51\743.,9.ik. kc.jiklmnompaqhmhrasmt3>h?amy??a?3ujl^vwlne.axrhy`hraxzndmx?x?a?\u . @ABAD.EFGFHIJNOIGLT i,.0334.4\3.ikl.7-;.l^v.axrhy.931,94.93[8<9303-46.4\3.27Y,974,9:.19,><;35.4\3.=,22,Z<-].<-=,9074<,-.<-.4\3.=<-72.4354.931,94` . ab?b?ad.X.i<423 ab?b?hd.k703w7;;9355.,=.27Y,974,9: ab?b?cd.}\,-3.-80Y39.7-;.-703.,=./,-47/4.1395,- ab?b?bd. -<[83.<;3-4<=</74<,-.,=.4\3./394<=</743.,9.931,94.7-;.8-<[83.<;3-4<=</74<,-.,=.37/\.17]36.7-;.4\3.4,472.-80Y39.,=.17]35 ab?b?yd..k703.7-;.7;;9355.,=./2<3-46.Z\393.7119,19<743.7-;.19,~3/4.-703.<=.7112</7Y23. . ab?b?sd._35/9<14<,-.7-;.8-70Y<]8,85.<;3-4<=</74<,-.,=.4\3.43543;.570123.<-/28;<-].4\3./2<3-4.<;3-4<=</74<,-./,;3 ab?b?xd.l;3-4<=</74<,-.,=.9358245.;39<>3;.=9,0.5701235.4\74.;<;.-,4.0334.ikl.7//3147-/3.93[8<9303-45.58/\.75.<019,139 /,-47<-396.\,2;<-].4<036.,9.43013974893.jiklmnompaqhmhrasmt3>h?amy?ar?cujl^vwlne.axrhy`hraxzndmx??c?a?Yu?. . ab?b?d._743.,=.93/3<14.,=.5701236.;743.7-;.4<03.,=.570123./,223/4<,-6.;743z5d.,=.139=,907-/3.43546.7-;.4<03.,=.570123 19317974<,-.7-;w,9.7-72:5<5.<=.4\3.93[8<93;.\,2;<-].4<03.=,9.3<4\39.7/4<><4:.<5.2355.4\7-.,9.3[872.4,.xh.\,895.Z\3-.4<03./9<4</72 54315.793.<-/28;3;.<-.4\3.7-72:5<5.z3?]?6.3497/4<,-5.7-;.<-/8Y74<,-5d.jiklmnompaqhmhrasmt3>h?amb?ac?c?=?>6.y?ar?h?]ujl^vwlne axrhy`hraxzndmx??h?a?\u?. . ab?b?d.l;3-4<=</74<,-.,=.4\3.4354.034\,;.853;6.,9.8-70Y<]8,85.;35/9<14<,-.,=.7-:.-,-m547-;79;.034\,;.853;? ab?b?ard.g872<=</74<,-.,=.-8039</72.9358245.Z<4\.namnx.=27]5.,9.7119,19<743.;747.=27]5.=,9.>72835.,845<;3.4\3.Z,9f<-].97-]3? ab?b?aad.X-:.;3><74<,-5.=9,06.7;;<4<,-5.4,.,9.3/285<,-5.=9,0.4\3.4354.034\,;6.7-;.7-:.,4\39.<-=,9074<,-.9323>7-4.4,.7.513/<=</ 43546.58/\.75.3-><9,-03-472./,-;<4<,-5.<-/28;<-].4\3.853.,=.9323>7-4.;747.[872<=<395.7-;.4\3<9.037-<-]?.\3-.4\3./854,039 93[8<935.4\3.<430.4,.Y3.43543;.7/f-,Z23;]<-].7.;3><74<,-.=9,0.513/<=<3;./,-;<4<,-56.nnXmq.5\722.<-/28;3.7.;<5/27<039.<-.4\3 931,94.<-;</74<-].Z\</\.9358245.07:.Y3.7==3/43;.Y:.4\3.;3><74<,-.jl^vwlne.axrhy`hraxzndmx?b?cu? . ab?b?ahd.q37589303-46.370<-74<,-5.7-;.;39<>3;.9358245.7-;.<;3-4<=</74<,-.,=.7-:.=7<28935.z58/\.75.=7<23;.[872<4:./,-49,2d? t7;<,/\30<549:.9358245.5\722.Y3.931,943;.Z<4\.755,/<743;.037589303-4.8-/3947<-4:.jiklmnompaqsmhrasmt3>h?rma?y?bu?. . ab?b?acd.t358245.4\74.793.931,943;.,-.7.Y75<5.,4\39.4\7-.75.93/3<>3;.z3?]?.;9:.Z3<]\4d..jiklmnompaqhmhrasmt3>h?am UNCONTROLLED 103 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +
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`-]1^7>524;752<92F;HE@86CD2A68GA5284567898:;78<62<927>52875H <?2H;75?8;@2F;HE@542L86:@A486C27>526;H52<927>52H;6A9;:7A?5?D27>52H<45@2<?27BE52<9245F8C6;78<62;642F5?8;@26AH05?FD2;F ;EE?<E?8;75JD27>52@<:;78<62<92F;HE@86CD286:@A486C2;6B248;C?;HFD2FU57:>5F2<?2E><7<C?;E>FD2;2?595?56:527<27>52F;HE@86C2E@;62;64 F;HE@86C2H57><4D2457;8@F2<92;6B256N8?<6H567;@2:<64878<6F24A?86C2F;HE@86C27>;72;995:727>528675?E?57;78<62<927>52?5FA@7FD2;64 869<?H;78<62?5GA8?5427<25N;@A;752H5;FA?5H5672A6:5?7;867B29<?2FA0F5GA567275F786C2<?2:;@80?;78<62Z3K[\3QM .X/],^]/.XLQJPX-_-,1- 2 .I-I-._J2[E868<6F2;6428675?E?57;78<62;?526<72;@@<=54-2M<HH567F2;?520;F542<62a;7;2b@;CF2;642cAF865FF2dA@5F-2Y>5627>5 N;@84;78<62F75EF2;?52:<HE@5754D2;6427>52H;6;C5?F2;642FAE5?N8F<?F2>;N52U5B5428627>58?286878;@F28627>52;EE?<E?8;752R3eK2985@427< ?59@5:727>8FD27>52?5E<?726AH05?28F2;A7<H;78:;@@B27?;6F95??5427<2;625@5:7?<68:2@8F786C2862R3eK-2d5E<?7F2<627>8F2@8F72;?52E?867542<A7 4;8@B-2V>52?5E<?7F2;?52?5N85=5429<?2:<??5:765FF2;C;86F727>524;7;2862R3eK2;642F8C6542<9920B27>52T?<f5:72e;6;C5?2E?8<?27<20586C :<E85429<?27>5298@5F2;64245@8N5?B27<27>52:@8567-2S625g;HE@52<92;62;6;@BF8F2?5E<?729<?H28F2F><=62862b8CA?52.IP.-2S2F;HE@52<92;2hM d5E<?728F2F><=62862b8CA?52.IP`-2S975?27>52?5E<?728F28FFA5427<27>52:@8567D27>52@;0<?;7<?B2?5E<?7F2?5H;862A6:>;6C54-2V>52?5E<?7 F>;@@26<72052?5E?<4A:5425g:5E728629A@@D2=87><A727>52=?877562;EE?<N;@2<927>52@;0<?;7<?B2ZVO3PQRPi.e]P]/.WPd5N]-.P,-./-]1 Z3K[\3QM2.X/],^]/.XLQJPX-_-]-.2O<751- 2 S975?28FFA52<92?5E<?7D2H;75?8;@2;H564H567F27<27>5275F72?5E<?728F24<6528627>529<?H2<929A?7>5?24<:AH5672<?24;7;27?;6F95?286:@A486C 7>52F7;75H5672jd5E<?72?5N8F54D2?5E@;:5F27>52<?8C86;@2?5E<?7k2<627>52:<N5?2E;C52<927>52?5E<?7-2S2A68GA525P98@523a28F2;FF8C65427< 7>52?5N8F542?5E<?7-2b<?27>52QQSPe2?5N8F542?5E<?72:<N5?2E;C5D27>52?5E<?724;752?5E@;:5F27>52<?8C86;@275F72?5E<?724;752;642:@5;?@B 8456789B\6<7528627>52:<HH567D2<?28627>52:<HH5672F5:78<62<927>52?5E<?7D27>52?5;F<629<?27>52:>;6C5-2S@F<D2;H564H567F27<27>5 9<?H;@2?5E<?72HAF72H5572;@@27>52VO32;6423K[2.X/],2?5E<?786C2?5GA8?5H567F-2V>52@;0<?;7<?B26<78985F2:@8567F2862=?8786C2<92;6B 5N5672FA:>2;F27>5284567898:;78<62<924595:78N52H5;FA?5H5672<?275F725GA8EH56727>;72:;F7F24<A072<627>52N;@8487B2<92?5FA@7F2C8N56286 ;6B275F72?5E<?72<?2;H564H56727<2;2?5E<?72ZVO3PQRPi.e]P]/.WPd5N]-.PI-.I-,1-2V>52@;0<?;7<?B2;@F<256FA?5F27>;727>52VO3 ?5E<?786C2?5GA8?5H567F2;?52H5729<?275F72?5FA@7F27?;6FH8775420B275@5E><65D275@5gD29;:F8H8@52<?2<7>5?25@5:7?<68:2<?25@5:7?<H;C6578: H5;6F2;6427>;72;@@2?5;F<6;0@52F75EF27;U5627<2E?5F5?N52:@85672:<69845678;@87B- 2 V>52@;0<?;7<?B2F>;@@2052?5FE<6F80@529<?2;@@27>52869<?H;78<62E?<N845428627>52?5E<?7D25g:5E72=>562869<?H;78<628F2E?<N845420B27>5 :AF7<H5?-2a;7;2E?<N845420B2;2:AF7<H5?2F>;@@2052:@5;?@B28456789854-2362;44878<6D2;248F:@;8H5?2F>;@@2052EA72<627>52?5E<?72=>5627>5 869<?H;78<628F2FAEE@85420B27>52:AF7<H5?2;642:;62;995:727>52N;@8487B2<92?5FA@7F-2Y>5?527>52@;0<?;7<?B2>;F26<7205562?5FE<6F80@5 9<?27>52F;HE@86C2F7;C52L5-C-27>52F;HE@52>;F205562E?<N845420B27>52:AF7<H5?JD2872F>;@@2F7;7528627>52?5E<?727>;727>52?5FA@7F2;EE@B 7<27>52F;HE@52;F2?5:58N542Z3K[\3QM2.X/],^]/.XLQJPX-_-]-]1-2V>52@;02=8@@2>;N52?5E<?729<@45?2:<HH5672=>562QQSPe2:<@@5:7F2;64 ;6;@Bl5F27>52F;HE@5F- 2 Y>562;2F7;75H5672<92:<69<?H87B27<2;2FE5:898:;78<62<?2F7;64;?428F2E?<N8454D2QQSPe24<:AH567F27>5245:8F8<62?A@525HE@<B54D 7;U86C2867<2;::<A6727>52@5N5@2<92?8FU2LFA:>2;F29;@F52;::5E72;6429;@F52?5f5:72;642F7;78F78:;@2;FFAHE78<6FJ2;FF<:8;7542=87>27>5 45:8F8<62?A@525HE@<B54D2;642;EE@B27>5245:8F8<62?A@5-2Y>5?527>5245:8F8<62?A@528F2E?5F:?805420B27>52:AF7<H5?D2?5CA@;78<6F2<? 6<?H;78N524<:AH567FD2;29A?7>5?2:<6F845?;78<62<927>52@5N5@2<92?8FU28F26<7265:5FF;?B2Z3K[\3QM2.X/],^]/.XLQJPX-_-W-.1-2QQSPemF 45:8F8<62?A@528F248:7;75420B2H57><42;642?5CA@;7<?B2?5GA8?5H567FD27>5?59<?527>5?528F26<29A?7>5?2:<6F845?;78<62<927>52@5N5@2<9 ?8FU-2QQSPe2?5E<?7F2<627>52F7;75H5672<92:<69<?H87BD2FA:>27>;727>52F7;75H5672:@5;?@B2845678985F^ ;J27<2=>8:>2?5FA@7F27>52F7;75H5672<92:<69<?H87B2;EE@85Fn 0J2=>8:>2FE5:898:;78<6FD2F7;64;?4F2<?2E;?7F27>5?5<92;?52H572<?26<72H57n 2 :J27>5245:8F8<62?A@52;EE@8542LA6@5FF28728F286>5?56728627>52?5GA5F7542FE5:898:;78<62<?2F7;64;?4J2Z3K[\3QM 2 .X/],^]/.XLQJPX-_-W-]1- 2
b86;@2@;0<?;7<?B2?5E<?7286:@A45F2;2F7;75H56728627>52:<N5?2E;C52jS::?5487542862;::<?4;6:52=87>2VO32]/.W2;6423K[\3QM .X/],^]/.X-2R;0<?;7<?B2:5?78985F27>;727>5275F72?5FA@7F2H5572;@@2VO32]/.W2;6423K[\3QM2.X/],^]/.X2?5GA8?5H567F2A6@5FF26<754 A645?27>528648N84A;@2;6;@BF8F-2b<@@<=86C27>52:<N5?2E;C52;?52K7;752M5?7898:;78<62R8F7D23K[2.X/],2S::?5487542e57><42R8F7D S:U6<=@54C5H5672<92K;HE@5F2d5:58N54D2M<HH567FD2o87F2d5E<?7D2a;7;2d5E<?7D2hM2KAHH;?BD2hM2d5E<?72;642d5CA@;7<?B2b<?HFD ;F2;EE@8:;0@5-2V5F72?5FA@7F2?5@;752<6@B27<27>52F;HE@5LFJ275F754-2V>8F2?5E<?72F>;@@26<72052?5E?<4A:5425g:5E728629A@@D2=87><A727>5 =?877562;EE?<N;@2<927>52@;0<?;7<?B-k 2 392M@85672?5GA8?5F2H<67>@B2?5E<?7F2<924;7;27>;724<5F26<7286:@A452;@@[email protected]>52@;0<?;7<?B28F2F78@@2?5GA8?5427<2E?<N845 ;@@2869<?H;78<62862F7;64;?42VO32?5E<?729<?H;72?5GA8?5420B27>52M@856729<?2AF52862E?5E;?86C2FA:>2?5CA@;7<?B2?5E<?7F2ZVO3PQRPi.e]P ]/.WPd5N]-.P,-./-.12Z3K[\3QM2.X/],^]/.XLQJPX-_-.-.1- UNCONTROLLED 104 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +
,
-./012,.3,455,650178,91/.982,491,3051:,151689.706455;,07,4,61789450<1:,219=19,>;,;149,47:,650178,74?1@,A64771:,30512,491,?40784071: 3.9,BC,;1492@, , BD@D@BEF, G,8;/0645,91/.98,8.,4,650178,02,6481H.90<1:,42,4,I1=15,JJ,:484,/46K4H1@,,LM02,02,8M1,2N??49;,.3,91/.981:,:484,47:,8M1,2N??49; .3,O-,073.9?480.7@ PN98M19,:484,?4;,>1,91QN1281:,39.?,4,650178R,0765N:07H,081?2,50281:,07,8M1,I1=15,JJJSJT,6M16K5028@ J7,455,64212R,650178,073.9?480.7R,U08M,8M1,1V61/80.7,.3,8M1,91QN12807H,650178R,02,8.,>1,91:4681:@ LM1,54>.948.9;,452.,H17194812,I1=15,JT,:484,/46K4H12,3.9,455,WL,24?/512R,:N1,8.,8M1,91QN1282,.3,28481,17808012@,,J7,8M02,6421R,455 650178,073.9?480.7,02,8.,>1,91:4681:R,24=1,3.9,8M1,WL,082153@, , XYZ[\,]^]_`abcd_e`afcghdggdbcebiea]gj^`g J7,8M1,6421,.3,89472?0220.7,.3,17=09.7?17845,8128,912N582,>;,8151/M.71R,34620?051,.9,.8M19,151689.706,?1472R,8M1,54>.948.9; 172N912,/91219=480.7,.3,-50178,6.730:17804508;,>;,48846M07H,4,6.=19,/4H1,8M48,0765N:12,8M1,3.55.U07H,28481?178k , lLM02,89472?0220.7,47:S.9,48846M?1782,6.78407,073.9?480.7,UM06M,491,6.730:178045,47:S.9,/90=051H1:@,LM1,073.9?480.7,02 07817:1:,3.9,8M1,4::912211,.75;@,J3,;.N,491,7.8,8M1,07817:1:,9160/0178R,47;,:0221?07480.7R,:02890>N80.7,.9,6./;07H,.3,8M02 6.??N706480.7,02,/9.M0>081:@,J3,;.N,M4=1,91610=1:,8M02,6.??N706480.7,07,199.9R,/51421,7.803;,47:,918N97,8M1,.90H0745 6.??N706480.7,8.,8M1,217:19@m,nLoJpqIpTBrspsCBtpu1=s@Bpv@D@w@s@>x , XYZy\,zbb{efj`bhf`]{e^f|baf`ba}e~af_`d_]gezf^~\ LM1,54>.948.9;,422N912,8M48,455,91QN091?1782,.3,8M1,LoJ,47:,JA,BwCsv,2847:49:2,491,6.?/501:,U08M,UM191,6.?/N8192,.9 4N8.?481:,1QN0/?178,491,N21:,3.9,8M1,46QN02080.7R,64/8N91R,/9.612207HR,?470/N5480.7R,916.9:07HR,91/.9807HR,28.94H1,.9,918901=45 .3,8128,:484@ , LM1,54>.948.9;,172N912,8M48,8M1,6.?/N819,2.38U491,02,:.6N?1781:,47:,07,2N33060178,:18405,47:,02,2N084>5;,=450:481:,42,>107H 4:1QN481,3.9,N21@,L.,/9.8168,8M1,0781H908;,.3,:484,1789;,.9,64/8N91R,:484,28.94H1R,:484,89472?0220.7,47:,:484,/9.612207HR,8M1 54>.948.9;,1284>502M12,47:,0?/51?1782,/9.61:N912,07,6.?/504761,8.,H..:,4N8.?481:,54>.948.9;,/94680612@,J7,4::080.7R 4//9./90481,/9.61:N912,491,1284>502M1:,3.9,6.?/N819,47:,4N8.?481:,1QN0/?178,8.,172N91,/9./19,3N7680.707H,47:,491,/9.=0:1: U08M,8M1,17=09.7?17845,47:,./194807H,6.7:080.72,71612249;,8.,?4078407,8M1,0781H908;,.3,6450>9480.7,47:,8128,:484@,G52.,8M1 54>.948.9;,1284>502M12,47:,0?/51?1782,4//9./90481,/9.61:N912,3.9,8M1,?4078174761,.3,216N908;,.3,:484,0765N:07H,8M1,/91=1780.7 .3,N74N8M.90<1:,466122,8.,47:,8M1,N74N8M.90<1:,4?17:?178,.3,6.?/N819,916.9:2@,LM1,54>.948.9;,IJrA,2;281?,/9.=0:12,21=1945 51=152,.3,216N908;@,LM1,30928,51=15,02,8M1,1789;,.3,4,/422U.9:,8.,07080455;,5.H,.7,8.,8M1,6.?/N819R,8M17,8M1,/192.7,?N28,>1 :120H7481:,42,4,QN450301:,N219,.3,LGIA@,G::080.7455;R,8M1,:1/498?178R,/.2080.7R,47:,9.512,8.,UM06M,4,/192.7,02,4220H71:,H.=1972 46612212,8.,8M1,=490.N2,3N7680.72,.3,8M1,2;281?@,LM1,2;281?,452.,/9.=0:12,3.9,914:,,.75;,466122,8.,912N582,8.,3N98M19,/9.8168 8M1,:484,39.?,N74N8M.90<1:,?.:0306480.7,.9,:15180.7@, , XYZ\,g`f`]eg~]_did_ea]~ba`dczea]jda]h]c`g h
,,G55,4745;812,8M48,491,91/.981:,8.,8M1,28481,.3,r42246MN21882,?N28,M4=1,4,?1472,8.,:02807HN02M,>18U117,8M1 4745;812,3.9,UM06M,qqGpr,02,61980301:R,47:,8M1,4745;812,3.9,UM06M,qqGpr,02,7.8,61980301:@,L.,?118,8M02,91QN091?178R,qqGpr,.75; 217:2,30745,91/.982,8.,8M1,r42246MN21882,1/498?178,.3,q7=09.7?17845,W9.81680.7,8M1,4745;812,3.9,UM06M,qqGpr,02,61980301:,07 r42246MN21882@,W51421,211,21680.7,@E,3.9,?.91,073.9?480.7,4>.N8,8M1,61980306480.72,8M48,qqGpr,M.5:2@ , XYZ\,h_^ecb`did_f`dbcg r-I,7.80306480.7,491,0728478471.N2,8.,8M1,Wr,.761,:484,02,307450<1:@,LM1,W9.168,r474H19,02,912/.720>51,3.9,7.803;07H,8M109 6501782,.3,47;,1V611:4761,U08M07,sD,M.N92,.3,.>840707H,=450:,:484@,A0761,8M1,91/.98,02,2178,8.,455,W9.168,r474H192R,4>2178,Wr2 U055,M4=1,8M109,6501782,:484,6M16K1:,>;,8M109,>46KN/2,07,.9:19,8.,172N91,8M48,7.,7.80306480.72,491,?0221:@,u1319,8.,.9K J7289N680.7,BtBt,3.9,r-IR,Iu,47:,oI,o.80306480.7,8.,-501782@, , u1319,8.,8M1,AN>6.78946807H,.3,q7=09.7?17845,L1282,AWsvsD,3.9,7.80306480.7,39.?,2N>6.789468,54>.948.9012@ , XYZ\,]^]_`abcd_egdzcf`ja]g BD@E@B,LM1,0:17808;,.3,8M1,20H748.9;,?N28,>1,=190301:,>13.91,47,151689.706,20H748N91,647,>1,691481:,3.9,8M48,/192.7@ BD@E@s,q46M,151689.706,20H748N91,2M455,>1,N70QN1,8.,4,207H51,07:0=0:N45,47:,2M455,7.8,>1,91N21:,>;,.9,4220H71:,8.,47.8M19 07:0=0:N45@ BD@E@,A0H748.9012,?N28,M4=1,l//.98N708;,8.,u1=01Um,/90.9,8.,4//506480.7,.3,8M1,20H748N91@ BD@E@D,W192.72,N207H,47,151689.706,20H748N91,2M455,619803;,8M48,8M1,151689.706,20H748N912,07,8M1,2;281?,491,07817:1:,8.,>1,8M1 51H455;,>07:07H,1QN0=45178,8.,8M109,894:080.745,M47:U908817,20H748N91@,7,8M1,q51689.706,A0H748N91,GH911?178R,8M1,20H748.9;,U055 28481,8M48,8M109,/422U.9:2,491,8.,91?407,6.?/51815;,6.730:178045,47:,647,.75;,>1,N21:,>;,8M1,H17N071,.U719,.3,8M1,/422U.9: UNCONTROLLED 105 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +
,
-./,0123415617621280127149:2;6<14=>60144?03:@?6A03:12>6A2B6C4?@?23:@?69?ADE4?D FGHHIJKLMI,NJKLGOP,QNR,SI,HITULHIV,WXIO,KXIHI,LP,N,YNLZUHI,KG,QIIK,TUNZLKR,JGOKHGZ,NJJI[KNOJI,JHLKIHLN\,GH,WXIO,LOKIHONZ,GH I]KIHONZ,NUVLK,PNQ[ZIP,NHI,OGK,NJJI[KNSZI^,_UNZLKR,JGOKHGZ,QINPUHIP,YGH,WXLJX,JGOKHGZ,ZLQLKP,NHI,IPKNSZLPXIV,NOV,QNLOKNLOIV LOJZUVI`,aFb\,VU[ZLJNKIP\,QIKXGV,SZNOcP\,PUHHGdNKI,HIJGMIHLIP\,ebfebg\,ehaP\,JNZLSHNKLGOP\,JGOKLOULOd,JNZLSHNKLGOP,NOV PIOPLKLMLKR,JXIJcP^,hIYIH,KG,KXI,JUHHIOK,iGOjFGOYGHQLOd,kGHc,NOV,FGHHIJKLMI,lJKLGO,bmnoppq,YGH,iGOjJGOYGHQLOd,WGHc [HGJIVUHIP^ , -.r-/,0144?03:@?6A03:126C410?BE4?D>6st69?3u1B b[IJLYLJ,JGHHIJKLMI,NJKLGOP,GO,N,QIKXGVjSRjQIKXGV,SNPLP,JNO,SI,YGUOV,LO,LOVLMLVUNZ,QIKXGV,bmnP^,FGHHIJKLMI,NJKLGO,WLZZ,SI LOLKLNKIV,NP,N,HIPUZK,GY,YLOVLOdP,YHGQ,LOKIHONZ,GH,I]KIHONZ,NUVLKP\,OGK,NJJI[KNSZI,HIPUZKP,YHGQ,[IHYGHQNOJI,PNQ[ZIP\,ZNHdI MNHLNKLGO,YHGQ,P[ZLK,PNQ[ZIP,NOV,LONVITUNKI,TUNZLKR,NP,VIKIHQLOIV,SR,VNKN,MNZLVNKLGO,HIMLIW^ , -.rv/,0144?03:@?6A03:126C410?BE4?D>6411360AED?>6C4?@?23:@?69?ADE4?D>6BA3A6wEA5:7:?4D>6A2B 4?C14360199?23D, -.rvr-/,Dxyxz{|}~6~6:yxx~{{|}~6}60}xz{| x6Az{|}~ bRPKIQNKLJ,YNLZUHIP,KG,QIIK,JHLKIHLN,GY,KXI,aFb\,PUHHGdNKI,P[LcIP\,LOKIHONZ,PKNOVNHVP\,JGOKLOULOd,JNZLSHNKLGO,PKNOVNHVP\,XGZVLOd KLQI,I]JIIVNOJI\,LQ[HG[IHZR,[HIPIHMIV,PNQ[ZIP\,QIKXGV,SZNOc,JGOKNQLONKLGO,NHI,_F,YNLZUHIP,KXNK,KHLddIH,KXI,dIOIHNKLGO,GY JGHHIJKLMI,NJKLGOP,KG,LVIOKLYR,KXI,HGGK,JNUPI,GY,KXI,[HGSZIQ^,hGGK,JNUPIP,GY,KXI,[HGSZIQ,NHI,VGJUQIOKIV,LO,KXI,FGHHIJKLMI lJKLGO,hI[GHK,Flh,GO,Ihl^ , GH,LOPKNOJI\,WXIO,N,QNKHL],P[LcI,YNLZUHI,GJJUHP,VUHLOd,KHNJI,QIKNZP,NONZRPLP\,KXI,NONZRPK,YLHPK,JXIJcP,KXI,hbg,YGH,KXI QUZKL[ZI,QINPUHIQIOKP,KG,PII,LY,KXI,hbg,LP,ZIPP,KXNO,p^,XIO,KXI,JNZLSHNKLGO,MIHLYLJNKLGO,WLZZ,SI,JXIJcIV,NZGOd,KXI JNZLSHNKLGO,SZNOc\,[HI[NHNKLGO,SZNOc\,NOV,KXI,PIJGOV,PGUHJI,aFb,PKNOVNHV,HIJGMIHR^,XI,PKNOVNHVP,NOV,HINdIOKP,[HI[NHNKLGO NOV,I][LHNKLGO,VNKIP,NHI,HIMLIWIV^,b[LcLOd,PGZUKLGOP,NHI,MIHLYLIV,KG,IOPUHI,KXNK,XIHI,NHI,OG,IHHGHP,QNVI,LO,JNZJUZNKLGOP,NOV,LO P[LcLOd^,Y,KXI,ebfebg,HIJGMIHLIP,NHI,GUKPLVI,KXI,LOKIHONZ,_F,ZLQLKP,NOV,NZZ,KXI,NPPGJLNKIV,_FP,YGH,KXI,SNKJX,NHI,NJJI[KNSZI\ KXI,hng,YGH,ebfebg,HIJGMIHLIP,QUPK,SI,JXIJcIV^,Y,KXI,hng,LP,YGUOV,KG,SI,WLKXLO,KXI,p,JHLKIHLN\,KXI,UONJJI[KNSZI HIJGMIHLIP,NHI,NOOGKNKIV,LO,KXI,HI[GHK,NP,PUP[IJK,VUI,KG,QNKHL],IYYIJK^,Y,KXI,JGOJIOKHNKLGO,GY,KXI,SNJcdHGUOV,LP,QUJX,XLdXIH KXNO,KXI,P[LcLOd,NQGUOK,KXI,HI[GHK,WLZZ,SI,NOOGKNKIV,NZPG^,Y,KXI,hng,LP,GUKPLVI,KXI,ZLQLKP\,KXI,PNQ[ZI,KXNK,WNP,P[LcIV,LP JXIJcIV,MLPUNZZR,KG,PII,LY,KXI,PNQ[ZI,LP,XGQGdIOGUP\,LY,KXI,PNQ[ZI,LP,XGQGdIOGUP,KXI,SNKJX,WLZZ,SI,HINONZRIV^,eNKHL] YNLZUHI,WLZZ,OIIV,KG,SI,HINONZRIV,GH,HI[HGJIPP,KXI,SNJc,U[,PNQ[ZI,KG,JGOYLHQ,QNKHL],YNLZUHI^ XI,[HGJIVUHI,LP,KG,LVIOKLYR,HGGK,JNUPI\,XNMI,KXI,JGHHIJKLMI,NJKLGO,LQ[ZIQIOKIV\,NOV,KG,KXI,VIdHII,N[[HG[HLNKI,YGH,KXI QNdOLKUVI,NOV,HLPc,GY,KXI,[HGSZIQ^,lje,HIKNLOP,HIJGHVP,GY,OGOJGOYGHQLOd,WGHc,NOV,NJKLGOP,NP,P[IJLYLIV,LO,bmfF qp`pq^qp^q^, , -.rvrv/,B}zx~{{|}~6}60}xz{|
x6Az{|}~,
q^^^q,lje,UPIP,KWG,JGHHIJKLMI,NJKLGO,[HGKGJGZP`,QQIVLNKI,JGHHIJKLMI,NJKLGOPf,IJXOLJNZ,FGHHIJKLMI,lJKLGO,NOV,aGOd,KIHQ JGHHIJKLMI,NJKLGOPf,GHQNZ,FGHHIJKLMI,lJKLGO^,FGHHIJKLMI,NJKLGO,YGH,OGOjPRPKIQNKLJ,IHHGHP,GH,I][IJKIV,HNOVGQ,YNLZUHIP,LP VGJUQIOKIV,GO,NO,iFe^,l,ZGOdjKIHQ,NJKLGO,LP,VIPLdOIV,KG,IZLQLONKI,JNUPIP,GY,OGOJGOYGHQNOJI,WXIO,KXIHI,LP,N,[NKKIHO,GY,OGO GOYGHQNOJI,NOV,LP,VGJUQIOKIV,GO,N,Flh,YGHQ,LO,Ihl^,hIJGHVP,NHI,QNLOKNLOIV,LO,Ihl,GY,KXI,ONKUHI,GY,KXI OGOJGOYGHQLKLIP\,JNUPIP,NOV,NOR,PUSPITUIOK,NJKLGOP,KNcIO,NOV,KXI,HIPUZKP,GY,NOR,JGHHIJKLMI,NJKLGO^ , q^^^,hIPUZKP,NHI,YZNddIV,OGK,GOZR,YGH,TUNZLKR,JGOKHGZ,YNLZUHIP,WXIHI,iFeP,XNMI,SIIO,dIOIHNKIV,SUK,NZPG,YGH,NZZ,GKXIH,_F YNLZUHIP,KXNK,XNMI,LQ[NJK,GO,KXI,VNKN,TUNZLKR,GY,KXI,HIPUZK^,lZZ,HIPUZKP,NHI,YZNddIV,LY,VNKN,LP,PUP[IJK,GH,_F,WNP,OGK,NJJI[KNSZI^, , q^^^o,gNKN,TUNZLYLIHP,NHI,UPIV,SR,KXI,ZNSGHNKGHR,LO,HI[GHKLOd,NONZRKLJNZ,HIPUZKP,KG,YZNd,KXI,UPIH,NSGUK,KXI,VNKN^,bGQI,GY,KXI TUNZLYLIHP,SIZGW,WIHI,HITUIPKIV,SR,N,P[IJLYLJ,JZLIOK,NP,HITULHIV,LO,KXI,nHGIJKP,_UNZLKR,lPPUHNOJI,nZNO,KG,IOPUHI,KXNK,KXI,gNKN _UNZLKR,mSIJKLMIP,GY,KXI,[HGIJK,NHI,QIK^ , q^^^,FGQQIOKP,GO,KXI,HIPUZKP,NHI,[HGMLVIV,KG,KXI,JZLIOKP,GO,KXI,YLONZ,HI[GHK,YGH,_F,OGOJGOYGHQNOJI^,O,NVVLKLGO\,NOR,_F VNKN,I]JIIVLOd,_F,NJJI[KNOJI,JHLKIHLN,NHI,UOVIHZLOIV,KG,YZNd,KXI,UPIH,NSGUK,KXI,_F,YNLZUHI,NOV,LKP,LQ[NJK,KG,KXI,VNKN,TUNZLKR,GY KXI,NPPGJLNKIV,PNQ[ZIP,LO,KXI,SNKJX^, , q^^^,gI[IOVLOd,GO,KXI,PLdOLYLJNOJI,GY,OGOJGOYGHQNOJI\,KXI,FZLIOK,LP,OGKLYLIV,SR,KXI,nHGIJK,eNONdIH,NOV,WGHc,HIJNZZIV,LY OIJIPPNHR,ijajqejpqjhIM^qj^^q^V,bmfF,qp`pqj^qp^q^I^,XI,FZLIOK,LP,OGKLYLIV,LQQIVLNKIZR,YGH [GPPLSZI,HIjPNQ[ZLOd^ , q^^^,kXIHI,KXI,IMNZUNKLGO,LOVLJNKIP,KXNK,KXI,OGOJGOYGHQLOd,WGHc,JGUZV,HIJUH\,GH,KXNK,KXIHI,LP,VGUSK,NSGUK,KXI ZNSGHNKGHRP,JGQ[ZLNOJI,WLKX,LKP,GWO,QNONdIQIOK,PRPKIQ,[GZLJLIP,NOV,[HGJIVUHIP\,GH,GO,LKP,JGQ[ZLNOJI,WLKX,KXI,i,pq,bKV NOV,bm,qp,bKV\,KXI,ZNSGHNKGHR,PXNZZ,LQ[ZIQIOK,JGHHIJKLMI,NJKLGO,NOV,IOPUHI,KXNK,KXI,N[[HG[HLNKI,NHINP,GY,NJKLMLKR,NHI NUVLKIV,ijajqejpqjhIM^qj^qq^bmfF,qp`pqj^qp^o^ , q^^^,lJKLGOP,LOJZUVLOd,XNZKLOd,GH,HI[INKLOd,GY,WGHc,NOV,WLKXXGZVLOd,GY,HI[GHKP\,NP,OIJIPPNHR,NHI,SNPIV,U[GO,KXI,HLPc ZIMIZP,IPKNSZLPXIV,SR,lje,bmfF,qp`pqj^qp^q^S^,lje,U[VNKIP,HLPcP,NOV,G[[GHKUOLKLIP,VIKIHQLOIV,VUHLOd [ZNOOLOd\,LY,OIJIPPNHR,bmfF,qp`pqj^^q^I^,hLPcP,NHI,NPPIPPIV,SNPIV,U[GO,KXI,ZNSGHNKGHRP,NSLZLKR,KG,[HGVUJI ZIdNZZR,VIYIOPLSZI,VNKN,GY,cOGWO,NOV,VGJUQIOKIV,TUNZLKR\,WLKX,KXI,YGJUP,GY,KXI,LQ[NJK,GY,HLPc,JGOJIHOLOd,HI[GHKLOd,VNKN,YGH WXLJX,lje,JNO,ZIdNZZR,VIYIOV,NP,SILOd,MNZLV,YGH,LOKIOVIV,UPI,L^I^,KR[LJNZZR,JGQ[ZLNOJI^ UNCONTROLLED 106 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +
,
-./0/12,3456748659:4;:<488=>76?=:@>7645,
ABCDCECAF,GHIIJKLMNJ,OKLMHPQ,MRSTJRJPLJU,OIJ,RHPMLHIJU,MV,KHIIJKLMNJ,OKLMHPQ,OIJ,JVVJKLMNJ,LH,IJRHNJ,LWJ,SIHXTJR,YZ[\]^_] `AaD]DbAc]dJNDCA]eCAACefY\ghi\^G,AjbDBkDbAjl^F]mCjCACUfC, , ABCDCECDF,no,RHPMLHIQ,GodQ,VHI,LIJPUQ,OPU,PHLMVMJQ,LWJ,OPOTpQL,OPU,QqSJINMQHI,HV,LWJ,PJJU,LH,KHIIJKL,LWJ,SIHXTJR,OPU MRSTJRJPL,KHIIJKLMNJ,OKLMHP,LH,SIJNJPL,LWJ,SIHXTJR,VIHR,IJHKKqIIMPrC,o,IJSHIL,HV,VTOr,LIJPUQ,MQ,IJSHILJU,LH,ROPOrJRJPL,HP,O sJJtTp,XOQMQ,,HI,MRRJUMOLJTp,qSHP,UJLJKLMHP,HV,O,LIJPU,LWOL,ROp,WONJ,SHLJPLMOT,VHI,SqLLMPr,LWJ,TOXHIOLHIp,HI,KTMJPLQ,OL,IMQtC , -./0/u2,v8=?=576?=:3=wxy8=x,
ABCDCeCAF,GodQ,IJzqMIJ,LWJ,OPOTpQL,LH,UHKqRJPL,SIJNJPLMNJ,RJOQqIJQ,LH,JPQqIJ,LWOL,LWJ,SIHXTJRQ,sMTT,PHL,IJ]HKKqI,YZ[\]^_] `AaD]DbAc]dJNDCA]eCADCAfC,\ghi\^G,AjbDBkDbAj,WOQ,IJRHNJU,SIJNJPLMNJ,OKLMHP,MP,GodQ{,XqL,MPKHISHIOLJU,SIJNJPLMNJ OKLMHP,MP,HSSHILqPMLMJQ,VHI,MRSIHNJRJPL,Y\ghi\^G,AjbDBkDbAjl^F]mCcf,OPU,IMQtQ,Y\ghi\^G,AjbDBkDbAjl^F]mCBfC , ABCDCeCDF,|IJNJPLMNJ,OKLMHP{,IOLWJI,LWOP,KHIIJKLMNJ,OKLMHP{,OMRQ,OL,RMPMRM}MPr,HI,JTMRMPOLMPr,MPVJIMHI,UOLO,zqOTMLp,HI,HLWJI,PHP] KHPVHIROPKJ,LWIHqrW,QKWJUqTJU,ROMPLJPOPKJ,OPU,IJNMJs{,XJVHIJ,LWJ,PHP]KHPVHIROPKJ,HKKqIQC,|IJNJPLMNJ,OKLMHP,MQ,rJPJIOLJU sWJP,KMIKqRQLOPKJQ,OIJ,MUJPLMVMJU,sWJIJ,O,zqOTMLp,VOMTqIJ,HI,PHP]KHPVHIROPKJ,MQ,O,SHQQMXMTMLp,HI,sWJIJ,OP,HSSHILqPMLp,MQ MUJPLMVMJU,LH,QLIJPrLWJP,LWJ,zqOTMLp,QpQLJRC , ABCDCeCEF,|IJNJPLMNJ,OKLMHP,MPKTqUJQ{,XqL,MQ,PHL,TMRMLJU,LH{,IJNMJs,HV,nG,UOLO,LH,MUJPLMVp,zqOTMLp,LIJPUQ{,IJrqTOITp,QKWJUqTJU,QLOVV zqOTMLp,RJJLMPrQ{,OPPqOT,ROPOrJIMOT,IJNMJsQ{,IqPPMPr,O,PJs,_\ag,MP,LOPUJR,sMLW,LWJ,HTU,QpQLJR,LH,OQQqIJ,OL,TJOQL,HPJ sHItMPr,QpQLJR{,OPU,HLWJI,OKLMHPQ,LOtJP,LH,SIJNJPL,SIHXTJRQC , ABCDCeCeF,oTT,QLOVV,IJKHRRJPUQ,SIJNJPLMNJ,OKLMHP,SIHKJUqIJQ,LH,LWJ,nqOTMLp,aOPOrJI,OPU,ROPOrJRJPL,MQ,IJQSHPQMXTJ,VHI MRSTJRJPLMPr,SIJNJPLMNJ,OKLMHPC , -./12,~@
:@
@<
:3 ZWJ,MPKHISHIOLMHP,HV,zqOTMLp,KHPLIHT,QORSTJQ,OPU,IJVJIJPKJ,ROLJIMOTQ,MPLH,LWJ,TOXHIOLHIp,zqOTMLp,KHPLIHT,SIHrIOR,MQ,HV,TMLLTJ,qQJ MP,ROMPLOMPMPr,HNJIOTT,OPOTpLMKOT,zqOTMLp,KHPLIHT,qPTJQQ,LWJ,TOXHIOLHIp,WOQ,JQLOXTMQWJU,OKKJSLOPKJ,KIMLJIMO,VHI,LWJQJ,QORSTJQC nqOTMLp,KHPLIHT,QORSTJQ,VOTTMPr,HqLQMUJ,HV,LWJQJ,KIMLJIMO,QJINJ,OQ,VTOrQ,LH,QMrPOT,LWJ,SIHUqKLMHP,HV,qPOKKJSLOXTJ,UOLO,sWMKW,RqQL XJ,IJIqP,HI,IJSHILJU,OQ,QqQSJKL,UOLO,MV,IJ]IqPPMPr,MQ,PHL,OP,HSLMHP,UqJ,LH,JSMIJU,WHTUMPr,LMRJQ,HI,TOKt,HV,QORSTJ,NHTqRJC , -./1/-2,@84w>:74:=77659:667x HI,RJLWHUQ,LWOL,UH,PHL,QSJKMVp,OKKJSLOPKJ,TMRMLQ{,LWJ,TOX,JQLOXTMQWJQ,TMRMLQ,LWIHqrW,KHPLIHT,KWOILQC,ZWJQJ,TMRMLQ,RqQL,XJ qSUOLJU,HPKJ,O,pJOIC,ZWJQJ,TMRMLQ,OIJ,XOQJU,qSHP,WMQLHIMKOT,IJKHNJIMJQ,HV,_Gg,QORSTJQ,OQQHKMOLJU,sMLW,QSJKMVMK,ROLIMKJQ,lHI sWJIJ,_Gg,QORSTJQ,OIJ,PHL,qLMTM}JU{,LWJp,OIJ,XOQJU,HP,QSMtJ,IJKHNJIMJQ,HI,UqSTMKOLJ,TMRMLQ,VHI,ROLIM,QSJKMVMK,QORSTJQFC , HI,LWHQJ,KOQJQ,sWJIJ,MPQqVVMKMJPL,WMQLHIMKOT,MPVHIROLMHP,JMQLQ,LH,QJL,QLOLMQLMKOTTp,RJOPMPrVqT,_Gg,HI,ROLIM,QSJKMVMK,TMRMLQ{,^^o] a,WOQ,QJL,TMRMLQ,XOQJU,HP,LWJ,JSJKLJU,SJIVHIROPKJ,HV,LWJ,OPOTpQMQ,qPLMT,WMQLHIMKOT,TMRMLQ,KOP,XJ,KOTKqTOLJUC,ZWJQJ,TMRMLQ,OIJ LWJP,OQQHKMOLJU,sMLW,QSJKMVMK,KHPLIHT,IJzqMIJRJPLQ,LH,UJLJIRMPJ,HqL,HV,KHPLIHT,JNJPLQC, , -./1/02,:4>y=57w7645:4;:667x,
ABCECDCAF,dJOrJPL,TOPtQ,],dJOrJPL,XTOPt,NOTqJQ,RqQL,IJROMP,THsJI,LWOP,LWJ,IJSHILJU,ad_,lQHRJ,RJLWHUQ,IJzqMIJ,,HI,AiE ad_F,VHI,JOKW,OPOTpLMKOT,SIHKJUqIJC,\V,OP,OPOTpQL,PHLMKJQ,OP,MPKIJOQJ,MP,LWJ,IJOrJPL,XTOPt,sWMKW,MQ,XJrMPPMPr,LH,OSSIHOKW,LWMQ TMRML{,LWJ,QHqIKJ,HV,KHPLORMPOLMHP,RqQL,XJ,MPNJQLMrOLJU,XJVHIJ,VqILWJI,OPOTpQJQ,OIJ,SJIVHIRJUC , ABCECDCDF,^LJIPOT,dJVJIJPKJ,gORSTJQ,],dJKHNJIMJQ,HP,JLJIPOT,IJVJIJPKJ,QORSTJQ,RqQL,VOTT,sMLWMP,LWJ,OKKJSLOPKJ,TMRMLQ SIHNMUJU,sMLW,LWJ,LIqJ,NOTqJQC , ABCECDCEF,\PLJIPOT,OPU,gqIIHrOLJ,gLOPUOIUQ,],oQ,QSJKMVMJU,Xp,LWJ,RJLWHUQ{,MPLJIPOT,QLOPUOIUQ,OIJ,IqP,sMLW,JOKW,HV,LWJ KOTMXIOLMHP,QLOPUOIUQ,OPU,LWJ,OIJO,KHqPLQ,OIJ,IJKHIUJU,HP,LWJ,QORJ,VHIR,OQ,LWJ,IJQSHPQJ,VOKLHIQC,oPp,QLOPUOIU,LWOL,WOQ,OP MPLJIPOT,QLOPUOIU,OIJO,KHqPL,XJpHPU,Bb,HV,LWJ,ONJIOrJ,MPLJIPOT,QLOPUOIU,OIJO,KHqPL,VHI,OTT,MPMLMOT,KOTMXIOLMHP,QLOPUOIUQ,RqQL XJ,IJIqP,LH,RJJL,LWJQJ,KIMLJIMOC,oPp,QORSTJ,sMLW,OP,MPLJIPOT,QLOPUOIU,KHqPL,XJpHPU,Bb,lHI,OQ,QLOLJU,MP,LWJ,SOILMKqTOI,gh|F HV,LWJ,ONJIOrJ,MPLJIPOT,QLOPUOIU,KHqPLQ,VHI,LWJ,\Go_,QLOPUOIUQ,RqQL,XJ,IJIqPC,gqIIHrOLJ,QLOPUOIUQ,RqQL,RJJL,LWJ,IJKHNJIp TMRMLQ,QSJKMVMJU,MP,LWJ,OPOTpLMKOT,RJLWHU,HI,JQLOXTMQWJU,WMQLHIMKOT,TMRMLQ{,sWMKW,OIJ,qSUOLJU,SJIMHUMKOTTpC , ABCECDCeF,TMPU,GWJKt,gORSTJQ,],ZWJ,IJQqTLQ,HV,XTMPU,KWJKt,QORSTJ,OPOTpQJQ,RqQL,VOTT,sMLWMP,LWJ,OKKJSLOPKJ,KIMLJIMO,SIHNMUJU sMLW,LWJ,QORSTJQC , -./1/12,<:<45784:667x ^^o]a,qQJQ,RJLWHU,OKKJSLOPKJ,TMRMLQ,VHI,_Gg,TMRMLQ,MP,sOLJI,ROLIM,LH,OQQJQQ,OPOTpLMKOT,KHPLIHTC,oTT,OPOTpQLQ,WONJ,IJKJMNJU,O KHSp,HV,LWJQJ,OKKJSLOPKJ,TMRMLQ,OPU,RqQL,JPQqIJ,LWOL,LWJMI,_Gg,QORSTJ,IJQqTLQ,VOTT,sMLWMP,LWJ,QLOLJU,OKKJSLOXTJ,IOPrJQC,\V QSJKMVMK,KHPLIHT,TMRMLQ,WONJ,PHL,XJJP,SIHNMUJU,VHI,ROLIM,QSMtJQ,HI,UqSTMKOLJQ{,_Gg,KIMLJIMO,OIJ,qQJU,qPLMT,QqVVMKMJPL,UOLO,MQ rJPJIOLJU,LH,KOTKqTOLJ,WMQLHIMKOT,TMRMLQ,VHI,LWJ,agiag,QORSTJQ,VHI,O,SOILMKqTOI,ROLIMC,oPp,QORSTJQ,OQQHKMOLJU,sMLW qPOKKJSLOXTJ,_Gg,QORSTJQ,RqQL,XJ,IJ]IqP,qPTJQQ,HLWJI,KIMLJIMO,OIJ,ONOMTOXTJ,LH,OTTHs,OKKJSLOPKJ,HV,LWJ,UOLO,sMLWHqL zqOTMVMKOLMHPC,\V,O,QORSTJ,KOPPHL,XJ,IJIqP,UqJ,LH,JKJJUJU,WHTUMPr,LMRJQ,HI,TOKt,HV,QqVVMKMJPL,QORSTJ,NHTqRJ,HI,sJMrWL{,LWJP LWJ,UOLO,RqQL,XJ,zqOTMVMJU,OQ,JQLMROLJU,sWJP,IJSHILJU,LH,LWJ,KTMJPLC , -./u2,<
:<@UNCONTROLLED 107 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +
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`D4;53FI0S-0E4M?4K605@403?B?560:;<01@:E56052 <454EB?;40K@45@4E0:;F02G05@40<:5:0?602D5.2G.12;5E23I0AG05@4012;5E2301@:E560?;<?1:540:;02D5.2G.12;5E2304M4;5L0:CCE2CE?:54 12EE415?M40:15?2;0?60?BB4<?:543F05:R4;0520JE?;H05@40:;:3F6?60J:1R0?;52012;5E23I0 0 abcbd0efghijkfilmngfmjioifpqrqrsmtrjmfiegfoqrsmgkougnuhgrofgvmtrtvwlil0 abcbcad0jxyz{z{|m}{mg~uyuh{mt{}z -;0:;:3F6?60?602D5.2G.12;5E230K@4;4M4E0:0`D:3?5F012;5E2306:BC3402E0C:E:B454E0G:33602D56?<402G0:114C5:;1403?B?56I0SD:3?5F012;5E23 C:E:B454E60:E404M:3D:54<0G2E05@4?E0:114C5:J?3?5F02;0:0<:?3F0J:6?60:112E<?;H0520465:J3?6@4<0:114C5:;1403?B?560:;<0:E40:362 B2;?52E4<0K?5@012;5E2301@:E560520<4541505E4;<60?;0M:E?:J?3?5FL0K@?1@0:E40?;<?1:5?M402G0:06@?G50?;05@40B45@2<232HF0<D40520:;:3F5?1:3 4EE2EI 0 abcbcacad0hzxz}mkx
0 acmj}zm~}zmh{ O@40`D:3?5F012;5E230C:E:B454E60D5?3?N4<0JF0,,-./0K4E40<45:?34<0?;09415?2;0[[I[I0-3302G05@464012;5E2360:E404M:3D:54<02;0:0<:?3F J:6?60:;<0BD650C:6605@401E?54E?:0<45:?34<0?;05@?606415?2;I0,:1@0:;:3F650?60G:B?3?:E0K?5@05@401E?54E?:0G2E0@?6=@4E0:;:3F6460:;<0?6 E46C2;6?J340G2E0?;6DE?;H05@:50:330`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abcbcacad0cmt}xmmh{mh}mq{xx}z{ O@4012;5E2301@:E560H4;4E:54<0JF05@40O-790:E40:052230520:332K05@40:;:3F650520E412H;?N40C254;5?:30CE2J34B60K@4;4M4E064M4;02E B2E4012;641D5?M40C2?;560G:330:J2M402E0J432K05@40B4:;L02E025@4E05E4;<602E0C:554E;60?;05@40<:5:0211DEI 0 abcbcd0fx{
z{|mm}{mg~uyuh{mix{ A50?60?BC2E5:;50520@:M40:;02C4E:5?2;:306F654B0K?5@?;0,,-./0G2E0E412H;?N?;H02D5.2G.12;5E2304M4;560:60622;0:605@4F0211DE06205@4 :CCE2CE?:540:15?2;01:;0J405:R4;0520JE?;H05@40:;:3F6?60J:1R0?;52012;5E23I0O@?60K?330?;6DE405@:50;20<:5:0H4560E4C2E54<0GE2B0: C4E?2<0K@4;05@40:;:3F6?60K:602D5.2G.12;5E23I 0 abcbccad0fxm}{
mfx{zzzzx O@40:;:3F650@:60CE?B:EF0E46C2;6?J?3?5F0G2E0M4E?GF?;H05@:50:330<:?3F0S80C:E:B454E60G:330K?5@?;05@40:114C5:;1403?B?560J4G2E4 6DJB?55?;H05@40<:5:0G2E0E4M?4KI04M?4K0:505@40:;:3F65034M4304;:J3460B26504EE2E60520J401:DH@50?BB4<?:543F0:;<0CE4M4;56 E4C2E5?;H0<43:F6I02332K?;H05@40:;:3F6560M4E?G?1:5?2;L05@40<:5:0?60E4M?4K4<0JF0:;0:CCE2CE?:543F05E:?;4<0C44E0:;:3F6502E 6DC4EM?62EI0-3302G05@40`D:3?5F012;5E230C:E:B454E60:E40E4M?4K4<0G2E012BC3?:;140K?5@05@40:114C5:;1401E?54E?:0:;<05@401:31D3:5?2;6 2;05@40E:K0<:5:0G2EB60:E401@41R4<0G2E04EE2E60?;0<:5:0B:;?CD3:5?2;I0AG05@40E4M?4K4E0;25?1460:0CE2J34BL05@40:;:3F650?60;25?G?4< ?BB4<?:543F0:;<012EE415?M40:15?2;0?605:R4;I0-3306:BC3460:6621?:54<0K?5@0D;:114C5:J340`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email protected];5E2304M4;5606DBB:E?N4<0?;09415?2;0[II[0@:M40211DEE4<I0AG062L05@40:;:3F650BD650?;?5?:54012EE415?M4 :15?2;0J4G2E4012;5?;D?;H0K?5@05@40:;:3F6?6I0 0 abcbccd0jxyz{z{|ml~xml}x 9:BC340<:5:0?6012;6?<4E4<06D6C4150?G0:6621?:54<0K?5@0D;:114C5:J340/9=/9>0:;<078906:BC34602E0C:E502G0:;0:;:3F5?1:30ED;05@:5 UNCONTROLLED 108 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +,
-./0.1021.33456.78403.897:.69;10;:0.104<64:1.80:4=4:41340>.?5840@.>0;260;=0.104<54364/0:.1A4B0CDEFG0/.6.09>03;1>9/4:4/ >2>543609=06-409164:1.80;:0>2::;A.640>6.1/.:/>0@4:401;60:43;H4:4/[email protected]:.1A4B0G.?5840/.6.09>0.8>;03;1>9/4:4/ >2>543609=06-40:4.A416078.1I0-.>0>27>6.169.88J0913:4.>4/074J;1/01;:?.80:.1A40.1/04<344/>0.1J0;=06-403;?5;21/0FKLM>B 0 NOPOPQPRS0TUVWXYUZ[\]^\[_WV`ab\[c^\^[dXa[ef\[ga`fX\ah i609>06-402869?.640:4>5;1>979896J0;=06-40jjklF0>6.==06;041>2:406-.60>2>54360/.6.0.:401;60:45;:64/B0m-408.7;:.6;:J05:;34/2:4> 32::4168J0:4n29:406-.60.1.8J>6>0?.J01;604164:06-49:0=91.80/.6.0916;06-403;?5264:02169806-49:0.1.8J693.80/.6.0=;:?0.1/ .33;?5.1J91A0oD05.:.?464:>0-.H4074410:4H94@4/0.1/0.55:;H4/07J0.10.55:;5:9.648J06:.914/0544:0;:0>254:H9>;:B0m-40ok0C:;25 54:=;:?>054:9;/930>J>64?0.2/96>06;041>2:406-.606-9>05:;34/2:409>0@;:I91A05:;54:8J0.1/05:45.:4>0:45;:6>06;08.70?.1.A4?416 7.>4/0;106-4>40.2/96>B 0 NOPOPQPpS0qfXXab\Yra[db\YfU0
stBtBuBvw0sB0i=06-403.897:.69;10=.98>x06-40.1.8J>60?2>60/464:?9140@-46-4:06-405:;784?0894>0@96-06-40>6.1/.:/x06-40:4.A416>x0;:0.1 91>6:2?4160?.8=21369;1>B0m-9>09>02>2.88J0/464:?914/07J0:[email protected];=06-403.897:.69;10oD05.:.?464:>0.1/0/464:?9191A0@-93- >5439=9305.:.?464:>0/;01;60?44606-403:964:9.B0y;:04<.?584z0sw06-40:4A:4>>9;10>6.69>693>0.1/0:43.8328.64/0>6.1/.:/>08;;I0=914x0uw 6-4:40@.>08966840/:9=60/2:91A06-40:21x0{w06-4054.I>0.554.:0>.69>=.36;:Jx0vw06-40:4.A416078.1I09>08;@x07260tw06-404<64:1.80:4=4:4134 >.?5840@.>0;260;=0:.1A4x09609>089I48J06-.606-405:;784?0894>0@96-06-409164A:96J0;=06-40>6.1/.:/02>4/06;0?.I402506-40@;:I91A >6.1/.:/>0.1/0.014@0>6;3I0>6.1/.:/0?2>607405:45.:4/B 0 stBtBuBvw0uB0i=03.897:.69;10.554.:>0.33456.78407260>;?40;=06-40/25893.640.1/0>59I4/0>.?584>0.:4021.33456.784x06-40.1.8J>6 ?2>60/464:?9140@-46-4:06-4:409>0.0?.6:9<05:;784?09164:=4:[email protected]>9>0;:06-405:45.:.6;:J0/9A4>69;1B0i=0.880;=06-4 21.33456.7840/25893.64>0.1/0>59I4>0;332:0;10.0>5439=9306J540;=0?.6:9<x06-9>09>0A;;/04H9/413406-.606-4:409>0.0?.6:9<09164:=4:4134 5:;784?B0|-410.05:45.:.6;:J0/9A4>69;109>05.:60;=06-405:;34/2:4x06-405:;784?03.107409>;8.64/06;06-40/9A4>69;10;:06-4 91>6:2?416.80.1.8J>9>07J03;?5.:91A06-40LDGx0@-93-0@.>03.::94/06-:;2A-06-40/9A4>69;106;0.0LDG0>.?5840.1.8J}4/0@96-;26 /9A4>69;1B0i=0.0?.6:9<05:;784?09>091/93.64/x06-40.1.8J>60?2>60/464:?91406-40?;>60.55:;5:9.6405:;34/2:40=;:0.884H9.691A06-4 9164:=4:41340>23-0.>0/982691A06-40>.?584x02>91A0>6.1/.:/0.//969;1>x054:=;:?91A06-40.1.8J>9>0.60.0/9==4:[email protected]>91A0. /9==4:4160CD03;82?1x0;:0?;/9=J91A06-40/9A4>69;105:;34/2:4B 0 stBtBuBvw0{B0i=0.1021.33456.7840:4>28609>0;76.914/0;10.07891/03-43I0>.?584x06-405:;784?0?2>607409>;8.64/B0m;0?.916.9106-407891/ 1.62:40;=06-40>.?584>x06-40:2103;16.9191A06-407891/03-43I0>.?58409>0:4H94@4/07J06-40ok0C:;2506;0/464:?91409=0.1J0;=06-4 n2.896J03;16:;805.:.?464:>0@4:4021.33456.7840;:09=06-40>.?5840@.>0:210;26>9/406-40;569?2?0:.1A40;=06-403.897:.69;1B0i=01; .55.:41603.2>40;=04::;:09>0=;21/x0.0>43;1/03-43I0>.?58409>0>27?9664/06;0/464:?9140@-46-4:06-404::;:0;332::4/0/2:91A 5:45.:.69;10;=06-407891/03-43I0>.?584B 0 stBtBuBvw0vB0i=0.10;26l;=l3;16:;804H41609>091/93.64/07J0.0>-9=60;:06:41/0;10.03;16:;803-.:6x06-40=;88;@91A0/9.A1;>6930>6:.64AJ0@988 740.55894/z0 0 stBtBuBvw0vBsB0k0>-9=609106-40?4.10;=06-4054:3416.A40:43;H4:J03-.:603;28/07403.2>4/07J0913;::43605:45.:.69;10;=0.0>6.1/.:/0;:0. :4.A416x03;16.?91.69;10;=06-40>.?584x0913;::436091>6:2?41603.897:.69;1x091>6:2?41603;?5;14160/464:9;:.69;10.1.8J>604::;:x0/9:6J 5954664>05:4H41691A05:;54:0/:.91.A4x0;:0;6-4:05:45.:.6;:J0>645>B0 0 stBtBuBvw0vBuB0k06:41/0;=06-40?4.1025@.:/03;28/07403.2>4/07J0/464:9;:.69;10;=06-40>6.1/.:/0;:06-40:4.A416>0;:0.03-.1A409106-4 4<6:.369;104==939413J 0 stBtBuBvw0vB{B0k06:41/0;=06-40?4.10/;@1@.:/03;28/07403.2>4/07J03;13416:.69;10;=06-40>6.1/.:/0/2406;04H.5;:.69;1x /464:9;:.69;10;=0:4.A416>x0.1/0.03-.1A409106-404<6:.369;104==939413J0;:091>6:2?41603;?5;14160=.982:4 0 stBtBuBvw0vBvB0i13:4.>4/0H.:9.79896J03;28/07403.2>4/07J0>@963-91A06;0.0/9==4:4160.1.8J>6x0/4H9.69;10=:;?06-405:;34/2:4x0H.:9.784 4<6:.369;104==93941394> 0 stBtBuBvw0vBtB0k0>-9=609106-40?4.10;:0913:4.>4/0H.:9.79896J03.10>;?469?4>07403.2>4/07J0.0>.?58408;./0;=0.10212>2.80?.6:9<B0i= 6-9>09>0/464:?914/06;07406-403.2>40;=06-405:;784?x06-40.1.8J>9>0@98801;607403;1>9/4:4/0;26l;=l3;16:;8072606-40>962.69;10@988074 /;32?4164/B 0 N~S0TggdeqT[dec[__T[d
c_dedTTe[gTT m-40o2.896J0F.1.A4:0.60jjklF09>01;60/9:4368J091H;8H4/09106-405:;/2369;10;=0.1.8J693.80/.6.B0m-40ok0/45.:6?41609>0:4>5;1>9784 =;:0.10;1A;91A05:;A:.?0;=09164:1.80>J>64?0.2/96>0.1/054:=;:?.13404H.82.69;10>.?584>x0.1/0=;:03;;:/91.691A0.8804<64:1.80.2/96> .1/0m0>.?584>B0i10.//969;1x06-40ok0/45.:6?41609>0:4>5;1>97840=;:0?.916.9191A0>6.640.1/0.A413J034:69=93.69;1>B 0 N~PNS0eTged[d
c_ m-40.2/96>0.:403.::94/0;2607J06-40o2.896J0F.1.A4:0;:0/4>9A144>w0@-;0@988074091/4541/4160;=06-40.369H96J06;0740.2/964/B0k8>;x06; /4H48;50.05:;.369H405:;A:.?0=;:06-40/464369;10;=09?5:;54:x02146-93.80;:09884A.80.369;1>x06-40o2.896J0F.1.A4:0;:0/4>9A144x0/2:91A 6-409164:1.80.2/9605:;34/2:4x091382/4>06-40.2/9691A0;=0.1J09?5:;54:x02146-93.80;:09884A.80.369;103;??9664/07J06-40.1.8J>60;: >254:H9>;:B 0 N~PNPNS0dUUW^[^Uh[aXYfhYb^[U\aXU^[dWhY\V0
sBsBsBsw0m-408.7;:.6;:J0o2.896J0k>>2:.1340C:;2503;1/236>0.10.112.808.709164:1.80.2/9606;0H4:9=J06-.6096>0;54:.69;1>03;16912406; 3;?58J0@96-06-40:4n29:4?416>0;=06-408.7;:.6;:J>0n2.896J0>J>64?0.>054:0miljLlsFuluslK4HuBslvBsvBs0.1/0iGEijD UNCONTROLLED 109 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +
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`;CH@8UJC=8B@8;E=8MC8>CI<=A@DE@C>8@JE@8E=8COOC;@BQC8E?>B@8UBFF8MC8;EDDBC>8<?@78 8 ,V7,7,7a48bJC=8E?>B@8OB=>B=NA8;EA@8><?M@8<=8@JC8COOC;@BQC=CAA8<O8@JC8<HCDE@B<=A8<D8<=8@JC8;<DDC;@=CAA8<D8QEFB>B@G8<O8@JC FEM<DE@<DGcA8C=QBD<=IC=@EF8@CA@8<D8;EFBMDE@B<=8DCA?F@AP8@JC8FEM<DE@<DG8@ETCA8@BICFG8;<DDC;@BQC8E;@B<=P8EAACAACA8@JC8DBATP8E=> =<@BOBCA8@JC8;FBC=@A8B=8UDB@B=N8UJC=8@JC8B=QCA@BNE@B<=A8AJ<U8@JE@8@JC8FEM<DE@<DG8DCA?F@A8EDC8EOOC;@C>78SJC8FEM<DE@<DG8=<@BOBCA8@JC ;FBC=@8HD<IH@FGP8B=8UDB@B=N8<O8E=G8CQC=@8A?;J8EA8@JC8B>C=@BOB;E@B<=8<O8>COC;@BQC8ICEA?DB=N8<D8@CA@8CW?BHIC=@8@JE@8;EA@A8><?M@8<= @JC8QEFB>B@G8<O8@JC8DCA?F@A8NBQC=8B=8E=G8@CA@8DCH<D@8<D8@CA@8;CD@BOB;E@C8<D8EIC=>IC=@8@<8E8DCH<D@8<D8;CD@BOB;E@C8dSXK53e5f,:/5 /.,V5\CQ/7,5R7,R7/gdKYZ[K3]8,-./01/.,-23456767/7>g7 8 ,V7,7,7R48SJC8EDCE8<O8E;@BQB@G8E?>B@C>P8@JC8E?>B@8OB=>B=NAP8E=>8;<DDC;@BQC8E;@B<=A8@JE@8EDBAC8OD<I8@JCI8EDC8DC;<D>C>8<=8@JC B=@CD=EF8E?>B@8HFE=8E=>8OB=>B=NA8DC;<D>C>8B=8@JC8ChK\98]9\8O<DI8dSXK53e5f,:/5/.,V5\CQ/7,5R7,R7agdKYZ[K3] ,-./01/.,-23456767/7Cg78SJC8FEM<DE@<DG8IE=ENCIC=@8C=A?DCA8@JE@8@JCAC8E;@B<=A8EDC8>BA;JEDNC8UB@JB=8@JC8ENDCC>8@BIC8ODEIC EA8B=>B;E@C>8B=8@JC8E?>B@8OB=>B=N8><;?IC=@E@B<=78]<DDC;@BQC8E;@B<=A8EDC8DCW?BDC>8UB@JB=8a.5>EGA8EO@CD8OB=>B=NA8JEQC8MCC= DCH<D@C>8@<8@JC8SC;J=B;EF8:E=ENCD7 8 ,V7,7,7048i<FF<U8?H8E?>B@8E;@BQB@BCA8<O8@JC8FEM<DE@<DG8EDC8;<=>?;@C>8UB@JB=8a8I<=@JA8<O8;<IHFC@B<=8@<8QCDBOG8E=>8DC;<D>8@JC BIHFCIC=@E@B<=8E=>8COOC;@BQC=CAA8<O8@JC8;<DDC;@BQC8E;@B<=8@ETC=8dSXK53e5f,:/5/.,V5\CQ/7,5R7,R7RgdKYZ[K3] ,-./01/.,-234567-7,7;g7 8 jkljlmn8opqprsptupvwrxwyzw{|8
,V7,7/7,489A8HED@8<O8@JC8E==?EF8B=@CD=EF8E?>B@P8>E@E8HE;TENC8DCQBCU8BA8;<=>?;@C>8E==?EFFG8MG8@JC8^?EFB@G8:E=ENCD8<D8>CABN=CC7 9@8@JC8A@ED@8<O8@JC8E?>B@8HD<NDEIP8LS8DCA?F@A8<M@EB=C>8MG8?AB=N8@JC8>DB=TB=N8UE@CDP8UEA@CUE@CD8IC@J<>A8EDC8CQEF?E@C>8B=8<D>CD @<8JEQC8E=8<M}C;@BQC8EAACAAIC=@8<=8@JC8W?EFB@G8<O8@JC8>E@E8NC=CDE@C>8MG8@JC8FEM789==?EFFG8ACQCDEF8E=EFG@B;EF8IC@J<>A8B7C78E@ FCEA@8<=C8DCHDCAC=@E@BQC8@C;J=<F<NG8IC@J<>8OD<I8bC@8]JCIP8:C@EFAP8\E>P8~]P8Le]P8e]:YP8~]:YP89AMCA@<A8E=>8:B;D<MB<F<NG EDC8ACFC;@C>8CB@JCD8OD<I8LS8<D8;FBC=@8>E@E8DCH<D@A8O<D8>E@E8HE;TENC8DCQBCUA78SJC8FEM<DE@<DG8C=A?DCA8@JE@8E@8@JC8C=>8<O8@JC8GCEDP E8DCHDCAC=@E@BQC8IC@J<>8OD<I8CE;J8SXK8FBA@8<O8@C;J=<F<NG8O<D8>DB=TB=N8UE@CDP8UEA@CUE@CDP8E=>8JE_ED><?A8UEA@C8E=EFGABA8JEQC MCC=8DCQBCUC>78]<IHFBE=;C8UB@J8EFF8DCW?BDC>8^]8BA8CQEF?E@C>7898>E@E8HE;TENC8DCQBCU8;JC;TFBA@8BA8?AC>8@<8ACDQC8EA8N?B>CFB=CA >?DB=N8@JC8>E@E8HE;TENC8DCQBCU7898DCH<D@8<=8@JC8DCA?F@A8<O8@JC8>E@E8HE;TENC8DCQBCU8BA8A?MIB@@C>8@<8@JC8A?HCDQBA<DA8EO@CD8@JC >E@E8HE;TENC8DCQBCU8O<D8;<DDC;@BQC8E;@B<=A78 8 ,V7,7/7/48K=8E>>B@B<=P8E8DCAH<=AC8@<8@JC8OB=>B=NA8E=>8EHHD<HDBE@C8;<DDC;@BQC8E;@B<=8BA8BIHFCIC=@C>8MG8@JC8A?HCDQBA<DA8@<8C=A?DC ;<=@B=?<?A8;<IHFBE=;C8@<8EFF8IC@J<>8DCW?BDCIC=@A789FA<P8@<8>CQCF<H8E8HD<E;@BQC8HD<NDEI8O<D8@JC8>C@C;@B<=8<O8BIHD<HCDP ?=C@JB;EF8<D8BFFCNEF8E;@B<=AP8@JC8^?EFB@G8:E=ENCD8<D8>CABN=CC8>?DB=N8@JC8>E@E8HE;TENC8DCQBCU8B=;F?>CA8@JC8>C@C;@B<=8<O8E=G H<@C=@BEF8BIHD<HCDP8?=C@JB;EF8<D8BFFCNEF8E;@B<=8MG8E=G8<O8@JC8FEM8HCDA<==CF78SJC8>E@E8B=@CNDB@G8;JC;TFBA@8OD<I89DB_<=E8BA8?AC>8EA8E N?B>CFB=C8O<D8DCQBCUB=N8>E@E8HE;TENCA7 8 jklmn8x
ro8 ,V7/7,4883`@CD=EF8YGA@CI8E?>B@A8EDC8HCDO<DIC>8MG8<?@AB>C8ENC=;BCA8A?;J8EA8@JC8]EFBO<D=BE83e9LP8@EJ83=QBD<=IC=@EF8eEM<DE@<DG ]CD@BOB;E@B<=8LD<NDEI823e]L4P89/e98E=>8MG8<@JCD8A@E@C8ENC=;BCA8UJCDC83395:8BA8;CD@BOBC>7 8 ,V7/7/483`@CD=EF8E?>B@A8EDC8EFA<8;<=>?;@C>8MG8@JC8Y@E@C8<O89DB_<=E8CQCDG8,5/8GCEDAP8E=>8;FBC=@A789FF8<@JCD8SXK8A@E@CA DC;<N=B_C8@EJ83e]L8<=5AB@C8EAACAAIC=@8B=8E;;<D>E=;C8@<8SXK8AC;<=>EDG8E;;DC>B@E@B<=8HD<NDEI789FF8;<DDC;@BQC8E;@B<=8DCH<D@A E?>B@8OB=>B=NA8E=>8E?>B@8DCAH<=ACA8EDC8DC@EB=C>8MG8@JC8FEM<DE@<DG8O<D8E8IB=BI?I8<O8,.8GCEDA7 8 jkln8sxxro LS8AEIHFCA8EDC8?AC>8@<8HD<QB>C8E8>BDC;@8CQEF?E@B<=8<O8@JC8EMBFB@G8<O8@JC8E=EFG@B;EF8AGA@CIA8@<8NC=CDE@C8>E@E8@JE@8BA8;<=ABA@C=@ UB@J8@JC8FEM<DE@<DBCA8A@E@C>8<M}C;@BQCA8O<D8E;;?DE;G8E=>8HDC;BAB<=783395:8E=EFG_CA8B=@CD=EF8LS8AEIHFCA8EA8HED@8<O8@JC8<=N<B=N ^98HD<NDEIP8UJBFC8C`@CD=EF8LS8AEIHFCA8EDC8E=EFG_C>8EA8HED@8<O8@JC8;CD@BOB;E@B<=8E=>8EHHD<QEF8HD<;CAA8O<D8QEDB<?A8A@E@C8E=> OC>CDEF8ENC=;BCAP8EA8UCFF8EA8O<D8<@JCD8<DNE=B_E@B<=A7 8 jklljn8qwprsztzwtrw|qzvrpw|qwprwturpwrsvp K=@CD=EF8LS8LD<NDEI8BA8;<=>?;@C>8EA8HED@8<O8@JC8;<DDC;@BQC8E;@B<=8HD<;CAA8O<D8E=G8LS8DCH<D@C>8EA8?=E;;CH@EMFC8E=>8CQEF?E@C>8MG @JC8LS8HD<QB>CD8EA8;JC;T8O<D8CDD<D8<D8>B>8=<@8HEAA8@JC8LS8HD<QB>CDcA8UED=B=N8FBIB@A78K=@CD=EF8^]8AEIHFCA8EDC8EFA<8HD<QB>C>8EA =CC>C>8EA8HED@8<O8@JC8E=EFGA@cA8B=B@BEF8>CI<=A@DE@B<=8<O8;EHEMBFB@G78SJC8^98ND<?H8IEB=@EB=A8E8F<NM<<T8<O8EFF8MFB=>8LS8AEIHFCA8O<D @DE;CEMBFB@G8<O8@JC8@D?C8E=>8DCH<D@C>8QEF?CA7898eK:Y8DCH<D@8BA8NC=CDE@C>8O<D8CE;J8^]8AEIHFC8F<NNC>8B=8@JC8eK:Y8AGA@CI7 LD<MFCI8EDCEA8EDC8DCQBCUC>8EA8A<<=8EA8@JCG8A?DOE;C8@JC8HD<MEMFC8;E?AC8BA8>C@CDIB=C>8EA8C`HC>B@B<?AFG8EA8H<AABMFC8E=> ;<DDC;@BQC8E;@B<=8BIHFCIC=@C>78KO8E8ACQCDC8HD<MFCI8UB@J8@JC8E=EFGABA8BA8CQB>C=@P8@JC8E=EFGABA8BA8JEF@C>8?=@BF8@JC8;E?AC8BA8O<?=> UNCONTROLLED 110 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* +
,-./01223043.5 /
67898:;/<=>?@ABCDE@FGHIH?AIJDK?L>HAMDNEKDOBPQC?L; RS5T5U5RV/WX432-,Y/Z21[\0\3-0]/^3_4\-`/aZ^V/_,bcY3_/,23/,-,Y]d3./4e\03/,/]3,2/,_/c,24/1[/4f3/gWhiZ/,0023.\4,4\1-/,-./,cc21j,Y c2103__/[12/j,2\1k_/_4,43/,-./[3.32,Y/,`3-0\3_5 / RS5T5U5UV/lY\-./Z^/_,bcY3_/,23/c210k23./[21b/gmn^o^gmo/mnp/RqrsT/icc21j3./Z^/Z21j\.32_/41/\-0Yk.3/atk4/-14/Y\b\43./41V/4f3 [1YY1e\-`/_,bcY3_u v/n3b\w,--k,Y/x2\-y\-`/z,432/Z^/n,bcY3_/azn/_32\3_V/p2`,-\0/,-./m-12`,-\0/n,bcY3_{/|1Y\[12b/}\021t3{/~Z|{/,-. _1k203/e,432/W5|1Y\/ v/n3b\w,--k,Y/,.\10f3b\_42]/21__/iYcf,{/l34,/{/,.\kb/UU/,-./2,-\kb/Z^/_,bcY3_// / v/n3b\w,--k,Y/i_t3_41_/Z^/n,bcY3_/ /
v/n3b\w,--k,Y/z,_43e,432/Z^/n,bcY3_/azZ/_32\3_V /
/
678989;/E@FGHIH?AIJDK?L>HAMDE@F>FIFCD/
RS5T5T5RV/ZY3,_3/23[32/41/npZUTT/[12/4f3/Z^/c2103.k23/,-./23k\23b3-4_5 / / 678;/O
OK<DKODD<<KD<< m-/12.32/41/\-_k23/4f,4/4f3/k,Y\4]/i__k2,-03/c21`2,b/,4/4f3/Y,t12,412]/b,\-4,\-_/,/f\`f/c21[\Y3{/4f323/,23/_3j32,Y/b30f,-\_b_ / \-/cY,03/ef\0f/\-_k23/4f,4/i/\-[12b,4\1-/\_/21k4\-3Y]/01-j3]3./41/Y,t12,412]/b,-,`3b3-45/^f\_/\-0Yk.3_/,-/,--k,Y/i/23c124{ 23c124_/1-/\-432-,Y/,-./3X432-,Y/Z^/_,bcY3_{/,-./j32t,Y/42,-_b\44,Y/1[/i/\-[12b,4\1-/41/4f3/h,t12,412]/x\230412/,-./`21kc _kc32j\_12_/.k2\-`/,/e33yY]/_4,[[/b334\-`5 / / 67886;/OJL>?PDH>L n]_43b/,k.\4_/,23/c32[12b3./t14f/t]/3X432-,Y/,`3-0\3_{/,-./t]/4f3/Y,t12,412]/k,Y\4]/i__k2,-03/21kc5/^f3/[10k_/1[/4f3_3 / ,k.\4_/\_/4f3/1j32,YY/,-,Y]4\0,Y/_]_43b{/[21b/Y1`\-/41/.3Y\j32]/1[/4f3/[\-\_f3./23c124_5/^f3/ck2c1_3/1[/4f3/,k.\4_/\_/41/.10kb3-4 01bcY\,-03/e\4f/_c30\[\3./b34f1.1Y1`]/01-4,\-3./\-/4f3/npZ_5 / iYY/,k.\4/,-./23j\3e/[\-.\-`_/,-./,-]/0122304\j3/,04\1-_/4f,4/,2\_3/[21b/4f3b/_f,YY/t3/.10kb3-43.5/^f3/Y,t12,412]/_f,YY/3-_k23 4f,4/4f3_3/,04\1-_/,23/.\_0f,2`3./e\4f\-/4f3/,`233./4\b3/[2,b35/ / / 6788:;/BABM?P?A>D?H?/
RS5s5U5RV/^f3/k,Y\4]/},-,`32/c23c,23_/,-./_ktb\4_/,-/i--k,Y/},-,`3b3-4/3j\3e/ai}V/23c124/[12/4f3/Z23_\.3-4{ h,t12,412]/x\230412{/,-./^30f-\0,Y/x\2304125/WWiw}/\_/\bcY3b3-4\-`/012c12,43/Wk21[\-_/i}/43bcY,435//^f\_/23c124/.3_02\t3_/,YY 4f3/k,Y\4]/,__k2,-03/,04\j\4\3_/01-.k043./.k2\-`/4f3/]3,2{/\-0Yk.\-`/c21[\0\3-0]/43_4/_,bcY3/23_kY4_{/f1Y.\-`/4\b3/3X033.,-03_{ .3wt2\3[\-`/[21b/3X432-,Y/,-./\-432-,Y/_]_43b_/,k.\4_{/,-./,/_kbb,2]/1[/,YY/1k4/1[/01-421Y/3j3-4_/4f,4/23k\23./0122304\j3 ,04\1-oc23j3-4\j3/b3,_k23_/,-./4f3/3[[304\j3-3__/1[/4f3/\-\4\,43./0122304\j3/,04\1-5/zf3-3j32/,-]/_k0f/k,Y\4]/,__k2,-03 \-[12b,4\1-/\bc,04_/,/_c30\[\0/,-,Y]4\0,Y/c21304{/4f3/3j3-4_/,23/\bb3.\,43Y]/23Y,43./41/4f3/|Y\3-4/n32j\03_/21kc{/ef1/\_ 23_c1-_\tY3/[12/\-[12b\-`/4f3/0Y\3-45 / / RS5s5U5UV/^f3/,--k,Y/|/23c124/\-0Yk.3_/0f,-`3_/\-/\-432-,Y/,-./3X432-,Y/\__k3_/4f,4/,23/23Y3j,-4/41/4f3/Y,t12,412]{/[kY[\YYb3-4 1[/1t304\j3_{/_4,4k_/1[/,04\1-_/[21b/c23j\1k_/b,-,`3b3-4/23j\3e_{/4f3/1k401b3/1[/2303-4/\-432-,Y/,k.\4_{/,__3__b3-4_/t] 3X432-,Y/t1.\3_{/3[[304\j3-3__/1[/,-]/\bcY3b3-43./\bc21j3b3-4_{/23_kY4_/1[/2\_y/\.3-4\[\0,4\1-{/1k401b3_/1[/4f3/,__k2,-03/1[ 4f3/j,Y\.\4]/1[/23_kY4_{/4f3/23_kY4_/1[/\-432wY,t12,412]/01bc,2\_1-_/1[/c21[\0\3-0]/43_4_/,-./0122304\j3/,04\1-_5/^f3/,--k,Y/| 23c124/,Y_1/\-0Yk.3/,/.\_0k__\1-/1[/4f3/Y,t/0324\[\0,4\1-_{/4f3/Y,t12,412]/npZ_/`3-32,43./[12/4f3/]3,2/\-0Yk.\-`/npZ/kc.,43_{ 01-421Y/0f,24_{/,003c4,-03/Y\b\4_/kc.,43_{/k,Y\4]/},-k,Y/kc.,43_/,-./.,4,/23j\3e/23_kY4_5/ / / RS5s5U5TV/^f3/Z23_\.3-4{/h,t12,412]/x\230412{/,-./k,Y\4]/},-,`32/c32[12b/,-/,--k,Y/b,-,`32\,Y/23j\3e/ai}V/1[/4f3 Y,t12,412]/k,Y\4]/_]_43b/,-./\4_/43_4\-`/,-./0,Y\t2,4\1-/,04\j\4\3_/41/3-_k23/\4_/01-4\-k\-`/_k\4,t\Y\4]/,-./3[[304\j3-3__{/,-. _\`-_/4f3/i}/\[/3[[304\j3/12/-145/i-]/-303__,2]/0f,-`3_/12/\bc21j3b3-4_/\-/4f3/k,Y\4]/_]_43b/,-./Y,t12,412]/1c32,4\1-_/,23 \-421.k03./.k2\-`/4f3/,--k,Y/b,-,`32\,Y/23j\3e5/^fk_{/4f3/Z23_\.3-4{/h,t12,412]/x\230412{/^30f-\0,Y/x\230412{/k,Y\4]/},-,`32{ |n}{/,-./^30f-\0,Y/},-,`32_/23j\3e/4f3/,--k,Y/|/23c124{/c21j\.3/,-/1j32,YY/,__3__b3-4/1[/,YY/4f3/|/,04\j\4\3_/_4,43./\-/4f3 ,--k,Y/|/23c124{/,-./\-421.k03/,-]/-303__,2]/0f,-`3_/12/\bc21j3b3-4_/\-/4f3/k,Y\4]/_]_43b/,-./Y,t12,412]/1c32,4\1-_5/^f3 ,--k,Y/b,-,`32\,Y/23j\3e/,Y_1/4,y3_/\-41/,001k-4/2\_y_/,-./1cc124k-\4\3_/,__10\,43./e\4f/4f3/Y,t12,412]/,04\j\4\3_{/0f,-`3_/\- 4f3/j1Ykb3/,-./4]c3/1[/e12y/k-.324,y3-/[12/4f3/c23j\1k_/]3,2/,-./[33.t,0y/[21b/0Y\3-4_/at14f/c1_\4\j3/,-./-3`,4\j3V{ 01bcY,\-4_/,-./14f32/23Y3j,-4/[,0412_{/_k0f/,_/,.3k,0]/1[/23_1k203_/,-./_4,[[/42,\-\-`/^gmwWhwR}UwUrRSw3jU5Rws5R5R mnpomW|/RqrUuUrRqaWVw55U5/^f3/1k4ck4_/[21b/4f3/b,-,`3b3-4/23j\3e/_f,YY/23012./,YY/.30\_\1-_/,-./,04\1-_/23Y,43./41/,4 Y3,_4/4f3/3[[304\j3-3__/1[/4f3/b,-,`3b3-4/_]_43b/,-./\4_/c2103__3_{/\bc21j3b3-4/1[/4f3/Y,t12,412]/,04\j\4\3_/23Y,43./41/4f3 [kY[\YYb3-4/1[/4f3/23k\23b3-4_/1[/4f3/mnp/RqrU/,-./^gm/UrRS/n4,-.,2._{/c21j\_\1-/1[/23k\23./23_1k203_{/,-./,-]/-33./[12 0f,-`3/mnpomW|/RqrUuUrRqaWVw55U5/^f3/,--k,Y/b,-,`3b3-4/23j\3e/\_/[21b/kY]/R_4/41/k-3/Tr4f/,-./.k3/1-/n3c43bt32 Tr4f/1[/3,0f/]3,25/ / / RS5s5U5sV/^f3/i/21kc/01-.k04_/c32[12b,-03/,k.\4_/1[/4f3/Y,t12,412]/,-./,Y_1/b,\-4,\-_/,/c21`2,b/1[/3X432-,Y/tY\-. c21[\0\3-0]/43_4\-`/_,bcY3_5/3_kY4_/1[/4f3_3/3X432-,Y/tY\-./c32[12b,-03/_,bcY3_/,23/_0123./,0012.\-`/41/4f3/3X432-,Y/b34f1._ 02\432\,5/m-/,..\4\1-/,/.3t2\3[\-`/41/`21kc/Y3,.32_/,-./4f3/h,t12,412]/x\230412/\_/c23c,23./t]/4f3/i/`21kc/[1YY1e\-`/3,0f/_34/1[ UNCONTROLLED 111 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
!"#"
$"
%&'()'* ++
,-./01234/5.6703809:;</.;=.0<>.=0:38?4/.;<.4@94?<03.,-./01234/.0?4.2?420?4A.B>.C?;82.D824?7:/;?/.0<A./8110?:E4A.B>.9F4 G803:9>.H//8?0<I4.C?;82.=;?.9F4.I4?9:=>:<J.0J4<I:4/K.L:9F.I;2:4/.I;<74>4A.9;.9F4.M0B;?09;?>.N:?4I9;?5. .
OPQRS.TUVWXYZUZ[\ H/.24?.-]^_6M_`abc_cdae_f47c5a_g5ad.0<A.^Dhi^6j.akdclmcdakn6o_p5eK.:12?;7414<9.:<.9F4.;74?033.4==4I9:74<4//.;=.9F4 30B;?09;?>.10<0J414<9./>/941.:/.0.?4/839.;=.9F4.:123414<909:;<.;=.9F4.70?:;8/.0/24I9/.;=.9F4.30B;?09;?>q/.10<0J414<9 />/941m.r803:9>.2;3:I>.nD4I9:;<.s5c.t.uG803:9>.,;3:I>vo.0<A.;Bw4I9:74/.nD4I9:;<.l5d.t.uG803:9>.H//8?0<I4.hBw4I9:74/voK.:<94?<03 08A:9.2?0I9:I4/.nD4I9:;<.ae5a.t.u^<94?<03.H8A:9/voK.9F4.?47:4L.0<A.0<03>/:/.;=.A090.nD4I9:;<.e5d.t.uG803:9>.;=.-4/9.f4/839/voK.9F4 I;??4I9:74.0<A.2?474<9:74.0I9:;<.2?;I4//.nD4I9:;<.al5d.t.uj;<9?;3.;=.];<_j;<=;?1:<J.x;?yK.j;??4I9:74.HI9:;<K.0<A.,?474<9:74 b40/8?4/voK.0<A.9F4.0<<803.10<0J414<9.?47:4L.;=.9F4.r803:9>.10<0J414<9./>/941.nD4I9:;<.ae5g5c.t.ub0<0J414<9.f47:4Lvo LF4?4.9F4.70?:;8/.0/24I9/.;=.9F4.10<0J414<9ir803:9>.0?4./8110?:E4AK.0<A.47038094A.0<A.230</.=;?.:12?;7414<9.0?4 A4743;24A5.. .
OPQPS.WTz{z|}[~|XVVXW\[T\TZz ae5e5ao.66H_b.I;</:A4?/.9F4.?:/y/.0<A.;22;?98<:9:4/.0//;I:094A.L:9F.9F4.30B;?09;?>.0I9:7:9:4/.:<.;?A4?.9;m 0o.J:74.0//8?0<I4.9F09.9F4.10<0J414<9./>/941.0IF:474/.:9/.:<94<A4A.?4/839/ Bo.4<F0<I4.;22;?98<:9:4/.9;.0IF:474.9F4.28?2;/4.0<A.;Bw4I9:74/.;=.9F4.30B;?09;?> .
Io.2?474<9K.;?.?4A8I4K.8<A4/:?4A.:120I9/.0<A.2;94<9:03.=0:38?4/.:<.9F4.30B;?09;?>.0I9:7:9:4/ .
Ao.0IF:474.:12?;7414<9.^Dhi^6j.akdclmcdakn6o_p5l5a5 . .
ae5e5co.-F4.30B;?09;?>.230</m 0o.0I9:;</.9;.0AA?4//.9F4/4.?:/y/.0<A.;22;?98<:9:4/ Bo.F;L.9;m . .:<94J?094.0<A.:123414<9.9F4/4.0I9:;</.:<9;.9F4.10<0J414<9./>/941 . .47038094.9F4.4==4I9:74<4//.;=.9F4/4.0I9:;</5 .
ae5e5so.HI9:;</.90y4<.9;.0AA?4//.?:/y/.0<A.;22;?98<:9:4/./F033.B4.2?;2;?9:;<03.9;.9F4.2;94<9:03.:120I9.;<.9F4.703:A:9>.;= 30B;?09;?>.?4/839/5.h29:;</.9;.0AA?4//.?:/y/.I0<.:<I38A4.:A4<9:=>:<J.0<A.07;:A:<J.9F?409/K.90y:<J.?:/y.:<.;?A4?.9;.28?/84.0< ;22;?98<:9>K.43:1:<09:<J.9F4.?:/y./;8?I4K.IF0<J:<J.9F4.3:y43:F;;A.;?.I;</4r84<I4/K./F0?:<J.9F4.?:/yK.;?.?490:<:<J.?:/y.B> :<=;?14A.A4I:/:;<5.h22;?98<:9:4/.I0<.340A.9;.4@20<A:<J.9F4./I;24.;=.9F4.30B;?09;?>.0I9:7:9:4/K.0AA?4//:<J.<4L.I8/9;14?/K.8/:<J <4L.94IF<;3;J>.0<A.;9F4?.2;//:B:3:9:4/.9;.0AA?4//.I8/9;14?.<44A/5 . ae5e5go.-F4.30B;?09;?>.03/;.89:3:E4/.0.=;?103.2?;J?01.9;.4<I;8?0J4.:12?;7414<9/.9F?;8JF.A4743;214<9.;=.M40<.2?;I4//4/5. -F4.J;03.;=.9F:/.2?;J?01.:/.9;.;29:1:E4.2?;I4//4/.9;.4</8?4.4==:I:4<I>.0<A.;24?09:;<03.:12?;7414<9/.LF:34.10:<90:<:<J I;123:0<I45..-F4.4==:I:4<I>.J0:</.0?4.:<F4?4<93>.I;8234A.L:9F.1:<:1:E:<J.4??;?/.0<A.?4L;?y5..-401/.;=.4123;>44/.340?<.9F4 9;;3/.0<A.94IF<:r84/.9;.47038094.0.2?;I4//K.:A4<9:=>.2;94<9:03./;8?I4/.;=.4??;?/K.A430>/.;?.2?;B341/.:<.0<.;24?09:;<K.?:/y/K A494?1:<4./>/941.IF0<J4/.9F09.L:33.1:<:1:E4.9F4/4.0<A.L;?y.9;.:123414<9.9F4.:12?;7414<9/5..60IF.2?;w4I9.:<I38A4/.9F;?;8JF A;I814<909:;<.;=.9F4.4703809:;<K.140/8?414<9K.0<A.:123414<909:;<.2F0/4/5..-F4.2?;I4//.:/.I;<9:<8033>.1;<:9;?4A.9;.4</8?4 9F09.9F4.0<9:I:2094A.?4/839/.0?4./8/90:<4A5 H990IF14<9m Ng5.Gb.7gk50990IF14<9/.ad5a5cc52A=.n52A=o .
GH.
h.ddss5a.G803:9>.b0<803.D8110?>.;=.jF0<J4/.f47.g . k55ad5a5cc5@3/@.n5@3/@o . 6<A.;=.A;I814<9 .
Y| `4?/:;< H22?;703 f47:/:;<.:<=;?109:;< ge ad5 65cdcc ge5a al5bHf5cdcc gk ca5hj-5cdcc
UNCONTROLLED 112 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
113 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
114 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
115 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
116 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
117 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
118 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
119 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
120 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
121 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
122 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
123 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
124 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
125 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
126 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
127 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
128 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
129 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
130 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
131 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
132 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
133 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
134 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
135 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Attachment 1
136 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Attachment 2
137 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
138 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
139 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
January 09, 2020
Ali Hossain
California Environmental Laboratory Accreditation Program 500 North Central Avenue, Suite 500
Glendale, CA 91203
Dear Mr. Hossain:
Enclosed, please find Eurofins Eaton Analytical (EEA) - Monrovia Corrective Action Report in response to your On-Site Assessment Report for audit findings during the site inspection of EEA Monrovia on October 14-15, 2019.
EEA values your assessment findings as we are committed to the continuous improvement of our laboratory and quality systems and to the assurance of our continuous compliance with the California Environmental Laboratory Accreditation Program.
For any response with a corrective action plan, a proposed date of completion (by 2/9/2020) and the name of the person responsible for completing the corrective action are provided. For completed corrective actions, proof of implementation, summary of the change and provisions for training are also included. EEA-Monrovia performs a follow up of all the changes 90 days after corrective actions have been implemented. .
These corrective actions shall be deemed acceptable if CA ELAP requires no additional documentation about the finding.
Should you have any questions about this assessment response, please e-mail me at [email protected] or my supervisor, Nilda Cox at [email protected].
Sincerely,
Andora Nguyen
QA Scientist
140 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Finding # 1
For SM 4500-CN G-1999, the laboratory does not analyze samples containing sulfide interference within 24 hours. Samples must be checked for the presence of sulfide prior to analysis. (SM 1060-2011 Table I)
Regulation that establishes the requirement:
SM 1060 Table I
SM 4500-CN G-1999
Description of Laboratory Corrective Action:
Justification:
The testing for sulfide as stated in Section 1060 Table I was designed to be completed at the time of sample collection. Eurofins Eaton Analytical does not conduct sampling for clients. It is not possible to test for sulfide within 24-hours of collection as samples are received by the laboratory past the 24-hour mark.
Root Cause:
Samples arrive at the laboratory for testing after the 24-hr mark of collection. It is, therefore, not possible to test for sulfide within 24 hours. Standard procedure is to test for sulfide just prior to dosing for Amenable Cyanide. Samples with positive results are flagged H1.
Impact on Sample Data:
Results may not be valid for compliance. However, samples are flagged accordingly to note this status
Corrective Action Plan:
No means to correct this as samples do not arrive in time to the laboratory, and this is outside of the laboratory's control.
Preventive Action Plan:
N/A, data flagging is the only viable means of correcting this issue, and has already been approved by the state as part of the previous audit's corrective action on the same finding.
Laboratory Proposed Completion Date: Completed 1/8/2020 Responsible Party: Lisa Ramirez
ELAP Response to Proposed Corrective Action: Laboratory response is acceptable.
Additional ELAP Comments (if necessary):
141 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Finding # 2
For EPA 353.2, there is no documentation that at least one NO2 - standard is compared
to a reduced NO3
- standard at the same concentration to verify column reduction efficiency. (Section 10.1)
Regulation that establishes the requirement:
EPA 353.2
Description of Laboratory Corrective Action:
Justification:
This finding is confusing because every analytical run for the NO2+NO3 RFA analysis contains a NO2 1.0ppm standard labeled as such. The second source (LCS) is a nitrate standard at the same concentration. See attached runs for details.
Attachment 2.1 022719 NO3 Run
Attachment 2.2 102519 NO3 Run
Attachment 2.3 112219 NO3 Run
Root Cause:
Not Applicable
Impact on Sample Data:
No impact to data quality as the finding is erroneous.
Corrective Action Plan:
No action plan required as the process is already in place Laboratory Proposed Completion Date: Completed 1/8/2020 Responsible Party: Lisa Ramirez
ELAP Response to Proposed Corrective Action: Laboratory response is acceptable.
Additional ELAP Comments (if necessary):
142 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Finding # 3
For SRL 524M-TCP:
a. Samples collected in clear VOA vials are being analyzed. The method prescribes use of amber vials. (Section 7.1)
b. The laboratory considers the method blank acceptable when it does not contain target analytes equal to or greater than the reporting limit (RL). The method states that method blanks are acceptable when results are less than the MDL. (Section
8.2.1)
Regulation that establishes the requirement:
SRL-524M-TCP
Description of Laboratory Corrective Action:
3.a
Folder 832640 Samples 201910110578 & 201910110579
Justification:
The Client supplied vials and the laboratory proceeded with request for analysis and noted the deviation properly.
Root Cause:
Primary observer, Kipp Ramey, noted deviation with raw data and through QIR080247.
Reviewed data in LIMS and noted the "QP" flag was present.
The SOP was reviewed and the regulation was clearly stated in Section 08.A.
Impact on Sample Data:
Because the CA SRL method specifically states amber glass, the samples received in clear glass vials will be considered invalid for compliance. This was already standard practice in the laboratory.
Corrective Action Plan:
Provide client correct sampling information, noting that clear vials are not acceptable for this test. The client decided to cancel the sample and resample with correct containers.
Preventive Action Plan:
Reminded both our present and our future analysts to proceed with analysis, note the vial color with the data, flag the data QP, and write a QIR to notify the ASM if this is witnessed in the future.
143 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
3.b
Root Cause:
EEA-M lab SOP and Attachment III for blank criteria is ≤ 1/3 MRL. SOP data review checklist was not consistent with the SOP stating that blank criteria is < MRL. Thus analyst was implementing blank acceptance criteria as < MRL.
Impact on Sample Data:
No impact as the proper procedure was being followed.
Corrective Action Plan:
Since section 8.1.4 of SRL 524M-TCP method reference stated that "MRL should be no less than 3x the MDL", thus MDL <1/3 MRL. To meet Section 8.2.1 of the SRL 524MTCP that blank <MDL, all SOP documentation were updated for the blank limit < 1/3MRL.
Final LIMS QC Reports have a blank limit of <1/3 MRL. See attachment 3.b.
Attachment 3.b _ Example Final QC Report
Preventive Action Plan:
Current and future analysts will be trained that 1,2,3-trichloropropane cannot be present in method blanks above 1/3 the MRL (the required MDL of the method). If the result is greater than 1/3 the MRL, the data will need to be qualified using the appropriate "B" flag and a QIR will be required. The MDL is required to be 1/3 of the MRL as per section 8.1.4.
Laboratory Proposed Completion Date: Completed 1/8/2020 Responsible Party: Kipp Ramey
ELAP Response to Proposed Corrective Action:
3a. Laboratory response is acceptable. Note, however, that the laboratory must ensure that the “QP” or any other data flag applied can be clearly understood that the associated result to the flagged sample would be invalid for compliance purposes. Implementation of corrective action will be verified in the next assessment cycle.
3b. Laboratory response is acceptable. The laboratory’s acceptance criteria for blanks is currently linked to the MRL by being defined as ≤ 1/3 MRL. The laboratory must ensure that in the event a future MDL study resulted in a lower MDL, that the laboratory must also lower its MRL to maintain the MDL:MRL relationship. At any time this MDL:MRL relationship changes, the laboratory must only accept method blanks or LRBs (however named) that are below the MDL or the laboratory would render itself non-compliant to method requirements. Implementation of corrective action will be verified in the next assessment cycle.
Additional ELAP Comments (if necessary):
144 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Finding # 4
For EPA 537.1:
a. The laboratory uses a 5-µL sample extract injection for analysis. The method prescribes 10 µL. (EPA 537.1 Section 2)
b. The laboratory does not record information or details when changing columns in the analytical instrument. [22 CCR §64815(a) and (d)]
c. Similarly, as in the finding above, loose sheet records of maintenance or repair service provided by external vendors are not intact or attached to the maintenance logbook. [22 CCR §64815(a) and (d) and 22 CCR §64813(d)] Regulation that establishes the requirement:
EPA 537.1
22 CCR § 64813
22 CCR § 64815
Description of Laboratory Corrective Action:
4.a
Justification:
Reviewed reference method 537.1 versions 1.0. Section 6.12.1. LC SYSTEM – Instrument capable of reproducibly injecting up to 10-μL aliquots.
Section 1.6. METHOD FLEXIBILITY – mentions that LC conditions may be changed.
E-mailed EPA method 537 author J.A. Shoemaker for clarification whether a smaller volume, in this case 5uL may be injected as long as the same volume is used for calibration and samples.
J.A. Shoemaker approved using 5uL of sample injection from her email on 12/9/2019. In her email, she stated that smaller injection volume is always acceptable as long as enough sensitivity is achieved. Jody's contact information is listed in the email if you need further discussion with her.
Attachment 4 J.A.Shoemaker_email
Root Cause:
The assessor is referencing section 2 of the EPA 537.1 summary of the method on the use of 10uL injection into the LC system. Please refer to section 11.7.4 of EPA 537.1 that indicated that 10uL was used in the method development but it is not a requirement for the volume used.
Impact on Sample Data:
145 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
None since 5uL is allowed by the method.
Corrective Action Plan:
None since it is allowed by the method and no corrective action or preventive method required
4.b & c
Justification:
Column type, model and lot are documented on the sequence page with each analytical batch per calibration curve.
Root Cause:
Lack of documentation.
Impact on Sample Data:
none, column documented each batch.
Corrective Action Plan:
Whenever a new lot of column is installed, the lot number will be documented in the maintenance logbook going on forward.
Loose pages that contain important information from service engineers will be taped into the maintenance logbook going on forward.
Estimated completion date 2/9/2020
Laboratory Proposed Completion Date:
4.a Completed 1/8/2020
4.b & c estimated completion date 2/9/2020
Responsible Party: Karen Muroi
ELAP Response to Proposed Corrective Action:
4a. Laboratory response is acceptable.
4b. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
4c. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
Additional ELAP Comments (if necessary):
146 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Finding # 5
For SM 6251 B:
a. The silica gel being used in sample preparation does not meet the specifications defined in the method. The laboratory uses 60/200 mesh that is not being heated (activated) and is not stored in a desiccator, instead of 35/60 mesh activated at 180º and stored in a desiccator. (SM 6251-2007 Section B.4.g) b. The laboratory does not record whether samples are checked for air bubbles upon receipt or prior to analysis. [SM 6251-2007 Section B.2 and 22 CCR §64815(a) and (d)]
c. Micro volumetric flasks used are rinsed with MTBE instead of methanol. (SM 6251- 2007 Section B.3.d)
d. The laboratory SOP does not define the required pH for samples prior to extractions.
The laboratory SOP only instructs user to check and record the pH. [SM 6251-2007 Section B.5.a and 22 CCR §64815(a) and (d)]
e. The laboratory does not concentrate the MTBE extract with nitrogen blow-down and states so in their SOP but does not explain the reason for skipping the concentration. [SM 6251-2007 Section B.5.d and 22 CCR §64815(a) and (d)] f. Similarly, as in the above finding, the laboratory uses a different amount and concentration of diazomethane solution that is added to each extract, than that prescribed in the method. The laboratory SOP indicated that the final diazomethane concentrations added are approximately the same. If this is the case, there is no reason to modify the method procedure. The laboratory does not provide the rationale. [SM 6251-2007 Section B.5.d and 22 CCR §64815(a) and (d)] g. The laboratory SOP instructs users to use the quadratic calibration model (except for South Carolina compliance samples) to plot and evaluate the initial calibration curve.
Please explain why the average response factor model does not fit or why there is no attempt made to first fit other simpler calibration models like linear regression or their weighted functions thereof, before the quadratic model is used. [22 CCR §64815(a) and (d)]
Regulation that establishes the requirement:
SM 6251 B
Description of Laboratory Corrective Action:
147 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
5.a
Root Cause:
The current size mesh was used before the supervisor started working at Eurofins seven years ago, so not sure where the other size mesh silica gel came from. Perhaps, they could not find the 35/60 and ordered what was closest. SOP does not state mesh size.
Performance of 35/60 mesh silica gel, activated at 180 degrees C and stored in a dessicator will be compared with the IDOC results obtained using 60/200 mesh silica gel.
Impact on Sample Data:
None, all PTs pass for this method for the years this has occurred.
Corrective Action Plan:
New 35/60 mesh silica gel has arrived. Dessicator is being set up and dessicant will be ordered to store the silica gel after it has been activated at 180 degrees C. Comparison of MDL/IDOC of larger mesh size that is currently being use with new mesh size MDL/IDOC will be done. The expected date of completion of the initial study is on 1/25/2020.
Preventive Action Plan:
SOP does not state mesh size. So, SOP will be updated to include the mesh size, activating at 180 degrees C, and storing in dessicator once MDL/IDOC study of new mesh size is complete. All analysts will be trained on the updated SOP by 02/07/2020.
5.b
Root Cause:
HAA target analytes in UCMR4 552.3 are not volatile, so no need for bubble check, which means there is no need for bubble check for SM6251B. Attached email states that the bubble check section will be removed from SM6251B. Both EPA method 552.3 and SM6251B are EPA approved methods for disinfection byproducts compliance monitoring for HAAs.
Impact on Sample Data:
No impact on samples.
Corrective Action Plan:
None needed. Approval from John Gumpper of Standard Methods committee e-mail on 12/12/19 attached to CAR.
Attachment 5b. John Gumpper’s e-mail about bubble
5.c
148 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Root Cause:
MTBE was used to rinse the cleaned volumetric flasks before the extraction because it is the extraction solvent. SM6251B did not discuss what solvent to use before the extraction.
Impact on Sample Data:
No impact on data because methanol rinse section in SM6251B is performed for volumetric flasks after use. EEA sends the used flasks to dishwashing to be washed and baked in the oven.
Corrective Action Plan:
Methanol will be used to rinse the extraction volumetric flasks after use to remove any residue left behind before the dishwashing process as per method. Rinsing of cleaned glassware before extraction with MTBE will be retained since MTBE is the extraction solvent.
5.d
Root Cause:
SM6251B sections that are referenced in the finding mention that the pH is checked after the acid is added. Discussed with QA the process of the extraction and the acid is added in the middle of the extraction, so SM6251B has confusing wording on when to check the pH.
Impact on Sample Data:
The wording in the SM6251B sections referenced in the finding is very unclear on where the addition of acid is actually done. The acid is added in the middle of the extraction. The pH is taken and recorded in the webform at the beginning of the extraction and at the end of the extraction to make sure the sample has a pH below 0.5. The pH is not taken immediately after the acid is added because the surrogate, acid, salt, and MTBE+IS are all added at once and then the samples and QC are shaken and the MTBE layer is removed. Once the organic layer has been removed, the pH is taken in the sample. The pH cannot be taken before the MTBE layer has been removed because it will cause a loss of analytes, which would affect the recovery.
Corrective Action Plan:
pH acceptance limit of pH < 0.5 has been updated in SOP2402 Section 10.A.19. Please see attached draft SOP2402 Section 10.A.19.
Attachment 5.d SOP2402 Section 10.A.19 draft SOP
5.e
149 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Root Cause:
For SM 6251B, blow-down is only done when more than the standard amount of diazomethane listed in the SOP is used. Diazomethane is only added once for HAAs so blow-down is not necessary. Section B.5.d of SM6251B states that the drying step "may be" included if excess diazomethane is required to maintain the persistent yellow color of the sample and that it is not necessary every time and that it is at the discretion of the analyst whether or not it is necessary.
Impact on Sample Data:
None
Corrective Action Plan:
Corrective Action: none, following procedure. However, SOP2402 was updated to explain drying step and concentration of extract, if needed when excess diazomethane is added.
See attached draft SOP2402.
Attachment 5.e SOP2402 Section 10.A.15 draft SOP
5.f
Justification:
Final concentration of diazomethane is the same. See Deviations section of SOP.
Diazomethane is a carcinogen and explosive hazard. Volumes of the substance are kept at a minimum as much as possible to reduce waste production by volume, and potential explosive risks.
Root Cause:
SOP indicates the final diazomethane concentrations are about the same as in the method. Section 15.C explains the rationale:
"15) DEVIATIONS FROM REFERENCED METHODOLOGY
C. 100 uL of ~6M diazomethane solution (0.6mLM) is added to each extract, SM6251B specifies 250 uL of ~2M (0.5mLM). The final diazomethane concentrations are approximately equal."
Impact on Sample Data:
None, same concentration of diazomethane is added, so no impact on samples.
Corrective Action Plan:
None. See attached SOP2402 Section 15.C for the explanation with regard to SM6251B B.5.d that the drying step is not necessary in every case and may be used at the discretion of the analyst. See details in finding 5.e and corrective action response. 150 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
5.g
Root Cause:
Laboratory SOP states that 2nd order fit is used, but later in the section, it is stated that "R2 = 0.995 for first order fit", so it is not really clear in the first line that linear calibration is also used. Although, linear calibration is allowed and used by the analysts, sometimes 2nd order is a better fit. Please see attachment with screenshots of linear vs. quadratic calibration curves.
Attachment 5.g.1 HAA Lin vs Quad cal curves
Impact on Sample Data:
None, following proper method procedure.
Corrective Action Plan:
Updated SOP2402 9.B to be more consistent with Section 11.B of SOP. See attached SOP2402 draft update.
Attachment 5.g.2 SOP2402 Section 9.B draft SOP
Laboratory Proposed Completion Date:
5.a – estimated completion date: 2/7/2020
5, b, c, d, e, f and g – completed 1/8/2020
Responsible Party: Amy George
ELAP Response to Proposed Corrective Action:
5a. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
5b. Laboratory response is acceptable. Note that the laboratory’s root cause analysis says “Attached email states that the bubble check section will be removed from SM6251B.” However, that referenced E-mail states only that Mr. Gumpper is “hoping to remove the requirement for zero headspace from the SM, but [he doesn’t] know the process for this.” That statement and the laboratory’s summation thereof in its root cause analysis are not equivalent.
5c. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
5d. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
151 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
5e. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
5f. Laboratory response is acceptable.
5g. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
Additional ELAP Comments (if necessary):
152 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Finding # 6
The laboratory does not routinely practice adequate and complete documentation of analytical activities, which is critical to ensure that data are defensible, to meet laboratory accreditation requirements, and to ensure that all tests and samples are fully traceable. Example laboratory practices that potentially affect traceability and hence, the defensibility of analytical data are listed below:
a. Most of the SOPs accessible to the analysts via the laboratory portal (electronic versions) are not the same or not the latest version of the method SOPs being used by supervisors. The versions used by supervisors are not the versions approved by management and yet were reported to be already being followed or in use. b. Where sample or standard preparation, analysis, or other laboratory procedures involve weighing or measuring temperature, the ID of the weights used, the ID of the balance used, the ID of the thermometer used, the lot numbers of standards and reagents used, and the units of measurements taken are not always identified in the records. Examples, not limited to the following, were observed:
i. For EPA 504.1, the ID of the dispenser P21 recorded as calibrated on 9-14-19 did not match the ID of the dispenser itself, i.e., the ID recorded as had been calibrated was 10M74582 but P21 ID is 16H21434.
ii. Similarly, as in the finding above, the volume recorded in the same log did not identify the units of measurement for the dispenser calibration/verification performed on 8/12/19, 8/20/19, and 9/14/19.
c. Some support equipment are labeled with two names or identifiers. d. The date entries in some of the reagent bottles did not identify the year. For example, for R800146, the date entered for when reagent was first opened was “10/1.”
e. The COC for sample ID 570088 showed that the sample was relinquished to the laboratory for analysis before the sample was collected. The sample was recorded as collected on 10-13-19 but was relinquished to the laboratory on 10-12-19.
Regulation that establishes the requirement:
22 CCR §64815
Description of Laboratory Corrective Action:
6.a
153 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Root Cause:
This is a misunderstanding when we tried to explain to the auditor that the supervisor is working on the draft of the SOP and the analysts are only able to read and use the approved SOP.
Draft SOPs are SOPs that lab is working on the updates and only accessible to an editor (in this case the supervisor) and QA. A draft SOP is not to be used as a working SOP since it has not been reviewed or approved by the authorized personnel, and is not even accessible to the general laboratory staff.
A draft SOP would need to go through review, approval and publication process before it can be an approved & published SOP that the laboratory can use in the operation.
Impact on Sample Data:
None.
Corrective Action Plan:
None needed because it is a misunderstanding of our process. It is a standard practice that when an SOP is being reviewed and updated that there are two different versions of the SOP are concurrently available but only the approved version is available to the laboratory personnel and to be used for the analysis.
6.b
Root Cause:
i. Analyst used pump ID that was recorded on the front of the logbook. It looks as though the pump was changed out and was not updated, but has been corrected. ii. Units of measure are mL for pumps. Unit of measure added to logbook column. Lack of complete documentation.
Impact on Sample Data:
None. Lack of traceability to which dispenser was used, which is unlikely to impact sample results as this is not a volumetric-critical step.
Corrective Action Plan:
i. Pump serial number has been corrected. See attachment. ii. Units of measure added to logbook column. See attachment.
Attachment 6.b.1 GC Pump Logbook Example 1
Attachment 6.b.2 GC Pump Logbook Example 2
Preventive Action Plan:
Review other logbooks to ensure similar errors are not present. 154 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
6.c
Root Cause:
When we re-assigned the naming system to our balances to have a naming system, instead of serial numbers, some balances are already assigned an equipment name. We did not catch that until later on.
Impact on Sample Data:
None, since we have been keeping track of the status of the calibration and certification not only by the laboratory ID system but also by the manufacturer's serial number. There is no lapse of information on these items.
Corrective Action Plan:
We removed the QA reference and will update the vendor for the next calibration date to include only the B-naming.
Preventive Action Plan:
In the future, the laboratory will confirm that the naming system is consistent within the laboratory between departments.
6.d
Root Cause:
Analyst did not record the full open date on the reagent bottle and only recorded "10/1", with no year. Dates recorded should be the full month, date, and year.
Impact on Sample Data:
None, since reagent bottles are used well before the expiration date of the one year from open date. Sample data was not in jeopardy of having expired reagent being used.
However, to make sure this is not an issue, analysts will write the full date so that no assumptions of the year are made.
Corrective Action Plan:
Analysts will record the full date and year for reagent bottles to make sure no expired reagents are ever used. Please see attached photo of current opened bottle with open date, which is complete.
Attachment 6.d.1 – Example of Bottle with Completed Date
6.e
Root Cause:
During the audit, the auditor was shown an example of a COC that has not gone through the review process by the Project Management group. Therefore it is expected that none of the mistakes were caught at that time since to err is human. 155 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Impact on Sample Data:
None, since the issue was fixed prior to the final report was generated.
Corrective Action Plan:
The COC was corrected with a single line cross out upon review by the project manager group.
Attachment 6.e Final COC for folder 832809
Preventive Action Plan:
The project management group continues to review the COC for accuracy of the project.
Laboratory Proposed Completion Date: Completed. 1/8/2020 Responsible Party: Amy George and Andora Nguyen
ELAP Response to Proposed Corrective Action:
6a. Laboratory response is acceptable.
6b. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
6c. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
6d. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
6e. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
Additional ELAP Comments (if necessary):
156 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Finding # 7
For EPA 551.1:
a. The calibration standards that were recorded in the EEA GC 551 CH Standard Logbook as having been prepared on 09/26/2019 were recorded as the initial calibration standard used in the laboratory’s web form Prep Sheet for Run # 1198283. However, the calibration standards were entered in the web form as having been prepared on 09/27/2019 instead. [22 CCR §64815 Sections (a) and (d)]
b. Similarly, as in the finding above, the injection volume for two of the calibration standards were recorded as “NA” in the web form. It turned out the web form is not accepting numbers with decimal places. [22 CCR §64815 Sections (a) and (d)] c. Sample containers are not being cleaned as prescribed in the method prior to use or following each use. (EPA 551.1 Section 6.1)
d. The laboratory does not have records that the sodium chloride used in extractions is purified by heating at 400ºC for 30 minutes. (EPA 551.1 Section 7.1.5) e. The phosphate buffer is used to lower the sample matrix pH to be between 4.5 and
5.5. The method prescribes 4.8 to 5.5. (EPA 551.1 Section 7.1.7.1) f. The laboratory SOP does not include provisions for a solvent rinse cleanup procedure. [22 CCR §64815 Sections (a) and (d)]
g. The laboratory prepares stock solutions of the surrogate standard in methanol. The method prescribes use of acetone. (EPA 551.1 Section 7.3.5) h. When spiking the laboratory fortified matrix (LFM) sample with chloral hydrate, the laboratory prepares the LFM by adding an acetone-based chloral hydrate standard solution. The method prescribes use of a methanol-based chloral hydrate standard solution. (EPA 551.1 Section 9.6.3)
Regulation that establishes the requirement:
EPA 551.1
22 CCR §64815
Description of Laboratory Corrective Action:
7.a & b
Root Cause:
157 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
a. Due to lack of attention to detail. Analyst wrote the wrong dates for standard prep. b. Webform cannot handle numbers with decimal places in the injection volume column.
Impact on Sample Data:
a. None. The date when the standards were made was written incorrectly. Samples and standards were extracted on the same day as per the method. b. None. Lack of documentation, however, method and SOP was properly followed and spiking levels are correct.
Corrective Action Plan:
a. Discussed with analyst the importance of correct dates and attention to detail. b. Opened ticket with IT to fix the cells that don't allow for decimal places. Ticket # 2019121110048175. IT has fixed issue. Please see attachment for updated spiking amounts with decimals.
Attachment 7.b 551 CH Updated Webform for Spiking Amounts Preventive Action Plan:
Other IT concerns should be addressed when the webform limits the information that can be put in the form itself.
7.c
Root Cause:
Sample containers are pre-cleaned by QEC, using their proprietary method. QEC sample containers that EEA received already have preservatives added into these containers.
Therefore we would not be able to wash them without washing away the preservatives.
Impact on Sample Data:
No impact on samples, since we are following the method procedure.
Corrective Action Plan:
None, since we are following the method procedure.
7.d
Root Cause:
The SOP documentation does not state the procedure on the baking of the Sodium Chloride at 400°C for 30 minutes.
Impact on Sample Data:
158 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
None.
Dishwashing records when salt is baked. The salt is baked at 800°C for 8 hours in order to ensure that all organics are completely burned away. This is shown to be effective by the lack of contaminants in our blanks and passing PT studies.
Corrective Action Plan:
The SOP will be updated to include the procedure of baking the NaCl at 400°C for 30 minutes as per method requirement.
Preventive Action Plan:
The SOP will be updated to include the baking procedure of the NaCl at 400°C for 30 minutes and store in glass bottles and not in plastic containers.
Estimated completion date: 1/25/2020
7.e
Root Cause:
pH strips that were available were 4.6 - 5.5, with 0.3 increments. However, method states range is 4.8 - 5.5.
Impact on Sample Data:
None, samples are usually never at or below 4.6. Almost all samples have a pH of 4.9 or
5.2, unless there is a wrong or no preservative, but then the ASMs are notified and, if analyzed, the samples are qualified.
Corrective Action Plan:
SOP will be updated to denote the proper method pH of 4.8-5.5. For samples that read outside of those limits they will be flagged as not valid for compliance and a resample will be requested.
Estimated completion date: 2/7/2020
7.f
Root Cause:
EPA Method 551.1, Section 7.1.7.5 states:
"If background contaminants are detected in the salts listed in Sections 7.1.7.1 through
7.1.7.3 [phosphate buffer, ammonium chloride, and sodium sulfite present in QEC sample/QC vials], a solvent rinse cleanup procedure may be required. These contaminants may coelute with some of the high molecular weight herbicides and pesticides. These salts cannot be muffled since they decompose when heated to 400 degrees C. This solvent rinsing procedure is applied to the homogenous mixture prepared in Section 7.1.7.4. (Phosphate buffer)
159 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Note: If a laboratory is not conducting analyses for the high molecular weight herbicides and pesticides, this cleanup may not be required if no interfering peaks are observed within the retention time window (Section 12.2) for any target analytes in the laboratory reagent blank."
This does not apply to the EEA SOP because:
1. High molecular herbicides and pesticides are not conducted via 551.1, they are conducted via 505 and 515.4, so any interfering peaks with herbicides and pesticides would not be an issue since these are not target analytes for 551.1.
2. None of the QCs or samples have interfering peaks with target analytes on the primary column for 551.1.
3. None of the reagent blanks have had any contamination.
4. There is no evidence of absorption or desorption of contaminants in the MRL checks, which is at the lower end of the curve.
5. EEA only reports the THMs, HANs, CH, EDB, and DBCP for 551.1.
Therefore, the solvent rinse cleanup procedure is not required.
Corrective Action Plan:
Not applicable
7.g
Root Cause:
Surrogate is prepared in methanol because the stock ampules come in methanol.
Impact on Sample Data:
None, all QC and PTs have been passing.
Corrective Action Plan:
None since our stock standards and PT are in methanol.
7.h
Root Cause:
Chloral hydrate is currently prepared in acetone. When Sophia Liang was the GC manager, the lab had an issue with failing PT samples. There were 2 failing PTs in a row, so Sophia ordered several stock ampules from different vendors in different solvents. She made standards for all and extracted and analyzed them to determine which solvent worked best for chloral hydrate. Acetone proved to be the most stable, so the standards have been made in acetone ever since, with no issues for standards or PTs.
Impact on Sample Data:
None.
160 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Corrective Action Plan:
We will look for chloral hydrate standards in methanol from our vendors and conduct a side by side evaluation with methanol and acetone.
Expected completion date: 2/7/2020
Laboratory Proposed Completion Date:
7.a, b, c, f and g – completed 1/8/2020
7.d - estimated completion date: 1/25/2020
7.e and h - estimated completion date: 2/7/2020
Responsible Party: Amy George
ELAP Response to Proposed Corrective Action:
7a. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
7b. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
7c. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
7d. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
7e. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
7f. Laboratory response is acceptable.
7g. Laboratory response is acceptable. Per 40 CFR § 141.27, the laboratory must also obtain approval from the U.S. EPA to use an alternate analytical technique that deviates from the method-specified standard preparation. Implementation of corrective action will be verified in the next assessment cycle.
7h. Laboratory response is acceptable. Per 40 CFR § 141.27, the laboratory must also obtain approval from the U.S. EPA to use an alternate analytical technique that deviates from the method-specified standard preparation. Implementation of corrective action will be verified in the next assessment cycle.
Additional ELAP Comments (if necessary):
161 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Finding # 8
For EPA 505:
a. The balance used in the sample preparation (B02 Scout Pro) was moved or physically displaced from its original location while interviewing the analyst during the OSA. Moving a balance from one location to another changes the conditions under which it was originally calibrated. Because precision and reproducibility of weighing results is closely associated with the location of the balance, recalibration after a balance is moved is essential to ensure that the laboratory is able to meet method requirements. It is not demonstrated that laboratory staff are aware that it is not permissible to move the balance unnecessarily and that recalibration would be needed each time moved. [22 CCR §64813(b)]
b. Similarly, as in the finding above, the same balance contains two different labels. [22 CCR §64815(a) and (d)]
c. The laboratory reported that it performs mercury clean-up procedures. Such procedures are not defined or listed in the laboratory SOP. [22 CCR §64815(a) and (d)]
d. MDL study was not available for review at the time of this OSA. Please submit the latest MDL study for the method for all analytes that the laboratory reports. (EPA 505 Section 9.1)
Regulation that establishes the requirement:
EPA 505
22 CCR §64815
Description of Laboratory Corrective Action:
8.a:
Root Cause:
The Balance SOP does not specify that we need to recalibrate the balance once the balance has been moved.
Impact on Sample Data:
None since our balance always passes the day-of-use basis verification check even though it may have been moved the day before.
Corrective Action Plan:
162 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
The balance in question is not the balance that the department normally uses on a daily basis and therefore it would've been re-verified if the balance is being used.
Preventive Action Plan:
The laboratory will update its SOP to emphasize that once a balance is moved, we will need to re-verify the calibration with a calibrated S-weight. If verification failed the acceptable limits, the laboratory will call service to calibrate the balance. A label will be posted near the balance to state "DO NOT MOVE the balance unnecessarily.” Refer to SOP 2510 for details.
Estimated completion date: 1/25/2020.
8.b:
Please see our response for 6.c
8.c:
Root Cause:
The laboratory conducts a mercury cleanup procedure as per EPA 608 for non-drinking water samples from time to time due to the sample matrix. This procedure will be added to the SOP.
Impact on Sample Data:
None this is a cleanup step to clean up interference.
Corrective Action Plan:
608 mercury clean up procedure will be added to SOP.
Estimated completion date 1/25/2020
8.d
Root Cause:
The auditor was running out of time to see documentation while she was on-site.
Additionally, an older MDL study was submitted to the auditors prior to their visit to our laboratory on 10/16/19 and the MDL study was still valid during the OSA.
Attachment 8.d.1 505 Blank Study
Attachment 8.d.2 505 IDOC
Attachment 8.d.3 505 MDL
Impact on Sample Data:
NA since we are performing MDL/DOC studies on a timely basis, but the auditor did not review due to a lack of time.
Corrective Action Plan:
N/A since the finding is not due to the lack of organization of the laboratory. 163 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Laboratory Proposed Completion Date:
8.a and c – estimated completion date: 1/25/2020
8.b and d – completed 1/8/2020
Responsible Party: Amy George and Andora Nguyen
ELAP Response to Proposed Corrective Action:
8a. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
8b. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
8c. Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
8d. Laboratory response is acceptable.
Additional ELAP Comments (if necessary):
164 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Finding # 9
For EPA 504.1, the laboratory considers the method blank acceptable when it does not contain target analytes equal to or greater than half the RL. The method states that method blanks are acceptable when results are less than the MDL. (Section 7.2) Regulation that establishes the requirement:
EPA 504.1
Description of Laboratory Corrective Action:
Root Cause:
The laboratory has historically evaluated blank result at < 1/2 MRL, as the laboratory does not report to the MDL.
Impact on Sample Data:
None. Laboratory reports down to MRL. When a client requests reporting down to the MDL, the results are "J" flagged as estimated since the data is below the MRL and above the MDL. To meet EPA method 504.1 section 7.2 that states lab reagent blank should be below the analytes' MDL, the laboratory will update the SOP to state that the LRB acceptable limits are < 1/3 MRL rather than < MDL. This is based on the relationship of the MRL and calculated MDL where MRL ~ 3xMDL, thus MDL < 1/3 MRL.
Corrective Action Plan:
The blank will be evaluated at < 1/3 of the MRL (as the MDL x3 is the typical MRL level).
See attached SOP2394 update.
Attachment 9 SOP2394 504.1 Draft SOP
Laboratory Proposed Completion Date: Completed 1/9/2020 Responsible Party: Amy George
ELAP Response to Proposed Corrective Action: Laboratory response is acceptable. The laboratory’s acceptance criteria for blanks is currently linked to the MRL by being defined as ≤ 1/3 MRL. The laboratory must ensure that in the event a future MDL study resulted in a lower MDL, that the laboratory must also lower its MRL to maintain the MDL:MRL relationship. At any time this MDL:MRL relationship changes, the laboratory must only accept method blanks or LRBs (however named) that are below the MDL or the laboratory would render itself non-compliant to method requirements. Implementation of corrective action will be verified in the next assessment cycle.
165 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Additional ELAP Comments (if necessary):
166 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Finding # 10
For analytical and support equipment, maintenance/service records reviewed did not include information on ‘return to control,’ (i.e., whether the maintenance or repair performed was effective in returning the analytical instrument to operation).
Regulation that establishes the requirement:
22 CCR § 64813
Description of Laboratory Corrective Action:
Root Cause:
Analysts have been trained to enter maintenance records in a problem/solution format unless it's routine change of materials. That the problem is solved is inherent in the solution part of the documentation. There has been no training in terms creating a formal statement regarding "return to control".
Impact on Sample Data:
None, a working instrument would be noted by the ability to produce data as per the SOP.
Corrective Action Plan:
SOP for documentation in the Maintenance logbook is to be updated regarding the requested practice.
The maintenance logbooks will be updated to include a statement or confirmation that the repair performed was effective.
Laboratory Proposed Completion Date: Estimated completion date 2/9/2020 Responsible Party: Lisa Ramirez & Walter Hsieh
ELAP Response to Proposed Corrective Action: Laboratory response is acceptable. Implementation of corrective action will be verified in the next assessment cycle.
Additional ELAP Comments (if necessary):
167 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Environmental Laboratory Accreditation Program
1001 I Street, Sacramento, California 95814
[email protected]
www.waterboards.ca.gov/elap
October 2, 2020
Fred Haley
Laboratory Director
Eurofins Eaton Analytical, LLC - Monrovia
750 Royal Oaks Drive, Suite 100
Monrovia, CA 91016
SUBJECT: APPROVED - CORRECTIVE ACTION REPORT, CERTIFICATE NO. 2813 (RENEWAL)
Dear Mr. Haley:
Pursuant to Title 22 of the California Code of Regulations (CCR) §64807, California Environmental Laboratory Accreditation Program (ELAP) conducted an on-site assessment of Eurofins Eaton Analytical, LLC – Monrovia on October 14 - 15, 2019. The corrective actions submitted by your laboratory have been approved.
Sincerely,
For Ali Hossain
Environmental Scientist
Environmental Laboratory Accreditation Program
Maria Friedman
Chief, Assessment Unit
Environmental Laboratory Accreditation Program
168 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
ID Major Topic Topic Subject Category Citation Does the laboratory comply with this section? Yes No N/A 1015 V1M4 1 CHEMICAL TESTING1016 1.1 Introduction V1M4 1.1 Introduction1017 1.1 Introduction V1M4 1.1 This document contains detailed quality control requirements for environmental testing activities involving chemical measurements. The evaluation of laboratories for this discipline is in conjunction with a quality system as specified in the general requirements module. Adherence to quality systems requirements will ensure that all quality control procedures specified in this module are being followed. 1018 1.2 Scope V1M4 1.2 Scope1019 1.2 Scope V1M4 1.2
The essential quality control procedures applicable to chemistry measurements are included in this module. Additional quality control requirements that are either specified by method, regulation or project shall be met by laboratories. 1020 1.3 Terms and Definitions V1M4 1.3 Terms and Definitions1021 1.3 Terms and Definitions V1M4 1.3 The relevant definitions from TNI, Volume 1, Module 2, Section 3.0 are the preferred references. Definitions related to this document, which are used differently or do not exist in the above references are defined below. 1022 1.3 Terms and Definitions V1M4 1.3.1 Additional Terms and Definitions1023 1.3 Terms and Definitions V1M4 1.3.1 Reserved1024 1.3 Terms and Definitions V1M4 1.3.2 Exclusions and Exceptions1025 1.3 Terms and Definitions V1M4 1.3.2 Reserved1026 1.4 Method Selection V1M4 1.4 Method Selection1027 1.4 Method Selection Reference Method Regulatory Definition V1M4 1.4 A reference method is a method issued by an organization generally recognized as competent to do so. (When ISO refers to a standard method, that term is equivalent to reference method). 1028 1.4 Method Selection Reference Method Regulatory Requirement V1M4 1.4 When a laboratory is required to analyze a parameter by a specified method due to a regulatory requirement, the parameter/method combination is recognized as a reference method. 1029 1.4 Method Selection Reference Method QC Requirement V1M4 1.4 If there is not a regulatory requirement for the parameter/method combination, the parameter/ method combination need not be validated under 1.5.1b) as a non-reference method if it can be analyzed by another similar reference method of the same matrix and technology. The inclusion of the parameter in the method shall meet all required calibration requirements and the quality control requirements of the method to which the parameter is being added. If no QC exists in the method, the laboratory shall adhere to the requirements outlined in the similar method. For example, when adding acetone to Method 624, the calibration and QC requirements shall follow Method 624.
Y
1030 1.4 Method Selection Added Analytes Identification Requirement A method that meets the above requirement shall be identified in such a way so that there is no confusion that the method has been modified. Y1031 1.4 Method Selection Non Reference Methods Customer Communication Requirement V1M4 1.4 When it is necessary to use methods not covered by reference methods, these shall be subject to agreement with the client and shall include a clear specification of the client's requirements and the purpose of the environmental test. Y1032 1.4 Method Selection Non Reference Methods Validation Requirement V1M4 1.4 The method developed shall have been validated appropriately before use. Y 1033 1.5 Method Validation V1M4 1.5 Method Validation1034 1.5 Method Validation 1.5.1 General V1M4 1.5.1 Validation of Methods 1035 1.5 Method Validation 1.5.1 General Reference Methods Requirement V1M4 1.5.1 a) The laboratory shall validate reference methods via the procedures specified in Sections 1.5.2 and 1.5.3. Y 1036 1.5 Method Validation 1.5.1 General Non Reference Methods Requirement V1M4 1.5.1 b) The laboratory shall validate non-reference methods, laboratory-designed/developed methods, reference methods used outside their published scope, and amplifications and modifications of reference methods to confirm that the methods are fit for the intended use. The validation shall be as extensive as is necessary to meet the needs of the given application or field of application. The laboratory shall record the results obtained, the procedure used for the validation, and a statement as to whether the method is fit for the intended use. In the absence of other specifications, the minimum requirements for method validation are given in Sections 1.5.2, 1.5.3 and 1.5.4.
Y
1037 1.5 Method Validation 1.5.2 LOD/LOQ V1M4 1.5.2 Limit of Detection and Limit of Quantitation (However Named) 169 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
1038 1.5 Method Validation 1.5.2 LOD/LOQ Documentation Procedure V1M4 1.5.2 Procedures used for determining limits of detection and quantitation shall be documented. Documentation shall include the quality system matrix type. All supporting data shall be retained.
Y
1039 1.5 Method Validation 1.5.2.1 LOD V1M4 1.5.2.1 Limit of Detection (LOD)1040 1.5 Method Validation 1.5.2.1 LOD LOD Study Exception V1M4 1.5.2.1 If the laboratory is not reporting a value below the Limit of Quantitation, a Limit of Detection study is not required.
Y
1041 1.5 Method Validation 1.5.2.1 LOD Appropriateness Requirement V1M4 1.5.2.1 The laboratory shall utilize a method that provides an LOD that is appropriate and relevant for the intended use of the data.
Y
1042 1.5 Method Validation 1.5.2.1 LOD Mandated Procedure Requirement V1M4 1.5.2.1 If a mandated method or regulation includes protocols for determining detection limits, these shall be followed.
Y
1043 1.5 Method Validation 1.5.2.1 LOD Selected Procedure Record V1M4 1.5.2.1 The laboratory shall document how LODs were derived from the determinations. If the protocol for determining the LOD is not specified, the selection of the procedure shall reflect instrument limitations and the intended application of the method.
Y
1044 1.5 Method Validation 1.5.2.1 LOD Processing Requirement V1M4 1.5.2.1 All sample-processing and analysis steps of the analytical method shall be included in the determination or validation of the LOD.
Y
1045 1.5 Method Validation 1.5.2.1 LOD Verification Requirement V1M4 1.5.2.1 a) When required, the laboratory shall determine or verify the LOD for the method for each target analyte of concern in the quality system matrices.
Y
1046 1.5 Method Validation 1.5.2.1 LOD Verification Procedure Requirement V1M4 1.5.2.1 b) The validity of the LOD shall be verified by detection (a value above zero) of the analyte(s) in a QC sample in each quality system matrix. This QC sample shall contain the analyte at no more than 3X the LOD for single analyte tests and 4X the LOD for multiple analyte tests.
Y
1047 1.5 Method Validation 1.5.2.1 LOD Extent of Verification Requirement V1M4 1.5.2.1 b) This verification shall be performed on every instrument that is to be used for analysis of samples and reporting of data. The validity of the LOD shall be verified as part of the LOD determination process. This verification shall be done prior to the use of the LOD for the sample analysis. 1048 1.5 Method Validation 1.5.2.1 LOD LOD Study Exception V1M4 1.5.2.1 c) An LOD study is not required for any component for which spiking solutions or quality control samples are not available such as temperature.
Y
1049 1.5 Method Validation 1.5.2.1 LOD Initial Determination Requirement V1M4 1.5.2.1 d) The LOD shall be initially determined for the compounds of interest in each method in a quality system matrix in which there are neither target analytes nor interferences at a concentration that would impact the results or the LOD shall be performed in the quality system matrix of interest.
Y
1050 1.5 Method Validation 1.5.2.1 LOD Frequency Requirement V1M4 1.5.2.1 e) An LOD shall be performed each time there is a change in the method that affects how the test is performed, or when a change in instrumentation occurs that affects the sensitivity of the analysis.
Y
1051 1.5 Method Validation 1.5.2.1 LOD Frequency Requirement V1M4 1.5.2.1 f) The LOD, if required, shall be verified annually for each quality system matrix, technology, and analyte.
Y
1052 1.5 Method Validation 1.5.2.2 LOQ V1M4 1.5.2.2 Limit of Quantitation (LOQ)1053 1.5 Method Validation 1.5.2.2 LOQ Processing Requirement V1M4 1.5.2.2 a) All sample-processing and analysis steps of the analytical method shall be included in the determination of the LOQ.
Y
1054 1.5 Method Validation 1.5.2.2 LOQ LOQ Study Exception V1M4 1.5.2.2 b) The LOQ study is not required for any component or property for which spiking solutions or quality control samples are not available or otherwise inappropriate (e.g., pH).
Y
1055 1.5 Method Validation 1.5.2.2 LOQ Verification Requirement V1M4 1.5.2.2 c) The validity of the LOQ shall be verified by successful analysis of a QC sample containing the analytes of concern in each quality system matrix at 1 to 2 times the claimed LOQ. A successful analysis is one where the recovery of each analyte is within the laboratory established method acceptance criteria or client data quality objectives for accuracy.
Y
1056 1.5 Method Validation 1.5.2.2 LOQ Verification Exception V1M4 1.5.2.2 d) When an LOD is determined or verified by the laboratory, the LOQ shall be above the LOD. Y1057 1.5 Method Validation 1.5.2.2 LOQ Frequency Requirement V1M4 1.5.2.2 e) The LOQ shall be verified annually for each quality system matrix, technology, and analyte. However, the annual LOQ verification is not required if the LOD was determined or verified annually on that instrument.
Y
1058 1.5 Method Validation 1.5.3 Precision & Bias V1M4 1.5.3 Evaluation of Precision and Bias 1059 1.5 Method Validation 1.5.3 Precision & Bias Reference Methods Requirement V1M4 1.5.3 a) Reference Methods. The laboratory shall evaluate the precision and bias of a reference method for each analyte of concern for each quality system matrix according to Section 1.6 or alternate documented procedure when the analyte cannot be spiked into the sample matrix and QC samples are not commercially available.
Y
1060 1.5 Method Validation 1.5.3 Precision & Bias Non Reference Methods Requirement V1M4 1.5.3 b) Non-Reference Methods. For laboratory-developed methods or non-reference methods that were not in use by the laboratory before July 2003, the laboratory shall have a documented procedure to evaluate precision and bias. The laboratory shall also compare results of the precision and bias measurements with criteria established by the client, by criteria given in the reference method or criteria established by the laboratory.
Y
170 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
1061 1.5 Method Validation 1.5.3 Precision & Bias Non Reference Methods Requirement V1M4 1.5.3 b) Precision and bias measurements shall evaluate the method across the analytical calibration range of the method. The laboratory shall also evaluate precision and bias in the relevant quality system matrices and shall process the samples through the entire measurement system for each analyte of interest.
Y
1062 1.5 Method Validation 1.5.3 Precision & Bias Non Reference Methods V1M4 1.5.3 b) Examples of a systematic approach to evaluate precision and bias could be the following:
1063 1.5 Method Validation 1.5.3 Precision & Bias Non Reference Methods Option V1M4 1.5.3 b) i.
Analyze QC samples in triplicate containing the analytes of concern at or near the limit of quantitation, at the upper-range of the calibration (upper 20%) and at a mid-range concentration. Process these samples on different days as three (3) sets of samples through the entire measurement system for each analyte of interest. Each day, one (1) QC sample at each concentration is analyzed. A separate method blank shall be subjected to the analytical method along with the QC samples on each of the three (3) days. (Note that the three (3) samples at the LOQ concentration can demonstrate sensitivity as well.) For each analyte, calculate the mean recovery for each day, for each level over each day, and for all nine (9) samples. Calculate the relative standard deviation for each of the separate means obtained. Compare the standard deviations for the different days and the standard deviations for the different concentrations. If the different standard deviations are all statistically insignificant (e.g., F-test), then compare the overall mean and standard deviation with the established criteria from above.
Y
1064 1.5 Method Validation 1.5.3 Precision & Bias Non Reference Methods Option V1M4 1.5.3 b) ii. A validation protocol, such as the Tier I, Tier II, and Tier III requirements in US EPA Office of Water’s Alternate Test Procedure (ATP) approval process. Y1065 1.5 Method Validation 1.5.4 Selectivity V1M4 1.5.4 Evaluation of Selectivity 1066 1.5 Method Validation 1.5.4 Selectivity Method Specified Requirement V1M4 1.5.4 The laboratory shall evaluate selectivity by following the checks established within the method, which may include mass spectral tuning, second column confirmation, ICP interelement interference checks, chromatography retention time windows, sample blanks, spectrochemical absorption or fluorescence profiles, co-precipitation evaluations, and electrode response factors.
Y
1067 1.6 DOC V1M4 1.6 Demonstration of Capability (DOC)1068 1.6 DOC 1.6.1 General V1M4 1.6.1 General 1069 1.6 DOC 1.6.1 General Initial DOC Requirement V1M4 1.6.1 Prior to acceptance and institution of any method for which data will be reported, a satisfactory initial DOC is required (see Section 1.6.2). 1070 1.6 DOC 1.6.1 General Ongoing DOC Requirement V1M4 1.6.1 Thereafter, ongoing DOC (Section 1.6.3), as per the quality control requirements in Section 1.7.3 (such as laboratory control samples) is required. Y 1071 1.6 DOC 1.6.1 General DOC Exception V1M4 1.6.1
In cases where a laboratory analyzes samples using a method that has been in use by the laboratory for at least one year prior to applying for accreditation, and there have been no significant changes in instrument type, personnel or method, the ongoing DOC shall be acceptable as an initial DOC.
Y
1072 1.6 DOC 1.6.1 General DOC Record V1M4 1.6.1 The laboratory shall have records on file to demonstrate that an initial DOC is not required. Y1073 1.6 DOC 1.6.1 General Documentation Record V1M4 1.6.1 For the initial DOC, appropriate records as discussed in Section 1.6.2 shall be completed. 1074 1.6 DOC 1.6.1 General Frequency Requirement V1M4 1.6.1 An initial DOC shall be completed each time there is a change in instrument type, personnel, or method. (see 1.6.2)1075 1.6 DOC 1.6.1 General Documentation Requirement V1M4 1.6.1 All demonstrations shall be documented. . Y 1076 1.6 DOC 1.6.1 General Data Record V1M4 1.6.1 All data applicable to the demonstration shall be retained and readily available at the laboratory. Y 1077 1.6 DOC 1.6.2 Initial DOC V1M4 1.6.2 Initial DOC
1078 1.6 DOC 1.6.2 Initial DOC DOC Frequency Requirement V1M4 1.6.2 An initial DOC shall be conducted prior to using any method, and at any time there is a change in instrument type, personnel or method or any time that a method has not been performed by the laboratory or analyst in a twelve (12) month period.
Y
1079 1.6 DOC 1.6.2 Initial DOC Documentation Record V1M4 1.6.2.1 The laboratory shall document each initial DOC in a manner such that the following information is readily available for each affected employee:
1080 1.6 DOC 1.6.2 Initial DOC DOC Record Contents V1M4 1.6.2.1 a) analyst(s) involved in preparation and/or analysis; Y 1081 1.6 DOC 1.6.2 Initial DOC DOC Record Contents V1M4 1.6.2.1 b) matrix; Y1082 1.6 DOC 1.6.2 Initial DOC DOC Record Contents V1M4 1.6.2.1 c) analyte(s), class of analyte(s), or measured parameter(s); Y1083 1.6 DOC 1.6.2 Initial DOC DOC Record Contents V1M4 1.6.2.1 d) identification of method(s) performed; Y1084 1.6 DOC 1.6.2 Initial DOC DOC Record Contents V1M4 1.6.2.1 e) identification of laboratory-specific SOP used for analysis, including revision number; Y 1085 1.6 DOC 1.6.2 Initial DOC DOC Record Contents V1M4 1.6.2.1 f) date(s) of analysis; and Y 1086 1.6 DOC 1.6.2 Initial DOC DOC Record Contents V1M4 1.6.2.1 g) summary of analyses, including information outlined in Section 1.6.2.2.c. Y1087 1.6 DOC 1.6.2 Initial DOC Procedure Option V1M4 1.6.2.2 If the method or regulation does not specify an initial DOC, the following procedure is acceptable. It is the responsibility of the laboratory to document that other approaches to initial DOC are adequate.
Y
171 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
1088 1.6 DOC 1.6.2 Initial DOC Procedure Option V1M4 1.6.2.2 a) The analyte(s) shall be diluted in a volume of clean quality system matrix (a sample in which no target analytes or interferences are present at concentrations that will impact the results of a specific method) sufficient to prepare four (4) aliquots at the concentration specified, or if unspecified, to a concentration of one (1) to four (4) times the limit of quantitation.
Y
1089 1.6 DOC 1.6.2 Initial DOC Procedure Option V1M4 1.6.2.2 b) At least four (4) aliquots shall be prepared and analyzed according to the method(s) either concurrently or over a period of days. Y 1090 1.6 DOC 1.6.2 Initial DOC Procedure Option V1M4 1.6.2.2 c) Using all of the results, calculate the mean recovery in the appropriate reporting units and the standard deviations of the sample (in the same units) for each parameter of interest. When it is not possible to determine mean and standard deviations, such as for presence/absence and logarithmic values, the laboratory shall assess performance against established and documented criteria.
Y
1091 1.6 DOC 1.6.2 Initial DOC Procedure Option V1M4 1.6.2.2 d) Compare the information from (c) above to the corresponding acceptance criteria for precision and accuracy in the method (if applicable) or in laboratory-generated acceptance criteria (if there are not established mandatory criteria). If all parameters meet the acceptance criteria, the analysis of actual samples may begin. If any one of the parameters does not meet the acceptance criteria, the performance is unacceptable for that parameter.
Y
1092 1.6 DOC 1.6.2 Initial DOC Procedure Option V1M4 1.6.2.2 e) When one or more of the tested parameters fail at least one of the acceptance criteria, the analyst shall proceed according to i) or ii) below. Y 1093 1.6 DOC 1.6.2 Initial DOC Procedure Option V1M4 1.6.2.2 e) i. Locate and correct the source of the problem and repeat the test for all parameters of interest beginning with b) above. Y 1094 1.6 DOC 1.6.2 Initial DOC Procedure Option V1M4 1.6.2.2 e) ii. Beginning with b) above, repeat the test for all parameters that failed to meet criteria. Y 1095 1.6 DOC 1.6.2 Initial DOC Procedure Option V1M4 1.6.2.2 f) Repeated failure, however, confirms a general problem with the measurement system. If this occurs, locate and correct the source of the problem and repeat the test for all compounds of interest beginning with b).
Y
1096 1.6 DOC 1.6.2 Initial DOC Added Analyte Requirement V1M4 1.6.2.2 g) When an analyte not currently found on the laboratory’s list of accredited analytes is added to an existing accredited method, an initial demonstration shall be performed for that analyte.
Y
1097 1.6 DOC 1.6.3 Ongoing DOC V1M4 1.6.3 Ongoing DOC
1098 1.6 DOC 1.6.3 Ongoing DOC Procedure Requirement V1M4 1.6.3.1 The laboratory shall have a documented procedure describing ongoing DOC. The analyst(s) shall demonstrate on-going capability by meeting the quality control requirements of the method, laboratory SOP, client specifications, and/or this Standard. It is the responsibility of the laboratory to document that other approaches to ongoing DOC are adequate.
Y
1099 1.6 DOC 1.6.3 Ongoing DOC V1M4 1.6.3.2 This on-going demonstration may be one of the following:
1100 1.6 DOC 1.6.3 Ongoing DOC Procedure Option V1M4 1.6.3.2 a) acceptable performance of a blind sample (single blind to the analyst); Y 1101 1.6 DOC 1.6.3 Ongoing DOC Procedure Option V1M4 1.6.3.2 a) Note: Successful analysis of a blind performance sample on a similar method using the same technology (e.g., GC/MS volatiles by purge and trap for Methods 524.2, 624 or 5030/8260) would only require documentation for one of the tests. Y 1102 1.6 DOC 1.6.3 Ongoing DOC Procedure Option V1M4 1.6.3.2 b) another initial DOC; Y1103 1.6 DOC 1.6.3 Ongoing DOC Procedure Option V1M4 1.6.3.2 c) at least four (4) consecutive laboratory control samples with acceptable levels of precision and accuracy. The laboratory shall determine the acceptable limits for precision and accuracy prior to analysis. The laboratory shall tabulate or be able to readily retrieve four (4) consecutive passing LCSs for each method for each analyst each year; Y
1104 1.6 DOC 1.6.3 Ongoing DOC Procedure Option V1M4 1.6.3.2 d) a documented process of analyst review using QC samples. QC samples can be reviewed to identify patterns for individuals or groups of analysts and determine if corrective action or retraining is necessary; Y 1105 1.6 DOC 1.6.3 Ongoing DOC Procedure Option V1M4 1.6.3.2 e) if a) through d) are not technically feasible, then analysis of real-world samples with results within a predefined acceptance criteria (as defined by the laboratory or method) shall be performed. Y1106 1.7 Technical Requirement V1M4 1.7 Technical Requirements1107 1.7 Technical Requirement 1.7.1.Initial Calibration V1M4 1.7.1 Initial Calibration 1108 1.7 Technical Requirement 1.7.1.Initial Calibration V1M4 1.7.1.1 Instrument Calibration 172 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
1109 1.7 Technical Requirement 1.7.1.Initial Calibration V1M4 1.7.1.1 This module specifies the essential elements that shall define the procedures and documentation for initial instrument calibration and continuing instrument calibration verification to ensure that the data shall be of known quality for the intended use. This Standard does not specify detailed procedural steps (“how to”) for calibration, but establishes the essential elements for selection of the appropriate technique(s). This approach allows flexibility and permits the employment of a wide variety of analytical procedures and statistical approaches currently applicable for calibration. 1110 1.7 Technical Requirement 1.7.1.Initial Calibration Multiple/Conflicting Requirements Requirement V1M4 1.7.1.1 If more stringent standards or requirements are included in a mandated method or by regulation, the laboratory shall demonstrate that such requirements are met. If it is not apparent which Standard is more stringent, then the requirements of the regulation or mandated method are to be followed.
Y
1111 1.7 Technical Requirement 1.7.1.Initial Calibration Essential Elements V1M4 1.7.1.1 The following items are essential elements of initial instrument calibration:
1112 1.7 Technical Requirement 1.7.1.Initial Calibration Process Procedure V1M4 1.7.1.1 a) the details of the initial instrument calibration procedures including calculations, integrations, acceptance criteria and associated statistics shall be included or referenced in the method SOP. When initial instrument calibration procedures are referenced in the method, then the referenced material shall be retained by the laboratory and be available for review; Y
1113 1.7 Technical Requirement 1.7.1.Initial Calibration Data Record V1M4 1.7.1.1 b) sufficient raw data records shall be retained to permit reconstruction of the initial instrument calibration (e.g., calibration date, method, instrument, analysis date, each analyte name, analyst’s initials or signature; concentration and response, calibration curve or response factor; or unique equation or coefficient used to reduce instrument responses to concentration); Y
1114 1.7 Technical Requirement 1.7.1.Initial Calibration Quantitation Requirement V1M4 1.7.1.1 c) sample results shall be quantitated from the initial instrument calibration and may not be quantitated from any continuing instrument calibration verification unless otherwise required by regulation, method, or program; Y
1115 1.7 Technical Requirement 1.7.1.Initial Calibration Second Source Standard Requirement V1M4 1.7.1.1 d) all initial instrument calibrations shall be verified with a standard obtained from a second manufacturer or from a different lot. Traceability shall be to a national standard, when commercially available; Y
1116 1.7 Technical Requirement 1.7.1.Initial Calibration Acceptance Criteria Requirement V1M4 1.7.1.1 e) criteria for the acceptance of an initial instrument calibration shall be established (e.g., correlation coefficient or relative percent difference). The criteria used shall be appropriate to the calibration technique employed; Y
1117 1.7 Technical Requirement 1.7.1.Initial Calibration Lowest Calibration Concentration Requirement V1M4 1.7.1.1 f) the lowest calibration standard shall be at or below the LOQ. Any data reported below the LOQ shall be considered to have an increased quantitative uncertainty and shall be reported using defined qualifiers or explained in the narrative; Y
1118 1.7 Technical Requirement 1.7.1.Initial Calibration Highest Calibration Concentration Requirement V1M4 1.7.1.1 g) the highest calibration standard shall be at or above the highest concentration for which quantitative data are to be reported. Any data reported above the calibration range shall be considered to have an increased quantitative uncertainty and shall be reported using defined qualifiers or explained in the narrative; Y
1119 1.7 Technical Requirement 1.7.1.Initial Calibration One-Point Calibration Requirement V1M4 1.7.1.1 h) the following shall occur for instrument technology (such as ICP or ICP/MS) with validated techniques from manufacturers or methods employing standardization with a zero point and a single point calibration standard:
Y
1120 1.7 Technical Requirement 1.7.1.Initial Calibration One-Point Calibration Requirement V1M4 1.7.1.1 h) i.
Prior to the analysis of samples, the zero point and single point calibration standard shall be analyzed and the linear range of the instrument shall be established by analyzing a series of standards, one of which shall be at or below the LOQ. Sample results within the established linear range will not require data qualifiers.
Y
1121 1.7 Technical Requirement 1.7.1.Initial Calibration One-Point Calibration Requirement V1M4 1.7.1.1 h) ii. A zero point and single point calibration standard shall be analyzed with each analytical batch.
Y
1122 1.7 Technical Requirement 1.7.1.Initial Calibration One-Point Calibration Requirement V1M4 1.7.1.1 h) iii. A standard corresponding to the limit of quantitation shall be analyzed with each analytical batch and shall meet established acceptance criteria.
Y
1123 1.7 Technical Requirement 1.7.1.Initial Calibration One-Point Calibration Requirement V1M4 1.7.1.1 h) iv. The linearity is verified at a frequency established by the method and/or the manufacturer.
Y
1124 1.7 Technical Requirement 1.7.1.Initial Calibration Corrective Actions Requirement V1M4 1.7.1.1 i) if the initial instrument calibration results are outside established acceptance criteria, corrective actions shall be performed and all associated samples re-analyzed. If re-analysis of the samples is not possible, data associated with an unacceptable initial instrument calibration shall be reported with appropriate data qualifiers; and Y
1125 1.7 Technical Requirement 1.7.1.Initial Calibration Minimum Calibration Points Requirement V1M4 1.7.1.1 j) if a reference or mandated method does not specify the number of calibration standards, the minimum number of points for establishing the initial instrument calibration shall be three.
Y
1126 1.7 Technical Requirement 1.7.2 Continuing Calibration V1M4 1.7.2 Continuing Calibration 1127 1.7 Technical Requirement 1.7.2 Continuing Calibration Frequency Requirement V1M4 1.7.2 When an initial instrument calibration is not performed on the day of analysis, the validity of the initial calibration shall be verified prior to sample analyses by a continuing instrument calibration verification with each analytical batch. The following items are essential elements of continuing instrument calibration verification.
Y
173 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
1128 1.7 Technical Requirement 1.7.2 Continuing Calibration Documentation Procedure V1M4 1.7.2 a) The details of the continuing instrument calibration procedure, calculations and associated statistics shall be included or referenced in the method SOP.
Y
1129 1.7 Technical Requirement 1.7.2 Continuing Calibration Extent of Verification Requirement V1M4 1.7.2 b) Calibration shall be verified for each compound, element, or other discrete chemical species, except for multi-component analytes such as aroclors, chlordane, total petroleum hydrocarbons, or toxaphene, where a representative chemical, related substance or mixture can be used.
Y
1130 1.7 Technical Requirement 1.7.2 Continuing Calibration CC Performance V1M4 1.7.2 c) Instrument calibration verification shall be performed:
1131 1.7 Technical Requirement 1.7.2 Continuing Calibration Batch Frequency Requirement V1M4 1.7.2 c) i. at the beginning and end of each analytical batch. If an internal standard is used, only one verification needs to be performed at the beginning of the analytical batch; Y
1132 1.7 Technical Requirement 1.7.2 Continuing Calibration Time Frequency Requirement V1M4 1.7.2 c) ii. if the time period for calibration or the most recent calibration verification has expired; or Y1133 1.7 Technical Requirement 1.7.2 Continuing Calibration Method Frequency Requirement V1M4 1.7.2 c) iii. for analytical systems that contain a calibration verification requirement. Y1134 1.7 Technical Requirement 1.7.2 Continuing Calibration Calibration Reconstruction Record V1M4 1.7.2 d) Sufficient raw data records shall be retained to permit reconstruction of the continuing instrument calibration verification (e.g., method, instrument, analysis date, each analyte name, concentration and response, calibration curve or response factor, or unique equations or coefficients used to convert instrument responses into concentrations). Continuing calibration verification records shall explicitly connect the continuing verification data to the initial instrument calibration.
Y
1135 1.7 Technical Requirement 1.7.2 Continuing Calibration Acceptance Criteria Requirement V1M4 1.7.2 e) Criteria for the acceptance of a continuing instrument calibration verification shall be established.
Y
1136 1.7 Technical Requirement 1.7.2 Continuing Calibration Corrective Actions Requirement V1M4 1.7.2 e) If the continuing instrument calibration verification results obtained are outside the established acceptance criteria and analysis of a second consecutive (immediate) calibration verification fails to produce results within acceptance criteria, corrective actions shall be performed.
Y
1137 1.7 Technical Requirement 1.7.2 Continuing Calibration Verification of Correction Action Requirement V1M4 1.7.2 e) The laboratory shall demonstrate acceptable performance after corrective action with two consecutive calibration verifications, or a new initial instrument calibration shall be performed.
Y
1138 1.7 Technical Requirement 1.7.2 Continuing Calibration Process without verified calibration Requirement V1M4 1.7.2 e) If the laboratory has not verified calibration, sample analyses may not occur until the analytical system is calibrated or calibration verified.
Y
1139 1.7 Technical Requirement 1.7.2 Continuing Calibration Process without verified calibration Requirement V1M4 1.7.2 e) If samples are analyzed using a system on which the calibration has not yet been verified the results shall be flagged.
Y
1140 1.7 Technical Requirement 1.7.2 Continuing Calibration Process without verified calibration Requirement V1M4 1.7.2 e) Data associated with an unacceptable calibration verification may be fully useable under the following special conditions:
1141 1.7 Technical Requirement 1.7.2 Continuing Calibration Data Usability Option V1M4 1.7.2 e) i. when the acceptance criteria for the continuing calibration verification are exceeded high (i.e., high bias) and there are associated samples that are non-detects, then those non-detects may be reported. Otherwise the samples affected by the unacceptable calibration verification shall be re-analyzed after a new calibration curve has been established, evaluated and accepted; or Y
1142 1.7 Technical Requirement 1.7.2 Continuing Calibration Data Usability Option V1M4 1.7.2 e) ii. when the acceptance criteria for the continuing calibration verification are exceeded low (i.e., low bias), those sample results may be reported if they exceed a maximum regulatory limit/decision level. Otherwise the samples affected by the unacceptable verification shall be re-analyzed after a new calibration curve has been established, evaluated and accepted.
Y
1143 1.7 Technical Requirement 1.7.3 QC V1M4 1.7.3 Quality Control 1144 1.7 Technical Requirement V1M4 1.7.3 The laboratory shall have quality control procedures for monitoring the validity of environmental tests undertaken as specified in this Section.(see requirements below) 1145 1.7 Technical Requirement 1.7.3.1 Negative Control V1M4 1.7.3.1 Negative Control – Method Performance: Method Blank1146 1.7 Technical Requirement 1.7.3.1 Negative Control Method Blank Processing Requirement V1M4 1.7.3.1 a) The method blank is used to assess the samples in the preparation batch for possible contamination during the preparation and processing steps.
Y
1147 1.7 Technical Requirement 1.7.3.1 Negative Control Method Blank Processing Requirement V1M4 1.7.3.1 a) The method blank shall be processed along with and under the same conditions as the associated samples to include all steps of the analytical procedure.
Y
1148 1.7 Technical Requirement 1.7.3.1 Negative Control Blank Assessment Procedure V1M4 1.7.3.1 a) Procedures shall be in place to determine if a method blank is contaminated. Y1149 1.7 Technical Requirement 1.7.3.1 Negative Control Reporting Requirement V1M4 1.7.3.1 a) Any affected samples associated with a contaminated method blank shall be reprocessed for analysis or the results reported with appropriate data qualifying codes.
Y
1150 1.7 Technical Requirement 1.7.3.1 Negative Control Frequency Requirement V1M4 1.7.3.1 b) The method blank shall be analyzed at a minimum of one (1) per preparation batch. Y 174 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
1151 1.7 Technical Requirement 1.7.3.1 Negative Control Frequency Requirement V1M4 1.7.3.1 b) In those instances for which no separate preparation method is used (for example, volatiles in water), the batch shall be defined as environmental samples that are analyzed together with the same method and personnel, using the same lots of reagents, not to exceed the analysis of twenty (20) environmental samples, not including method blanks, LCS, matrix spikes and matrix duplicates.
Y
1152 1.7 Technical Requirement 1.7.3.1 Negative Control Matrix Attributes Requirement V1M4 1.7.3.1 c) The method blank shall consist of a quality system matrix that is similar to the associated samples and is known to be free of the analytes of interest.
Y
1153 1.7 Technical Requirement 1.7.3.1 Negative Control Performing Exception V1M4 1.7.3.1 d) Method blanks are not applicable for certain analyses, such as pH, Conductivity, Flash Point and Temperature.
Y
1154 1.7 Technical Requirement 1.7.3.2 Positive Controls V1M4 1.7.3.2 Positive Control – Method Performance: Laboratory Control Sample (LCS) 1155 1.7 Technical Requirement 1.7.3.2 Positive Controls Purpose and Use Requirement V1M4 1.7.3.2.1 The LCS is used to evaluate the performance of the total analytical system, including all preparation and analysis steps. Results of the LCS are compared to established criteria and, if found to be outside of these criteria, indicates that the analytical system is “out of control.” Any affected samples associated with an out of control LCS shall be reprocessed for re-analysis or the results reported with appropriate data qualifying codes.
Y
1156 1.7 Technical Requirement 1.7.3.2 Positive Controls Frequency Requirement V1M4 1.7.3.2.2 The LCS shall be analyzed at a minimum of one (1) per preparation batch. Y 1157 1.7 Technical Requirement 1.7.3.2 Positive Controls Performance Exception V1M4 1.7.3.2.2 Exceptions would be for those analytes for which no spiking solutions are available, such as total suspended solids, total dissolved solids, total volatile solids, total solids, pH, color, odor, temperature, dissolved oxygen or turbidity.
Y
1158 1.7 Technical Requirement 1.7.3.2 Positive Controls Frequency Requirement V1M4 1.7.3.2.2 In those instances for which no separate preparation method is used (example: volatiles in water) the batch shall be defined as environmental samples that are analyzed together with the same method and personnel, using the same lots of reagents, not to exceed the analysis of twenty (20) environmental samples, not including method blanks, LCS, matrix spikes and matrix duplicates.
Y
1159 1.7 Technical Requirement 1.7.3.2 Positive Controls Matrix Attributes Requirement V1M4 1.7.3.2.3 The LCS is a quality system matrix, known to be free of analytes of interest, spiked with known concentrations of analytes.
Y
1160 1.7 Technical Requirement 1.7.3.2 Positive Controls Substitution Option V1M4 1.7.3.2.3 Note: The matrix spike may be used in place of this control as long as the acceptance criteria are as stringent as for the LCS.
Y
1161 1.7 Technical Requirement 1.7.3.2 Positive Controls CRM Option V1M4 1.7.3.2.3 Alternatively, the LCS may consist of a media containing known and verified concentrations of analytes or as Certified Reference Material (CRM). All analyte concentrations shall be within the calibration range of the methods. The following shall be used in choosing components for the spike mixtures:
Y
1162 1.7 Technical Requirement 1.7.3.2 Positive Controls Spike Components Requirement V1M4 1.7.3.2.3 The components to be spiked shall be as specified by the mandated method or regulation or as requested by the client. In the absence of specified spiking components, the laboratory shall spike per the following:
Y
1163 1.7 Technical Requirement 1.7.3.2 Positive Controls Spike Components Option V1M4 1.7.3.2.3 a) for those components that interfere with an accurate assessment, such as spiking simultaneously with technical chlordane, toxaphene and PCBs, the spike shall be chosen that represents the chemistries and elution patterns of the components to be reported; and Y
1164 1.7 Technical Requirement 1.7.3.2 Positive Controls Spike Components Option V1M4 1.7.3.2.3 b) for those methods that have extremely long lists of analytes, a representative number may be chosen. The analytes selected shall be representative of all analytes reported.
Y
1165 1.7 Technical Requirement 1.7.3.2 Positive Controls Multi Analytes Methods Requirement V1M4 1.7.3.2.3 b) The following criteria shall be used for determining the minimum number of analytes to be spiked. However, the laboratory shall insure that all targeted components are included in the spike mixture over a two (2) year period:
Y
1166 1.7 Technical Requirement 1.7.3.2 Positive Controls Multi Analytes Methods Option V1M4 1.7.3.2.3 b) i. For methods that include one (1) to ten (10) targets, spike all components. Y 1167 1.7 Technical Requirement 1.7.3.2 Positive Controls Multi Analytes Methods Option V1M4 1.7.3.2.3 b) ii. For methods that include eleven (11) to twenty (20) targets, spike at least ten (10) or 80%, whichever is greater.
Y
1168 1.7 Technical Requirement 1.7.3.2 Positive Controls Multi Analytes Methods Option V1M4 1.7.3.2.3 b) iii. For methods with more than twenty (20) targets, spike at least sixteen (16) components. Y 1169 1.7 Technical Requirement 1.7.3.3 Sample Specific Controls V1M4 1.7.3.3 Sample Specific Controls1170 1.7 Technical Requirement 1.7.3.3 Sample Specific Controls Documentation Procedure V1M4 1.7.3.3 The laboratory shall document procedures for determining the effect of the sample matrix on method performance. These procedures relate to the analyses of quality system matrix specific Quality Control (QC) samples and are designed as data quality indicators for a specific sample using the designated method. These controls alone are not used to judge laboratory performance.
Y
1171 1.7 Technical Requirement 1.7.3.3 Sample Specific Controls Documentation Procedure V1M4 1.7.3.3 Examples of matrix-specific QC include: Matrix Spike (MS), Matrix Spike Duplicate (MSD), sample duplicates, and surrogate spikes. The laboratory shall have procedures in place for tracking, managing, and handling matrix-specific QC criteria, including spiking appropriate components at appropriate concentrations, calculating recoveries and relative percent difference, and evaluating and reporting results based on performance of the QC samples.
Y
175 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
1172 1.7 Technical Requirement 1.7.3.3.1 MS/MSD MS/MSD V1M4 1.7.3.3.1 Matrix Spike; Matrix Spike Duplicates 1173 1.7 Technical Requirement 1.7.3.3.1 MS/MSD Use Requirement V1M4 1.7.3.3.1 a) Matrix-specific QC samples indicate the effect of the sample matrix on the precision and accuracy of the results generated using the selected method. The information from these controls is sample/matrix specific and would not normally be used to determine the validity of the entire batch.
Y
1174 1.7 Technical Requirement 1.7.3.3.1 MS/MSD Frequency Requirement V1M4 1.7.3.3.1 b) The frequency of the analysis of matrix spikes are as specified by the method or may be determined as part of the contract review process.
Y
1175 1.7 Technical Requirement 1.7.3.3.1 MS/MSD Spike Components Requirement V1M4 1.7.3.3.1 c) The components to be spiked shall be as specified by the mandated method. Any permit specified analytes, as specified by regulation or client requested analytes, shall also be included. If there are no specified components, the laboratory shall spike per the following:
Y
1176 1.7 Technical Requirement 1.7.3.3.1 MS/MSD Multi-peak Components Requirement V1M4 1.7.3.3.1 c) For those components that interfere with an accurate assessment such as spiking simultaneously with technical chlordane, toxaphene and PCBs, the spike shall be chosen that represents the chemistries and elution patterns of the components to be reported.
Y
1177 1.7 Technical Requirement 1.7.3.3.1 MS/MSD Spike Components Requirement V1M4 1.7.3.3.1 c) For those methods that have extremely long lists of analytes, a representative number may be chosen using the following criteria for choosing the number of analytes to be spiked. However, the laboratory shall insure that all targeted components are included in the spike mixture over a two (2) year period.
Y
1178 1.7 Technical Requirement 1.7.3.3.1 MS/MSD Spike Components Option V1M4 1.7.3.3.1 c) i. For methods that include one (1) to ten (10) targets, spike all components. Y1179 1.7 Technical Requirement 1.7.3.3.1 MS/MSD Spike Components Option V1M4 1.7.3.3.1 c) ii. For methods that include eleven (11) to twenty (20) targets, spike at least ten (10) or 80%, whichever is greater.
Y
1180 1.7 Technical Requirement 1.7.3.3.1 MS/MSD Spike Components Option V1M4 1.7.3.3.1 c) iii. For methods with more than twenty (20) targets, spike at least sixteen (16) components. Y1181 1.7 Technical Requirement 1.7.3.3.2 Matrix Duplicates V1M4 1.7.3.3.2 Matrix Duplicates1182 1.7 Technical Requirement 1.7.3.3.2 Matrix Duplicates Use V1M4 1.7.3.3.2 a) Matrix duplicates are defined as replicate aliquots of the same sample taken through the entire analytical procedure. The results from this analysis indicate the precision of the results for the specific sample using the selected method. The matrix duplicate may provide a usable measure of sample homogeneity. It may also provide a measure of precision when target analytes are present. 1183 1.7 Technical Requirement 1.7.3.3.2 Matrix Duplicates Frequency Requirement V1M4 1.7.3.3.2 b) The frequency of the analysis of matrix duplicates are as specified by the method or may be determined as part of the contract review process.
Y
1184 1.7 Technical Requirement 1.7.3.3.2 Matrix Duplicates Origin Requirement V1M4 1.7.3.3.2 c) Matrix duplicates are performed on replicate aliquots of actual samples. The composition is usually not known.
Y
1185 1.7 Technical Requirement 1.7.3.3.3 Surrogate Spikes V1M4 1.7.3.3.3 Surrogate Spikes 1186 1.7 Technical Requirement 1.7.3.3.3 Surrogate Spikes Preparation Requirement V1M4 1.7.3.3.3 a) Surrogates, when required, are chosen to reflect the chemistries of the targeted components of the method and are added prior to sample preparation/extraction.
Y
1187 1.7 Technical Requirement 1.7.3.3.3 Surrogate Spikes Extent Requirement V1M4 1.7.3.3.3 b) Except where the matrix precludes its use or when not commercially available, surrogate compounds shall be added to all samples, standards, and blanks for all appropriate methods.
Y
1188 1.7 Technical Requirement 1.7.3.3.3 Surrogate Spikes Source Requirement V1M4 1.7.3.3.3 c) Surrogate compounds are chosen to represent the various chemistries of the target analytes in the method. They are often specified by the mandated method and are deliberately chosen for their being unlikely to occur as an environmental contaminant. Often this is accomplished by using deuterated analogs of select compounds.
Y
1189 1.7 Technical Requirement 1.7.3.4 Data Reduction V1M4 1.7.3.4 Data Reduction1190 1.7 Technical Requirement 1.7.3.4 Data Reduction Documentation Procedure V1M4 1.7.3.4 The procedures for data reduction, such as use of linear regression, shall be documented. Y1191 1.7 Technical Requirement 1.7.3.5 Reagent & Water Quality V1M4 1.7.3.5 Reagent Quality, Water Quality and Checks1192 1.7 Technical Requirement 1.7.3.5 Reagent & Water Quality Grade Requirement V1M4 1.7.3.5 a) In methods where the purity of reagents is not specified, analytical reagent grade shall be used. Reagents of lesser purity than those specified by the method shall not be used. Documentation of purity shall be available.
Y
1193 1.7 Technical Requirement 1.7.3.5 Reagent & Water Quality Water Monitoring Requirement V1M4 1.7.3.5 b) The quality of water sources shall be monitored and documented and shall meet method specified requirements.
Y
1194 1.7 Technical Requirement 1.7.3.5 Reagent & Water Quality Titrant Verification Requirement V1M4 1.7.3.5 c) The laboratory shall verify the concentration of titrants in accordance with written laboratory procedures.
Y
1195 1.7 Technical Requirement 1.7.3.6 Selectivity V1M4 1.7.3.6 Selectivity1196 1.7 Technical Requirement 1.7.3.6 Selectivity Documentation Procedure V1M4 1.7.3.6 The laboratory shall document selectivity by following the checks established within the method.
Y
176 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
1197 1.7 Technical Requirement 1.7.4 Acceptance/Rejecti on Criteria V1M4 1.7.4 Data Acceptance/Rejection Criteria 1198 1.7 Technical Requirement 1.7.4.1 Negative Control V1M4 1.7.4.1 Negative Control – Method Performance: Method Blank1199 1.7 Technical Requirement 1.7.4.1 Negative Control Evaluation Requirement V1M4 1.7.4.1 While the goal is to have no detectable contaminants, each method blank shall be critically evaluated as to the nature of the interference and the effect on the analysis of each sample within the batch.
Y
1200 1.7 Technical Requirement 1.7.4.1 Negative Control Investigation Requirement V1M4 1.7.4.1 The source of contamination shall be investigated and measures taken to minimize or eliminate the problem and affected samples reprocessed or data shall be appropriately qualified if: (1.7.4.1.c) 1201 1.7 Technical Requirement 1.7.4.1 Negative Control Data Qualifiers Requirement V1M4 1.7.4.1 a) the concentration of a targeted analyte in the blank is at or above the reporting limit as established by the method or by regulation, AND is greater than 1/10 of the amount measured in the sample; Y
1202 1.7 Technical Requirement 1.7.4.1 Negative Control Data Qualifiers Requirement V1M4 1.7.4.1 b) the blank contamination otherwise affects the sample results as per the method requirements or the individual project data quality objectives; and a blank is determined to be contaminated.
Y
1203 1.7 Technical Requirement 1.7.4.1 Negative Control Investigation Requirement V1M4 1.7.4.1 c) The cause shall be investigated and measures taken to minimize or eliminate the problem. Samples associated with a contaminated blank shall be evaluated as to the best corrective action for the samples (e.g., reprocessing or data qualifying codes). In all cases the corrective action shall be documented.
Y
1204 1.7 Technical Requirement 1.7.4.2 Positive Control V1M4 1.7.4.2 Positive Control – Method Performance: Laboratory Control Sample (LCS) 1205 1.7 Technical Requirement 1.7.4.2 Positive Control Calculation Requirement V1M4 1.7.4.2 a) The results of the individual batch LCS are calculated in percent recovery or other appropriate statistical technique that allows comparison to established acceptance criteria. The laboratory shall document the calculation.
Y
1206 1.7 Technical Requirement 1.7.4.2 Positive Control Evaluation Requirement V1M4 1.7.4.2 a) The individual LCS is compared to the acceptance criteria as published in the mandated method. Where there are no established criteria, the laboratory shall determine internal criteria and document the method used to establish the limits or utilize client specified assessment criteria.
Y
1207 1.7 Technical Requirement 1.7.4.2 Positive Control Unacceptable Results Requirement V1M4 1.7.4.2 a) An LCS that is determined to be within the criteria effectively establishes that the analytical system is in control and validates system performance for the samples in the associated batch. Samples analyzed along with an LCS determined to be “out of control” shall be considered suspect and the samples reprocessed and re-analyzed or the data reported with appropriate data qualifying codes. This includes any allowable marginal exceedance as described in b) below.
Y
1208 1.7 Technical Requirement 1.7.4.2 Positive Control Unacceptable Results Option V1M4 1.7.4.2 a) i. when the acceptance criteria for the positive control are exceeded high (i.e., high bias) and there are associated samples that are non-detects, then those non-detects may be reported with data qualifying codes; or Y
1209 1.7 Technical Requirement 1.7.4.2 Positive Control Unacceptable Results Option V1M4 1.7.4.2 a) ii. when the acceptance criteria for the positive control are exceeded low (i.e., low bias), those sample results may be reported if they exceed a maximum regulatory limit/decision level with data qualifying codes.
Y
1210 1.7 Technical Requirement 1.7.4.2 Positive Control Allowable Marginal Exceedances Requirement V1M4 1.7.4.2 b) Allowable Marginal Exceedances. If a large number of analytes are in the LCS, it becomes statistically likely that a few will be outside control limits. This may not indicate that the system is out of control, therefore corrective action may not be necessary. Upper and lower marginal exceedance (ME) limits can be established to determine when corrective action is necessary. A ME is defined as being beyond the LCS control limit (three standard deviations), but within the ME limits. ME limits are between three (3) and four (4) standard deviations around the mean. The number of allowable marginal exceedances is based on the number of analytes in the LCS. If more analytes exceed the LCS control limits than is allowed, or if any one analyte exceeds the ME limits, the LCS fails and corrective action is necessary. This marginal exceedance approach is relevant for methods with long lists of analytes. It will not apply to target analyte lists with fewer than eleven analytes.
Y
1211 1.7 Technical Requirement 1.7.4.2 Positive Control Allowable Marginal Exceedances V1M4 1.7.4.2 b) The number of allowable marginal exceedances is as follows:
1212 1.7 Technical Requirement 1.7.4.2 Positive Control Allowable Marginal Exceedances Option V1M4 1.7.4.2 b) Number of Analytes in LCS >90 Number Allowed as Marginal Exceedances 5 Y 1213 1.7 Technical Requirement 1.7.4.2 Positive Control Allowable Marginal Exceedances Option V1M4 1.7.4.2 b) Number of Analytes in LCS 71-90 Number Allowed as Marginal Exceedances 4 Y1214 1.7 Technical Requirement 1.7.4.2 Positive Control Allowable Marginal Exceedances Option V1M4 1.7.4.2 b) Number of Analytes in LCS 51-70 Number Allowed as Marginal Exceedances 3 Y1215 1.7 Technical Requirement 1.7.4.2 Positive Control Allowable Marginal Exceedances Option V1M4 1.7.4.2 b) Number of Analytes in LCS 31-50 Number Allowed as Marginal Exceedances 2 Y1216 1.7 Technical Requirement 1.7.4.2 Positive Control Allowable Marginal Exceedances Option V1M4 1.7.4.2 b) Number of Analytes in LCS 11-30 Number Allowed as Marginal Exceedances 1 Y 177 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
1217 1.7 Technical Requirement 1.7.4.2 Positive Control Allowable Marginal Exceedances Option V1M4 1.7.4.2 b) Number of Analytes in LCS <11 Number Allowed as Marginal Exceedances 0 Y 1218 1.7 Technical Requirement 1.7.4.2 Positive Control Corrective Actions Requirement V1M4 1.7.4.2 b) If the same analyte exceeds the LCS control limit consecutively, it is an indication of a systemic problem. The source of the error shall be located and corrective action taken. Laboratories shall have a written procedure to monitor the application of marginal exceedance allowance to the LCS.
Y
1219 1.7 Technical Requirement 1.7.4.3 Sample Specific Controls V1M4 1.7.4.3 Sample Specific Controls1220 1.7 Technical Requirement 1.7.4.3a MS/MSD V1M4 1.7.4.3 a) Matrix Spike; Matrix Spike Duplicates 1221 1.7 Technical Requirement 1.7.4.3a MS/MSD Documentation Procedure V1M4 1.7.4.3 a) The results from matrix spike/matrix spike duplicate are primarily designed to assess the precision and accuracy of analytical results in a given matrix and are expressed as percent recovery (%R), relative percent difference (RPD), or other appropriate statistical technique that allows comparison to established acceptance criteria. The laboratory shall document the calculation for %R, RPD or other statistical treatment used.
Y
1222 1.7 Technical Requirement 1.7.4.3a MS/MSD Evaluation Requirement V1M4 1.7.4.3 a) The results are compared to the acceptance criteria as published in the mandated method. Where there are no established criteria, the laboratory shall determine internal criteria and document the method used to establish the limits. For matrix spike results outside established criteria, corrective action shall be documented or the data for that sample reported with appropriate data qualifying codes.
Y
1223 1.7 Technical Requirement 1.7.4.3.b Matrix Duplicates V1M4 1.7.4.3 b) Matrix Duplicates 1224 1.7 Technical Requirement 1.7.4.3.b Matrix Duplicates V1M4 1.7.4.3 b) The results from matrix duplicates are primarily designed to assess the homogeneity of the particular sample chosen. If that sample is homogenous it may also describe the precision of analytical results in a given matrix. 1225 1.7 Technical Requirement 1.7.4.3.b Matrix Duplicates Documentation Procedure V1M4 1.7.4.3 b) These may be expressed as relative percent difference (RPD) or another statistical treatment (e.g., absolute differences). The laboratory shall document the calculation for relative percent difference or other statistical treatments.
Y
1226 1.7 Technical Requirement 1.7.4.3.b Matrix Duplicates Evaluation Requirement V1M4 1.7.4.3 b) Results are compared to the acceptance criteria as published in the mandated method.
Where there are no established criteria, the laboratory shall determine internal criteria and document the method used to establish the limits. For matrix duplicates results outside established criteria, corrective action shall be documented or the data for that sample reported with appropriate data qualifying codes.
Y
1227 1.7 Technical Requirement 1.7.4.3.c Surrogates V1M4 1.7.4.3 c) Surrogate Spikes 1228 1.7 Technical Requirement 1.7.4.3.c Surrogates Acceptance Criteria Requirement V1M4 1.7.4.3 c) The results are compared to the acceptance criteria as published in the mandated method. Where there are no established criteria, the laboratory shall determine internal criteria and document the method used to establish the limits.
Y
1229 1.7 Technical Requirement 1.7.4.3.c Surrogates Evaluation Requirement V1M4 1.7.4.3 c) Surrogates outside the acceptance criteria shall be evaluated for the effect indicated for the individual sample results. The appropriate corrective action may be guided by the data quality objectives or other site-specific requirements.
Y
1230 1.7 Technical Requirement 1.7.4.3.c Surrogates Reporting Requirement V1M4 1.7.4.3 c) Results reported from analyses with surrogate recoveries outside the acceptance criteria shall include appropriate data qualifiers.
Y
1231 1.7 Technical Requirement 1.7.5 Sample handing V1M4 1.7.5 Sample Handling 1232 1.7 Technical Requirement 1.7.5 Sample handing Temperature Requirement V1M4 1.7.5 a) All samples that require thermal preservation shall be considered acceptable if the arrival temperature of a representative sample container is either within 2°C of the required temperature or the method specified range. For samples with a specified temperature of 4°C, samples with a temperature ranging from just above the freezing temperature of water to 6°C shall be acceptable.
Y
1233 1.7 Technical Requirement 1.7.5 Sample handing Temperature Exception V1M4 1.7.5 a) i. Samples that are delivered to the laboratory on the same day they are collected may not meet the requirements of Section 1.7.5.a. In these cases, the samples shall be considered acceptable if the samples were received on ice.
Y
1234 1.7 Technical Requirement 1.7.5 Sample handing Temperature Exception V1M4 1.7.5 a) ii. If sample analysis is begun within fifteen (15) minutes of collection, thermal preservation is not required.
Y
1235 1.7 Technical Requirement 1.7.5 Sample handing Temperature Exception V1M4 1.7.5 a) iii. Thermal preservation is not required in the field if the laboratory receives and refrigerates the sample within fifteen (15) minutes of collection.
Y
1236 1.7 Technical Requirement 1.7.5 Sample handing Preservation Checks Requirement V1M4 1.7.5 b) The laboratory shall implement procedures for checking sample preservation using readily available techniques, such as pH or chlorine, prior to or during sample preparation or analysis.
Y
1237 1.7 Technical Requirement 1.7.5 Sample handing Preservation Checks Exception V1M4 1.7.5 b) An exception is allowed for volatile organic compound analyses; chemical preservation may be checked after analysis.
Y
178 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Comments
QM 9.0
QM 14.4.11
QM 9.1.2.1QM 9.1.2.1
QM 9.4
QM 9.4.1 & 13.7.3.3.13
179 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
QM 9.2
QM 9.2.1.3QM 9.2.1.1QM 6.3.1.1QM 6.3.1.1QM 9.2.1.1QM 9.2.1.1QM 9.2.1.2QM 9.2.1.2QM 9.2.1.3QM 6.3.1.2QM 6.3.1.5QM 6.3.1.4 QM 9.2.2
QM 9.2.2.2QM 9.2.2.3
QM 6.3.2.2 & 9.2.2.1
QM 9.2.3.3QM 9.1.1.1QM 9.1.2.2
180 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
QM 9.2.2.4
QM 9.2.2.4.1QM 9.2.2.4.2
QM 9.2.2.5
QM 4.3.2
QM 4.3.3 & 6.3.3.3QM 4.3.3 & 6.3.3.3
QM 6.3.3.4
DOC TemplateDOC TemplateDOC TemplateDOC TemplateDOC TemplateDOC TemplateDOC Template
6.3.3.1 181 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
QM 6.3.3.7
QM 6.3.3.7
QM 6.3.3.7 & 6.3.3.8
QM 6.3.3.10QM 6.3.3.10QM 6.3.3.10QM 6.3.3.10QM 6.3.3.10 QM 6.3.3.1
QM 4.3.2
QM 4.3.2.1.3 QM 4.3.2.1.3 QM 4.3.2.1.2QM 4.3.2.1.4 QM 4.3.2.1.4 QM 4.3.2.1.5 182 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
QM 9.1.1.2
QM 11.1 & SOP for each method
QM 13.2.2.1 & NM 23 Calibration
SOP Section 6
NM 23 Calibration SOP Section
4.H
NM 23 Calibration SOP Section
4.E
QM 11.1.8 and Individual Method
SOPs
QM 11.1.6.2 QM 11.1.6.3
QM 11.6.4
Metals 1 SOP Section 9.F
Metals 1 SOP Section 9.F.2
Metals 1 SOP Section 9.F.2.d
Metals 1 SOP Section 9.F.2
QM 11.3
NM 23 Calibration SOP Section
4.D.1.a
NM 23 Calibration SOP Section
5.A
183 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
NM 23 Calibration SOP Section
5.G
QM 11.2.4 & NM 23 Calibration
SOP Section 5.B
QM 11.2.5.1QM 11.2.5.3QM 11.2.5.4QM 13.2.2.1
NM 23 Calibration SOP Section
5.F
QM 11.2.7
NM 23 Calibration SOP Section
5.F.3
QM 11.3.2 QM 11.3.2
QM 11.3.4.1QM 11.3.4.2
QM 6.1.1.1QM 6.1.1.1
QM 6.1.1.1 & Individual Method
SOPs
QM 6.1.1.1QM 6.1.1.1
184 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
QM 6.1.1.1
QM 6.1.1.1
Individual Method SOPs & QM
6.1.2.1 & QM Figure 15-1
QM 6.1.2.1QM 6.1.2.1QM 6.1.2.1QM 6.1.2.6
6.1.2.1 QM 6.1.2.4.2 & 6.1.2.4.6
QM 6.1.2.4.6QM 6.1.2.4.3QM 6.1.2.4.3QM 6.1.2.4.3QM 6.1.2.4.3QM 6.1.2.4.3 QM 6.2.2
QM 6.2 and Individual Method
SOPs
185 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
QM 6.1.2.2
QM 6.1.2.2
QM 6.1.2.3 & 6.1.2.4
QM 6.1.2.4.6 QM 6.1.2.4.3QM 6.1.2.4.3QM 6.1.2.4.3QM 6.1.2.4.3 QM 6.1.2.2QM 6.1.2.2
QM 6.2.1 & Individual Method
SOPs
QM 6.2.1 & Individual Method
SOPs
QM 6.2.1 & Individual Method
SOPs
QM 14.1
QM 10.2.1QM 12.2.6
QM 6.4.2.2QM 9.2.2.5
186 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
6.1.1.1 QM 6.1.1.1QM 6.1.1.1QM 6.1.1.1
QM 5.2.2, 6.1.2.8, & 13.2.2
QM 6.1.2.8QM 6.1.2.8
QM 11.3.4.1QM 11.3.4.2
QM 6.1.2.9QM 6.1.2.9QM 6.1.2.9QM 6.1.2.9QM 6.1.2.9QM 6.1.2.9 187 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
QM 6.1.2.9
QM 6.1.2.9
QM 5.1, 5.2, 13.2.2, 6.2.2
QM 6.1.2.8 & QM 15.0 & QM
Figure 15-1 & Individual Method
SOPs
QM 6.2.3, 13.2.2
Individual SOPs & QM 6.2.3, 15.0
& QM Figure 15-1
QM 6.2.1 & Individual Method
SOPs
QM 15.0 & Individual Method
SOPs
Individual Method SOPs & QM
Figure 15-1
QM 8.1QM 8.1
NM 1 Sample Receiving SOP
Section 8.D & Individual SOPs
Individual Method SOPs
188 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Document Document name Version
US Eurofins Eaton Analytical (Monrovia)
R-HS-6517 Chemical Hygiene Plan 6
R-HS-6518 Emergency Action Plan 5
R-HS-6562 Radiation Safety Manual 5
Quality Manual
QM-Monrovia-QM2598 Quality Manual - Monrovia 45
Standard Operating Procedure
Courier-27866 Courier SOP 1
Non Method-SOP2525 Influence, Confidentiality, Independence 5 NonMethod -SOP2415 1050B: Retention of Significant Figures 11 NonMethod-SOP7277 Calculations 4.1
NonMethod -SOP2509 Compositing and Subsampling in the Laboratory 11 NonMethod-SOP2519 Contracts Review 5
NonMethod-SOP2523 Control and Review of Records 5
NonMethod-SOP3002 Document Control 7
NonMethod-SOP2514 Glassware Cleaning 14
NonMethod-SOP2497 Laboratory Ethics/Data Integrity Plan 16 NonMethod-SOP3001 Non-Conforming Work and Corrective Action 8 NonMethod-SOP2520 Purchasing Supplies, Equipment, and Services 6 NonMethod-SOP2401 Standards and Reagent Preparation, Documentation, and Labelling 15 NonMethod-SOP2338 States Certification & Performance Tests Requirements 10 Non Method-SOP2511 Manual Integration 16
NonMethod-SOP2517 Calibration 5
NonMethod-SOP2521 Evaluation of Measurement Uncertainty 7 NonMethod-SOP2512 Instrument Maintenance 14
NonMethod-SOP2510 Balance Maintenance 13
NonMethod-SOP2515 Temperature Monitoring and Thermometer Calibration 10 NonMethod-SOP2513 Use of Class A Glassware and Pipette Function Verification 13 R-R&D-SOP24123 New Test and Expansion or Modification of Current Tests 2 NonMethod-R-6041-SOP2877 Hazardous Waste Management and Sample Disposal Procedures 15 R-HS-SOP25400 Business Continuity Plan 3
NonMethod-SOP2524 Subcontracting of Environmental Tests 7 NonMethod-SOP2526 Field Sampling and Measurements 4
NonMethod-SOP2876 Preparation and Shipment of Sample Kits 10 NonMethod-SOP2518 Handling of Controlled Substances 7
NonMethod-SOP2600 Sample Receiving and Log-In 30
UCMR4-SOP16869 Standardized Procedure for pH and Free and Total Chlorine Checks for UCMR4 Samples 5 Metals-SOP2369 150.1/180.1: pH / Turbidity Check for Metals 10 Metals-SOP2370 200.7 & 200.8: Metals Digestion by Hot Block 18 Metals-SOP2364 200.8 TRACE METALS ANALYSIS BY ICP/MS 39 Metals-SOP2400 Arsenic Speciation Preparation 6
Metals-SOP2363 ICP EPA 200.7 28
Metals-SOP2368 SM 2340B HARDNESS BY CALCULATION 15
Metals-SOP6316 UCMR4 200.8: TRACE METALS ANALYSIS BY ICP/MS 5 Metals-SOP39704 UCMR5: Analysis of Lithium by ICP-AES Using EPA Method 200.7 2 Wet Chemistry-SOP2481 150.1: pH 12
Wet Chemistry-SOP2468 2120B: Color 17
Wet Chemistry-SOP2489 2330B: Langelier Index By Calculation 11 Wet Chemistry-SOP2469 2510B/120.1: Conductivity (EC) 17 Wet Chemistry-SOP2466 2540B: Total Solids (TS) in Aqueous Sample 12 Wet Chemistry-SOP2467 2540F: Settleable Solids 13
Wet Chemistry-SOP2487 335.4: Determination of Total Cyanide by Semi-Automated Colorimetry 18 Wet Chemistry-SOP2366 3500Cr-B: Hexavalent Chromium, Colorimetric Method 16 Wet Chemistry-SOP2476 351.2: Total Kjedahl Nitrogen (TKN) by Colorimetric Analysis Following 18 Wet Chemistry-SOP2475 353.2: Determination of Nitrate/Nitrite 18 Wet Chemistry-SOP2488 365.1/4500P-H: Total Phosphorus By Automated Colorimetry 13 Wet Chemistry-SOP2486 410.4/5220D: Chemical Oxygen Demand (COD) 17 Wet Chemistry-SOP2474 420.1 & 420.4: Phenolics 19
Eurofins Eaton Analytical, Monrovia CA: SOP Inventory
1 of 4 EEA SOP Inventory 189 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Wet Chemistry-SOP2326 4500-CLO2-D: Chlorine Dioxide Analysis 9 Wet Chemistry-SOP2458 4500-CN-F: Cyanide Analysis by Ion Selective Electrode (ISE) (CNDW by ISE) 20 Wet Chemistry-SOP2485 4500-S2D SULFIDE Determination (Methylene Blue) 12 Wet Chemistry-SOP2482 5540C: Surfactants, Anionic (MBAS) 14 Wet Chemistry-SOP2492 A Simplified and Rapid Method for Biodegradable Dissolved Organic Carbon Measurement (BDOC) 8 Wet Chemistry-SOP3569 Cyanuric Acid 3
Wet Chemistry-SOP2479 EPA 160.4/SM 2540E: Total Volatile Solids/Total Volatile Residue/Volatile Suspended Solids in Liquid 14 Wet Chemistry-SOP2465 EPA 180.1: Turbidity - Nephelometric 15 Wet Chemistry-SOP29094 EPA 350.1 Ammonia by Gas Diffusion Segmented Flow Analysis 2 Wet Chemistry-SOP2493 EPA 420.4 MOD Phenolics- Low Level with Inline Distillation 8 Wet Chemistry-SOP2462 SM 2320B: Alkalinity 19
Wet Chemistry-SOP2463 SM 2540C: Total Dissolved Solids (TDS) in water 23 Wet Chemistry-SOP2464 SM 2540D: Total Suspended Solids (TSS) in water 14 Wet Chemistry-SOP2404 SM 4500-Cl-G: Free and Total Chlorine Analysis and PalinTest ChlordioX Plus: Chlorine Dioxide 17 Wet Chemistry-SOP2459 SM 4500-F C:Fluoride by ISE 19
Wet Chemistry-SOP2491 SM 4500-O G: Dissolved Oxygen, Membrane Electrode 9 Wet Chemistry-SOP2471 SM 4500P-E: Orthophosphate 13
Wet Chemistry-SOP2367 SM 4500-SiO2C/Silica by the Molybdosilicate Method 11 Wet Chemistry-SOP2494 SM 4500-SO3B: SULFITE Determination 5 Wet Chemistry-SOP2473 SM 5210B: BOD, 5-Day BOD Test 21
Wet Chemistry-SOP2472 SM2150 Odor at 60ºC 17
Wet Chemistry-SOP24467 SM4500 CN-J: Determination of Cyanogen Chloride by Manual Colorimetry 3 Wet Chemistry-SOP2483 SM5310C: Total Organic Carbon (TOC) and Dissolved Organic Carbon (DOC) by UV/Persulfate Oxidation 18 Wet Chemistry-SOP2484 SM5910B: Analytical method for Ultraviolet Absorption of Organic constituents at 254 nm (UV254) 10 Wet Chemistry-SOP2470 Total CN by Manual/ Midi Distillation by 335.4 and Cyanide Amenable by SM 4500 CN-G 17 IC-SOP2453 218.6/218.7 Hexavalent Chromium Ion Chromatography 13 IC-SOP18678 300.0: Determination of Anions by Ion Chromatography 3 IC-SOP2451 300.1/317: Determination of Inorganic Anions and Trace Bromate in Drinking Water Using Ion Chromatography b27 IC-SOP2457 314.0: DETERMINATION OF PERCHLORATE IN DRINKING WATER USING ION CHROMATOGRAPHY15 IC-SOP16821 Determination of Disinfectant By-Products (ClO3, ClO2, Br) 3 IC-SOP2454 EDTA & NTA in Water Using Ion Chromatography 6 GCMS-SOP2427 1613B: Determination of 2,3,7,8-TCDD in Drinking Water by Capillary Column Gas Chromatography with Large Vo10 GCMS-SOP2425 521.1 - Determination of Nitrosamines in Drinking Water by EEA-Agilent Method 521.1 for the Analysis of Nitrosa11 GCMS-SOP2496 522: Determination of 1,4-Dioxane in Drinking Water by Solid Phase Extraction with GCMS with Selected Ion Mon9 GCMS-SOP2412 524.2: Determination of tert-Butanol, Epichlorohydrin, 1,2-Dichloropropane, and 1,2,3-Trichloropropane in drink9 GCMS-SOP2395 524.2: Volatile Organic Compounds in Drinking Water by GC/MS 35 GCMS-SOP2396 525.2: Determination of Semivolatile Organic Compounds in Drinking Water by Gas Chromatography/Mass Spect36 GCMS-SOP2414 548.1: Endothall Analysis by GCMS 20
GCMS-SOP2424 6040E: Taste and Odor Analytes by Solid Phase Micro-Extraction and GCMS 12 GCMS-SOP2411 Determination of Low Level 5 ng/L (ppt) 1,2,3-trichloropropane (TCP) in drinking water by purge and trap GC/MS 13 GCMS-SOP35489 EPA 525.3: Determination of Semivolatile Organic Chemicals in Drinking Water by Solid Phase Extraction and Cap1 GCMS-SOP2428 Polybrominated diphenyl ethers (PBDE’s), pyrethroids, pesticides, and personal care product compounds Analyse3 GCMS-SOP6317 UCMR4 525.3: Determination of Semivolatile Organic Compounds (Pesticides) in Drinking Water by Capillary Colu8 GCMS-SOP6632 UCMR4 530: Determination of Select Semivolatile Organic Chemicals in Drinking Water by Gas Chromatography M7 GCMS-SOP6639 UCMR4 541: Determination of 1-Butanol, 2-Methoxyethanol, and 2-Propen-1-ol in Drinking Water by Gas Chroma5 GC-SOP2409 2350B: Chlorine Demand 7
GC-SOP2394 504.1: Analysis of 1,2-Dibromoethane (EDB), 1,2-Dibromo-3-chloropropane (DBCP) and 1,2,3-Trichloropropane (119 GC-SOP2406 505 Chlorinated Pesticides and PCBs 20
GC-SOP2408 515.4: Chlorinated Acids in Drinking Water by Liquid-Liquid Micro-Extraction, Derivatization and Gas Chromatogra15 GC-SOP2906 551.1 CH: Determination of Chlorination Disinfection Byproducts, Chlorinated Solvents, and Halogenated Pesticid4 GC-SOP2397 551.1 EDB/DBCP/HANs - Determination of Chlorination Disinfection Byproducts, Chlorinated Solvents, and Haloge5 GC-SOP2495 551.1: Chlorination Disinfection Byproducts and Chlorinated Organic Solvents by Liquid-Lquid Extraction and Gas 30 GC-SOP2410 556: Aldehydes 8
GC-SOP2405 5710B/5710D: Formation of Trihalomethanes and Other Disinfection By-Products 10 GC-SOP2402 6251B Haloacetic Acids and Trichlorophenol 25 HPLC-SOP2344 531.2 Carbamates Analysis in Drinking Water By High Performance Liquid Chromatography (HPLC) With Post Colu16.1 HPLC-SOP2343 547 Glyphosate Analysis in Drinking Water by High Performance Liquid Chromatography (HPLC)22 HPLC-SOP2392 549.2 Determination of Diquat and Paraquat in Drinking Water by High Performance Liquid Chromatography 23 Radiochemistry-SOP2373 EPA 900.0 GROSS α AND ß RADIOACTIVITY 25 2 of 4 EEA SOP Inventory 190 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Radiochemistry-SOP2374 GIT: Radium-226 and Radium-228 Determination in Drinking Water by Gamma-ray Spectrometry Using HPGE Det 12 Radiochemistry-SOP2449 SM 7110C: CO-PRECIPITATION METHOD for GROSS α 12 Radiochemistry-SOP2372 SM 7500RN Radon 222 16
Micro-SOP2350 9020B: Inhibitory Residues 16
Micro-SOP2358 9020B: pH Check of Clean Glassware Using Bromthymol Blue 11 Micro-SOP2349 9020B: Water Suitability Test 15
Micro-SOP2356 9215A,B: Heterotrophic Plate Count 23
Micro-SOP2359 Colilert 18H/SM9223B: Determination of Coliforms in Water by the 18 Hour ONPG-MUG Technique 16 Micro-SOP3134 DETERMINATION OF ENTEROCOCCUS IN WATER BY ENTEROLERT USING QUANTI-TRAY/2000 TECHNIQUE 6 Micro-SOP2461 DETERMINATION OF PSEUDOMONAS AERUGINOSA IN WATER BY THE PSEUDALERT METHOD 6 Micro-SOP2436 Environmental Monitoring For Microbiological Contaminants 15 Micro-SOP2393 EPA 100.2 Determination of Asbestos Fibers over 10 um in Length in Drinking Water 28 MICRO-SOP7048 EPA 546 (UCMR4 and non-UCMR4): Determination of Total Microcystins and Nodularins in Drinking Water and Am10 Micro-SOP16471 Legiolert (TM) by IDEXX 5
Micro-SOP2348 Microbiology Demonstration of Capability 12 Micro-SOP8041 Rapid Assimilable Organic Carbon (AOC) Luminescence Test (Weinrich Method) 6 Micro-SOP2352 SM 10200/ 10900: Algae Enumeration and Identification 7 Micro-SOP5424 SM 10200F: Analysis of Phytoplankton by Flow Cytometry 4 Micro-SOP2353 SM 9221 DETERMINATION OF TOTAL COLIFORMS, FECAL COLIFORMS AND ESCHERICHIA COLI IN DRINKING WATE28 Micro-SOP2346 SM 9223: COLISURE: DETERMINATION OF COLIFORMS IN WATER BY THE CPRG-MUG METHOD 19 Micro-SOP3012 SM 9223B/Colilert 24H: Determination of Coliforms in Water by the 24 Hour ONPG-MUG Technique 31 Micro-SOP2354 SM 9230B DETERMINATION OF FECAL STREPTOCOCCI AND ENTEROCOCCI IN WATER AND WASTEWATER BY MUL20 Micro-SOP2361 SM 9610 D: Membrane Filter Technique for Yeast and Mold Determination in Water 9 Extractions-SOP2390 1613B: Extraction for Determination of 2,3,7,8-TCDD in Drinking Water 8 Extractions-SOP2391 522: Extraction for Determination of 1,4-Dioxane in Drinking Water by Solid Phase Extraction 8 Extractions-SOP2376 548.1: Extraction of Endothall in Drinking Water 19 Extractions-SOP2377 549.2 - Liquid Solid Extraction of Diquat/Paraquat 17 Extractions-SOP2383 EEA 521.1: Determination of Nitrosamines in Drinking Water by Solid Phase Extraction 10 Extractions-SOP2375 EPA 525.2: Extraction for the Determination of Organic Compounds in Drinking Water by Liquid-Solid Extraction a23 Extractions-SOP23447 Extraction for the Determination of Emerging Contaminants in Drinking Water by Capillary Column Gas Chromato1 Extractions-SOP6631 UCMR 4 EPA 525.3: Extraction for the Determination of Semivolatile Organic Compounds in Drinking Water by So7 Extractions-SOP6633 UCMR 4 EPA 530: Determination of Select Semivolatile Organic Chemicals in Drinking Water by Solid Phase Extrac7 Extractions-SOP6640 UCMR4 EPA 541: Determination of 1-Butanol, 2-Methoxyethanol, and 2-Propen-1-ol in Drinking Water by Solid P7 LCMS-SOP2443 `The Determination of Personal Care Products, Pharmaceutical (PPCP) and Endocrine Disrupters Compounds (EDC6 LCMS-SOP2430 331: Determination of Perchlorate for PHG in Drinking Water by Liquid Chromatography/Electrospray Ionization T6 LCMS-SOP2446 331: Determination of Perchlorate in Drinking Water by Liquid Chromatography/Electrospray Ionization Tandem 10 LCMS-SOP30814 533 Determination of Selected PFAS in Drinking Water by Anion Exchange SPE and LC/MS/MS Using Isotope Dilut3 LCMS-SOP3617 536: Determination of Triazine Pesticides and Their Degradates in Drinking Water by Liquid Chromatography Elec6 LCMS-SOP2435 537 v1.1: Determination of Selected Perfluorinated Alkyl Acids in Drinking Water by Solid Phase Extraction and Liq10 LCMS-SOP2431 539: Determination of Hormones in Drinking Water by Solid Phase Extraction (SPE) and Liquid Chromatography E11 LCMS-SOP2440 Determination of Acrylamide in Drinking Water by Liquid Chromatography Electrospray Ionization/Mass Spectrom8 LCMS-SOP3570 Determination of Algal toxins in Environmental Matrices with High-Performance Liquid Chromatography/Mass Sp6 LCMS-SOP2447 Determination of Bromate in Drinking Water by Liquid Chromatography/Electrospray Ionization Tandem Mass Sp6 LCMS-SOP36447 Determination of Diphenhydramine in Water by LC/ESI-MS/MS 1 LCMS-SOP2444 Determination of Iodide and Iodate in Drinking Water by Liquid Chromatography/Electrospray Ionization Tandem 5 LCMS-SOP24130 EPA 537.1 - Determination of Selected Per- and polyfluorinated Alkyl Acids in Drinking Water by Solid Phase Extra5 LCMS-SOP16547 Explosives: Determination of Selected Explosives in Drinking Water by in-line SPE and Liquid Chromatography Ele3 LCMS-SOP2448 M532/M555: Determination of Phenylurea Compounds and Chlorinated Phenoxyacids (MCPA and MCPP) in Drin4 LCMS-SOP2445 The Determination of Endothall in Environmental Matrices by Online Solid-Phase Extraction Coupled with High-Pe8 LCMS-SOP3618 The Determination of Glyphosate and AMPA in Environmental Matrices by Online Solid-Phase Extraction Coupled 5 LCMS-SOP6636 UCMR4 EPA 545: Determination of Cylindrospermopsin and Anatoxin-A in Drinking Water by Liquid Chromatogra7 LCMS-SOP39620 UCMR5 533 Determination of Selected PFAS in Drinking Water by Anion Exchange SPE and LC/MS/MS Using Isoto1 LCMS-SOP39621 UCMR5 537.1 - Determination of Selected Per- and polyfluorinated Alkyl Acids in Drinking Water by Solid Phase E2 Work Instruction
QA-WI38980 2021 Data Integrity Training Presentation 1
QA-WI44377 2021 ISO Essentials Training 1
WI21466 Bubbles Policy 2
WI25084 Chemistry Initial and Continuing Demonstration of Capability 3 WI26472 Glossary - Terms and Definitions 4
3 of 4 EEA SOP Inventory 191 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
WI25066 Method Detection Limit (MDL) Procedure 3
WI25171 Chlorine Neutralization Efficacy for each New Bottle Lot # 1 WI12546 Microbiology QC Summary 3
R-6041-WI27819 Compliance with SB14 and Hazardous Waste Management Performance Report 1 NonMethod-R-6041-WI28090 Vyleater Operation and Maintenance 2 NonMethod-WI16374 Lean 5S 1
Field Sampling-WI40172 California PFAS Drinking Water Sampling Instructions 1 Field Sampling-WI17540 Free Chlorine Check Using SenSafe Test Strips 2 Shipping-WI20823 Sample Container Check for New Lot Number 1 Shipping-WI34437 Shipping with the FedEx station 2
Shipping-WI34436 Steps for Printing Bottle Kits and Labels 2 Shipping-WI34435 TCCC Sample Kit Packaging 2
Shipping-WI34434 Test List vs Container & HT 2
Shipping-WI36676 VOA TB Preparation and Storage 1
WI39702 Runner Instructions and Analyst Responsibilities for Short HT and Rush 1 Sample Receiving-WI5450 International Overtemp Exceptions 3 WI23134 Client Services Goals and Standards 1
WI23137 Customer Service Charter 1
WI23136 Customer Service Reference Guide - On the Phone 1 WI23160 Data Quality Elements 1
WI23135 Elements of Customer Service 1
WI16955 Massachusetts Reporting Requirement 2
WI16816 MCL, DLR and NL Notification Reporting to Clients 5 WI17310 Pennsylvania SDWA Reporting 1
WI23139 Phone Etiquette Basics and Goals 1
WI23138 Regulatory World 1
WI23140 Time Management 1
WI24963 UCMR4 QC Override Instructions 1
WI40398 U.S. Pharmacopeia Protocol 1
WI26044 Confirmation of Volatile Hits Instruction 2
WI17125 Re-work Instruction 2
WI37645 pH meter 1
Micro-WI27991 Autoclave Quality Control (QC) Requirements 2 Micro-WI30580 Microbiology Analyst Monthly Duplicate Reads 2 Micro-WI28896 Moisture Loss Testing Instructions 1
Micro-WI29885 Water Quality Table 1
Extractions-WI22481 EPA Method 525.2 pH and Chlorine Check 4 Extractions-WI23016 pH and Chlorine Check for Extractions 2 4 of 4 EEA SOP Inventory 192 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Eurofins Eaton Analytical, LLC
(EEA) Organizational Chart as of 11/30/22
Business Unit Manager
Caroline Sangari
D P: Eduardo Rodriguez
Quality/ Regulatory
Consulting Manager Nilda Cox
Inorganics TM: Walter Hsieh D: TBD
Asbestos TM: Carol Jeanne (CJ) Belt Lisa Hernandez Ashley Garcia Organics TM: Marnellie Ramos D: TBD Metals
Group Leader: Lupe Alvarez Runner Dominick Ferrar
Xinwei Ouyang Donnie Morquecho
Sandra Dansereau Max Young
GCMS SVOA
Supervisor: Marnellie Ramos
Ion Chromatography
Group Leader: Joan Luong Wet Chemistry Radiochemistry TM:Walter Hsieh D TM: Yoon Cha Extraction Supervisor: Mary Ann Viernes LCMS
Supervisor: Marnellie Ramos
Client Services Division Manager Rick Zimmer D CSDM: TBD Group Lead: Robert Dean Rosalinda Lomboy Yoon Cha Kathryn Chang Andora Nguyen John Ruane
Southwest Service Center/ PM
Thomas French
Steve Waichulaitis
Jesus Gonzalez Portland Service Center/ PM
Vanessa Berry Monrovia Project Managers Rachelle Arada Alejandra Gomez Rosalynn Dang Carmen Aguila Anisha Zachariah Anh Tran Christine Novshadayan Bethany Crim Alice Lee Nate Fresquez Corey Hurst PM Assistants Steve Waichulaitis Thinzar Win Audrey Armienta Mandre Armienta Michelle Do Mila Inukai Chris Gerfen James Colister Konjit Tadigo
Patrick Chapman
Kate Munson
Tyler Salverda
Ligia Barbu
Larisa Bognitskaya Terry Babayan Mike Castle Douglas Tang Benjamin Lieu Jackson Feng Melissa Taber Michelle Madriz Alejandro Delgado Noah Angel James Tuyay Gabriel Duran Minh Ngo Mikkel Lopez Alex Woo Rosie Bocanegra GCMS VOA Supervisor: Kipp Ramey Brian Wollard
Kevin Rodriguez
Jenny Wu
Jihun Ko
Kenneth Lee Alexandria Burton Cina Tamayo
Ellen Kim
Tricia Gutierrez
Jacobo Moreano
Kamille Day Nancy Rodriguez
Jenny Wu Robert Figueroa Ryan Moiseoff Lena Walters Adam Smith Rick Delmonico Danny Hsieh Jose Flores Paul Merilles Cecilia Pena
Petrus Komintas Su Zhen
Karen Muroi Konjit Tadigo Adrienne Geary Microbiology TM:Lisa Louie Deputy TM: TBD Selina Chan
Susie Famisan
Esmeralda Sanchez Stuart Sartain
Timothy Oilar Taylor Clayton Danielle Hawkins Sabina Simjee Haz Waste/Sample Disposal Supervisor:
Luis Rodriguez Unis Fulton Carol Schaffer
Director of Operations Support
Jeremy Hansen
Courier
X-zer Baluyot Miguell Hernandez Upali Jayakody Nathaniel Hall Megan Davis David Valenzuela Sample Receiving
Supervisor: Joe Sanchez Shipping
Supervisor Manuel Vasquez Group Leader: Theodore Ngo
Yudi Mulyapatera Charles Brooks Gregory Reitner Gustavo Velasquez Mark Urrutia Ryan Segura Alex Figeuroa Rey Edrosa Kelly Carpenter Fidel Chavez Heidi Castro Matthew Elyas Shaunte Jordan Dara Banh-Thai Group Leader Guillermo Yaquian Lonnie Kukita Henry Vasquez Matthew Ramos David Olivares Subcontracting
Jaclyn Contreras
Sampling
Miguel Hernandez Nathaniel Hall Henry Vasquez Upali Jayakody Megan Davis Purchasing/Receiving/ Accounts Receivable Alexandra Serna National Sales Manager
Bradley Cahoon Brian Queen Ron Milke Kevin Calcagno
Samantha Carney Taylor Sullivan Mike Murphy Dan Huber Brianne Nehring IT Department Tom Moore
EHS Manager/Lean Manager/
Radiation Safety Officer Yoon Cha
Donnie Morquecho
Larisa Lebedeva
Fanny McGinnis Nidia Contreras Raymund Kum
Juan Paredes Diana Olivares
Julianna Flores Anne Martinez Brandon Hang
Julian Puentes
Joey Cheng Don Solijon Robert Rojo Wendy Maldonado David Villegas Elizabeth Bello Lena Walter Michelle Madriz Alejandro Delgado Dishwashing Supervisor: Mary Ann Viernes OrgChart-LI5800 v25 QA FO 0066.2 (FRM2592) (02/06/18) T= temp A = assistant D = deputy TM = technical manager TBD: To be determined GC
Supervisor: Brittany Curry HPLC
Supervisor: Brittany Curry
Laboratory Director
Eduardo Rodriguez D: TBD Nor Cal Service Center/ PM
Monica Van Natta
Manager Supporting Executive Transfer Fred Haley
Sales Lauren Collins
193 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Model Month
Acquired
Year
Acquired Detectors Tests Serial # Software Version #
IC Dionex (IC 13/14) ICS3000 X 2006 IC w/Conductivity Detector 300.0/317/300.1 06030479 IC Dionex (IC 13/14) VWD3000 X 2006 IC-UV/VIS Dectector 317 8022929 IC Dionex (IC 13/14) IP25 X 2000 IC-Pump DX600 Series 317 00120038 IC Dionex (IC 13/14) ICS3000 pump X 2006 Dual Pump Module 300.0/317/300.1 10010477 IC Dionex (IC11/12) ICS3000 X 2007 IC w/Conductivity Detector 218.6/218.7/EDTA/NTA 07050797 IC Dionex (IC11/12) VWD3400 X 2010 IC-UV/VIS Detector 218.6/218.7 8074345 IC Dionex (IC11/12) IP25 X 2000 IC-Pump-DX500 Series 218.6/218.7 00120237 IC Dionex (IC11/12) ICS3000 pump X 2007 Dual Pump Module 218.6/218.7/EDTA/NTA 06110766 IC Dionex(IC9/10) ICS3000 X 2006 IC w/Conductivity Detector 314/300.1/317 07101026 IC Dionex(IC9/10) ICS3000 pump X 2012
Dual Pump Module
(replacement for original
module that died)
314/300.1/317 11041052
IC Dionex(IC9/10) VWD3400 X 2008 IC-UV/VIS Dectector 317 8004187 IC Dionex(IC9/10) GP40 X 1998 IC-Pump-DX500 Series 317 98070271 IC Dionex/Thermo (IC15) ICS1500 X 2012 IC w/Conductivity Detector UCMR 3 300.1/300.0 12090982 Chromeleon Client 6.80.SR11 IC Dionex/Thermo (IC16) ICS1500 X 2012 IC w/Conductivity Detector UCMR 3 300.1/300.0 12090984 Chromeleon Client 6.80.SR11 IC Dionex/Thermo (IC17) ICS-5000 + DC 7 2017 IC w/Conductivity Detector 218.6/218.7 & 300.0 17031049 Chromeleon Client 6.80.SR11 IC Dionex/Thermo
(IC17/18) ICS-5000 + DC X 2017 IC w/Conductivity Detector 218.6/218.7 & 300.0 17040451 IC Dionex/Thermo
(IC17/18) VWD3400 X 2017 IC-UV/VIS Detector 218.6/218.7 & 300.0 17020895 IC Dionex/Thermo
(IC17/18)
AS-AP
Autosampler X 2017 Autosampler 218.6/218.7 & 300.0 17040044 IC Dionex/Thermo
(IC17/18)
AS-AP
Autosampler X 2017 Autosampler 218.6/218.7 & 300.0 17040486 IC Dionex/Thermo (IC18) ICS-5000 + DC 7 2017 IC w/Conductivity Detector 218.6/218.7 & 300.0 17031048 Chromeleon Client 6.80.SR11 IC Metrohm
881 Compact IC
w/Conductivity
Detector
X 2009 IC Fluoride 3170 MagIC Net
IC Metrohm 887 UV/VIS X 2010 IC-Detector UV/VIS 218.6 3146 MagIC Net IC Metrohm 818 External Pump X 2009 IC-Pump 218.6 10156 MagIC Net IC Metrohm 858 Autosampler X 2009 IC-Autosampler All tests 2797 MagIC Net Metals Agilent 7700X X 2014 ICP/MS UCMR3/200.8 JP13292550 Mass Hunter for ICPMP G7201B B.01.03
Metals Agilent ICP-OES 5110
SVDV 5 2017 ICP 200.7 MY17100004
Metals Agilent SPS4 6 2017 Autosampler for 5110 200.7 AU16472186 Metals Cetac ASX-500 Model
510 Autosampler X 2011 ICP/MS Autosampler 200.8 10047ASX N/A N/A Metals Environmental Express Hot Block X 2002 Digestion Block Metals Prep 1763CEC1134 N/A N/A Metals Environmental Express Hot Block X 2012 Digestion Block Metals Prep 6974CECW3257 N/A N/A Chromeleon Client 6.80.SR11
ICP Expert 7.3.1.9507
Chromeleon Client 6.80.SR11
Chromeleon Client 6.80.SR11
Chromeleon Client 6.80.SR11
QA FO 0031.2 (04.06.16)
194 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Model Month
Acquired
Year
Acquired Detectors Tests Serial # Software Version #
Metals Environmental Express Hot Block X 2014 Digestion Block Metals Prep 9150CDCW4008 N/A N/A Metals HACH 2100Q
Turbidimeter X 2017 Nephelometric Turbidity for P&Tchecks 16120C054840 N/A N/A Metals Nelsab Merlin M75 Chiller X 2011 ICP/MS Chiller 200.8 107043069 N/A N/A ESI SC 2.9.0.361
ELAN Build
3.4.57.1133
3.5 Metals Perkin-Elmer FIMS400 X 2000 Mercury Analyzer Mercury 4605 WINLab 32 for AA 7.4.1.0730 Metals Thermo Lindberg/blue
WB1130C-1 X
Mercury Digestion Water
Bath Mercury Prep R12R-507226-RR N/A N/A
Rad Beckman 6500 X 1993 Liquid Scintillation System Radon 7067177 N/A N/A Rad Beckman Coulter Allegra 6 X 2003 Benchtop Centrifuge Ra 228 ALS02M09 N/A N/A Rad Canberra, Inc Gamma Spec X 2010 High Purity Ge Detector Ra 226 and Ra 228 9771 APEX-Alpha/ Beta 1.3.0.1077 Rad Canberra, Inc Gamma Spec X 2013 High Purity Ge Detector Ra 226 and Ra 228 10466 APEX-Alpha/ Beta 1.3.0.1077 Rad Canberra, Inc Gamma Spec X 2015 High Purity Ge Detector Ra 226 and Ra 228 10808 APEX-Alpha/ Beta 1.3.0.1077 Rad Canberra, Inc LB4200 X 2015 Proportional Counter Gross Alpha/Beta 13000216,-217,-218, - 219 APEX-Alpha/ Beta 1.3.0.1077
Rad Gamma Products Inc T7500 X 2006 Proportional Counter Gross Alpha/Beta and Ra 228 APEX Gamma 1.3
Rad Linberg Blue HP53025C X 2001 Hot Plate Gross Alpha/Beta W01K-496436-WK N/A N/A Rad Sartorius Analytic A200S X Balance N/A 37020275 N/A N/A Wetchem Analytik Jena APU2 X 2013 TOX extractor TOX 111/M N/A N/A Wetchem Carone 2050-1 X 1998 Circulator Cyanide/Phenol/Ammoni a
03301120501288 N/A N/A
Wetchem COSA/Xantaur TOX-100 X 2007 Coulometric TOX A7M-42726 TOX100 5.1 WetChem Environmental Express
HotBlock COD
Reactor - 56
position
X 2017 COD Digestors COD 2016CODWT03 N/A N/A
Wetchem GE Analytical 5310C X 2005 UV-Persulfate TOC, DOC 1210-6054 Slevers 5310C 02.05 2 Wetchem OI Analytical Aurora 1030 TOC Analyzer4 2018 UV-Persulfate TOC, DOC P751730245 Wetchem HACH 2100AN X 2004 Nephelometric Turbidity 040300006425 N/A N/A Wetchem HACH DR5000 X 2008 UV/VIS UV254 1141523 N/A N/A Wetchem HACH DR6000 X 2014 Spectrophotometer COD, R-SIO2, Cr+6, etc.
1557508 N/A N/A
WetChem HACH TL2300
Turbidimeter X 2018 Nephelometric Turbidity 2017090C0244 N/A N/A Wetchem Metrohm 1 855 X 2011 Titrosampler EC, pH, Alk 03263 TIAMO Build 109 2.4 Wetchem Metrohm 2 855 X 2011 Titrosampler Flouride 03312 TIAMO Build 109 2.4 Wetchem Mettler Multi-7 Meter X 2007 pH/Ion Meter pH, EC, 1228045058 N/A N/A Wetchem Mettler Muli-7 Meter X pH/Ion Meter pH/ISE, Fluoride, CNDW 1225267116 N/A N/A
WetChem Mettler Seven Excellence 2017 pH/Ion Meter VFA B641136759 N/A N/A Metals Perkin-Elmer ELAN 6000 X 1999 ICP/MS 200.8 3929707 QA FO 0031.2 (04.06.16)
195 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Model Month
Acquired
Year
Acquired Detectors Tests Serial # Software Version #
Wetchem OI Aanalytical (Dewey) 390 Autosampler X 2014 Autosampler CN, CNAMEN 101331A520 Wetchem OI Aanalytical (Dewey) FS3100 X 2014 Analyzer Module CN, CNAMEN 446833249 Wetchem OI Aanalytical (Dewey) 3212OIS X 2014 UV Digestor CN, CNAMEN 434814884 Wetchem OI Analytical (Hewey) 390 Autosampler 6 2011 Autosampler Phenolics Low Level 021102A130 Wetchem OI Analytical (Hewey) FS3100 X 2011 Analyzer Module Phenolics Low Level 114831572 Wetchem OI Analytical (Hewey) A515000 X 2011 Distillation Module Phenolics Low Level 114815572 Wetchem OI Analytical (Louie) 390 Autosampler X 2014 Autosampler NH3, TKN 101331A520 Wetchem OI Analytical (Louie) FS3100 X 2014 Analyzer Module NH3, TKN 438831373 Wetchem Orion 101 X 1990 Conductivity Conductance 127 N/A N/A Wetchem Palintest Chlordiox Plus 2015 Potentiometric Reader Free chlorine/chlorine dioxide 60210150009 N/A N/A
Wetchem Seal AQ2 X 2005 AQ2 Analyzer Cyanide, Nitrate 090497 AQ2 1.1 Wetchem YSI YSI-5000 X 2010 DO Meter/Probe BOD, CBOD, DO 10A101086 N/A N/A Wetchem Pall Shaker p/n 4821A Shaker MBAS 121413 N/A N/A WetChem VWR
Refrigerator
Incubator Model
10783-894
2018 Incubator BOD, CBOD 300193022 N/A N/A
Metals Agilent 7900 2018 ICP/MS 200.8 SG18334180
IC Dionex/Thermo (IC19) Aquion 2018 Conductivity Anions 180523874 Chromeleon Client Metals Environmental Express Hot Block 2018 N/A 200.7/200.8 2018CECW5010 N/A Wet Chemistry Palintest Chlorosense 2018 Amperometric Reader Chlorine, Free and Total 60004180003 N/A Radiochemistry Canberra, Inc Gamma Spec 2018 High Purity Ge Detector Ra 226 and Ra 228 11177 APEX-Alpha/ Beta 1.3.0.1077 Wet Chemistry Benchmark ORBi-Shaker 2018 Shaker Table BDOC 1706N101SBC236 N/A Wet Chemistry Environmental Express TKN054 2018 Digestion Block TKN 2018TKN162 N/A Wet Chemistry HACH DR4000V 2004 Spectrophotometer MBAS,OPO4, S2- 006V0000995 N/A Wetchem Reliance Glass MIDI-STIL X 2018 Distillation System Phenol, CN N/A N/A OI WIN Flow
Firmware 0.57
4.20.00.234
OI WIN Flow
Firmware 0.57
4.20.00.234
OI WIN Flow
Firmware 0.57
4.20.00.234
QA FO 0031.2 (04.06.16)
196 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Model Month
Acquired
Year
Acquired Detectors Tests ID Serial # Software Version # Extractions Thermo 12 2016 Extractor 537, 555, 528, 522, 540, 521, 530 C AT0607N4667
Auto Trace SPE 1.00.00
Extractions Thermo 12 2016 Extractor 539 D 14063019
Auto Trace SPE 1.00.00
Extractions
Thermo
280
12 2016 Extractor 537, 555, 528, 522, 540,
521, 530
B 12091036 Auto Trace SPE 1.00.00
Extractions
Thermo
280
1 2017 Extractor 537, 555, 528, 522, 540,
521, 530
E 17030339 Auto Trace SPE 1.00.00
Extractions
Thermo
280
1 2017 Extractor 537, 555, 528, 522, 540,
521, 530
A 17030338 Auto Trace SPE 1.00.00
Extractions
Thermo
280
1 2017 Extractor 537, 555, 528, 522, 540,
521, 530
F Auto Trace SPE 1.00.00
GC Varian 3800 X 2002 Dual ECDs 505 23 3800-08827
Chromeleon Client 6.80.SR11
GC Agilent 3800 X 2003 Dual ECDs 515LOW 24 US10306042
Chromeleon Client 6.80.SR11
GC Agilent 3800 X 2003 Dual ECDs 515.4 25 US10315085
Chromeleon Client 6.80.SR11
GC Agilent 3800 X 2003 Dual ECDs HAA 26 US10315084
Chromeleon Client 6.80.SR11
GC Agilent 6890N X 2005 Dual ECDs Used as Oven only 28 US10427028 Chromeleon Client 6.80.SR11
GC Agilent 6890N X 2005 Dual ECDs 551.1 29 US10440020
Chromeleon Client 6.80.SR11
QA FO 0031.2 (04.06.16)
197 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Model Month
Acquired
Year
Acquired Detectors Tests ID Serial # Software Version # GC Agilent 6890N X 2005 Dual ECDs HAA – 6251B/556 30 US10512068 Chromeleon Client 6.80.SR11
GC Agilent 6890N X 2005 Dual ECDs HAA – 6251B 31 CN10518044 Chromeleon Client 6.80.SR11
GC Agilent 6890N X 2005 Dual ECDs 551.1 32 CN10505035
Chromeleon Client 6.80.SR11
GC Varian 3800 X 2006 Dual ECDs 551 Soda 33 3800-12789
Chromeleon Client
GC Agilent 6890N X 2007 Dual ECDs 515 34 CN10706031
Chromeleon Client 6.80.SR11
GC Agilent 6890N X 2007 Dual ECDs 551.1CH, 504 35 CN10706032 Chromeleon Client 6.80.SR11
GC Agilent 6890N X 2007 Dual ECDs 6251B (HAA), 552.3
(HAA) 36 CN10706030
Chromeleon Client 6.80.SR11
GC Agilent 7890B 3 2016 Dual ECDs 505 37 CN16103131
Chromeleon Client 6.80.SR11
GC Agilent 7890B
4 2017 Dual ECDs
551SODA 38 CN17113090 Chromeleon Client 6.80.SR11
GC Agilent 7890B
4 2018
Dual ECDs HAA, 515
39 CN18063066 Chromeleon Client 6.80.SR11
GCMS Agilent 6890/5973 X 2003 MSD 524 SIM L US33246003
Enviromental MSD ChemStation D.01.02.16
GCMS Agilent 5973/6890 X 2005 MSD 524.2/624/8260 N US4647377 Enviromental MSD ChemStation D.01.02.16
QA FO 0031.2 (04.06.16)
198 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Model Month
Acquired
Year
Acquired Detectors Tests ID Serial # Software Version # GCMS Agilent 5973/6890 X 2005 MS 524.2/624/8260 P US44647375 Enviromental MSD ChemStation D.00.00.38
GCMS Varian CP 3800/4000 X 2009 GC/MS 521 ITS6 4000-0488 MS Workstation 6.9.3
GCMS Agilent 6890N X 2005 GC 525.2, 526, 527 M CN10416008 ChemStation D.01.02
GCMS Agilent 5973 inert X 2005 MS 525.2, 526, 527 M US40610242 GCMS Agilent 6890N X 2006 GC Endothall S CN10534101
ChemStation E.02.02
GCMS Agilent 5975N X 2006 MS S US52420838
GCMS Agilent 6890N X 2005 GC 625/8270/522 R CN10517080
ChemStation D.01.00
GCMS Agilent 5973 inert X 2005 MS R US44610770
GCMS Agilent 6890N X 2003 GC 525.2, 526, 527 K CN10331006 ChemStation D.01.02
GCMS Agilent 5973N X 2003 MS K US30945838
GCMS Varian CP-3800 X 2006 GC 521/Nitrosamines ITS5 3800-12765 MS Workstation 6.9.3
GCMS Varian 4000CIMSM X 2006 MS 521/Nitrosamines ITS5 4000-00291 QA FO 0031.2 (04.06.16)
199 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Model Month
Acquired
Year
Acquired Detectors Tests ID Serial # Software Version # GCMS Agilent 5975 X 2007 GCMS 524.2, 624, 8260, 524.3 U US65115374 Enviromental MSD ChemStation D.03.00.611
GCMS Agilent 6850 X 2010 GC CN10646018
GCMS Agilent 7890B X 2014 GC 524.2, 624 W CN14093023
MassHunter Data Analysis
B.07.00.SP2
1654
GCMS Agilent 5977A X 2014 MS W US1409J204
GCMS Agilent 7890B X 2014 GC 524.2 Y CN14233072
Enviromental MSD ChemStation F.01.01.2317
GCMS Agilent 5977A X 2014 MS Y US1421J204
GCMS Agilent 7890B X 2013 GC SPME ITS7 CN13193019
MS Workstation 7.0.1
GCMS Agilent 240 Ion trap X 2013 MS ITS7 US1322E001
GCMS Agilent 7890A X 2010 GC 1613B (Dioxin) TQ2 CN10111041 MassLynx V4.1
GCMS Waters Quattro Micro
Triple Quad X 2010 MS TQ2 RAB354
GCMS Agilent 7890A X 2010 GC 1613B (Dioxin) TQ3 CN1015111 MassLynx V4.1
GCMS Waters Quattro Micro
Triple Quad X 2010 MS TQ3 RAB355
QA FO 0031.2 (04.06.16)
200 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Model Month
Acquired
Year
Acquired Detectors Tests ID Serial # Software Version # GCMS Agilent 5975 X 2011 GCMS 524 TCP LOW X US11179701
Enviromental MSD ChemStation E.02.01.1177
GCMS Thermo ISQ X 2012 GCMS 524, 524.3 V ISQ120827
Trace Finder 3.2.512.0
GCMS Thermo ISQ X 2012 GCMS 522 T ISQ120935
Trace Finder 5.2.513.0
GCMS
Agilent
7890B
5 2015 GC 521 TQ
TQ4 CN15073217 MassHunter Data B.07.00
GCMS
Agilent
7010
5 2015 MS TQ 521 TQ
TQ4 US1509W001
GCMS
Agilent
7820A
4 2017 GC 525.3 / 525.2
Z CN17092024 ChemStation F.01.03
GCMS
Agilent
5977B
4 2017 MS 525.3 / 525.2
Z US1711R022
GCMS
Agilent
7890B
4 2018 GC 541 / 530
AA CN18043159 ChemStation F.01.03
GCMS
Agilent
5977
4 2018 MS 541 / 530
AA US1804M022
GCMS
Thermo
Trace 1310
1 2018 GC 1613
TQ5 717102012 Trace Finder 4.1
GCMS
Thermo
TSQ 8000Evo
1 2018 ms 1613
TQ5 TSQ81711517
GCMS
Agilent
6890
6 2018 GC CA SRL TCP
AB CN10633087 ChemStation F.01.03
QA FO 0031.2 (04.06.16)
201 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Model Month
Acquired
Year
Acquired Detectors Tests ID Serial # Software Version # GCMS
Agilent
5775
6 2018 MS CA SRL TCP
AB US73337435
GCMS
Agilent
7890A
9 2018 GC 521TQ, 1613
TQ6 US11291011 MassHunter Data B.07.01
GCMS
Agilent
7000
9 2018 MS TQ 521TQ, 1613
TQ6 US11196604
GCMS
Agilent
7890B
4 2018 GC 525.2 / 525.3
AC US18523029
Mass Hunter Acquisition / ChemStation
Data Analysis
B.07.06 /
F.01.03
GCMS
Agilent
5977
4 2018 MS 525.2 / 525.3
AC US1843M014
HPLC Dionex P580 X 2001 Fluorescence 531.1, 531.2 HPLC1 8027611 Chromeleon Client 6.80.SR11
HPLC Waters 2690/2487 X 1998 UV Detector 549, 555 HPLC2 H96SM4168R Chromeleon Client 6.80.SR11
HPLC Dionex P680 X 2005 Fluorescence 547 HPLC3 8085404 Chromeleon Client 6.80.SR11 HPLC Dionex UltiMate 3000 X 2014 Diode Array 549 HPLC6 8093385 Chromeleon Client 6.80.SR11 HPLC Dionex P580 4 2015 Fluorescence 531.1, 531.2 HPLC5 8068048 Chromeleon Client 6.80.SR11 HPLC Dionex UltiMate 3000 12 2017 Photometer 549 HPLC7 8137474 Chromeleon Client 6.80.SR11 QA FO 0031.2 (04.06.16)
202 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Model Month
Acquired
Year
Acquired Detectors Tests ID Serial # Software Version #
LCMS AB
SCIEX API 5000 X 2008 MS/MS CLO4, Acrylamide, EDC, 537, 536, PFC, Expl, DXABI LCMS4 AG22860808 Multi Quant 2.1.1742.0 LCMS Agilent 1200 SL X 2007 HPLC UCMR 3, EDC2, 532-LCMS LCMS3 Multi Quant 2.1.1742.0
LCMS AB
SCIEX API 4000 X 2007 MS/MS UCMR 3, EDC2, 532-LCMS LCMS3 V20670708 Multi Quant 2.1.1742.0 Lcquan 2.7.0 SP1 28 Build 2806
Foundation 2.0 SP1 Build 57
ToxID 2.1.2 SP2 Build 24
TraceFinder Core 3.0 Build 742
TraceFinder EFS 3.0 Build 742
TraceFinder General Quan 3.0 Build 742
Xcalibur 2.2 SP1 Build 48
Dionex Chromatography MS Link 2.12 Build 3404
TSQ Vantage 2.3.0 1214 SP3
Foundation 2.0 SP1 Build 57
ToxID 2.1.2 SP4 Build 24
TraceFinder Core 3.1 Build 19
TraceFinder EFS 3.1 Build 19
TraceFinder General Quan 3.1 Build 19
Xcalibur SP1 Build 48
Dionex Chromatography MS Link 2.14 Build 3818
TSQ Vantage 2.3.0 Build 1214 SP3
Foundation 2.0 SP1 Build 57
ToxID 2.1.2 SP4 Build 24
TraceFinder Core 3.1 Build 13
TraceFinder EFS 3.1 Build 13
Xcalibur 2.2 SP1 Build 48
Dionex Chromatography MS Link 2.14 Build 3818
TSQ Vantage 2.3.0 Build 1214 SP3
UCMR 3, 539 LCMS5 TQU03178
LCMS Thermo TSQ Vantage X 2012 MS/MS UCMR 3, 539 LCMS6 TQU02731 LCMS Thermo TSQ Vantage X 2012 MS/MS
LCMS Thermo TSQ Quantum
Ultra May 2015 MS/MS Bromate, Iodide, @331, 331-2ppb, 331- 5ppb LCMS7 EXR-TQU03747
QA FO 0031.2 (04.06.16)
203 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Model Month
Acquired
Year
Acquired Detectors Tests ID Serial # Software Version # Foundation 3.1 SP3 3.1.103.0
FreeStyle 1.1 SP1 Build 175 rev 0
TraceFinder Core 4.1 Build 191 rev 0
TraceFinder EFS 4.1 Build 191 rev 0
TraceFinder General Quan 4.1 Build 191 rev 0
Xcalibur 4.0 4.0.27.19
Aria MX 2.2 build 2.2.21
TSQ Quantiva 2.0 Build 1292
Foundation 3.1 SP3 3.1.103.0
Freestyle 1.1 SP1 build 175 rev 0
MZVault 1.0 SP1 Build 30 rev 0
TraceFinder EFS 4.1 Build 191 rev 0
TraceFinder Core 4.1 Build 191 rev 0
TraceFinder General Quan 4.1 Build 191 rev 0
Xcalibur 4.0 4.0.27.19
Thermo Scientific SII for Xcalibur 1.3.0.73
Q Exactive - Orbitrap MS 2.8 SP1 Build 2806
LCMS
@PFC, @536, algal toxins, DX-ABIneg (partial list) LCMS8 TQH010286 DXABI, Unknowns LCMS9 02248L
LCMS Thermo TSQ Quantiva Oct 2015 MS/MS
Thermo TSQ Exactive 2017 Hi Res
QA FO 0031.2 (04.06.16)
204 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Model
Month
Acquired
Year
Acquired Equipment S/N Software Version #
Micro Abraxis 2900 Jan 2019 ELISA Plate Reader 2925-1087 NA NA Micro AmScope X - Microscope 1175951-10 NA NA
Micro Barnstead D7381 X - Ultrapure Water System 1286070563109 NA NA Micro Beckman Coulter Avanti JXN-26 X - Centrifuge 8436001 NA NA Micro Beckman Coulter J6-HC CEntrifuge JD1K20 NA NA
Micro Binder BD 240-UL X - Incubator #1 11-12786 NA NA
Micro Binder BD 240-UL X - Incubator #5 11-12790 NA NA
Micro Binder BD 240-UL X - Incubator #6 11-12791 NA NA
Micro Branson 2510-MT X 2000 Ultra-sonic Bath RLA 100033498D NA NA Micro Clear Water CD12 X 2000 Ozone Generator 03261-80254 NA NA Micro Corning PC351 X - Hot Plate/Stirrer NA NA NA
Micro Denton BTT-IV X 2007 Vacuum Evaporator 50189 NA NA Micro Fisher Scientific IU138A 2 2016 Deep Freezer 300056684 NA NA Micro Fluid Imaging Tech X 2012 Flowcam 568 NA NA
Micro Hanson 3SA-47 X 2003 Exhaust Fume Hood 2058 NA NA Micro Heratherm Incubator IMH60 51028066 10 2015 Incubator 41172542 NA NA Micro Hitchi HT 7700 March 2017 TEM 3155-02
Hitachi TEM
system 2.26
Micro Hotpack 305540 X - Incubator #4 61927 NA NA
Micro Hotpoint CTF21GVC X - Refrigerator 566914 NA NA
Micro IDEXX 89-0003936-00 2017 Quanti-Tray Sealer QTP13164901677 NA NA Micro IDEXX 89-0003936-00 2017 Quanti-Tray Sealer QTP13172402596 NA NA Micro Kenmore 1068668117 X - Refrigerator E74518755 NA NA Micro Labconco Logic+ 2015 Biosafety Cabinet 141099252F NA NA Micro Market Forge STM-EL X - Autoclave 240374 NA NA
Micro Market Forge STM-EL X - Autoclave 237331 NA NA
Micro Mettler Toledo New Classic SG X - Balance B2178796996 NA NA Micro Mettler Toledo Seven Easy X - pH Meter 1226276058 NA NA QA FO 0031.2 (04.06.16)
205 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Model
Month
Acquired
Year
Acquired Equipment S/N Software Version #
Micro Molecular Devices LMAX II 2017 Luminometer LU03623 SOFTmax®
PRO for LMax V.5.3
Micro Norlake X - Incubator 730 NA NA
Micro Ohaus Harvard Trip Balance X - Balance AA51930 NA NA Micro Olympus BH2-RFCA X - Microscope NA NA NA
Micro Precision Cat. No. 51221033 X - Waterbath 603102044 NA NA Micro Precision 2862 X - Waterbath 113027-681 NA NA
Micro Precision 2860 Waterbath 120536-789 NA NA
Micro Pure Aire VTM-48 X 1980 Laminar Flow Hood 38374 NA NA Micro Quebec 3325 X - Colony counter 00997-1205 NA NA
Micro Quebec 3325 X - Colony counter 2323-1108 NA NA
Micro Quebec 3325 X - Colony counter L-0068 NA NA
Micro Spectroline EA-160 X - Fluorescence Analysis 1554913 NA NA Micro TRUE GDM-47 X - Refrigerator 1-2489314 NA NA
Micro TRUE GDM-47 X - Refrigerator 1-2508309 NA NA
Micro UVP Pen-Ray PS-1 X 2009 Power Supply 070109-010 NA NA Micro UVP Pen-Ray 90-00120-1 X 2009 Submersible-UV Lamp 62902 NA NA Micro VWR Cat no. 97042-642 X - Hot Plate/Stirrer 150609007 NA NA Micro VWR 1555 X - Incubator #3 600897 NA NA
Micro VWR 945300 X - Vortex Mixer 141002002 NA NA
Micro Zeiss 473012-9902 X - Microscope NA NA NA
Micro Zeiss Axio Scope X 2014 Microscope 3323000419 NA NA Micro Precision 3721 X - Incubator #7 2405983436 NA NA
Micro Precision 2862 X - Waterbath (D) 123116764 NA NA
Micro Precision TSCIR35 X - Waterbath (B) 300135759 NA NA Micro Precision 184 X - Waterbath (AOC) 9505-204 NA NA
Micro Maytag MQF2056TEW00 X - Freezer #4 U20208111 NA NA Micro Spectroline CM-10A X - Fluorescence Analysis Cabinet 1979915 NA NA Micro VWR X - Vortex mixer 51115045 NA NA
Micro VWR X - mini vortex mixer NA NA
Micro VWR X - mini vortex mixer (AOC) NA NA
Micro Binder BD240-UL X - Incubator #9 14-16227 NA NA
Micro Mettler Toledo MS304TS/00 X - Balance B648374676 NA NA Micro Thermo SP88857100 X - Hot Plate/Stirrer C3710008081640514 NA NA Micro Fisher Scientific Cat no. 11-100-100SH X - Hot Plate/Stirrer C1886120735052 NA NA Micro Market Forge STM-EL X - Autoclave 239364 NA NA
Micro Gettinge October 2018 Autoclave NA NA
Micro Danby DAR044A4BDD X - Refridgerator (AOC) 4316113068147 NA NA Micro VWR X - Vortex mixer (Algae) 180111037 NA NA
QA FO 0031.2 (04.06.16)
206 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Model
Month
Acquired
Year
Acquired Equipment S/N Software Version #
Micro Binder BD 240-UL X - Incubator #2 15-02719 NA NA
Micro Thermo Scientific 100 Microanaysis System X 2017 System 7 1216406 NA NA Micro Thermo Scientific 4499A - 3UPS X 2017 Ultra Dry Detector 9186 NA NA Micro Binder BD 240-UL X Incubator #11 12-08887 NA NA
Micro Haskris LX2-W2 X 2017 Water Chiller HB 31476 NA NA QA FO 0031.2 (04.06.16)
207 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Dept Vendor Instrume
nt ID Model Year Acquired Detectors Tests Serial # Software Version # Sampling ISCO ISCO-1 GLS 2009 N/A Compositor 212D01571 NA NA Sampling HACH HQ11D-1 HQ11D 2016 pH/Ion meter pH 160500023072 NA NA Sampling HACH HQ11D-2 HQ11D 2016 pH/Ion meter pH 160500023499 NA NA Sampling HACH HQ11D-3 HQ11D 2016 pH/Ion meter pH 160500023498 NA NA Sampling HACH HQ11D-4 HQ11D 2016 pH/Ion meter pH 160500023500 NA NA Sampling HACH PC-1
Pocket
Colormeter
II 2009 Colormetry
Free/ Total
Chlorine 12100E209516 NA NA
Sampling HACH PC-2 Pocket Colormeter II 2010 Colormetry Free/ Total
Chlorine 13010E215419 NA NA
Sampling HACH PC-3 Pocket Colormeter II 2010 Colormetry Free/ Total
Chlorine 1302E216593 NA NA
Sampling HACH PC-4 Pocket Colormeter II 2017 Colormetry Free/ Total
Chlorine 16100E312942 NA NA
Sampling HACH FS-TURB1 2100Q-01 2016 Nephelometric Turbidity 16010C047257 NA NA 208 Eurofins Eaton Analytical, LLC
RFP 20231
February 24, 2023
Method Analytes
# of
Containers Container Preservative Hold Time MRL MDL Units 200.8 Aluminum 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 20 0.782 ug/L 200.8 Antimony 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 1 0.159 ug/L200.8 Arsenic 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 1 0.06 ug/L200.8 Barium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 2 0.171 ug/L200.8 Beryllium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 1 0.054 ug/L200.8 Cadmium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.5 0.012 ug/L200.8 Chromium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 1 0.088 ug/L200.8 Cobalt 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 2 0.053 ug/L200.8 Copper 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 2 0.197 ug/L200.8 Lead 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.5 0.038 ug/L200.8 Manganese 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 2 0.056 ug/L200.8 Molybdenum 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 2 0.061 ug/L200.8 Nickel 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 5 0.323 ug/L200.8 Selenium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 5 0.153 ug/L200.8 Silver 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.5 0.014 ug/L200.8 Thallium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 1 0.02 ug/L200.8 Vanadium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 3 0.034 ug/L200.8 Zinc 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 20 1.235 ug/L200.8 Mercury 1 500ml acid poly 2ml HNO3 (18%) 28 DAY 0.2 0.0353 ug/L200.7 Aluminum 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.05 0.023 mg/L200.7 Antimony 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.05 0.011 mg/L200.7 Arsenic 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.1 0.019 mg/L200.7 Barium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.02 0.001 mg/L200.7 Beryllium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.001 0.001 mg/L200.7 Boron 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.05 0.008 mg/L200.7 Cadmium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.005 0.001 mg/L200.7 Calcium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 1 0.118 mg/L200.7 Cobalt 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.05 0.001 mg/L200.7 Copper 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.01 0.003 mg/L200.7 Iron 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.01 0.00262 mg/L200.7 Iron 10 ppb 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.01 0.00262 mg/L200.7 Lead 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.02 0.007 mg/L200.7 Magnesium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.1 0.003 mg/L200.7 Manganese 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.002 0.001038 mg/L200.7 Molybdenum 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.02 0.003 mg/L200.7 Nickel 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.02 0.002 mg/L200.7 Potassium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 1 0.13 mg/L200.7 Selenium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.05 0.034 mg/L200.7 Silver 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.01 0.002 mg/L200.7 Sodium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 1 0.113 mg/L200.7 Thallium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.1 0.008 mg/L200.7 Vanadium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.002 0.001 mg/L200.7 Zinc 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.02 0.003 mg/L200.7 Lithium 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.005 0.00145 mg/L Eurofins Eaton Analytical, LLC - Monrovia MRL/MDL Information 1 of 13 EEA MRL/MDL Information 2023 209 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Method Analytes
# of
Containers Container Preservative Hold Time MRL MDL Units SM 2340B Total Hardness 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 3 0.307 mg/L 300.0 Chloride 1 125ml poly no preservative 28 DAY 0.5 0.025 mg/L300.0 Sulfate 1 125ml poly no preservative 28 DAY 0.5 0.06 mg/L300.0 Nitrate as Nitrogen by IC 1 125ml poly no preservative 48 HOUR 0.05 0.005 mg/L300.0 Nitrite as Nitrogen by IC 1 125ml poly no preservative 48 HOUR 0.05 0.004 mg/L300.0 Chlorite 1 60mL poly 0.3mL 1% EDA solution 14 DAY 0.01 0.00142 mg/L300.0 Bromide 1 60mL poly 0.3mL 1% EDA solution 28 DAY 5 2.25 ug/L SM6251B D/DBP Haloacetic Acids (HAA5) 3 40ml amber glass vial 65mg NH4Cl 21 DAY 2 2 ug/LSM6251B Dibromoacetic acid 3 40ml amber glass vial 65mg NH4Cl 21 DAY 1 0.054 ug/LSM6251B Dichloroacetic acid 3 40ml amber glass vial 65mg NH4Cl 21 DAY 1 0.105 ug/LSM6251B Monobromoacetic acid 3 40ml amber glass vial 65mg NH4Cl 21 DAY 1 0.055 ug/LSM6251B Monochloroacetic acid 3 40ml amber glass vial 65mg NH4Cl 21 DAY 2 0.41 ug/LSM6251B Trichloroacetic acid 3 40ml amber glass vial 65mg NH4Cl 21 DAY 1 0.103 ug/L 524.2 1,1,1,2-Tetrachloroethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.149 ug/L524.2 1,1,1-Trichloroethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.079 ug/L524.2 1,1,2,2-Tetrachloroethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.101 ug/L524.2 1,1,2-Trichloroethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.075 ug/L524.2 1,1-Dichloroethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.133 ug/L524.2 1,1-Dichloroethylene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.11 ug/L524.2 1,1-Dichloropropene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.113 ug/L524.2 1,2,3-Trichlorobenzene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.105 ug/L524.2 1,2,3-Trichloropropane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.054 ug/L524.2 1,2,4-Trichlorobenzene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.07 ug/L524.2 1,2,4-Trimethylbenzene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.112 ug/L524.2 1,2-Dichloroethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.119 ug/L524.2 1,2-Dichloropropane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.071 ug/L524.2 1,3,5-Trimethylbenzene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.066 ug/L524.2 1,3-Dichloropropane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.101 ug/L524.2 2,2-Dichloropropane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.154 ug/L524.2 2-Butanone (MEK) 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 5 1.061 ug/L524.2 4-Methyl-2-Pentanone (MIBK) 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 5 0.683 ug/L524.2 Benzene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.117 ug/L524.2 Bromobenzene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.086 ug/L524.2 Bromochloromethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.177 ug/L524.2 Bromodichloromethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.117 ug/L524.2 Bromoethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.182 ug/L524.2 Bromoform 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.142 ug/L524.2 Bromomethane (Methyl Bromide) 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.118 ug/L524.2 Carbon disulfide 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.085 ug/L524.2 Carbon Tetrachloride 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.087 ug/L524.2 Chlorobenzene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.066 ug/L524.2 Chlorodibromomethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.062 ug/L524.2 Chloroethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.078 ug/L524.2 Chloroform (Trichloromethane) 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.113 ug/L 2 of 13 EEA MRL/MDL Information 2023 210 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Method Analytes
# of
Containers Container Preservative Hold Time MRL MDL Units 524.2 Chloromethane(Methyl Chloride) 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.113 ug/L524.2 cis-1,2-Dichloroethylene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.138 ug/L524.2 cis-1,3-Dichloropropene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.108 ug/L524.2 Dibromomethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.099 ug/L524.2 Dichlorodifluoromethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.099 ug/L524.2 Dichloromethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.074 ug/L524.2 Di-isopropyl ether 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 3 0.107 ug/L524.2 Ethyl benzene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.112 ug/L524.2 Hexachlorobutadiene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.085 ug/L524.2 Isopropylbenzene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.084 ug/L524.2 m,p-Xylenes 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.226 ug/L524.2 m-Dichlorobenzene (1,3-DCB) 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.084 ug/L524.2 Methyl Tert-butyl ether (MTBE) 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.074 ug/L524.2 Naphthalene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.146 ug/L524.2 n-Butylbenzene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.056 ug/L524.2 n-Propylbenzene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.088 ug/L524.2 o-Chlorotoluene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.057 ug/L524.2 o-Dichlorobenzene (1,2-DCB) 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.076 ug/L524.2 o-Xylene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.072 ug/L524.2 p-Chlorotoluene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.122 ug/L524.2 p-Dichlorobenzene (1,4-DCB) 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.092 ug/L524.2 p-Isopropyltoluene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.099 ug/L524.2 sec-Butylbenzene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.102 ug/L524.2 Styrene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.114 ug/L524.2 tert-amyl Methyl Ether 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 3 0.112 ug/L524.2 tert-Butyl Ethyl Ether 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 3 0.171 ug/L524.2 tert-Butylbenzene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.094 ug/L524.2 Tetrachloroethylene (PCE) 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.276 ug/L524.2 Toluene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.057 ug/L524.2 Total 1,3-Dichloropropene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.108 ug/L524.2 Total THM 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.062 ug/L524.2 Total xylenes 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.298 ug/L524.2 trans-1,2-Dichloroethylene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.105 ug/L524.2 trans-1,3-Dichloropropene 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.135 ug/L524.2 Trichloroethylene (TCE) 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.097 ug/L524.2 Trichlorofluoromethane 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.183 ug/L524.2 Trichlorotrifluoroethane(Freon 113) 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.5 0.14 ug/L524.2 Vinyl chloride (VC) 3 40ml amber glass vial 4drops 6N HCL (36%) 14 DAY 0.3 0.077 ug/L524.2 Tert-Butyl Alcohol (TBA) 3 40 ml amb glass+AA+Maleic Acid 25 mg AA + Maleic Acid 14 DAY 1 0.24 ug/L524.2 1,2,3-Trichloropropane 3 40ml amber glass vial 25mg Ascorbic+drop 2ml 1:1 HCL 14 DAY 0.5 0.054 ug/L524.2 Bromodichloromethane 3 40ml amber glass vial 0.25ml thio (8%) 14 DAY 0.5 0.117 ug/L524.2 Bromoform 3 40ml amber glass vial 0.25ml thio (8%) 14 DAY 0.5 0.142 ug/L524.2 Chlorodibromomethane 3 40ml amber glass vial 0.25ml thio (8%) 14 DAY 0.5 0.062 ug/L524.2 Chloroform (Trichloromethane) 3 40ml amber glass vial 0.25ml thio (8%) 14 DAY 0.5 0.113 ug/L524.2 Total THM 3 40ml amber glass vial 0.25ml thio (8%) 14 DAY 0.5 0.062 ug/L 3 of 13 EEA MRL/MDL Information 2023 211 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Method Analytes
# of
Containers Container Preservative Hold Time MRL MDL Units 525.2 2,4-DDD 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.044 ug/L525.2 2,4-DDE 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.019 ug/L525.2 2,4-DDT 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.014 ug/L525.2 2,4-Dinitrotoluene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.013 ug/L525.2 2,6-Dinitrotoluene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.036 ug/L525.2 4,4-DDD 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.015 ug/L525.2 4,4-DDE 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.018 ug/L525.2 4,4-DDT 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.031 ug/L525.2 Acenaphthene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.016 ug/L525.2 Acenaphthylene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.014 ug/L525.2 Acetochlor 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.009 ug/L525.2 Alachlor 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.022 ug/L525.2 Alpha-BHC 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.018 ug/L525.2 alpha-Chlordane 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.029 ug/L525.2 Anthracene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.02 0.019 ug/L525.2 Atrazine 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.048 ug/L525.2 Benz(a)Anthracene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.011 ug/L525.2 Benzo(a)pyrene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.02 0.011 ug/L525.2 Benzo(b)Fluoranthene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.02 0.011 ug/L525.2 Benzo(g,h,i)Perylene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.012 ug/L525.2 Benzo(k)Fluoranthene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.02 0.017 ug/L525.2 Beta-BHC 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.02 ug/L525.2 Bromacil 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.029 ug/L525.2 Butachlor 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.033 ug/L525.2 Butylbenzylphthalate 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.5 0.063 ug/L525.2 Caffeine by method 525mod 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.02 ug/L525.2 Chlorobenzilate 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.019 ug/L525.2 Chloroneb 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.016 ug/L525.2 Chlorothalonil(Draconil,Bravo) 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.016 ug/L525.2 Chlorpyrifos (Dursban) 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.019 ug/L525.2 Chrysene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.02 0.014 ug/L525.2 Delta-BHC 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.033 ug/L525.2 Di-(2-Ethylhexyl)adipate 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.6 0.063 ug/L525.2 Di(2-Ethylhexyl)phthalate 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.6 0.149 ug/L525.2 Diazinon (Qualitative) 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.025 ug/L525.2 Dibenz(a,h)Anthracene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.033 ug/L525.2 Dichlorvos (DDVP) 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.022 ug/L525.2 Dieldrin 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.2 0.017 ug/L525.2 Diethylphthalate 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.5 0.051 ug/L525.2 Dimethoate 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.033 ug/L525.2 Dimethylphthalate 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.5 0.039 ug/L525.2 Di-n-Butylphthalate 2 1L amber glass 525_2ml of 6N HCL 30 DAY 1 0.074 ug/L525.2 Di-N-octylphthalate 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.027 ug/L525.2 Endosulfan I (Alpha) 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.058 ug/L525.2 Endosulfan II (Beta) 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.052 ug/L525.2 Endosulfan Sulfate 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.04 ug/L525.2 Endrin 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.038 ug/L 4 of 13 EEA MRL/MDL Information 2023 212 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Method Analytes
# of
Containers Container Preservative Hold Time MRL MDL Units 525.2 Endrin Aldehyde 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.084 ug/L525.2 EPTC 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.013 ug/L525.2 Fluoranthene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.01 ug/L525.2 Fluorene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.013 ug/L525.2 gamma-Chlordane 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.021 ug/L525.2 Heptachlor 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.04 0.013 ug/L525.2 Heptachlor Epoxide (isomer B) 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.023 ug/L525.2 Hexachlorobenzene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.041 ug/L525.2 Hexachlorocyclopentadiene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.038 ug/L525.2 Indeno(1,2,3,c,d)Pyrene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.027 ug/L525.2 Isophorone 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.5 0.02 ug/L525.2 Lindane 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.04 0.022 ug/L525.2 Malathion 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.025 ug/L525.2 Methoxychlor 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.032 ug/L525.2 Metolachlor 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.044 ug/L525.2 Metribuzin 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.016 ug/L525.2 Molinate 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.015 ug/L525.2 Naphthalene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.3 0.014 ug/L525.2 Parathion 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.037 ug/L525.2 Pendimethalin 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.047 ug/L525.2 Permethrin (mixed isomers) 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.2 0.037 ug/L525.2 Phenanthrene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.04 0.008 ug/L525.2 Propachlor 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.02 ug/L525.2 Pyrene 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.008 ug/L525.2 Simazine 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.028 ug/L525.2 Terbacil 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.069 ug/L525.2 Terbuthylazine 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.023 ug/L525.2 Thiobencarb 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.2 0.017 ug/L525.2 trans-Nonachlor 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.05 0.026 ug/L525.2 Trifluralin 2 1L amber glass 525_2ml of 6N HCL 30 DAY 0.1 0.044 ug/L504.1 1,2-Dibromo-3-chloropropane 3 40ml amber glass vial no preservative 14 DAY 0.01 0.002 ug/L504.1 1,2-Dibromoethane 3 40ml amber glass vial no preservative 14 DAY 0.01 0.005 ug/L 505 Aldrin 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.01 0.002 ug/L505 Alachlor (Alanex) 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.1 0.041 ug/L505 Chlordane 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.1 0.032 ug/L505 Endrin 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.01 0.005 ug/L505 Heptachlor 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.01 0.003 ug/L505 Heptachlor Epoxide 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.01 0.005 ug/L505 Lindane (gamma-BHC) 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.01 0.007 ug/L505 Methoxychlor 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.05 0.022 ug/L505 PCB 1016 Aroclor 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.08 0.022 ug/L505 PCB 1221 Aroclor 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.1 0.079 ug/L505 PCB 1232 Aroclor 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.1 0.085 ug/L505 PCB 1242 Aroclor 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.1 0.072 ug/L505 PCB 1248 Aroclor 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.1 0.023 ug/L505 PCB 1254 Aroclor 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.1 0.035 ug/L 5 of 13 EEA MRL/MDL Information 2023 213 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Method Analytes
# of
Containers Container Preservative Hold Time MRL MDL Units 505 PCB 1260 Aroclor 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.1 0.033 ug/L505 Total PCBs 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.1 0.022 ug/L505 Toxaphene 4 40ml amber glass vial 1drop thio (8%) 7 DAY 0.5 0.083 ug/L 515.4 2,4,5-T 4 60ml amber glass 3 mg NaSulfite 35 DAY 0.2 0.098 ug/L515.4 2,4,5-TP (Silvex) 4 60ml amber glass 3 mg NaSulfite 35 DAY 0.2 0.058 ug/L515.4 2,4-D 4 60ml amber glass 3 mg NaSulfite 35 DAY 0.1 0.062 ug/L515.4 2,4-DB 4 60ml amber glass 3 mg NaSulfite 35 DAY 2 0.467 ug/L515.4 3,5-Dichlorobenzoic acid 4 60ml amber glass 3 mg NaSulfite 35 DAY 0.5 0.161 ug/L515.4 Acifluorfen 4 60ml amber glass 3 mg NaSulfite 35 DAY 0.2 0.03 ug/L515.4 Bentazon 4 60ml amber glass 3 mg NaSulfite 35 DAY 0.5 0.239 ug/L515.4 Dalapon 4 60ml amber glass 3 mg NaSulfite 35 DAY 1 0.327 ug/L515.4 Dicamba 4 60ml amber glass 3 mg NaSulfite 35 DAY 0.1 0.03 ug/L515.4 Dichlorprop 4 60ml amber glass 3 mg NaSulfite 35 DAY 0.5 0.056 ug/L515.4 Dinoseb 4 60ml amber glass 3 mg NaSulfite 35 DAY 0.2 0.07 ug/L515.4 Pentachlorophenol 4 60ml amber glass 3 mg NaSulfite 35 DAY 0.04 0.02 ug/L515.4 Picloram 4 60ml amber glass 3 mg NaSulfite 35 DAY 0.1 0.051 ug/L515.4 Tot DCPA Mono&Diacid Degradate 4 60ml amber glass 3 mg NaSulfite 35 DAY 0.1 0.021 ug/L531.2 3-Hydroxycarbofuran 2 40ml amber glass vial 0.37g KH2Citrate+6mg ThioSO4 28 DAY 0.5 0.143 ug/L531.2 Aldicarb (Temik) 2 40ml amber glass vial 0.37g KH2Citrate+6mg ThioSO4 28 DAY 0.5 0.16 ug/L531.2 Aldicarb sulfone 2 40ml amber glass vial 0.37g KH2Citrate+6mg ThioSO4 28 DAY 0.5 0.172 ug/L531.2 Aldicarb sulfoxide 2 40ml amber glass vial 0.37g KH2Citrate+6mg ThioSO4 28 DAY 0.5 0.142 ug/L531.2 Baygon 2 40ml amber glass vial 0.37g KH2Citrate+6mg ThioSO4 28 DAY 0.5 0.247 ug/L531.2 Carbaryl 2 40ml amber glass vial 0.37g KH2Citrate+6mg ThioSO4 28 DAY 0.5 0.16 ug/L531.2 Carbofuran (Furadan) 2 40ml amber glass vial 0.37g KH2Citrate+6mg ThioSO4 28 DAY 0.5 0.104 ug/L531.2 Methiocarb 2 40ml amber glass vial 0.37g KH2Citrate+6mg ThioSO4 28 DAY 0.5 0.114 ug/L531.2 Methomyl 2 40ml amber glass vial 0.37g KH2Citrate+6mg ThioSO4 28 DAY 0.5 0.174 ug/L531.2 Oxamyl (Vydate) 2 40ml amber glass vial 0.37g KH2Citrate+6mg ThioSO4 28 DAY 0.5 0.173 ug/L 547 Glyphosate 1 125ml amber glass no preservative 14 DAY 6 1.6 ug/L 548.1 Endothall 1 250ml amber glass no preservative 14 DAY 5 2.653 ug/L549.2 Diquat 1 1L amber poly 1ml thio (8%) 21 DAY 0.4 0.344 ug/L Explosives (LCMS) 2,4,6-Trinitrotoluene (TNT) 2 40ml amber glass vial EXPLOSIVES_0.25ml thio (8%) 30 DAY 0.1 0.05 ug/LExplosives (LCMS) HMX 2 40ml amber glass vial EXPLOSIVES_0.25ml thio (8%) 30 DAY 0.1 0.05 ug/LExplosives (LCMS) RDX 2 40ml amber glass vial EXPLOSIVES_0.25ml thio (8%) 30 DAY 0.1 0.05 ug/L LC-MS-MS Acrylamide 1 125ml amber glass ACRYL_no preservative 28 DAY 0.1 0.051 ug/L EPA 1613 2,3,7,8-TCDD (Dioxin) 2 1L amber glass D1613_1ML_8% THIOSULFATE 40 DAY 5 2.1 pg/L EPA 522 1,4-Dioxane 3 125ml amber glass 6.88 Sulfite +138 mg Bisulfate 28 DAY 1 0.085 ug/L GC-QQQ PBDE-100 2 1L amber glass PBDEs_no pres 14 DAY 5 ng/LGC-QQQ PBDE-138 2 1L amber glass PBDEs_no pres 14 DAY 5 ng/L 6 of 13 EEA MRL/MDL Information 2023 214 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Method Analytes
# of
Containers Container Preservative Hold Time MRL MDL Units GC-QQQ PBDE-153 2 1L amber glass PBDEs_no pres 14 DAY 5 ng/LGC-QQQ PBDE-154 2 1L amber glass PBDEs_no pres 14 DAY 5 ng/LGC-QQQ PBDE-17 2 1L amber glass PBDEs_no pres 14 DAY 5 ng/LGC-QQQ PBDE-28 2 1L amber glass PBDEs_no pres 14 DAY 5 ng/LGC-QQQ PBDE-47 2 1L amber glass PBDEs_no pres 14 DAY 5 ng/LGC-QQQ PBDE-49 2 1L amber glass PBDEs_no pres 14 DAY 5 ng/LGC-QQQ PBDE-85 2 1L amber glass PBDEs_no pres 14 DAY 5 ng/LGC-QQQ PBDE-99 2 1L amber glass PBDEs_no pres 14 DAY 5 ng/L 532 Chlorotoluron 2 40ml amber glass vial TRIZMA + CuSO4 28 DAY 0.1 0.07 ug/L532 Diuron 2 40ml amber glass vial TRIZMA + CuSO4 28 DAY 0.1 0.07 ug/L532 Isoproturon 2 40ml amber glass vial TRIZMA + CuSO4 28 DAY 0.1 0.04 ug/L532 Linuron 2 40ml amber glass vial TRIZMA + CuSO4 28 DAY 0.1 0.1 ug/L532 MCPA 2 40ml amber glass vial TRIZMA + CuSO4 28 DAY 0.1 0.035 ug/L532 MCPP (Mecoprop) 2 40ml amber glass vial TRIZMA + CuSO4 28 DAY 0.1 0.035 ug/L532 Metazachlor 2 40ml amber glass vial TRIZMA + CuSO4 28 DAY 0.1 0.09 ug/L532 Metoxuron 2 40ml amber glass vial TRIZMA + CuSO4 28 DAY 0.1 0.06 ug/L532 Propanil 2 40ml amber glass vial TRIZMA + CuSO4 28 DAY 0.1 0.03 ug/L532 Pyriproxyfen 2 40ml amber glass vial TRIZMA + CuSO4 28 DAY 0.1 0.03 ug/L532 Tebuthiuron 2 40ml amber glass vial TRIZMA + CuSO4 28 DAY 0.1 0.05 ug/L533 11-chloroeicosafluoro-3-oxaundecane-sulfonic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.377 ng/L533 1H,1H,2H,2H-Perfluorodecane sulfonic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.381 ng/L533 1H,1H,2H,2H-Perfluorohexane sulfonic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.366 ng/L533 1H,1H,2H,2H-Perfluorooctane sulfonic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.476 ng/L533 4,8-dioxa-3H-perfluorononanoic acid (ADONA) 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.146 ng/L533 9-chlorohexadecafluoro-3-oxanone-sulfonic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.245 ng/L533 Hexafluoropropylene oxide dimer acid (HFPO-DA) 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.746 ng/L533 Nonafluoro-3,6-dioxaheptanoic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.466 ng/L533 Perfluoro(2-ethoxyethane)sulfonic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.247 ng/L533 Perfluoro-3-methoxypropanoic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.46 ng/L533 Perfluoro-4-methoxybutanoic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.152 ng/L533 Perfluorobutanesulfonic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.25 ng/L533 Perfluorobutanoic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.688 ng/L533 Perfluorodecanoic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.358 ng/L533 Perfluorododecanoic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.344 ng/L533 Perfluoroheptanesulfonic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.355 ng/L533 Perfluoroheptanoic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.189 ng/L533 Perfluorohexanesulfonic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.218 ng/L533 Perfluorohexanoic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.207 ng/L533 Perfluorononanoic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.268 ng/L533 Perfluorooctanesulfonic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.169 ng/L533 Perfluorooctanoic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.275 ng/L533 Perfluoropentanesulfonic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.385 ng/L533 Perfluoropentanoic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.376 ng/L533 Perfluoroundecanoic acid 2 250 ml polypro w polypro cap 0.25g ammonium acetate 28 DAY 2 0.315 ng/L 537.1 11-chloroeicosafluoro-3-oxaundecane-sulfonic acid 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.000296 ug/L 7 of 13 EEA MRL/MDL Information 2023 215 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Method Analytes
# of
Containers Container Preservative Hold Time MRL MDL Units 537.1 4,8-dioxa-3H-perfluorononanoic acid (ADONA) 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.0006 ug/L537.1 9-chlorohexadecafluoro-3-oxanone-sulfonic acid 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.0003 ug/L537.1 Hexafluoropropylene oxide dimer acid (HFPO-DA) 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.001 ug/L537.1 N-ethyl Perfluorooctanesulfonamidoacetic acid 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.00042 ug/L537.1 N-methyl Perfluorooctanesulfonamidoacetic acid 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.00058 ug/L537.1 Perfluorobutanesulfonic acid (PFBS) 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.00037 ug/L537.1 Perfluorodecanoic acid (PFDA) 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.00031 ug/L537.1 Perfluorododecanoic acid (PFDoA) 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.00054 ug/L537.1 Perfluoroheptanoic acid (PFHpA) 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.00039 ug/L537.1 Perfluorohexanesulfonic acid (PFHxS) 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.00032 ug/L537.1 Perfluorohexanoic acid (PFHxA) 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.00046 ug/L537.1 Perfluorononanoic acid (PFNA) 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.0004 ug/L537.1 Perfluorooctanesulfonic acid (PFOS) 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.00043 ug/L537.1 Perfluorooctanoic acid (PFOA) 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.00038 ug/L537.1 Perfluorotetradecanoic acid (PFTA) 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.00054 ug/L537.1 Perfluorotridecanoic acid (PFTrDA) 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.00046 ug/L537.1 Perfluoroundecanoic acid (PFUnA) 2 275 ml polypro w polypro cap 1.4 g Trisma 28 DAY 0.002 0.00042 ug/L 539 17 alpha-ethynylestradiol 2 500ml amber glass 40 mg NaThio+ 33 mg 2-mercaptopyr 28 DAY 0.0009 ug/L539 17-beta-Estradiol 2 500ml amber glass 40 mg NaThio+ 33 mg 2-mercaptopyr 28 DAY 0.0004 ug/L539 4-androstene-3,17-dione 2 500ml amber glass 40 mg NaThio+ 33 mg 2-mercaptopyr 28 DAY 0.0003 ug/L539 Equilin 2 500ml amber glass 40 mg NaThio+ 33 mg 2-mercaptopyr 28 DAY 0.004 ug/L539 Estriol 2 500ml amber glass 40 mg NaThio+ 33 mg 2-mercaptopyr 28 DAY 0.0008 ug/L539 Estrone 2 500ml amber glass 40 mg NaThio+ 33 mg 2-mercaptopyr 28 DAY 0.002 ug/L539 Testosterone 2 500ml amber glass 40 mg NaThio+ 33 mg 2-mercaptopyr 28 DAY 0.0001 ug/L 551.1 Dibromochloropropane (DBCP) 3 60ml amber glass EDB1g(1%NaP/99%KP)+0.6%NH4CL 14 DAY 0.01 0.0084 ug/L551.1 Ethylene Dibromide (EDB) 3 60ml amber glass EDB1g(1%NaP/99%KP)+0.6%NH4CL 14 DAY 0.01 0.0057 ug/L 556 Acetaldehyde 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 1 0.19 ug/L556 Benzaldehyde 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 1 0.17 ug/L556 Butanal 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 1 0.11 ug/L556 Crotonaldehyde 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 1 0.39 ug/L556 Cyclohexanone 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 1 0.14 ug/L556 Decanal 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 1 0.27 ug/L556 Formaldehyde 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 5 0.81 ug/L556 Glyoxal 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 10 2.7 ug/L556 Heptanal 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 1 0.25 ug/L556 Hexanal 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 1 0.14 ug/L556 Methyl glyoxal 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 10 1.8 ug/L556 Nonanal 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 1 0.42 ug/L556 Octanal 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 1 0.13 ug/L556 Pentanal 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 1 0.16 ug/L556 Propanal 3 40ml amber glass vial 20mg NH4Cl + 20 mg CuSO4 14 DAY 1 0.45 ug/L317 Bromate by UV/VIS 1 60mL poly 0.3mL 1% EDA solution 28 DAY 1 0.196 ug/L331 Perchlorate 1 125ml poly CLO4 - no preservative 28 DAY 2 0.08609 ug/L 8 of 13 EEA MRL/MDL Information 2023 216 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Method Analytes
# of
Containers Container Preservative Hold Time MRL MDL Units 314 Perchlorate 1 125ml poly CLO4 - no preservative 28 DAY 2 0.294 ug/L EPA 350.1 Ammonia Nitrogen 1 250ml poly 0.5ml H2SO4 (50%) 28 DAY 0.05 0.003 mg/LEPA 351.2 Kjeldahl Nitrogen 1 250ml poly 0.5ml H2SO4 (50%) 28 DAY 0.2 0.044 mg/L SM 2320B Alkalinity in CaCO3 units 1 250ml poly no preservative 14 DAY 2 0.834 mg/LSM 2320B Bicarb.Alkalinity as HCO3calc 1 250ml poly no preservative 2 2 mg/LSM 2320B Carbonate (as CaCO3) 1 250ml poly no preservative 2 mg/LSM 2320B Hydroxide as OH Calculated 1 250ml poly no preservative 180 DAY 2 2 mg/LEPA 335.4 Total Cyanide 1 250 ml poly 2 ml NaOH (30%)+6 scoops AA 14 DAY 0.005 0.002 mg/L SM4500CN-F Free Cyanide 1 250 ml poly 2 ml NaOH (30%)+6 scoops AA 14 DAY 0.025 0.006 mg/L SM 4500F-C Fluoride 1 250 ml poly FLUORIDE_no preservative 28 DAY 0.05 0.007 mg/L 218.7 Hexavalent Chromium 1 125ml poly 1.25 ml NH4SO4/NH4OH buffer 14 DAY 0.02 0.009 ug/L E160.1/SM2540C Total Dissolved Solid (TDS) 1 500ml poly TDS - no preservative 7 DAY 10 4.224 mg/L SM 2510B Specific Conductance 1 250ml poly no preservative 28 DAY 2 0.509 umho/cm SM 2120B Apparent Color 1 1L amber glass ODOR_no preservative 2 DAY 3 3 ACU SM 2150B Odor 1 1L amber glass ODOR_no preservative 1 DAY 1 1 TON EPA 180.1 Turbidity 1 125ml poly TURB_no preservative 2 DAY 0.1 0.008 NTU SM 9221F E. Coli 1 250ml poly sterilized 0.25ml thio (8%) 5 DAY 1.8 MPN/100 mL SM 2540F Settleable Solid 1 1L poly SS - No preservative 2 DAY 0.1 0.1 ml/l 4500HB/ E 150 pH 1 125ml poly no preservative 7 DAY 0.1 0.1 Units SM5210B BOD 1 1L poly no preservative 48 HOUR 2 1 mg/L
SM 4500-PE/EPA 365.1 Total Phosphorus 1 250ml poly 0.5ml H2SO4 (50%) 28 DAY 0.02 0.0084 mg/L MWH 420/SW9066 Phenolic Compounds 1 250ml amber glass 1ml H2SO4 28 DAY 0.01 0.0018 mg/L SM 5310C Total Organic Carbon 1 125ml amber glass 0.5ml H2SO4 (50%) 28 DAY 0.2 0.042 mg/L SM 9215B Heterotrophic Plate Count 1 100ml poly sterilized 0.25ml thio (8%) 24 HOUR 1 1 CFU/ml EPA 900.0 Gross alpha 2 500ml poly 2ml 18%HNO3+125ml poly/no pres 180 DAY 3 2.68 pCi/LEPA 900.0 Gross Beta 2 500ml poly 2ml 18%HNO3+125ml poly/no pres 180 DAY 3 2.66 pCi/L 9 of 13 EEA MRL/MDL Information 2023 217 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Method Analytes
# of
Containers Container Preservative Hold Time MRL MDL Units Ra-226 GA Radium 226 2 1L poly RA_226_4ml HNO3 18% 180 DAY 1 pCi/L Ra-228 GA Radium 228 2 1L poly 4ml HNO3 (18%) 180 DAY 1 pCi/L EPA 200.8 Uranium by ICPMS as pCi/L 1 500ml acid poly 2ml HNO3 (18%) 180 DAY 0.7 0.049 pCi/L LC-MS-MS Anatoxin-a 3 250ml amber glass 25 mg Ascorbic Acid 28 DAY 0.02 ug/LLC-MS-MS Cylindrospermopsin 3 250ml amber glass 25 mg Ascorbic Acid 28 DAY 0.05 ug/LLC-MS-MS Microcystin-LA (MC-LA) 3 250ml amber glass 25 mg Ascorbic Acid 28 DAY 0.3 ug/LLC-MS-MS Microcystin-LF (MC-LF) 3 250ml amber glass 25 mg Ascorbic Acid 28 DAY 0.3 ug/LLC-MS-MS Microcystin-LR (MC-LR) 3 250ml amber glass 25 mg Ascorbic Acid 28 DAY 0.3 ug/LLC-MS-MS Microcystin-LY (MC-LY) 3 250ml amber glass 25 mg Ascorbic Acid 28 DAY 0.3 Ug/LLC-MS-MS Microcystin-RR (MC-RR) 3 250ml amber glass 25 mg Ascorbic Acid 28 DAY 0.3 ug/LLC-MS-MS Microcystin-YR (MC-YR) 3 250ml amber glass 25 mg Ascorbic Acid 28 DAY 0.3 ug/LLC-MS-MS Nodularin (NOD) 3 250ml amber glass 25 mg Ascorbic Acid 28 DAY 0.3 ug/L 546/ELISA Total Microcystins 1 125ml amber glass 12.5 mg Na Thiosulfate 14 DAY 0.3 0.0409 ug/LEPA 100.2 Asbestos 1 1L poly sonicated no preservative 10 DAY 0.2 0.01 MFL SM 5540C/EPA 425.1 MBAS 1 500ml poly no preservative 2 DAY 0.1 0.014 mg/L SM 9221B Total Coliform Bacteria 1 100ml poly sterilized 0.25ml thio (8%) 6 HOUR 1.8 MPN/100 mL SM 4500CL-G/HACH Chloramines 1 125ml amber glass CHL_no preservative 1 DAY 0.1 0.1 mg/L SM 4500-CLO2-D/HACH Chlorine Dioxide 1 125ml amber glass CHL_no preservative 1 DAY 0.24 0.077 mg/L SM 4500-CL G Chlorine Residual, Total 1 125ml amber glass CHL_no preservative 1 DAY 0.1 0.024 mg/L EEA 521.1 N-Nitroso dimethylamine (NDMA) 1 500ml amber glass 40-50 mg Na Thiosulfate 28 DAY 2 0.9 ng/LEEA 521.1 N-Nitrosodibutylamine (NDBA) 1 500ml amber glass 40-50 mg Na Thiosulfate 28 DAY 2 1.338 ng/LEEA 521.1 N-Nitrosodiethylamine (NDEA) 1 500ml amber glass 40-50 mg Na Thiosulfate 28 DAY 2 1.03 ng/LEEA 521.1 N-Nitrosodi-n-propylamine (NDPA) 1 500ml amber glass 40-50 mg Na Thiosulfate 28 DAY 2 1.488 ng/LEEA 521.1 N-Nitrosomethylethylamine (NMEA) 1 500ml amber glass 40-50 mg Na Thiosulfate 28 DAY 2 1.107 ng/LEEA 521.1 N-Nitrosomorpholine (NMOR) 1 500ml amber glass 40-50 mg Na Thiosulfate 28 DAY 2 1.145 ng/LEEA 521.1 N-Nitrosopiperidine (NPIP) 1 500ml amber glass 40-50 mg Na Thiosulfate 28 DAY 2 1.28 ng/LEEA 521.1 N-Nitrosopyrollidine (NPYR) 1 500ml amber glass 40-50 mg Na Thiosulfate 28 DAY 2 1.222 ng/L EPA 522 1,4-Dioxane 1 125ml amber glass 6.88 Sulfite +138 mg Bisulfate 28 DAY 0.07 0.0185 ug/L LC-MS-MS 2,4-D 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 50 3.16 ng/LLC-MS-MS 4-nonylphenol - semi quantitative 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 400 50 ng/LLC-MS-MS 4-tert-octylphenol 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 25 6.9 ng/LLC-MS-MS Acesulfame-K 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 20 16.7 ng/LLC-MS-MS Bendroflumethiazide 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 10 2.21 ng/LLC-MS-MS BPA 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 10 2.88 ng/L 10 of 13 EEA MRL/MDL Information 2023 218 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Method Analytes
# of
Containers Container Preservative Hold Time MRL MDL Units LC-MS-MS Butalbital 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 10 2.32 ng/LLC-MS-MS Butylparben 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 5 2.04 ng/LLC-MS-MS Chloramphenicol 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 10 3.59 ng/LLC-MS-MS Clofibric Acid 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 5 3.34 ng/LLC-MS-MS Diclofenac 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 5 2.08 ng/LLC-MS-MS Estradiol 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 10 4.45 ng/LLC-MS-MS Estriol 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 10 3.58 ng/LLC-MS-MS Estrone 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 10 3.07 ng/LLC-MS-MS Ethinyl Estradiol - 17 alpha 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 10 3.32 ng/LLC-MS-MS Ethylparaben 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 20 11 ng/LLC-MS-MS Gemfibrozil 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 5 1.82 ng/LLC-MS-MS Ibuprofen 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 25 5.57 ng/LLC-MS-MS Iohexal 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 20 8.93 ng/LLC-MS-MS Iopromide 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 10 4.38 ng/LLC-MS-MS Isobutylparaben 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 10 3.42 ng/LLC-MS-MS Methylparaben 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 20 8.07 ng/LLC-MS-MS Naproxen 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 20 4.4 ng/LLC-MS-MS Propylparaben 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 5 3.94 ng/LLC-MS-MS Salicylic Acid 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 200 21.3 ng/LLC-MS-MS Sucralose 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 100 48.6 ng/LLC-MS-MS Triclocarban 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 50 13.4 ng/LLC-MS-MS Triclosan 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 25 10.4 ng/LLC-MS-MS Warfarin 1 40ml amber glass vial 0.5ml (1.04g/L NaOmadine+4g/L AA) 27 DAY 5 3.42 ng/LLC-MS-MS 1,7-Dimethylxanthine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 3.35 ng/LLC-MS-MS Acetaminophen 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 10 2.51 ng/LLC-MS-MS Albuterol 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 2.54 ng/LLC-MS-MS Amoxicillin (semi-quantitative) 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 20 6.81 ng/LLC-MS-MS Andorostenedione 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 10 1.77 ng/LLC-MS-MS Atenolol 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.63 ng/LLC-MS-MS Atrazine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 4.71 ng/LLC-MS-MS Bezafibrate 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.86 ng/LLC-MS-MS Bromacil 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 6.02 ng/LLC-MS-MS Caffeine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 10 3.85 ng/LLC-MS-MS Carbadox 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 2.1 ng/LLC-MS-MS Carbamazepine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.2 ng/LLC-MS-MS Carisoprodol 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 3.43 ng/LLC-MS-MS Chloridazon 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.51 ng/LLC-MS-MS Chlorotoluron 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 2.62 ng/LLC-MS-MS Cimetidine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 4.94 ng/LLC-MS-MS Cotinine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 10 6.68 ng/LLC-MS-MS Cyanazine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 3.45 ng/LLC-MS-MS DACT (semi-quantitative) 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 20 5.7 ng/LLC-MS-MS DEA 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 4.58 ng/LLC-MS-MS DEET 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 10 1.19 ng/LLC-MS-MS Dehydronifedipine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.54 ng/LLC-MS-MS DIA 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 4.25 ng/LLC-MS-MS Diazepam 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.53 ng/LLC-MS-MS Dilantin 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 20 7.9 ng/L 11 of 13 EEA MRL/MDL Information 2023 219 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Method Analytes
# of
Containers Container Preservative Hold Time MRL MDL Units LC-MS-MS Diltiazem 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.42 ng/LLC-MS-MS Diuron 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 2.48 ng/LLC-MS-MS Erythromycin (semi-quantitative) 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 20 3.59 ng/LLC-MS-MS Flumeqine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 20 16.9 ng/LLC-MS-MS Fluoxetine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 10 3.34 ng/LLC-MS-MS Isoproturon 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 20 12.3 ng/LLC-MS-MS Ketoprofen 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 2.59 ng/LLC-MS-MS Ketorolac 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 2.07 ng/LLC-MS-MS Lidocaine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.11 ng/LLC-MS-MS Lincomycin 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 10 1.68 ng/LLC-MS-MS Linuron 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 2.84 ng/LLC-MS-MS Lopressor 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 20 5.14 ng/LLC-MS-MS Meclofenamic Acid 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 20 4.66 ng/LLC-MS-MS Meprobamate 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 2.03 ng/LLC-MS-MS Metazachlor 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.27 ng/LLC-MS-MS Metformin 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 20 2.22 ng/LLC-MS-MS Metolachlor 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 3.12 ng/LLC-MS-MS Nifedipine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 20 12.4 ng/LLC-MS-MS Norethisterone 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 10 2.26 ng/LLC-MS-MS OUST (Sulfameturon,methyl) 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 2.5 ng/LLC-MS-MS Oxolinic acid 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 10 2.46 ng/LLC-MS-MS Pentoxifylline 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.53 ng/LLC-MS-MS Phenazone 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 5 ng/LLC-MS-MS Primidone 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 4.77 ng/LLC-MS-MS Progesterone 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 10 2.94 ng/LLC-MS-MS Propazine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.81 ng/LLC-MS-MS Quinoline 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 20 2.5 ng/LLC-MS-MS Simazine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.23 ng/LLC-MS-MS Sulfachloropyridazine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 2.09 ng/LLC-MS-MS Sulfadiazine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 3.94 ng/LLC-MS-MS Sulfadimethoxine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.6 ng/LLC-MS-MS Sulfamerazine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 4.58 ng/LLC-MS-MS Sulfamethazine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.46 ng/LLC-MS-MS Sulfamethizole 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.42 ng/LLC-MS-MS Sulfamethoxazole 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 3.21 ng/LLC-MS-MS Sulfathiazole 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.68 ng/LLC-MS-MS TCEP 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 10 4.52 ng/LLC-MS-MS TCPP 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 200 11.8 ng/LLC-MS-MS TDCPP 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 100 2.26 ng/LLC-MS-MS Testosterone 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 10 4.54 ng/LLC-MS-MS Theobromine 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 50 4.54 ng/LLC-MS-MS Theophylline 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 10 6.58 ng/LLC-MS-MS Thiabendazole 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 2.38 ng/LLC-MS-MS Trimethoprim 1 40ml amber glass vial 0.5ml (100 g/L NaAzide+4g/L AA) 27 DAY 5 1.61 ng/L EPA 1613B 2,3,7,8-TCDD 1 1 L Amber unpreserved 14 day 4.00 0.873 pg/LEPA 1613B 13C-1,2,3,4,6,7,8-HpCDD 1 1 L Amber unpreserved 14 day 12 of 13 EEA MRL/MDL Information 2023 220 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Method Analytes
# of
Containers Container Preservative Hold Time MRL MDL Units EPA 1613B 13C-1,2,3,4,6,7,8-HpCDF 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-1,2,3,4,7,8-HxCDD 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-1,2,3,4,7,8-HxCDF 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-1,2,3,4,7,8,9-HpCDF 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-1,2,3,6,7,8-HxCDD 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-1,2,3,6,7,8-HxCDF 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-1,2,3,7,8-PeCDD 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-1,2,3,7,8-PeCDF 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-1,2,3,7,8,9-HxCDD 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-1,2,3,7,8,9-HxCDF 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-2,3,4,6,7,8-HxCDF 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-2,3,4,7,8-PeCDF 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-2,3,7,8-TCDD 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-2,3,7,8-TCDF 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-OCDD 1 1 L Amber unpreserved 14 dayEPA 1613B 13C-OCDF 1 1 L Amber unpreserved 14 day 13 of 13 EEA MRL/MDL Information 2023 221 Eurofins Eaton Analytical, LLC RFP 20231
February 24, 2023
Eurofins Eaton Analytical, LLC - Monrovia
Monrovia, CA 91016
CALIFORNIA STATE
ENVIRONMENTAL LABORATORY ACCREDITATION PROGRAM
Fields of Accreditation
Certificate Number: 2813
Phone: 6263861100
Expiration Date: 2/1/2024 750 Royal Oaks Drive, Suite 100
INTERIM
Field of Accreditation:101 - Microbiology of Drinking Water 101.010 001 Heterotrophic Bacteria SM 9215 B
101.020 001 Total Coliform P/A SM 9221 B
101.020 002 Fecal Coliform P/A SM 9221 B,E
101.020 003 E. coli P/A SM 9221 B,F
101.020 004 Total Coliform (Enumeration) SM 9221 B,C
101.020 005 Fecal Coliform (Enumeration) SM 9221 B,E
101.020 006 E. coli (Enumeration) SM 9221 B,F
101.050 001 Total Coliform P/A SM 9223 B Colilert
101.050 002 E. coli P/A SM 9223 B Colilert
101.050 003 Total Coliform (Enumeration) SM 9223 B Colilert 101.050 004 E. coli (Enumeration) SM 9223 B Colilert
101.050 005 Total Coliform P/A SM 9223 B Colilert 18
101.050 006 E. coli P/A SM 9223 B Colilert 18
101.050 007 Total Coliform (Enumeration) SM 9223 B Colilert 18 101.050 008 E. coli (Enumeration) SM 9223 B Colilert 18 101.050 009 Total Coliform P/A SM 9223 B Colisure
101.050 010 E. coli P/A SM 9223 B Colisure
101.140 001 Enterococci SM 9230 B
101.170 001 Enterococci Enterolert
Field of Accreditation:102 - Inorganic Chemistry of Drinking Water 102.015 001 Hydrogen Ion (pH) EPA 150.1
102.020 001 Turbidity EPA 180.1
102.026 001 Calcium EPA 200.7
102.026 002 Magnesium EPA 200.7
102.026 003 Potassium EPA 200.7
102.026 004 Silica EPA 200.7
102.026 005 Sodium EPA 200.7
102.026 006 Hardness (Calculation) EPA 200.7
102.030 001 Bromide EPA 300.0
102.030 002 Chlorate EPA 300.0
102.030 003 Chloride EPA 300.0
102.030 004 Chlorite EPA 300.0
102.030 006 Nitrate (as N) EPA 300.0
As of 1/26/2023 , this list supersedes all previous lists for this certificate number.
Customers: Please verify the current accreditation standing with the State. Page 1 of 9 Certificate Number: 2813
Expiration Date: 2/1/2024
Eurofins Eaton Analytical, LLC - Monrovia
102.030 007 Nitrite (as N) EPA 300.0
102.030 009 Sulfate (as SO4) EPA 300.0
102.040 001 Bromide EPA 300.1
102.040 003 Chlorate EPA 300.1
102.040 004 Bromate EPA 300.1
102.040 008 Nitrite (as N) EPA 300.1
102.044 001 Bromate EPA 317.0
102.045 001 Perchlorate EPA 314.0
102.047 001 Perchlorate EPA 331.0
102.050 001 Cyanide, Total EPA 335.4
102.060 001 Nitrate (as N) (Calculation) EPA 353.2
102.061 001 Nitrite (as N) EPA 353.2
102.100 001 Alkalinity SM 2320 B-1997
102.120 001 Hardness (Calculation) SM 2340 B-1997
102.130 001 Specific Conductance SM 2510 B-1997
102.140 001 Residue, Filterable TDS SM 2540 C-1997
102.175 001 Chlorine, Free SM 4500-Cl G-2000
102.175 002 Chlorine, Total Residual SM 4500-Cl G-2000
102.180 001 Chlorine Dioxide SM 4500-ClO2 D-2000
102.191 001 Cyanide, Total SM 4500-CN F-1999
102.192 001 Cyanide, Amenable SM 4500-CN G-1999
102.200 001 Fluoride SM 4500-F C-1997
102.203 001 Hydrogen Ion (pH) SM 4500-H+ B-2000
102.240 001 Phosphate,Ortho (as P) SM 4500-P E-1999
102.242 001 Silica SM 4500-SiO2 C-1997
102.262 001 Organic Carbon-Total (TOC) SM 5310 C-2000
102.263 001 Dissolved Organic Carbon (DOC) SM 5310 C-2000 102.270 001 Surfactants SM 5540 C-2000
102.280 001 UV254 SM 5910 B-2011
Field of Accreditation:103 - Toxic Chemical Elements of Drinking Water 103.130 001 Aluminum EPA 200.7
103.130 003 Barium EPA 200.7
103.130 004 Beryllium EPA 200.7
103.130 007 Chromium EPA 200.7
103.130 008 Copper EPA 200.7
103.130 009 Iron EPA 200.7
103.130 011 Manganese EPA 200.7
103.130 012 Nickel EPA 200.7
103.130 015 Silver EPA 200.7
103.130 017 Zinc EPA 200.7
103.130 018 Boron EPA 200.7
103.140 001 Aluminum EPA 200.8
As of 1/26/2023 , this list supersedes all previous lists for this certificate number.
Customers: Please verify the current accreditation standing with the State. Page 2 of 9 Certificate Number: 2813
Expiration Date: 2/1/2024
Eurofins Eaton Analytical, LLC - Monrovia
103.140 002 Antimony EPA 200.8
103.140 003 Arsenic EPA 200.8
103.140 004 Barium EPA 200.8
103.140 005 Beryllium EPA 200.8
103.140 006 Cadmium EPA 200.8
103.140 007 Chromium EPA 200.8
103.140 008 Copper EPA 200.8
103.140 009 Lead EPA 200.8
103.140 010 Manganese EPA 200.8
103.140 011 Mercury EPA 200.8
103.140 012 Nickel EPA 200.8
103.140 013 Selenium EPA 200.8
103.140 014 Silver EPA 200.8
103.140 015 Thallium EPA 200.8
103.140 016 Zinc EPA 200.8
103.140 018 Vanadium EPA 200.8
103.301 001 Asbestos EPA 100.2
103.310 001 Chromium VI (Hexavalent Chromium) EPA 218.6 103.311 001 Chromium VI (Hexavalent Chromium) EPA 218.7 Field of Accreditation:104 - Volatile Organic Chemistry of Drinking Water 104.030 001 1,2-Dibromoethane (EDB) EPA 504.1
104.030 002 1,2-Dibromo-3-chloropropane (DBCP) EPA 504.1 104.035 001 1,2,3-Trichloropropane (TCP) SRL 524M-TCP
104.200 001 1,1,1,2-Tetrachloroethane EPA 524.2
104.200 002 1,1,1-Trichloroethane EPA 524.2
104.200 003 1,1,2,2-Tetrachloroethane EPA 524.2
104.200 004 1,1,2-Trichloroethane EPA 524.2
104.200 005 1,1-Dichloroethane EPA 524.2
104.200 006 1,1-Dichloroethylene (1,1-Dichloroethene) EPA 524.2 104.200 007 1,2,3-Trichlorobenzene EPA 524.2
104.200 008 1,2,4-Trichlorobenzene EPA 524.2
104.200 009 1,2,4-Trimethylbenzene EPA 524.2
104.200 010 1,2-Dichlorobenzene EPA 524.2
104.200 011 1,2-Dichloroethane (Ethylene Dichloride) EPA 524.2 104.200 012 1,2-Dichloropropane EPA 524.2
104.200 013 1,3,5-Trimethylbenzene EPA 524.2
104.200 014 1,3-Dichlorobenzene EPA 524.2
104.200 015 1,4-Dichlorobenzene EPA 524.2
104.200 016 2-Chlorotoluene EPA 524.2
104.200 017 4-Chlorotoluene EPA 524.2
104.200 018 Benzene EPA 524.2
104.200 019 Carbon Disulfide EPA 524.2
As of 1/26/2023 , this list supersedes all previous lists for this certificate number.
Customers: Please verify the current accreditation standing with the State. Page 3 of 9 Certificate Number: 2813
Expiration Date: 2/1/2024
Eurofins Eaton Analytical, LLC - Monrovia
104.200 020 Carbon Tetrachloride EPA 524.2
104.200 021 Chlorobenzene EPA 524.2
104.200 022 cis-1,2-Dichloroethylene (cis 1,2 Dichloroethene) EPA 524.2 104.200 023 cis-1,3-Dichloropropylene (cis 1,3 Dichloropropene) EPA 524.2 104.200 024 Dichlorodifluoromethane EPA 524.2
104.200 025 Dichloromethane (Methylene Chloride) EPA 524.2 104.200 027 Ethyl tert-butyl Ether (ETBE) EPA 524.2
104.200 028 Ethylbenzene EPA 524.2
104.200 029 Isopropylbenzene EPA 524.2
104.200 030 Methyl isobutyl ketone (MIBK, 4-Methyl-2-pentanone) EPA 524.2 104.200 031 Methyl tert-butyl Ether (MTBE) EPA 524.2
104.200 032 Naphthalene EPA 524.2
104.200 033 n-Butylbenzene EPA 524.2
104.200 034 N-propylbenzene EPA 524.2
104.200 035 sec-Butylbenzene EPA 524.2
104.200 036 Styrene EPA 524.2
104.200 037 t-Butyl alcohol (2-Methyl-2-propanol) EPA 524.2 104.200 038 tert-Amyl Methyl Ether (TAME) EPA 524.2
104.200 039 tert-Butylbenzene EPA 524.2
104.200 040 Tetrachloroethylene (Tetrachloroethene) EPA 524.2 104.200 041 Toluene EPA 524.2
104.200 042 trans-1,2-Dichloroethylene (trans- 1,2 Dichloroethene) EPA 524.2 104.200 043 trans-1,3-Dichloropropylene (trans-1,3 Dichloropropen EPA 524.2 104.200 044 Trichloroethylene (Trichloroethene) EPA 524.2 104.200 045 Trichlorofluoromethane EPA 524.2
104.200 046 Trichlorotrifluoroethane EPA 524.2
104.200 047 Vinyl Chloride EPA 524.2
104.200 101 m-Xylene EPA 524.2
104.200 102 m+p-Xylene EPA 524.2
104.200 103 o-Xylene EPA 524.2
104.200 104 p-Xylene EPA 524.2
104.200 201 Bromodichloromethane EPA 524.2
104.200 202 Bromoform EPA 524.2
104.200 203 Chloroform EPA 524.2
104.200 204 Dibromochloromethane (Chlorodibromomethane) EPA 524.2 Field of Accreditation:105 - Semi-volatile Organic Chemistry of Drinking Water 105.010 002 Alachlor EPA 505
105.010 004 Chlordane EPA 505
105.010 006 Endrin EPA 505
105.010 007 Heptachlor EPA 505
105.010 008 Heptachlor Epoxide EPA 505
105.010 011 Lindane (HCH-gamma) EPA 505
As of 1/26/2023 , this list supersedes all previous lists for this certificate number.
Customers: Please verify the current accreditation standing with the State. Page 4 of 9 Certificate Number: 2813
Expiration Date: 2/1/2024
Eurofins Eaton Analytical, LLC - Monrovia
105.010 012 Methoxychlor EPA 505
105.010 014 Toxaphene EPA 505
105.010 015 PCBs as Aroclors (screen) EPA 505
105.083 001 2,4-D EPA 515.4
105.083 002 Dinoseb EPA 515.4
105.083 003 Pentachlorophenol EPA 515.4
105.083 004 Picloram EPA 515.4
105.083 005 2,4,5-TP (Silvex) EPA 515.4
105.083 006 Dalapon EPA 515.4
105.083 007 Bentazon EPA 515.4
105.083 008 Dicamba EPA 515.4
105.085 001 1,4-Dioxane EPA 522
105.090 001 Alachlor EPA 525.2
105.090 002 Aldrin EPA 525.2
105.090 003 Atrazine EPA 525.2
105.090 004 Benzo(a)pyrene EPA 525.2
105.090 005 Butachlor EPA 525.2
105.090 006 Chlordane EPA 525.2
105.090 007 Dieldrin EPA 525.2
105.090 008 Di(2-ethylhexyl) Adipate EPA 525.2
105.090 009 Di(2-ethylhexyl) Phthalate EPA 525.2
105.090 013 Endrin EPA 525.2
105.090 014 Heptachlor EPA 525.2
105.090 015 Heptachlor Epoxide EPA 525.2
105.090 016 Hexachlorobenzene EPA 525.2
105.090 017 Hexachlorocyclopentadiene EPA 525.2
105.090 018 Lindane (HCH-gamma) EPA 525.2
105.090 019 Methoxychlor EPA 525.2
105.090 022 Molinate EPA 525.2
105.090 025 Simazine EPA 525.2
105.090 028 Thiobencarb EPA 525.2
105.101 001 Carbofuran (Furadan) EPA 531.2
105.101 002 Oxamyl EPA 531.2
105.101 003 Aldicarb (Temik) EPA 531.2
105.101 004 Aldicarb Sulfone EPA 531.2
105.101 005 Aldicarb Sulfoxide EPA 531.2
105.101 006 Carbaryl (Sevin) EPA 531.2
105.101 007 3-Hydroxycarbofuran EPA 531.2
105.101 008 Methomyl (Lannate) EPA 531.2
105.103 001 11-Chloroeicosafluoro-3-oxaundecane-1-sulfonic acid EPA 533 105.103 002 9-Chlorohexadecafluoro-3-oxanonane-1-sulfonic acid EPA 533 105.103 003 4,8-Dioxa-3H-perfluorononanoic acid (ADONA) EPA 533 As of 1/26/2023 , this list supersedes all previous lists for this certificate number.
Customers: Please verify the current accreditation standing with the State. Page 5 of 9 Certificate Number: 2813
Expiration Date: 2/1/2024
Eurofins Eaton Analytical, LLC - Monrovia
105.103 004 Hexafluoropropylene Oxide Dimer Acid (HFPO-DA) EPA 533 105.103 005 Nonafluoro-3,6-dioxaheptanoic acid (NFDHA) EPA 533 105.103 006 Perfluorobutanoic Acid (PFBA) EPA 533
105.103 007 Perfluorobutane Sulfonic Acid (PFBS) EPA 533 105.103 008 1H,1H, 2H, 2H-Perfluorodecane sulfonic acid (8:2FTS EPA 533 105.103 009 Perfluorodecanoic Acid (PFDA) EPA 533
105.103 010 Perfluorododecanoic Acid (PFDoA) EPA 533
105.103 011 Perfluoro(2-ethoxyethane) sulfonic acid (PFEESA) EPA 533 105.103 012 Perfluoroheptane Sulfonic Acid (PFHpS) EPA 533 105.103 013 Perfluoroheptanoic Acid (PFHpA) EPA 533
105.103 014 1H,1H, 2H, 2H-Perfluorohexane sulfonic acid (4:2FTS EPA 533 105.103 015 Perfluorohexane Sulfonic Acid (PFHxS) EPA 533 105.103 016 Perfluorohexanoic Acid (PFHxA) EPA 533
105.103 017 Perfluoro-3-methoxypropanoic acid (PFMPA) EPA 533 105.103 018 Perfluoro-4-methoxybutanoic acid (PFMBA) EPA 533 105.103 019 Perfluorononanoic Acid (PFNA) EPA 533
105.103 020 1H,1H, 2H, 2H-Perfluorooctane sulfonic acid (6:2FTS) EPA 533 105.103 021 Perfluorooctane Sulfonic Acid (PFOS) EPA 533 105.103 022 Perfluorooctanoic Acid (PFOA) EPA 533
105.103 023 Perfluoropentanoic Acid (PFPeA) EPA 533
105.103 024 Perfluoropentane Sulfonic Acid (PFPeS) EPA 533 105.103 025 Perfluoroundecanoic Acid (PFUnDA) EPA 533
105.106 001 11-Chloroeicosafluoro-3-oxaundecane-1-sulfonic acid EPA 537.1 105.106 002 9-Chlorohexadecafluoro-3-oxanonane-1-sulfonic acid EPA 537.1 105.106 003 4,8-Dioxa-3H-perfluorononanoic acid (ADONA) EPA 537.1 105.106 004 Hexafluoropropylene Oxide Dimer Acid (HFPO-DA) EPA 537.1 105.106 005 N-Ethylperfluorooctane Sulfonamido Acetic Acid (NEt EPA 537.1 105.106 006 N-Methylperfluorooctane Sulfonamido Acetic Acid (N EPA 537.1 105.106 007 Perfluorobutane Sulfonic Acid (PFBS) EPA 537.1 105.106 008 Perfluorodecanoic Acid (PFDA) EPA 537.1
105.106 009 Perfluorododecanoic Acid (PFDoA) EPA 537.1
105.106 010 Perfluoroheptanoic Acid (PFHpA) EPA 537.1
105.106 011 Perfluorohexane Sulfonic Acid (PFHxS) EPA 537.1 105.106 012 Perfluorohexanoic Acid (PFHxA) EPA 537.1
105.106 013 Perfluorononanoic Acid (PFNA) EPA 537.1
105.106 014 Perfluorooctanoic Acid (PFOA) EPA 537.1
105.106 015 Perfluorooctane Sulfonic Acid (PFOS) EPA 537.1 105.106 016 Perfluorotetradecanoic Acid (PFTDA) EPA 537.1 105.106 017 Perfluorotridecanoic Acid (PFTrDA) EPA 537.1 105.106 018 Perfluoroundecanoic Acid (PFUnDA) EPA 537.1 105.108 001 Anatoxin-A EPA 545
105.108 002 Cylindrospermopsin EPA 545
As of 1/26/2023 , this list supersedes all previous lists for this certificate number.
Customers: Please verify the current accreditation standing with the State. Page 6 of 9 Certificate Number: 2813
Expiration Date: 2/1/2024
Eurofins Eaton Analytical, LLC - Monrovia
105.109 001 Total microcystins EPA 546
105.120 001 Glyphosate EPA 547
105.140 001 Endothall EPA 548.1
105.150 001 Diquat EPA 549.2
105.170 010 1,2-Dibromo-3-chloropropane (DBCP) EPA 551.1 105.170 011 1,2-Dibromoethane (EDB) EPA 551.1
105.175 001 Bromodichloromethane EPA 551.1
105.175 002 Bromoform EPA 551.1
105.175 003 Chloroform EPA 551.1
105.175 004 Dibromochloromethane (Chlorodibromomethane) EPA 551.1 105.190 001 Bromoacetic Acid SM 6251 B
105.190 003 Chloroacetic Acid SM 6251 B
105.190 005 Dibromoacetic Acid SM 6251 B
105.190 006 Dichloroacetic Acid SM 6251 B
105.190 007 Trichloroacetic Acid SM 6251 B
105.230 002 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Screenin EPA 1613 B Field of Accreditation:106 - Radionuclides in Drinking Water 106.010 001 Gross Alpha EPA 900.0
106.010 002 Gross Beta EPA 900.0
106.092 001 Uranium EPA 200.8
106.270 001 Gross Alpha SM 7110 C
106.610 001 Radon-222 SM 7500-Rn
106.640 001 Radium-226 Georgia Inst. of Tech. rev 1.2
106.640 002 Radium-228 Georgia Inst. of Tech. rev 1.2
Field of Accreditation:107 - Microbiological Methods for Non-Potable Water and Sewage Sludge 107.001 001 Total Coliform (Enumeration) SM 9221 B,C-2006 107.001 002 Fecal Coliform (Enumeration) SM 9221 C,E-2006 107.001 003 E. coli (Enumeration) SM 9221 C,F-2006
107.007 001 Enterococci SM 9230 B-2007
107.007 002 Fecal Streptococci SM 9230 B-2007
107.013 001 E. coli (Enumeration) SM 9223 B-2004 Colilert 107.015 001 E. coli (Enumeration) SM 9223 B-2004 Colilert 18 107.017 001 Enterococci Enterolert
Field of Accreditation:108 - Inorganic Constituents in Non-Potable Water 108.007 001 Residue, Volatile EPA 160.4
108.009 001 Turbidity EPA 180.1
108.013 001 Calcium EPA 200.7
108.013 002 Magnesium EPA 200.7
108.013 004 Potassium EPA 200.7
108.013 005 Silica, Dissolved EPA 200.7
108.013 006 Sodium EPA 200.7
108.017 001 Bromide EPA 300.0
As of 1/26/2023 , this list supersedes all previous lists for this certificate number.
Customers: Please verify the current accreditation standing with the State. Page 7 of 9 Certificate Number: 2813
Expiration Date: 2/1/2024
Eurofins Eaton Analytical, LLC - Monrovia
108.017 002 Chloride EPA 300.0
108.017 004 Nitrate (as N) EPA 300.0
108.017 005 Nitrate-Nitrite (as N) EPA 300.0
108.017 006 Nitrite (as N) EPA 300.0
108.017 008 Sulfate (as SO4) EPA 300.0
108.023 001 Cyanide, Total EPA 335.4
108.025 001 Ammonia (as N) EPA 350.1
108.029 001 Kjeldahl Nitrogen,Total (as N) EPA 351.2
108.033 001 Nitrate-Nitrite (as N) EPA 353.2
108.033 002 Nitrite (as N) EPA 353.2
108.035 002 Phosphorus,Total EPA 365.1
108.045 001 Chemical Oxygen Demand EPA 410.4
108.049 001 Phenols, Total EPA 420.4
108.055 001 Color SM 2120 B-2011
108.063 001 Alkalinity SM 2320 B-2011
108.065 001 Hardness (Calculation) SM 2340 B-2011
108.069 001 Specific Conductance SM 2510 B-2011
108.071 001 Residue, Total SM 2540 B-2011
108.073 001 Residue, Filterable TDS SM 2540 C-2011
108.075 001 Residue, Non-filterable TSS SM 2540 D-2011
108.077 001 Residue, Volatile SM 2540 E-2011
108.079 001 Residue, Settleable SM 2540 F-2011
108.114 001 Chlorine, Total Residual SM 4500-Cl G-2011
108.114 002 Chlorine, Free SM 4500-Cl G-2011
108.129 001 Cyanide, Available SM 4500-CN G-2011
108.137 001 Hydrogen Ion (pH) SM 4500-H+ B-2011
108.175 001 Phosphate,Ortho (as P) SM 4500-P E-2011
108.184 001 Silica, Dissolved SM 4500-SiO2 C-2011
108.201 001 Sulfide (as S) SM 4500-S D-2011
108.207 001 Biochemical Oxygen Demand SM 5210 B-2011
108.207 002 Carbonaceous BOD SM 5210 B-2011
108.213 001 Chemical Oxygen Demand SM 5220 D-2011
108.217 001 Organic Carbon-Total (TOC) SM 5310 C-2011
108.225 001 Surfactants SM 5540 C-2011
Field of Accreditation:109 - Metals and Trace Elements in Non-Potable Water 109.623 001 Aluminum EPA 200.7
109.623 002 Antimony EPA 200.7
109.623 004 Barium EPA 200.7
109.623 005 Beryllium EPA 200.7
109.623 006 Boron EPA 200.7
109.623 007 Cadmium EPA 200.7
109.623 008 Chromium EPA 200.7
As of 1/26/2023 , this list supersedes all previous lists for this certificate number.
Customers: Please verify the current accreditation standing with the State. Page 8 of 9 Certificate Number: 2813
Expiration Date: 2/1/2024
Eurofins Eaton Analytical, LLC - Monrovia
109.623 009 Cobalt EPA 200.7
109.623 010 Copper EPA 200.7
109.623 011 Iron EPA 200.7
109.623 012 Lead EPA 200.7
109.623 013 Manganese EPA 200.7
109.623 014 Molybdenum EPA 200.7
109.623 015 Nickel EPA 200.7
109.623 017 Silver EPA 200.7
109.623 018 Thallium EPA 200.7
109.623 019 Tin EPA 200.7
109.623 020 Titanium EPA 200.7
109.623 021 Vanadium EPA 200.7
109.623 022 Zinc EPA 200.7
109.625 001 Aluminum EPA 200.8
109.625 002 Antimony EPA 200.8
109.625 003 Arsenic EPA 200.8
109.625 004 Barium EPA 200.8
109.625 005 Beryllium EPA 200.8
109.625 007 Cadmium EPA 200.8
109.625 008 Chromium EPA 200.8
109.625 009 Cobalt EPA 200.8
109.625 010 Copper EPA 200.8
109.625 013 Lead EPA 200.8
109.625 014 Manganese EPA 200.8
109.625 015 Molybdenum EPA 200.8
109.625 016 Nickel EPA 200.8
109.625 017 Selenium EPA 200.8
109.625 018 Silver EPA 200.8
109.625 019 Thallium EPA 200.8
109.625 020 Tin EPA 200.8
109.625 021 Titanium EPA 200.8
109.625 022 Vanadium EPA 200.8
109.625 023 Zinc EPA 200.8
109.629 001 Chromium VI (Hexavalent Chromium) EPA 218.6 Field of Accreditation:112 - Radionuclides in Non-Potable Water 112.001 001 Gross Alpha EPA 900.0
112.001 002 Gross Beta EPA 900.0
As of 1/26/2023 , this list supersedes all previous lists for this certificate number.
Customers: Please verify the current accreditation standing with the State. Page 9 of 9 Core Items: Sample Fee List 1
SPECIFIC TESTS METHOD OR TECHNIQUE USED Alternative Method / Added Items Environmental (Drinking Water) Environmental (Wastewater) Standard Fee Expedited Fee Expedited Turn Around Time 1,4-Dioxane EPA 522 x $ 175.00 $ 350.00 1-3 WD
1,2,3 Trichloropropane (low level) EPA 524 SRL 524M-TCP x $ 90.00 $ 180.00 1-3 WD 2,3,7,8-TCDD Modified EPA 1613B x $ 225.00 $ 450.00 1-3 WD Acrylamide In House Method (2440) LC/MS/MS x $ 175.00 $ 350.00 1-3 WD Ammonia EPA 350.1 x $ 30.00 $ 60.00 1-3 WD
Ammonia SM 4500-NH3 H x $ 30.00 $ 60.00 1-3 WD
Asbestos EPA 100.2 x $ 150.00 $ 300.00 1-3 WD
Asbestos EPA 100.2 Added item x $ 250.00 $ 500.00 1-3 WD Bicarbonate Alkalinity as HCO3 SM 2320B x x $ 10.00 $ 20.00 1-3 WD Carbamates EPA 531.2 x $ 110.00 $ 220.00 1-3 WD
Carbonate as CO3 SM 2330B x x $ 10.00 $ 20.00 1-3 WD
Carbonyls EPA 556 x $ 200.00 $ 400.00 1-3 WD
Chloramines SM 4500-CL G x x $ 20.00 $ 40.00 1-3 WD
Chlorinated Acids EPA 515.4 x $ 110.00 $ 220.00 1-3 WD
Chlorinated Acids EPA 555 (by 515.4) x $ 175.00 $ 350.00 1-3 WD Chlorine Dioxide SM 4500-CLO2 D x $ 25.00 $ 50.00 1-3 WD Cryptosporidium EPA 1623 x $ 425.00 $ 850.00 NA
Cyanide, Amenable SM 4500-CN G x x $ 50.00 $ 100.00 1-3 WD Cyanide, Free SM 4500CN F x x $ 30.00 $ 60.00 1-3 WD
Cyanide, Total EPA 335.4 x x $ 40.00 $ 80.00 1-3 WD
Diquat and Paraquat EPA 549.2 x $ 110.00 $ 220.00 1-3 WD Dissolved Oxygen SM 4500-O G x $ 40.00 $ 80.00 1-3 WD
DOC SM 5310C x $ 45.00 $ 90.00 1-3 WD
E. Coli (MTF/EC+MUG) x $ 50.00 $ 100.00 1-3 WD
E. Coli CFR 141.21(f)(6)(i) x $ 50.00 $ 100.00 1-3 WD
E. Coli (Enumeration) SM 9221B.1/ SM 9221F x $ 50.00 $ 100.00 1-3 WD E. Coli (Enumeration) SM 9223B x $ 30.00 $ 60.00 1-3 WD EDB/DCBP EPA 504.1 x $ 75.00 $ 150.00 1-3 WD
EDB/DBCP and DBP EPA 551.1 x $ 95.00 $ 190.00 1-3 WD
Endothall EPA 548.1 x $ 110.00 $ 220.00 1-3 WD
Enterococci SM 9230B x x $ 150.00 $ 300.00 1-3 WD
City of Vallego - Water Department: Lab Services RFP
SPECIFIC TESTS METHOD OR TECHNIQUE USED Alternative Method / Added Items Environmental (Drinking Water) Environmental (Wastewater) Standard Fee Expedited Fee Expedited Turn Around Time Fecal Coliform SM 9221 E (MTF/EC) x $ 50.00 $ 100.00 1-3 WDFecal Coliform (Enumeration)
SM 9221E
(MTF/EC) x $ 50.00 $ 100.00 1-3 WD
Fecal Streptococci SM 9230B x x $ 125.00 $ 250.00 1-3 WD Fluoride SM 4500-F C x x $ 20.00 $ 40.00 1-3 WD
Giardia EPA 1623 x $ 425.00 $ 850.00 1-3 WD
Giardia / Cryptosporidium EPA 1623 Added item x $ 425.00 $ 850.00 1-3 WD Glyphosate EPA 547 x $ 95.00 $ 190.00 1-3 WD
Gross Alpha/Beta EPA 900.0 x x $ 70.00 $ 140.00 1-3 WD
Gross Alpha
Coprecipitation SM 7110 C x x $ 75.00 $ 150.00 1-3 WD
Heterotrophic Bacteria SM 9215 B x $ 30.00 $ 60.00 1-3 WD Hexavalent Chromium EPA 218.6 x x $ 65.00 $ 130.00 1-3 WDHexavalent Chromium EPA 218.7 x $ 85.00 $ 170.00 1-3 WD Hormones EPA 539 x $ 300.00 $ 600.00 1-3 WD
Hydroxide as OH Calc. SM 2330B x $ 10.00 $ 20.00 1-3 WD Legionella CDC Legionella x $ 125.00 $ 250.00 1-3 WD
Mercury EPA 245.1 or 200.8 x x $ 30.00 $ 60.00 1-3 WD
Metals EPA 200.7 / 200.8 x x $ 15.00 $ 30.00 1-3 WD
Microcystin LR ELISA (2360) x $ 100.00 $ 200.00 1-3 WD
NDMA EPA 521 x $ 225.00 $ 450.00 1-3 WD
Nitrate/Nitrite Nitrogen EPA 353.2 x x $ 25.00 $ 50.00 1-3 WD OCL, Pesticides/PCB EPA 505 x $ 110.00 $ 220.00 1-3 WD
Ortho Phosphate EPA 365.1 x x $ 25.00 $ 50.00 1-3 WD
Ortho Phosphorous SM 4500P E x $ 20.00 $ 40.00 1-3 WD
Perchlorate EPA 331.0 x $ 100.00 $ 200.00 1-3 WD
Perchlorate (low and
high) EPA 314.0 x $ 50.00 $ 100.00 1-3 WD
Perfluorinated Alkyl
Acids EPA 537 x $ 250.00 $ 500.00 1-3 WD
Perfluorinated Alkyl
Acids EPA 533 Added item x $ 290.00 $ 580.00 1-3 WD
Radium-226 GA Method/EPA 903.0 x $ 125.00 $ 250.00 1-3 WDRadium-228 GA Method/EPA 904.0 x $ 125.00 $ 250.00 1-3 WD Radon-222 SM 7500RN x x $ 75.00 $ 150.00 1-3 WD
Semi-VOC EPA 525.2 x x $ 175.00 $ 350.00 1-3 WD
Silica SM 4500-Si D x x $ 40.00 $ 80.00 1-3 WDSilica SM 4500-SiO2 C x x $ 40.00 $ 80.00 1-3 WD City of Vallego - Water Department: Lab Services RFP
SPECIFIC TESTS METHOD OR TECHNIQUE USED Alternative Method / Added Items Environmental (Drinking Water) Environmental (Wastewater) Standard Fee Expedited Fee Expedited Turn Around Time Sulfite SM 4500-SO3B x x $ 85.00 $ 170.00 1-3 WD
Surfactants SM 5540C x x $ 40.00 $ 80.00 1-3 WD
Total Coliform (P/A) SM 9221 A, B x $ 50.00 $ 100.00 1-3 WD Total Coliform
(Enumeration) SM 9221 A, B, C x $ 50.00 $ 100.00 1-3 WD Total Coliform / E. coli Colisure SM 9223 x $ 30.00 $ 60.00 1-3 WD Total Coliform / E.coli (P/A and
Enumeration) SM 9223 x $ 30.00 $ 60.00 1-3 WD
Total Phenols EPA 420.4 x x $ 100.00 $ 200.00 1-3 WD
Uranium by ICP/MS EPA 200.8 x $ 25.00 $ 50.00 1-3 WD
UV 254 SM 5910B x $ 40.00 $ 80.00 1-3 WD
VOC EPA SW 846 8260 x $ 100.00 $ 200.00 1-3 WD
VOC EPA 524.2 x $ 90.00 $ 180.00 1-3 WD
VOC EPA 524.3 Added item x $ 175.00 $ 350.00 1-3 WD
Core Items: Sample Fee List 2
SPECIFIC TESTS METHOD OR TECHNIQUE USED Standard Fee Expedited Fee Metals SW6020 $ 30.00 $ 60.00
pH SW9045 $ 15.00 $ 30.00
Mercury EPA 7471A $ 45.00 $ 90.00
Percent Moisture SM2540 G $ 20.00 $ 40.00
xxxx
Expedited Turn Around
Time
1-3 WD1-3 WD1-3 WD1-3 WD
Solids Analyses
City of Vallego - Water Department: Lab Services RFP
Core Items: Sample Fee List 3
SPECIFIC TESTS METHOD OR TECHNIQUE USED Alternative Method / Added Items Environmental (Drinking Water) Environmental (Wastewater) Standard Fee Expedited Fee Expedited Turn Around Time
SPECIFIC TESTS
METHOD OR
TECHNIQUE
USED
Alternative Method /
Added Items
UCMR4
for
drinking
water
UCMR5
for
drinking
water
Standard
Fee
Expedited
Fee
Expedited Turn Around
Time
TOC SM5310C x $ 40.00 NA NA
Bromide EPA 300.0 x $ 40.00 NA NA
HAAs EPA 552.3 x $ 150.00 NA NA
Total Microcystins EPA 546 x $ 100.00 NA NA
Cylindrospermopsim/ Anatoxin-a EPA 545 x $ 300.00 NA NA Metals EPA 200.8 x $ 40.00 NA NA
Pesticides EPA 525.3 x $ 275.00 NA NA
Semivolatiles EPA 530 x $ 275.00 NA NA
Alcohols EPA 541 x $ 275.00 NA NA
Microcystins/Nodularin EPA 544 x $ 300.00 NA NA
PFAS (25x Chemicals) EPA 533 x $ 290.00 NA NA
PFAS (4x Chemicals) EPA 537.1 x $ 250.00 NA NA
Lithium EPA 200.7 x $ 40.00 NA NA
Core Items: Sample Fee List 4
SPECIFIC TESTS METHOD OR TECHNIQUE USED Standard Fee Expedited Fee Lead Total EPA 200.8 $ 15.00 $ 30.00
Core Items: Sample Fee List 5
SPECIFIC TESTS METHOD OR TECHNIQUE USED Standard Fee Expedited Fee Lead Total and Copper Total EPA 200.8 $ 20.00 $ 40.00
Expedited Turn Around Time
1-3 WD
Expedited Turn Around Time
1-3 WD
LCR
x
Lead in Schools for drinking water
x
City of Vallego - Water Department: Lab Services RFP
Core Items: Sample Fee List 6
SPECIFIC TESTS METHOD OR TECHNIQUE USED Standard Fee Expedited Fee TTHMs (VOC) EPA 524.2/EPA 524.3 $ 50.00 $ 100.00
HAAs SM6251B $ 125.00 $ 250.00
Bromate EPA 317.0 $ 75.00 $ 150.00
Core Items: Sample Fee List 7
SPECIFIC TESTS METHOD OR TECHNIQUE USED Standard Fee Expedited Fee Odor SM2150B $ 30.00 $ 60.00
Turbidity EPA 180.1 $ 15.00 $ 30.00 Turbidity SM2130B $ 15.00 $ 30.00 Color SM2120B $ 20.00 $ 40.00
Core Items: Sample Fee List 8
SPECIFIC TESTS METHOD OR TECHNIQUE USED Standard Fee Expedited Fee TOC SM 5310C $ 40.00 $ 80.00
Bromide (DBPs by 300.0) EPA 300.0 $ 40.00 $ 80.00
Core Items: Sample Fee List 9
SPECIFIC TESTS METHOD OR TECHNIQUE USED Standard Fee Expedited Fee Anions and DBPs by IC EPA 300.0 $ 60.00 $ 120.00
Anions and DBPs by IC EPA 300.1 $ 40.00 $ 80.00
Expedited Turn Around Time
1-3 WD1-3 WD1-3 WD
Drinking Water - DBPs
xxx
Expedited Turn Around Time
1-3 WD1-3 WD
Drinking Water -DBP Precursors
xx
Expedited Turn Around Time
1-3 WD1-3 WD
Drinking Water - DBP Precursors
xx
Expedited Turn Around Time
1-3 WD1-3 WD1-3 WD1-3 WD
Drinking Water - Physicals
xxxx
City of Vallego - Water Department: Lab Services RFP
Core Items: Sample Fee List 10
SPECIFIC TESTS METHOD OR TECHNIQUE USED Standard Fee Expedited Fee Alkalinity-Total SM 2320B $ 20.00 $ 40.00
Conductivity SM 2510B $ 12.00 $ 24.00
Hardness SM 2340B $ 20.00 $ 40.00
Chloride EPA 300.0 $ 15.00 $ 30.00
Calcium - Metals EPA 200.8 or 200.7 $ 15.00 $ 30.00
Magnesium - Metals EPA 200.8 or 200.7 $ 15.00 $ 30.00
Total Dissolved Solids SM 2540C $ 15.00 $ 30.00
Salinity SM 2520B $ 20.00 $ 40.00
pH SM 4500-H+B $ 15.00 $ 30.00
SPECIFIC TESTS METHOD OR TECHNIQUE USED
Miscellaneous
Physical/
Conventional
Chemistry
Parameters
Expedited
Fee
Langlier Index SM 2320B $ 40.00
Expedited Turn Around Time
1-3 WD
Standard Fee
$ 20.00
Expedited Turn Around Time
1-3 WD1-3 WD1-3 WD1-3 WD1-3 WD1-3 WD1-3 WD1-3 WD1-3 WD
General Chemistry
xxxxxxxxx
City of Vallego - Water Department: Lab Services RFP
Õÿ—À‘‹ fl“« —⁄ Ãÿ¤ flfi— ¤ ‹¤Õ›Œ×fi¤‹ –—‘×›×¤Õ fi¤ ›fl“›¤‘‘¤‹ fi¤⁄—Œ¤ Ãÿ¤ ¤»–׌flÃ×—“ ‹flä Ãÿ¤Œ¤—⁄Ù “—Ã×›¤ …ב‘ fi¤ ‹¤‘× ¤Œ¤‹ ד fl››—Œ‹fl“›¤ …×Ãÿ Ãÿ¤ –—‘×›« –Œ— ×Õ×—“ÕÚ
דÕÀŒ¤Œ¯Õ˜ fl⁄⁄—Œ‹×“Ÿ ›— ¤ŒflŸ¤
דÕÀŒ¤Œ ⁄ Ê
דÕÀŒ¤Œ ¤ Ê
דÕÀŒ¤Œ ‹ Ê
דÕÀŒ¤Œ › Ê
דÕÀŒ¤Œ fi Ê
דÕÀŒ¤Œ fl Ê
“fl×› ˝
“fl”¤Ê
›—“Ãfl›Ã
¯flÒ›Ù “±˜Ê
⁄fl»
¤Û”flב
fl‹‹Œ¤ÕÕÊ
–Œ—‹À›¤Œ
¯flÒ›Ù “±Ù ¤®¨˜Ê
–ÿ—“¤
דÕÀŒ¤‹
›— ¤ŒflŸ¤Õ ›¤ŒÃ×⁄×›flä “À”fi¤ŒÊ Œ¤ ×Õ×—“ “À”fi¤ŒÊ
×”–—ŒÃfl“ÃÊ ×º ¨¸ª ½ªÆ¨·º·½ø¨ª ¸±¥ºªÆ · ø² fl‹‹×Ã×—“fl‘ דÕÀŒ¤‹Ù ¨¸ª °±¥·½ß¯·ª˜ ³´¨ ¸ø™ª fl‹‹×Ã×—“fl‘ דÕÀŒ¤‹ °Æ±™··±² ±Æ æª ª²º±ÆªºÚ ׺ ÕÀfiŒ—ŸflÃ×—“ ×Õ …fl× ¤‹Ù ´æ¶ª½¨ ¨± ¨¸ª ¨ªÆ³ ø²º ½±²º·¨·±² ±º ¨¸ª °±¥·½ßÙ ½ªÆ¨ø·² °±¥·½·ª ³øß ÆªØ´·Æª ø² ª²º±Æª³ª²¨Ú fl ¨ø¨ª³ª²¨ ±² ¨¸· ½ªÆ¨·º·½ø¨ª º±ª ²±¨ ½±²ºªÆ Æ·¹¸¨ ¨± ¨¸ª ½ªÆ¨·º·½ø¨ª ¸±¥ºªÆ ·² ¥·ª´ ±º ´½¸ ª²º±Æª³ª²¨¯˜Ú Ãÿ×Õ ›¤ŒÃ×⁄×›flä ×Õ ×ÕÕÀ¤‹ flÕ fl ”flÃäŒ —⁄ ד⁄—Œ”flÃ×—“ —“‘« fl“‹ ›—“⁄¤ŒÕ “— Œ×ŸÿÃÕ À–—“ Ãÿ¤ ›¤ŒÃ×⁄×›flä ÿ—‘‹¤ŒÚ Ãÿ×Õ ›¤ŒÃ×⁄×›flä ‹—¤Õ “—à fl⁄⁄׌”flÃ× ¤‘« —Œ “¤ŸflÃ× ¤‘« fl”¤“‹Ù ¤»Ã¤“‹ —Œ fl‘äŒ Ãÿ¤ ›— ¤ŒflŸ¤ fl⁄⁄—Œ‹¤‹ fi« Ãÿ¤ –—‘×›×¤Õ fi¤‘—…Ú Ãÿ×Õ ›¤ŒÃ×⁄×›flä —⁄ דÕÀŒfl“›¤ ‹—¤Õ “—à ›—“ÕÃ×ÃÀä fl ›—“ÃŒfl›Ã fi¤Ã…¤¤“ Ãÿ¤ ×ÕÕÀדŸ דÕÀŒ¤Œ¯Õ˜Ù flÀÃÿ—Œ×Ƥ‹ Œ¤–Œ¤Õ¤“ÃflÃ× ¤ —Œ –Œ—‹À›¤ŒÙ fl“‹ Ãÿ¤ ›¤ŒÃ×⁄×›flä ÿ—‘‹¤ŒÚ —Ãÿ¤ŒÊ
¯–ªÆ ø½½·ºª²¨˜
¯¤ø ø½½·ºª²¨˜
¸
¸
“ Ò fl
ÕÀfiŒ
… ‹
fl‹‹‘
דՋ
Ãÿ×Õ ×Õ Ã— ›¤ŒÃ×⁄« Ãÿflà Ãÿ¤ –—‘×›×¤Õ —⁄ דÕÀŒfl“›¤ ‘×Õä‹ fi¤‘—… ÿfl ¤ fi¤¤“ ×ÕÕÀ¤‹ × Ãÿ¤ דÕÀŒ¤‹ “fl”¤‹ flfi— ¤ ⁄—Œ Ãÿ¤ –—‘×›« –¤Œ×—‹ ד‹×›flä‹Ú “—Ã…×ÃÿÕÃfl“‹×“Ÿ fl“« Œ¤œÀ׌¤”¤“Ã٠䌔 —Œ ›—“‹×Ã×—“ —⁄ fl“« ›—“ÃŒfl›Ã —Œ —Ãÿ¤Œ ‹—›À”¤“à …×Ãÿ Œ¤Õ–¤›Ã × …ÿ×›ÿ Ãÿ×Õ ›¤ŒÃ×⁄×›flä ”fl« fi¤ ×ÕÕÀ¤‹ —Œ ”fl« –¤ŒÃflד٠Ãÿ¤ דÕÀŒfl“›¤ fl⁄⁄—Œ‹¤‹ fi« Ãÿ¤ –—‘×›×¤Õ ‹¤Õ›Œ×fi¤‹ ÿ¤Œ¤×“ ×Õ ÕÀfi÷¤›Ã × fl‘‘ Ãÿ¤ 䌔ÕÙ ¤»›‘ÀÕ×—“Õ fl“‹ ›—“‹×Ã×—“Õ —⁄ ÕÀ›ÿ –—‘כפÕÚ ‘×”×ÃÕ Õÿ—…“ ”fl« ÿfl ¤ fi¤¤“ Œ¤‹À›¤‹ fi« –fl׋ ›‘fl×”ÕÚ ¸
¸
¸
¸
–Œ—–¤ŒÃ« ‹fl”flŸ¤
fi—‹×‘« ד÷ÀŒ« ¯–ªÆ ø½½·ºª²¨˜
fi—‹×‘« ד÷ÀŒ« ¯–ªÆ °ªÆ±²˜
›—”fiד¤‹ ÕדŸ‘¤ ‘×”×Ã
flÀÃ—Õ —“‘«
flÀÃ—Õ —“‘« flÀ×Õ
“—“Û—…“¤‹
—…“¤‹ Õ›ÿ¤‹À‘¤‹
fl“« flÀ×
flÀ×”—fiב¤ ‘×flfiב×ë
« Ò “
…—Œ’¤ŒÕ ›—”–¤“ÕflÃ×—“
fl“‹ ¤”–‘—«¤ŒÕ˘ ‘×flfiב×ë
—⁄⁄×›¤ŒÒ”¤”fi¤Œ ¤»›‘À‹¤‹·
¯”ø²ºø¨±Æß ·² “ÿ˜
‹¤Õ›Œ×–Ã×—“ —⁄ —–¤ŒflÃ×—“Õ æª¥±©
׺ ߪ٠ºª½Æ·æª ´²ºªÆ
fl“« –Œ—–Œ×¤Ã—ŒÒ–flŒÃ“¤ŒÒ¤»¤›ÀÃ× ¤
¸
¸
¸
¤Ú‘Ú ‹×Õ¤flÕ¤ Û –—‘×›« ‘×”×Ã
¤Ú‘Ú ‹×Õ¤flÕ¤ Û ¤fl ¤”–‘—«¤¤
¤Ú‘Ú ¤fl›ÿ fl››×‹¤“Ã
¤Œ
—ÃÿÛ
ÕÃflÃÀä
–¤Œ
¯””Ò‹‹Ò««««˜ ‘×”×ÃÕ –—‘×›« ¤»–¯””Ò‹‹Ò««««˜
–—‘×›« ¤⁄⁄
‘ÃŒ ë–¤ —⁄ דÕÀŒfl“›¤ –—‘×›« “À”fi¤Œ
דՌ
‹¤Õ›Œ×–Ã×—“ —⁄ —–¤ŒflÃ×—“Õ Ò ‘—›flÃ×—“Õ Ò ¤ÿ×›‘¤Õ ¯fl›—Œ‹ ÔðÔÙ flºº·¨·±²ø¥ Œª³øƵ Õ½¸ªº´¥ªÙ ³øß æª ø¨¨ø½¸ªº ·º ³±Æª °ø½ª · ƪش·Æªº˜ ¤»›¤ÕÕ ‘×flfi
À”fiŒ¤‘‘fl ‘×flfi ¤fl›ÿ —››ÀŒŒ¤“›¤ ¸
flŸŸŒ¤Ÿflä ¸
¸
—››ÀŒ
›‘fl×”ÕÛ”fl‹¤
‹¤‹ Œ¤Ã¤“Ã×—“ ¸
–Œ—‹À›ÃÕ Û ›—”–Ò—– flŸŸ ¸
Ÿ¤“¤Œfl‘ flŸŸŒ¤Ÿflä ¸
–¤ŒÕ—“fl‘ ˙ fl‹ ד÷ÀŒ« ¸
”¤‹ ¤»– ¯fl²ß ±²ª °ªÆ±²˜ ¸
¤fl›ÿ —››ÀŒŒ¤“›¤ ¸
‹fl”flŸ¤ × Œ¤“ä‹
–Œ¤”×Õ¤Õ ¯¤ø ±½½´Æƪ²½ª˜ ¸
›—””¤Œ›×fl‘ Ÿ¤“¤Œfl‘ ‘×flfiב×ë
›‘fl×”ÕÛ”fl‹¤ —››ÀŒ
Ÿ¤“˘‘ flŸŸŒ¤Ÿflä ‘×”×à fl––‘×¤Õ –¤ŒÊ
–—‘×›« –Œ—Û
÷¤›Ã ‘—›
›¤ŒÃ×⁄×›flä —⁄ ‘×flfiב×ë דÕÀŒfl“›¤ ‹flä ¯””Ò‹‹Ò««««˜ ›fl“›¤‘‘flÃ×—“
flÀÃÿ—Œ×Ƥ‹ Œ¤–Œ¤Õ¤“ÃflÃ× ¤
fl›—Œ‹ ÓÎ ¯ÓðÔÍÒð̘
w ÔÁËËÛÓðÔÍ fl›—Œ‹ ›—Œ–—ŒflÃ×—“Ú fl¥¥ Æ·¹¸¨ ƪªÆ™ªºÚ
›¤ŒÃ×⁄×›flä ÿ—‘‹¤Œ
øª fl›—Œ‹ ²ø³ª ø²º ¥±¹± øƪ ƪ¹·¨ªÆªº ³øƵ ±º fl›—Œ‹ ÿ׌¤‹
flÀÃ—Õ —“‘«
Willis Towers Watson Northeast, Inc.
c/o 26 Century Blvd
P.O. Box 305191
Nashville, TN 372305191 USA
Eurofins Eaton Analytical, LLC
750 Royal Oaks Drive, Suite 100,
Monrovia, CA 91016
For Bid or Proposal Purposes Only
12/29/2021
1-877-945-7378 1-888-467-2378
[email protected]
Travelers Property Casualty Company of Ame 25674
Phoenix Insurance Company 25623
W23552573
A
2,000,000
HC2J-CAP-162D3822-TIL-22 01/01/2022 01/01/2023
UB-2R857672-22-I2-K
B 1,000,000
No 01/01/2022 01/01/2023 1,000,000
1,000,000
A Excess Auto Liability HJEX-9P529942-TIL-22 01/01/2022 01/01/2023 $3,000,000 excess of SR ID: 22009171 BATCH: 2353997
$2,000,000
Willis Towers Watson Certificate Center